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Abstract  
Echinococcosis is highly endemic in northwestern China. In order to improve 
sero-testing in support of community screening and for hospital use, a dot 
immunogold filtration assay (DIGFA) for rapid serodiagnosis of human CE and AE 
was developed. DIGFA incorporated four antigen preparations: crude E. granulosus 
cyst fluid, crude extract of E. granulosus protoscoleces, E.granulosus native antigen B, 
and a metacestode extract (Em2) from E. multilocularis. The overall sensitivity of 
DIGFA in a hospital diagnostic setting using archived sera was 80.7% for human CE 
(n=857 samples) and 92.9% for human AE (n=42 samples). In endemic communities 
(Qinghe, Hobukersaier, Wenquan, Xinyuan County and Bayanbulak Pasture in 
Xinjiang; Xiji County in Ningxia; Ganzi County in Sichuan; Dangxiong and Dingqing 
County in Tibet AR) in northwest China screened for echinococcosis, the sensitivity of 
DIGFA ranged from 71.8% to 90.7% in comparison to abdominal ultrasound as the 
gold standard; specificity for CE using AgB was 94.6% and for AE using Em2 was 
97.1%. This simple eye-read rapid test was judged useful for both clinical diagnostic 
supports, as well as in conjunction with ultrasound for mass screening in endemic CE 
and AE areas. An immunochromatographic assay (ICA) test for rapid E.granulosus 
antigen detection showed AgB detection in human cyst fluid biopsy samples had a 
sensitivity of 93.6%. Application of ICA for rapid coproantigen detection in dog faeces, 
indicated a test sensitivity and specificity generally lower (66.7%) than for coproELISA 
(72.2%) after 20 days post infection (dpi).  A faecal sample time-course from 
experimental E.granulosus in dogs (n=9) indicated ICA coproantigen detection by 16 
dpi and coproDNA detection by 20dpi. Epidemiological results also showed the overall 
ultrasound prevalence of human echinococcosis was 3.28% (615/18766), with cystic 
echinococcosis (CE) 2.73% (513/18766) and alveolar echinococcosis (AE) 0.54% 
(102/18766) respectively. Meanwhile the DIGFA serological positive rate was 22.4% 
(2388/10684), females had a relative higher seropositive rate (p<0.05). Relative risk 
factors for human CE were dog and livestock ownership, occupation as herdsman, 
ethnic groups as Mongolian and Kazakh. Another risk factor for seropositive might be 
involved with the gender as a female. This research has implications for further 
development of rapid tests in support of human and canine echinococcosis diagnosis 
and for surveillance of transmission in China and elsewhere.  
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Chapter 1. Introduction 
 
1.1 General background of Echinococcus spp. and Echinococcosis 
Echinococcosis, which also called hydatidosis, or hydatid disease, is an ancient 
chronic zoonosis, with a worldwide distribution caused by adult or larval 
(metacestode) stages of tapeworms (cestodes) belonging to the genus 
Echinococcus Rudolphi, 1801, family Taeniidae, order Cyclophyllidea, subclass 
Eucestoda, Class Cestoda, Phylum Platyhelminthes, and Kingdom Animalia. 
(Ding et al, 2000, WHO/OIE, 2001; Oxford Medical Dictionary, 2007) 
 
The Scientific classification: 
Kingdom: Animalia 
Phylum: Platyhelminthes 
Class: Cestoda 
Order: Cyclophyllidea 
Family: Taeniidae 
Genus: Echinococcus 
 
The classic 4 species (WHO/OIE, 2001) of Echinococcus are recognized as 
Echinococcus granulosus (Batsch, 1786), E. multilocularis (Leuckart, 1863; 
Rausch, 1995; 1997), E. oligarthrus (Diesing, 1863), and E. vogeli (Rausch and 
Bernstein, 1972). Other species however have recently been described or 
proposed (see below 1.2). The parasites have life-cycles which utilize carnivores 
as definitive hosts, harbouring the adult egg-producing stage in the intestine; and 
ungulates, rodents or other small mammals as intermediate hosts, developing the 
metacestode stage (also called larval stage) in inner organs (mostly liver and lung) 
after egg infection. The two major species of medical and pubic health importance 
in northwestern China are Echinococcus granulosus and Echinococcus 
multilocularis, which cause cystic echinococcosis (CE) and alveolar 
echinococcosis (AE) respectively (Craig et al., 1995, 2000, 2003, 2006, 2007; 
Wen et al., 1997, 2000; Zhou et al., 2000, Ito, 2003). Both are serious and severe 
life-threatening diseases, the latter especially with high fatality rates and poor 
prognosis if careful clinical treatment is not available in early stages. Human CE 
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often occurs as a fluid-filled cyst (bladder-like, single or multiple), with or without 
daughter cysts. It was occurred in most internal organs of humans but especially 
the liver (around 70%), lung (around 20%), peritoneal cavity, spleen, kidney, brain, 
bone, pelvic, heart, and also muscle or subcutis (Ding & Wen, 2000, WHO/OIE, 
2001). Meanwhile human AE mainly occurs as a tumor-like lesion mostly in the 
liver (>99%) (Ammann et al, 1996, Sato, et al 1993, WHO/OIE, 2001, Craig 2000, 
2001, 2003; McManus 2003), with possible lung and/or brain secondary lesions in 
late stages. Mixed human CE and AE cases are rare but have been described 
(Wen et al.1992, Yang, et al 2006). Mortality for human CE varied between 0.5% 
and 4.5%, and for human AE between 10-15% (WHO Guidelines, 1996; Ito, 2003; 
Vuitton, 2003; McManus, 2003). 
Early diagnosis becomes difficult because human CE or AE cases usually have no 
signs or symptoms during the first few years. The clinical diagnosis of CE or AE 
mainly relies on imaging techniques such as ultrasound (US), X-ray, computerized 
tomography (CT) or magnetic resonance imaging (MRI). Surgery is currently the 
main initial choice for the treatment of most CE and AE cases. Medical treatment 
using Mebendazole and albendazole chemotherapy may not always kill the 
cyst/lesion but can control the growth of the parasites, and could be applied pre- 
or post surgery or alone if the patient was not operable or refused surgical 
treatment (Vuitton, 2001, Kern, 2006). Different formulations of albendazole (ABZ) 
such as tablet (cheapest), liposomal-ABZ or emulsion-ABZ have now been widely 
used in severe endemic area of China (Wen et al., 1994; Chai et al., 2004, Li et al, 
2006). Serological tests can give useful confirmative information to support a 
clinical diagnosis, and may also indicate exposure at community levels (Rogan 
and Craig, 1997, 2002). Prevention and control of echinococcosis is quite difficult 
in many endemic areas due to complex factors including ethnic belief, religion, 
education level, sanitary habits, husbandries, transmission ecology etc. However, 
control programmes against CE in 5 ‘island-based’ countries/areas (Iceland, New 
Zealand, Tasmania, Falkland Islands and Cyprus) have been successful in the 
eventual elimination of CE as a public health problem, and in some cases even to 
elimination of transmission of the parasite in dogs and sheep (Craig and Larrieu, 
2006).  
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1.2 Genus and species of Echinococcus 
Members of the genus Echinococcus are small intestinal tapeworms with an adult 
length of 1.2–7 mm, and a maximum of 7 segments (proglottides). The 
metacestode of Echinococcus spp. develops and settles in the internal organs 
(mostly the liver and lungs) of a wide range of mammalian intermediate hosts and 
is a fluid-filled cystic or vesicular structure composed of two main parasite layers 
with an outer host layer of fibrous capsule. The outer layer of the parasite is the 
laminated membrane, a carbohydrate-rich, acellular structure that is unique to the 
genus Echinococcus. It supports and also encloses the germinal membrane, 
which also produces protoscoleces asexually and these are the infective stage for 
the carnivore definitive host. The asexual production of protoscoleces by 
Echinococcus spp. is the reason for high adult worm burdens in carnivore 
definitive hosts. 
The genus Echinococcus includes up to 8 species of tapeworms in the family 
Taeniidae. Infection with Echinococcus results in hydatid disease, also known as 
hydatidosis and echinococcosis. 
Recommended Species (2008):  
Echinococcus granulosus 
Echinococcus multilocularis 
Echinococcus oligarthrus 
Echinococcus vogeli 
Echinococcus shiquicus 
Echinococcus ortleppi 
Echinococcus equinus 
Echinococcus canadensis 
Currently of these, the first five recognized species of cestode are undisputed 
within the genus Echinococcus, which includes E. Shiquicus described in China in 
2006 (Xiao, et al., 2005; Xiao et al., 2006). Some authorities however, consider 
that E. granulosus is not a single species but rather comprises at least 4 species 
i.e. E. granulosus sensu strictu, E. ortleppi, E. equinus and E. canadensis 
(McManus, 2002; Nakao et al., 2006). In addition, a ninth species E. felidis has 
very recently been proposed for the parasite that uses lions as a definitive host in 
sub-Saharan Africa (Huttner et al, 2008)  
 4
The species E. granulosus has, until recently, been divided into 10 genotypes 
(G1-G10). The G1 sheep strain of E. granulosus is the most widespread and 
important zoonotic genotype, although cattle, cervid, pig and camel genotypes 
also show zoonotic potential. The G4 horse strain is recommended to become E. 
equinus, the G5 E. ortleppi and G6–G10 (E. Canadensis) (Nakao et al, 2006). 
Human infection with the metacestode (hydatid cyst) of E. granulosus is 
geographically widely distributed, from the sub-arctic to the tropics, with an 
estimated 2 million cases mostly associated with regions of sheep herding (Craig, 
Rogan & Allan, 1996). The other three major Echinococcus species (E. 
multilocularis, E. vogeli and E. oligarthrus) are also potential zoonoses. E. 
multilocularis is a species distributed only in the Nearctic and Palearctic regions, 
but also cause more human infections (probably >100 000 cases) than either E. 
vogeli (approximately 120 cases described) or E. oligarthrus (<5 cases described). 
The latter two species are limited to neotropical forest and wet savannah due to 
their forest transmission cycles, and only a few epidemiological studies has been 
reported. Within the species E. multilocularis, intraspecific variation appears low in 
comparison to E. granulosus, and based on current assessments nucleic acid 
analysis can only broadly differentiate E. multilocularis regional isolates from 
Alaska, Eurasia, Japan and US/Canada (Rinder et al. 1997; Nakao et al. 2006). 
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1.3 The lifecycle of Echinococcus spp. 
1.3.1 Echinococcus granulosus 
E. granulosus is a small tapeworm (approximately 2 to 7 mm in length) with 
typically three segments and other morphological characteristics (e.g. length of 
hooks or strobila, position of genital pore, testes number, form of uterus, onset of 
egg production, etc.) which allow a species diagnosis (WHO/OIE, 2001; Ding and 
Wen 2000, Shan 2001) (Fig. 1.3). Eggs of E. granulosus are difficult to 
differentiate through morphologic descriptions from those of other tapeworms in 
the genus Taenia. Egg hatches in the stomach after ingested by their intermediate 
host and release oncospheres in the small intestine. Oncospheres are activated 
and penetrate the mucosa of the small intestine and enter into the circulatory 
system and reach its final location and develops into the metacestode stage. A 
unilocular hydatid cyst develops and several thousands protoscoleces (called 
‘hydatid sand’) may be produced by asexually budding from inner germinal 
membrane, within a single cyst or within daughter cysts. The protoscoleces 
evaginates in the upper duodenum after being ingested by a suitable definitive 
host and develops into the sexually mature adult tapeworm in approximately 45 
days (Ding and Wen, 2000; WHO/OIE, 2001) . 
In the natural cycle, dogs and other canids are typical definitive hosts and 
domestic ungulates (sheep, goats, pigs, horses, etc.) intermediate hosts (Fig. 1.1). 
The cycle mainly occurs as a dog-sheep, so called domestic cycle. A sylvatic cycle 
also occurs with wolves as definitive host and cervids as intermediate host. In 
Australia wild dogs (dingo) are also a good definitive host and a sylvatic cycle 
occurs by predation of dingoes on macropod species (kangaroos and wallabies) 
(Jenkins 1995; Craig 2000; Torgerson 2003). Both domestic and sylvatic cycles 
could overlap as has been shown in Australia (Jenkins et al., 2006, WHO/OIE, 
2001). The metacestode stage develops in the intermediate host and can be 
develop in a broad range of mammals, including ungulates, marsupials, 
lagomorphs, rodents, non-human primates, and humans. These and other hosts 
may play a role in the transmission cycle (intermediate hosts) or are dead ends of 
the development (aberrant hosts). Hydatid cysts of E. granulosus occur in internal 
organs (mainly in liver and lung) of humans and other intermediate hosts (Fig. 1.2).  
The disease is called cystic echinococcosis (CE). 
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Fig. 1.1: Life cycle of E. granulosus (common sheep strain).   
(Image adapted from original available at the United States Centres for Disease Control 
Parasitology Identification Laboratory).  
(http://www.dpd.cdc.gov/dpdx/HTML/ImageLibrary/Echinococcosis_il.htm) 
The adult Echinococcus granulosus (3 to 6 mm long) resides in the small bowel of the 
definitive hosts, dogs or other canids.  Gravid proglottids release eggs that are 
passed in the feces.  After ingestion by a suitable intermediate host (under natural 
conditions: sheep, goat, swine, cattle, horses, camel), the egg hatches in the small 
bowel and releases an oncosphere that penetrates the intestinal wall and migrates 
through the circulatory system into various organs, especially the liver and lungs.  In 
these organs, the oncosphere develops into a cyst  that enlarges gradually, 
producing protoscolices and daughter cysts that fill the cyst interior.  The definitive 
host becomes infected by ingesting the cyst-containing organs of the infected 
intermediate host.  After ingestion, the protoscolices evaginate, attach to the 
intestinal mucosa , and develop into adult stages in 32 to 80 days. Humans 
become infected by ingesting eggs , with resulting release of oncospheres in the 
intestine and the development of cysts , , ,  , ,   in various organs. 
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Fig. 1.2: CE cysts and E. Granulosus protoscoleces 
(Above left, CE cysts in a sheep’s liver, Bayinbuluk, Xinjiang, China, 2004; above 
right, E. granulosus protoscoleces from protoscoleces culture in XMUH, made by Dr. 
Chunfang Zhao; bottom, CE cysts taken during a human operation, XMUH, April 28th, 
2001). 
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Fig. 1.3: Echinococcus granulosus adult worms  
(The left diagram is from a book named Human Parasitology, Chinese, Shan XM Eds, 
2001, and the right one was a photography of E. granulosus infected intestine of a dog, 
Xinjiang, China, Ding and Wen 2000). 
 
1.3.2 Echinococcus multilocularis 
The adult stage of E. multilocularis is characterized by its small size (length of up 
to 4.5 mm), a mean number of five segments, a sack-like uterus, and other 
morphological features, allowing its differentiation from E. granulosus and other 
Echinococcus species (WHO/OIE, 2001; Ding and Wen, 2000). The metacestode 
stage of E. multilocularis develops in the intermediate host (99% in liver) by 
forming aggregates of grape-like lesions composed of many smaller cysts or 
vehicles (alveolar hydatid) with a jelly-like matrix that enlarges by external budding 
off of germinal cells or microvesicles. Alveolar hydatid cysts have no host fibrous 
outer capsule, and they invade and may eventually destroy normal tissue in a host 
organ. Its development resembles a ‘slower’ style of malignant tumor, so called 
“colloid carcinoma”, ”tumor-like” disease or “parasite tumor” and “alveolar liver” in 
some endemic areas of China (Ding and Wen, 2000; Wen et al. 2001).  
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Transmission of E. multilocularis occurs in a sylvatic cycle, which is sometimes 
linked via infected small mammals to domestic dogs (and possibly cats) (Fig. 1.4). 
In the typical sylvatic cycle, foxes (mainly the Arctic fox [Alopex lagopus], and the 
red fox [Vulpes vulpes]) play a key role as definitive hosts and small mammals, 
mainly microtine rodents, act as intermediate hosts. In some areas, other wild 
canids, such as coyotes (Canis latrans), Tibetan fox (V. ferrilata), raccoon dogs 
(Nyctereutes procyonoides), and wolves (Canis lupus) can also serve as definitive 
hosts (WHO/OIE, 2001; Ding and Wen, 2000). Among potential intermediate hosts 
species of small mammals (more than 40) that are susceptible to E. multilocularis 
under natural conditions, members of the family Arvicolidae (voles and lemmings) 
and Cricetidae (hamsters, gerbils, and related rodents) are most important as 
intermediate hosts. Aberrant host animals (including domestic dogs, domestic and 
wild pigs, horses, monkeys, and large rodents (e.g. Myocastor coypus) (Eckert, 
1996; Ohbayashi, 1996; Losson and Coignoul, 1997; Deplazes, 2001) and 
humans can also become infected with the metacestode stage, which has the 
potential to cause alveolar echinococcosis (AE), one of the most lethal helminthic 
infection in humans (Fig. 1.5). Although some variation between E. multilocularis 
isolates from North America and Eurasia has been described, there is little 
evidence so far major for sub-specific genetic differences (Haag et al., 1997, 
Eckert, 2004, Nakao et al., 2006). This is in accordance with the fact that E. 
multilocularis in various regions, including large areas of the northern hemisphere 
(Asia, Europe, and North America), appears to be equally infective to humans 
(Eckert, 1999, 2004; Vuitton 2003; Kimura, 1999; Schantz, 1995, 1996). 
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Fig. 1.4: Life cycle of E. multilocularis.  
Image modified from http://www.dpd.cdc.gov /dpdx /HTML /ImageLibrary 
/Echinococcosis_il.htm).  
(1) E. multilocularis is a small tapeworm (1, 2-4, 5 mm in length) that parasites carnivores 
(fox, dog and wolf) which as definitive hosts. (2) The adult tapeworm, consisting of 2 to 6 
proglottids, lives attached to the luminal surface of the small intestine in the definitive 
hosts. The terminal proglottid contains mature eggs. (3) The embryonated eggs, the 
infectious stage, are long-lived and highly resistant to high and low temperature (more 
than 50ºC and down to -40ºC). The mature eggs are shed with faeces and are spread in 
the environment. It is assumed that the intermediate host acquires the infections through 
the ingestion of contaminated environment. (4) When the intermediate hosts 
(predominantly rodents or other small mammals, or, accidentally, humans) ingest eggs, 
the onchosphere hatches from the egg in the duodenum.  (5) The activated oncosphere 
penetrates the small intestine, enters blood vessels and reaches primarily the liver via the 
portal vein. In the liver the oncosphere proliferates into the metacestode surrounded by 
an inner germinal membrane and an outer laminated layer.  (6) The lifecycle is 
completed when an intermediate host, carrier of viable protoscoleces within the cysts, is 
devoured by a definite host. (7) Humans become infected by ingesting eggs , with 
resulting release of oncospheres in the intestine and the development of lesions   in 
mainly liver (99%), lung and brain. 
 
Fox, wolf, dog, etc.)
Small mammals, rodents, etc
Alveolar lesion 
metacestode 
⑦
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Fig. 1.5: Alveolar echinococcosis (AE) in intermediate host 
(Left, experimentally infected gerbil with E. multilocularis from the Animal Center of 
XMUH); right, an AE lesion from human liver (above) after surgery in the XMUH. 
 
1.4. Global distribution of Echinococcus species and echinococcosis 
1.4.1 Echinococcus granulosus  
E. granulosus is geographically by distributed worldwide and involves almost all 
continents. Highest prevalence occurs in parts of Eurasia (especially in China, 
Kazakhstan, Russian Federation and adjacent Independent States), 
Mediterranean countries, North and East Africa, Australia, and South America 
(WHO/OIE, 2001). In the UK, the parasite has a restricted distribution, being found 
mainly in mid and southern Wales (Williams, 1976; Staullbaumer et al., 1986; 
Jones and Walters, 1992; Richards et al., 1995). In Europe, zoonotic strains of E. 
granulosus are present in every country with the possible exceptions of Ireland, 
Iceland and Denmark. It is most intensely endemic in the Mediterranean areas 
and parts of Eastern Europe such as Bulgaria and Romania (WHO/OIE, 2001). In 
Asia the parasite is highly endemic in large parts of north and west China and is 
an important re-emerging zoonosis in the former Soviet Republics in Central Asia 
(Wang 2000; WHO/OIE, 2001; Craig 2003, Torgerson, 2003). The parasite is also 
found throughout the Indian Subcontinent and the Middle East. In Africa, E. 
granulosus is widespread and is a particular problem in northern African countries 
such as Tunisia, Morocco, Libya and Algeria. South of the Sahara the parasite is 
of specific concern in certain locations such as Turkana District in Kenya. In North 
America E. granulosus is found in Canada and Alaska, but seems to assume 
mainly a sylvatic cycle involving wolves and cervids. In the continental USA, the 
parasite is endemic in a few foci such as traditional pastoral Native-American 
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communities in Utah and California. In South America the parasite is widely 
distributed, particularly in Argentina, Chile, Uruguay, southern Brazil and the 
Peruvian Andes (Schantz, 2006). In Australia the parasite is common in domestic 
sheep-dog and sylvatic dingo-macropod cycles, the latter with over 25% of 
dingoes and up to 65% of macropod marsupials infected (Jenkins and Morris, 
1995; Jenkins, 2002). In some more developed countries, due to the application of 
successful control programmes, CE has become less prevalent. In Iceland, New 
Zealand, Tasmania and southern Cyprus the parasite has been effectively 
eradicated (Economides and Christofi, 2002; Craig and Larrieu, 2006). In many 
poorer parts of world, however particularly where sheep husbandry is an important 
agricultural industry, CE remains widespread (Craig et al, 2007).  
 
1.4.2 Echinococcus multilocularis 
Echinococcus multilocularis, commonly known as the fox tapeworm, can be found 
in areas of central and northern Europe, northern Asia, and parts of North America. 
It has also been proposed that E. multilocularis may occur in parts of northern 
Africa, but currently there is not enough information to substantiate this claim 
(Schantz et al., 1995). The life cycle of E. multilocularis is primarily sylvatic. The 
red fox (Vulpes vulpes) is the most well known host but the arctic fox (Alopex 
lagopus), the coyote (Canis latrans), the wolf (Canis lupus), the raccoon-dog 
(Nyctereutes procyanoides), the sand fox (Vulpes corsac), and the Tibetan fox 
(Vulpes ferrilata) are all known definitive hosts, depending on geographic location. 
Other canids (including domestic dogs), and occasionally felids, can also be 
definitive hosts if they be come infected through the ingestion of an intermediate 
host harboring an infective metacestode. The principal intermediate hosts include 
rodents of the family Arvicolidae, with a number of reports of infection in the 
Sciuridae, Cricetidae, Dipodidae and Muridae; some of which maybe important 
locally. Lagomorphs of the family Ochotonidae are frequently infected in parts of 
China. There have been occasional reports of infections in insectivores such as 
the Soricidae and Talpidae situation in China (Torgerson and Budke, 2003). 
 
1.4.3 Echinococcus and echinococcosis in the People’s Republic of China 
1.4.3.1 Echinococcus granulosus and cystic echinococcosis (CE) 
Echinococcus granulosus is endemic in northwest of the People’s Republic of 
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China. Patients with cystic echinococcosis (CE) have been recorded in 21 of 
People Republic of China’s 31 provinces, municipalities and autonomous regions 
(covered approximately 87% of Chinese territories) and it is a major public health 
problem in several north-western provinces and autonomous regions (Fig. 1.6 to 
Fig. 1.8). The prevalence of Echinococcus granulosus was showed decrease from 
west to east and Echinococcus multilocularis appeared overlap in some area 
(Wen 1997, WHO/OIE 2001) (Fig. 1.6, Fig. 1.9). 
 
Fig. 1.6: Initial national survey of human echinococcosis cases (10,790) in P. 
R. China from 2004-2008 (Ministry of Health, China. 2005 and 2009) 
Human echinococcosis cases were indicated in each province/autonomous region 
involved in this study, and the proportion (%) of all these HD cases (10790) were 
shown in high endemic areas as well. 
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Average indirect economic burden for 2018 cases CE patients from 5 official
appoined  hospitals in Xinjiang, P.R.China
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Fig. 1.7: Average indirect economic burden for 2018 cases CE in-hospital 
patients from 5 officials appointed hospitals in Xinjiang, P. R. China (Wang et 
al., 2010) (10000RMB would be approximately 800 to 1000 sterling pounds) 
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Fig. 1.8: Average DALY for 2018 cases CE in-hospital patients from 5 officials 
appointed hospitals in Xinjiang, P. R. China (Wang et al., 2010) 
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Fig. 1.9: Endemic areas of human cystic echinococcosis (marked with    ) 
and alveolar echinococcosis (sporadic dots “º”) in China (Ding and Wen, 
2000) 
 
Main lifecycle of Echinococcus granulosus in China is mainly domestic dog and 
herbivores (i.e. Sheep, goat, cattle, yak, horse, camel, pig and farmed red deer 
(Cervus elaphus)) (Schantz et al., 1995; WHO/OIE 2001). Main strain of 
Echinococcus granulosus is the common sheep strain (G1) and reports showed 
the camel strain (G6) found in Xinjiang (Zhang 1998).  
Human cystic echinococcosis (CE) was firstly reported in China in 1905 and since 
then at least 26,065 cases have been reported in China during four decades 
between 1951-1990 (Yu et al., 1994; Chai, 1995), with the greatest surgical 
incidence recorded in Xinjiang, followed by Ningxia, Qinghai, Sichuan, Gansu, 
Tibet, Inner Mongolia, Yunnan and other provinces. Prevalence baseline 
investigation organized by Chinese Ministry of Public Health showed 1.08% 
human CE diagnosed by abdominal ultrasound in 12 provinces or autonomous 
regions, mean financial burden 2700 RMB (approximately GBP 270) per case and 
estimated 380,000 human CE cases totally in 2005. 
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Xinjiang Uygur Autonomous Region (XUAR). XUAR is in the northwest China 
with 16 million populations. More than half (58.4%) of hospital CE cases in China 
were recorded in XUAR (Jiang 1991). Human CE cases were recorded all over 
the region, which consisted of all of 12 prefectures including 5 minority ethnic 
autonomous prefectures. Main CE endemic area is in north Xinjiang where from 
Tianshan Mountain to Altai Mountain including Bayinguoleng Mongolian 
Autonomous Prefecture, Yili Kazak Autonomous Prefecture, Tacheng Prefecture, 
Altai Prefecture, Changji Prefecture and Hami Prefecture (Fig. 1.10, Fig. 1.11). 
Hospital records indicated 16,663 cases of CE were surgical treated in Xinjiang 
during 1951 to 1991 (National Hydatid Disease Center of China, 1993) (Fig. 1.10). 
Human CE were more endemic in Tianshan Mountain (2.23% 47/2103) and Altai 
Mountain (2.28% 41/1420) than in Kunlun Mountain (0.6% 6/1000) from a study in 
4 counties community screening (Wei 1994). 4407 CE cases were recorded in 
Xinjiang Medical University Hospital from 1957 to 1997 and annual cases curve 
showed to be increasing during last decade (Qiu et al., 1999). 1126 hospital CE 
cases were registered in north 4 counties in Tacheng Prefecture (Qi et al., 1995). 
1965 hospital CE cases were reported in Yili Valley which consists of 8 counties 
and 1 city from 1993 to 2003 (Gao et al., 2005). Communities screening data 
showed 2.22% (45/2044) CE prevalence in Wulasitai Commune of Nileke County, 
Yili Valley (Dingmulati et al., 2005); 4.5% (34/755) and 1.91% (17/889) in Habahe 
County (Song et al., 1999; Zhao et al., 2003), 5.78% (31/536) in Qinghe County 
(Zhao et al., 2003), Altai Prefecture; 2.4% (49/1844) in Hobuksar County, Tacheng 
Prefecture (Wang et al., 2001) (Table 1.2).  
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Table 1.2: Human cystic echinococcosis (CE) cased reviewed in Xinjiang AR 
 
Locations Duration Hospital 
records
Community 
Prevalence 
Refs. 
Xinjiang 1951- 1991 16663  NHDC a of China, 
(1993) 
Tianshan 
Mountain  
Altai Mountain 
Kunlun Mountain 
1994  2.23%, 47/2103;
2.28%, 41/1420 
0.6%, 6/1000 
Wei, 1994 
XMUH b 1957-1997 4407  Qiu et al., 1999 
Yili Valley 1993-2003 1126  Gao et al., 2005 
Yili /Nileke 2004  2.22%, 45/2044 Dingmulati, 2005
Altai / Habahe 1998/2002  4.5%, 34/755 
1.91%, 17/889 
Song et al., 1999; 
Zhao et al., 2003
Altai / Qinghe 2002  5.78%, 31/536 Zhao et al., 2003
Tacheng / 
Hobuksar 
1995- 1996  2.4%, 49/1844 Wang et al., 2001
a NHFC: National Hydatid Disease Center 
b XMUH: Xinjiang Medical University Hospital 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.10: Echinococcus granulosus is high endemic in Xinjiang Uygur 
Autonomous Region. CE cases could be found in all 12 prefectures with higher 
prevalence in north than in south of Xinjiang. Average annual incidence in 1990 was 8.7 
cases per 100,000 populations in Xinjiang, which the lowest was 0.07 in Hotan prefecture 
and highest 28.4 in Tacheng prefecture (data from Menghebate et al., 1993; WHO/OIE, 
2001). 
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Fig. 1.11: Human or animal infections with Echinococcus granulosus and 
Echinococcus multilocularis recorded in Xinjiang in 1980s (Ding, 1986-1989) 
 
Ningxia Hui Autonomous Region. 2134 human CE cases were recorded in all of 
Ningxia’s five prefecture-level cities: Guyuan, Shizuishan, Wuzhong, Yinchuan 
(capital city), and Zhongwei with higher endemic and overlap with human AE in 
three counties (Xiji, Guyuan, Haiyuan) of Guyuan Prefecture (Yang et al., 2005, 
2006). A community study in Xiji, Guyuan and Longde in Guyuan Prefecture 
showed 0-7.4% (mean 1.6%) human CE prevalence and 2% in Xiji County (Yang 
et al.,2006) (Fig. 1.12). 
Surgical CE ● and AE ● 
■ human serological record (ID, IHA, ELISA) 
▲Echinococcus granulosus in dogs 
● Echinococcus multilocularis in foxes 
♠ Echinococcus multilocularis in wolves 
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Fig. 1.12: Geographic distribution of confirmed AE and CE cases (numbers in 
parenthesis) from hospital records (1985–2001) in Ningxia Hui Autonomous 
Region, China. The shaded areas show the locations of hospitals involved in the 
survey (Yang et al., 2006). 
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Gansu Province. 3233 human hospital CE cases were recorded in 13 prefectures 
and 52 counties (60%) exclude Jiayuguan City in Gansu Province from 1951 to 
1990, and 1160 CE cases from 1991 to 1995. Main endemic areas included 
Jingyuan County (Baiyin prefecture), Huan County (Qingyang Prefecture), Gulang 
County and Tianzhu Tibetan Autonomous County (Wuwei Prefecture), Jiuquan 
City (Jiuquan Prefecture), Zhang County (Dingxi Prefecture) and Yongdeng 
(Lanzhou Prefecture) (Wang et al., 1995; Wang and Zhang, 2000) (Fig. 1.13).  
 
Fig. 1.13: Higher endemic prefectures (yellow areas) for Echinococcus 
granulosus in Gansu Province (data from Wang et al., 1995; Wang and 
Zhang, 2000). 
 
Qinghai Province. Qinghai is administratively divided into one prefecture-level 
city Xining, one prefecture Haidong, and six autonomous prefectures: Golog, 
Haibei, Hainan, Huangnan, Yushu Tibetan Autonomous Prefecture and Haixi 
Mongolian and Tibetan Autonomous Prefecture. The higher endemic areas for CE 
in Qinghai were Gangcha County (4.0%) in Haibei AP, Gonghe County (1.8%) in 
Haihan AP (Wu et al., 2006), Tongren County (1.6%) and Zeku County (7.5%) in 
Huangnan AR (Liu et al., 2006; Han et al., 2006), Gande County (5.77%), Jiuzhi 
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County (5.4%) and Banma County (6.1%) in Guoluo AP (Han et al., 2006; Wu et 
al., 2006), Chengduo County (5% to 9.7%) in Yushu AP (He et al., 2006; Han et al., 
2006) (Fig. 1.14). 
 
Fig. 1.14: Human CE endemic areas according community screening data 
(prevalence) in Qinghai Province (data from Wang et al., 2006, Ma et al., 2006; 
Wu et al.,2006) 
 
Sichuan Province. Ganzi Tibetan Autonomous Prefecture and Aba Tibetan and 
Qiang Autonomous Prefecture in west Sichuan are the main endemic area for 
both CE and AE. Higher endemic area were showed 4.8% (60/1291 in 1998) to 
6.8% (216/3199 in 2005) in Shiqu County, 2.04% in Baiyu and Seda County, 
0.91% (25/2748 in 1998) in Ganzi County, all in Ganzi Tibetan Autonomous 
Prefecture (Qiu et al., 2000; Yu et al., 2005; Li et al., 2005). Hospital diagnosed 
610 cases of human echinococcosis were recorded in a hospital in Aba Prefecture 
from 1992 to 2000, which among them 562 cases got surgical treatment including 
AE 92, CE 347, abscess 93 and calcificated lesion 30 cases (Renzhen et al., 
2006). Another report said 35 CE in one year (Oct 2004 – Aug 2005) in Aba 
Prefecture Hospital (Liu 2006). 
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Tibet Autonomous Region. Human CE cases were recorded in all of its 7 
prefectures and hospital cases showed much higher in Naqu, Lhasa, Shannan 
and Chamdo (Gong et al., 2001) (Fig. 1.15). An early hospital data showed 94 
echinococcosis (not sure CE or AE) in Chamdo Prefecture in 1993 (Luo and Zhao, 
1993). And 80 cases of human echinococcosis were reported in a hospital in 
Shannan ((Zhao et al., 2002). A community study in Naidong County of Shannan 
Prefecture showed 2.4% (81/3379) prevalence of human CE (Zhou and Xi, 2004). 
A study using Casoni test as first trial confirmed 48 CE cases by ultrasound in total 
20160 populations in Mozugongka and Dangxiong County in Lhasa Prefecture 
(Hu et al., 1999). 
Fig. 1.15: Tibetan Autonomous Region in People’s Republic of China. 
 
Inner Mongolia Autonomous Region. 675 CE cases were recorded in main 
hospitals of Huhehaote (capital) from 1986-1996 (Li et al., 1996). Bayinxile Qi in 
Xilingele Alliance was regarded with higher prevalence (1.08%) (Zhang et al., 
1996) 
 
1.4.3.2 Echinococcus multilocularis and Alveolar echinococcosis (AE) 
The first five alveolar echinococcosis (AE) cases in China were reported in 
Xinjiang in 1965 (Yao, 1965, Wen 1997). Following reports showed human AE 
cases in Qinghai, Ningxia Hui Autonomous Region, Gansu, Aba and Ganzi 
Tibetan Autonomous Prefecture of Sichuan, and a few cases reported in Inner 
Mongolian Autonomous Region, Tibet Autonomous Region and Heilongjiang 
Province (Table 1.3) (Craig, 1992, 2004; Schantz et al., 1995; WHO/OIE, 2001; 
Vuitton et al., 2003; Ito et al., 2003).  Echinococcus multilocularis infections were 
found in fox, Tibetan fox, wolf and even domestic dogs. Microtus ilaeus and 
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Arvicola terrestris Linnaeus in Xinjiang, pika (Tibetan plateau) were involved as an 
intermediate host role in Echinococcus multilocularis lifecycle. 
Xinjiang Uygur Autonomous Region. Higher prevalence (3.9/100,000) were 
observed in Altai Mountain (Zhou et al., 2000) and also 84 hospital AE cases were 
recorded between 1993-2003 in Ili valley in Tianshan Mountain of Xinjiang Uygur 
Autonomous Region (Gao et al., 2005). 0.636% (13/2044) human AE were 
observed in a community survey in Nileke County of Ili valley (Dingmulati et al., 
2005). 79 cases of human AE in 4486 hydatid disease records during 1957 and 
1997 were treated in Xinjiang Medical University Hospital (Qiu et al., 1999). 
Ningxia Hui Autonomous Region. Human AE cases were found in three 
counties (60 in Xiji, 3 in Haiyuan and 19 in Guyuan) in Guyuan Prefecture through 
Liupan Mountain area from 1985 to 2001 (Lin and Hong 1991;, Wang et al. 1991, 
Yang et al., 2006). A community study in 1980s showed 5.9% (141/2389) AE 
prevalence in Xiji County (Wang et al., 1991). Recent screening in Ningxia in 
2001-2003 found 2.4% (88/3629) AE prevalence in Xiji, 0.5% (5/983) in Guyuan 
and no cases in Longde, all 3 counties are in Guyuan Prefecture (Yang et al., 
2006). 
Qinghai Province. 90 human AE cases from hospital records were reported from 
1960-1991 (Xin, 1994) (another speaking are 111 from 1959-1998 by Wang et al., 
2006; 143 from 1980-1992, Vuitton 2003). Several community studies had been 
reported Echinococcus multilocularis was endemic mainly in southeast Qinghai 
which showed 0.8% (10/1253) in Chengduo County, 2% (8/394) in Yushu County 
of Yushu Tibetan Autonomous Prefecture; 2.52% (39/1549) in Jiuzhi County, 
0.71%(10/1403) in Gande County, 6.11% (65/1277) in Banma County in Guoluo 
Tibetan Autonomous Prefecture, 0.29% (3/1046) in Zeku County of Huangnan 
Tibetan Autonomous Prefectures (Wang et al., 2006).  
Gansu Province. Human AE endemic area in south Gansu were focus on Zhang 
and Min County in Dingxi Prefecture from 1980s (Jiang 1981; Craig 1992, 2000; 
Vuitton 2003). Community study in 1994-1997 showed 3% (84/2482) incidence 
and overall prevalence of 4.1% (135/3331) in Zhang and Min County. Village 
(n=31) human AE prevalence rates varied from 0-15.8% which the latter was the 
highest report in an individual village (Craig et al., 2000). 
Sichuan Province. Human cases of AE were found mainly in Shiqu, Ganzi, Seda, 
Baiyu Kangking County in Ganzi Tibetan Autonomous Prefecture and Nuoergai 
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County in Aba Tibetan and Qiang Autonomous Prefecture (Lin and Hong 1991; 
Qiu et al., 1999; Yu et al., 2005; Li et al., 2005). Community study showed highest 
prevalence of human AE was 2.96% (37/1291 in 1998) and 6.2% (198/3199 in 
2005) in Shiqu County, followed by 1.79% in Baiyu and Seda County, 1.42% 
(39/2748) in Ganzi County (Qiu et al., 1999; Yu et al., 2005; Li et al., 2005). 
Tibet AR. First two human AE were reported from Chamdo (Peng, 1988). 12 
hospital AE samples were reported in 1993 in main hospitals in Lhasa city of Tibet 
Autonomous Region (Luo et al., 1993). Cases from Naqu, Lhasa and Chamdo 
and no more details were published. Two brain AE cases (one was secondary AE) 
were recorded respectively (Pu 1999; Yixijiacuo et al., 2001). Three human AE 
cases were reported in Linzhi Prefecture (Duan et al., 2006). So totally 19 human 
AE cases were reported in Tibet AR. Recently 11 human AE cases were found in a 
pilot study (n=242) in Dengqing County of Chamdo Prefecture. 
Inner Mongolian AR and Heilongjiang. Echinococcus multilocularis infection in 
rodents has been reported in Inner Mongolian Autonomous Region (Tang et 
al.,2001, 2002, 2006) but just 1 hospital AE case were reported (Li, 1996) without 
details. 4 human AE cases in Heilongjiang Province were recorded in 1980s and 
no new report after that (Yu et al.,1994). 
Mixed CE and AE individuals were reported in Xinjiang, Ningxia and Sichuan 
(Wen and Yang1997; Yang et al., 2005; Yu et al., 2005). 
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Table 1.3: Human alveolar echinococcosis (AE) cased reviewed in Western 
China 
 
Locations Duration Hospital  
records 
Community 
Prevalence 
Refs. 
Xinjiang /    Altai 2000 3.9/100,00  Zhou et al., 2000 
/       Yili 1993-2003 84  Gao et al., 2005 
      /  Yili/Nileke 2004  0.6%, 13/2044 Dingmulati, 2005 
      /     XMUH 1957-1997 79  Qiu et al., 1999 
Ningxia  /    Xiji 1985-2001 60  
      /   Haiyuan 1985-2001 3  
      /   Guyuan 1985-2001 19  
Lin and Hong, 
1991, Wang et al., 
1991, Yang et al., 
2006 
      /   Xiji 1980s  5.9%, 141/2389 Wang et al., 1991 
/   Xiji 2001-2003  2.4%, 88/3629 Yang et al., 2006 
      /   Guyuan 2001-2003  0.5%, 5/983 Yang et al., 2006 
Qinghai  1960-1991 90  Xin, 1994 
 1959-1998 111  Wang et al., 2006 
 1980-1992 143  Vuitton, 2003 
Yushu/Chengduo 2006  0.8%, 10/1253 Wang et al., 2006 
     /   Yushu 2006  2%, 8/394 Wang et al., 2006 
Guoluo/  Jiuzhi 2006  2.52%, 39/1549 Wang et al., 2006 
      /   Gande 2006  0.71%, 10/1403 Wang et al., 2006 
/   Banma 2006  6.11%, 65/1277 Wang et al., 2006 
Huangman/Zeku 2006  0.29%, 3/1046 Wang et al., 2006 
Gansu 
   Zhang & Min
 
1994-1997 
  
4.1%, 135/331 
 
Craig et al., 2000 
Sichuan     
Shiqu 1998  2.96%, 37/1291 Qiu et al., 1999 
2005  6.2%, 198/3199 Yu et al., 2005; Li et 
al., 2005 
Baiyu & Seda 2005  1.79% Yu et al., 2005; Li et 
al., 2005 
Ganzi 2005  1.42, 39/2748 Li et al., 2005 
Tibet     
Not sure, Lhasa, 
Naqu, Shannan and 
Changdu, Linzhi 
and Sichuan Origin 
1960-2006 19  Peng, 1988; Luo et 
al., 1993; Pu 1999; 
Yixijiacuo et al., 
2001; Duan et al., 
2006 
Inner Mongolia 1996 1  Li, 1996 
Heilongjiang 1980s 4  Yu et al.,1994 
XMUH: Xinjiang Medical University Hospital 
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1.4.3.3 Risk factors for human CE and AE in China 
XUAR. Hospital cases and community studies indicated that the risk factors for 
human CE might be age over 20s, occupation as farmers and herdsmen, Ethnity 
as Mongolian, Xibo, Kazak and Han Chinese (National Hydatid Disease Center of 
China, 1993; Qiu et al., 1999; Gao et al., 2005; Dingmulati et al., 2005; Song et al., 
1999; Zhao et al., 2003; Wang et al., 2001). Meanwhile, female, countryside 
residents, dog ownership, poor disease knowledge, home-slaughter of livestocks, 
were also involved with higher CE prevalence. As for serological positives, female, 
different areas (ie, Tacheng Prefecture, Tianshan Mountain), occupation as 
herdsmen, ethnity as Han, Mongolian were regarded as main risk factors in above 
studies (National Hydatid Disease Center of China, 1993; Wei 1994; Qi et al., 
1995). Human AE was relatively common occurred in the certain areas around  
Altai, western Junggar, and Tianshan mountain ranges, semi-nomadic groups, 
Kazakh of Mongol origin,  and also to be correlated with aspects of the local 
climate (Zhou et al., 2000). 
Ningxia Hui AR. Hospital based study showed sheep farming, home-slaughter of 
livestock and lack of piped water were higher risk factors for human CE (Yang et 
al., 2006). Ages older than 30 yrs, farmers and dog owners were related to higher 
human CE and AE prevalence, however, Hui ethnic group, female were mainly 
risk factors for human AE (Yang et al., 2005) 
Gansu. Dog and livestock ownership, drinking water contaminatiion were main 
risk for human CE in Gansu (Wang and Zhang, 2000). Female, age group 20-59 
years, a long period dog ownership and close contact were the main risk factors 
for human AE, meanwhile the ecological features were involved for the risk, such 
as  village surround (\50% ratio scrub:grassland total area, might due to a 
process of deforestation), density indices of voles, semi-domestic (or synanthropic) 
cycle of E. multilocularis (Craig et al., 2000). 
Qinghai. Main risk factors for human CE in Qinghai Plateau from epidemiological 
studies were analyzed. With the occupation of livestock husbandry, traditional 
normad lifestyle, lower education level, dogs ownership, increased stray dogs, 
drinking surface water, unwashed hand and gender as female, were involved with 
both CE and AE. (Wang, 2004). 
Sichuan. In Tibetan areas of western Sichuan, ages below 19 years old, nomadic 
lifestyle, playing with dogs, hygienic behariors, and yaks or sheep ownership, 
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were thought to increase the risk of suffering from CE (Wang et al., 2001). But 
human AE cases showed higher prevalence in ages group over 19 yrs old. Study 
in Shiqu County showed female, pastoral herdsmen, increased ages, the number 
of owned dogs, frequency of dog contaction and source of drinking water were risk 
factors for both CE and AE (Li et al., 2005).  
Tibet AR. Just a paper mentioned that the poor hygienic habits were involved with 
hydatidosis in Tibet AR, such as unwashed hands, eating uncooked meat, 
drinking surface water, close contact with dogs and dog ownership (Shen et al., 
2004). 
Inner Mongolia AR.  The community studies showed the lower education group, 
herdsmen, housewife, Mongolian had a relative higher risk for hydatidosis 
(serology and ultrasound) in Inner Mongolian AR (Zhang et al., 2007). Dog 
ownership, home slaughter for livestock, suspicious livestock organ to dogs 
became the main reason for human hydatidosis in Xilinhaote area (Liu et al., 
2009). 
 
1.5. Diagnosis of echinococcosis 
1.5.1 Human echinococcosis 
1.5.1.1 Clinical symptoms 
Human CE often occurs as a fluid-filled cyst, single or multiple, with or without 
daughter cysts in most internal organs of human but especially the liver (around 
70%), lung (around 20%), peritoneal cavity, spleen, kidney, brain, bone, and also 
muscle or subcutis (Ding & Wen, 2000, WHO/OIE, 2001). The initial phase of 
primary infection is always asymptomatic, and small (<5cm) well-encapsulated 
cysts located in organ sites, where they do not induce major pathological problem, 
may remain asymptomatic for many years or even permanently (Ammann & 
Eckert, 1996; Pawlowski, 1997; WHO/OIE 2001). Disease symptoms arise as the 
cysts grow bigger and start eroding and/or putting pressure on blood vessels and 
organs. Hepatomegaly, pain, or with cholestasis and jaundice often occur in 
human liver CE, symptoms similar to secondary biliary cirrhosis, liver abscess, 
calcified lesion, portal hypertension, Budd-chiari syndrome, cyst rupture, biliary 
fistula, etc may occur. Chest pain and chronic cough may happen in lung CE, also 
with pneumothorax, pleuritis, lung abscess, etc. Pains, tumor-like growth and 
other symptoms may anaphylactic vary in CE cases within different organ 
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locations. Large cysts can also cause shock if they happen to rupture (WHO/OIE, 
2001).  
Cases of human AE are characterized by an initial asymptomatic incubation 
period of 5 to 15 years duration and a subsequent chronic course. AE mainly 
occurs as tumor-like lesions mostly in the liver (>99%), with possible lung and/or 
brain secondary multiple organ involvement in late stages (Ammann et al, 1996, 
Sato, et al 1993, WHO/OIE, 2001, McManus 2003). AE lesions are typically 
tumor-like multivesicular, infiltrating structures consisting of numerous small 
vesicles embedded in stroma of connective tissue; the larval mass usually 
contains a semisolid matrix rather than clear fluid. The fatality rate of untreated or 
inadequately treated AE is high, 94% died within 10 years after diagnosis in a 
patient series described in Germany (Ammann and Eckert, 1995, 1996; WHO/OIE, 
2001). Symptoms of AE are primarily cholestatic jaundice (about a third of the 
cases) and/or epigastric pain (about a third of the cases). In the remaining third of 
patients, AE may be detected incidentally during medical examination for 
symptoms such as fatigue, weight loss, hepatomegaly, or abnormal routine 
laboratory findings (Ammann and Eckert, 1996; Vuitton, 1996; WHO/OLE, 2001).  
1.5.1.2 Imaging diagnostic techniques 
Individual CE and AE cases are best clinically diagnosed using various imaging 
techniques such as ultrasonography (US), standard radiology (X-ray), 
computerized tomography (CT) and/or magnetic resonance imaging (MRI). 
Aetiological confirmation or support may derive from specific serum antibody 
detection. Generally, portable US and serological testing has been applied in the 
diagnosis for human echinococcosis in epidemiological studies because other 
imaging procedures are often not readily available in resource-poor isolated 
communities (Bartholomat et al., 2000; Craig et al., 2001). 
A recent criteria for ultrasound classification of CE has been published by the 
WHO Informal Working Group on Echinococcosis (WHO, 2003), which has been 
suggested for use in both field epidemiological studies as well as for clinical 
investigators. This classification intends to follow the presumed natural history of 
CE and starts with undifferentiated simple cysts (CL), as presumably hydatid cysts 
evolve from these structures. These simple cysts, however, may be due to a 
number of different aetiologies (parasitic lesions, congenital disorders, biliary cysts 
or neoplasms) and, therefore, require further diagnostic tests to reveal their 
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identity. As their origin is uncertain they are not given the designation of a CE type 
lesion, and, in the proposed classification, should be recorded as cystic lesions 
(CL). The first clinical group starts with cyst types CE 1 and 2 and such cysts are 
considered active and usually fertile cysts containing viable protoscoleces and 
CE2 with daughter cysts. CE Type 3 is a cyst entering a transitional stage where 
the integrity of the cyst has been compromised either by the host or by 
chemotherapy and this transitional stage is assigned to the second clinical group. 
The third clinical group comprises CE Types 4 and 5 which are considered 
inactive cysts which they have normally lost their fertility and are degenerative. 
There is a uniform approach and principles of treatment currently recommended 
for each CE cyst type (Gharbi et al., 1981, WHO/OIE, 2001; Wang et al., 2003). 
Other classifications have also been considered for example, it was suggested 
that type-size-number (TSN) of CE types be described according to clinical, 
epidemiology and follow-up studies (Wang et al, 2003). US classification could 
also be considered to represent a natural history of hydatid cyst development, and 
provide the dynamic transmission information in community screening (Table 1.4) 
(Rogan et al., 2006). 
 
Table 1.4: Comparison of Gharbi, WHO and 'TSN' ultrasound classifications 
for human cystic echinococcosis cases from community and clinical 
surveys (Wang, et al, 2003) 
Gharbi a  WHO a  TSN c Description 
Type I  Type CL  T0 Univesicular without pathognomonic signs 
Type I  Type CE1  T1 Univesicular with pathognomonic signs 
Type II  Type CE3  T2 Sagging or floating laminated membrane 
Type III  Type CE2  T3 Cysts containing daughter cysts 
Type IV  Type CE4  T4 Solid mass or mixed cysts 
Type V  Type CE5  T5 Partial or full calcifications 
a Gharbi et al. (1981).                   b WHO/OIE (2001). 
c TSN, type, size and number (see Results). 
 
In AE patients, the liver is usually enlarged through many years of lesion growth 
and development. In US and CT imaging, lesions are characterized by 
heterogenous hypodense masses, often associated with a central necrotic cavity. 
The lesion contours are irregular and there is no obvious cyst wall to adjoin normal 
liver tissue. Calcifications are often found inside and/or around the lesion and 
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exhibit a typical pattern in regard to shape and distribution: clusters of 
microcalcifications or irregular plaque-like calcified foci are located in the central 
or peripheral parts of the lesions (Liu 1999; WHO/OIE, 2001; Kern et al 2006). A 
classification (PNM) for human AE based a parasite location (P), neighbor 
involvement organ (N) and occurrence of metastases (M) has been recommended 
(Table 1.5 and 1.6) (Eur Echino Reg, 1998, WHO/OIE, 2001, Kern, 2003, 2006)  
 
Table 1.5: PNM system for classification of human alveolar echinococcosis 
Classification of findings 
P:  Hepatic localisation of the Parasite 
P X:   Primary tumor cannot be assessed 
P 0:   No detectable tumor in the liver 
P 1:  Peripheral lesions without proximal vascular and/or biliar involvement 
P 2: Central lesions with proximal vascular and/or biliar involvement of one 
lobea 
P 3: Central lesions with hilar vascular or biliar involvement of both lobes 
and/ or with involvement of two hepatic veins 
P 4: Any liver lesion with extension along the vesselsb and the biliary tree 
N: Extra hepatic involvement of neighbouring organs  
Diaphragm, lung, pleura, pericardium, heart, gastric and duodenal wall, 
adrenal glands, peritoneum, retroperitoneum, parietal wall(muscles, skin, 
bone), pancreas, regional lymph nodes, liver ligaments, kidney 
N X: Not evaluable 
N 0: No regional involvement 
N 1: Regional involvement of contiguous organs or tissues 
M : The absence or presence of distant Metastasis 
Lung, distant lymph nodes, spleen, CNS, orbital, bone, skin, muscle, kidney, 
distant peritoneum and retroperitoneum 
M X: Not completely evaluated 
M 0: No metastasisc 
M 1;  Metastasis 
a For classification, the plane projecting between the bed of the gall bladder and the 
inferior vena cava divides the liver in two lobes. 
b Vessels mean inferior vena cava, portal vein and arteries. 
c Chest X-ray and cerebral CT negative. 
(Eur Echino Reg, 1998, WHO/OIE, 2001, Kern, 2003, 2006) 
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Table 1.6: PNM stage grouping of alveolar echinococcosis 
Staging of AE PNM classification 
Stage I P1 N0 M0 
Stage II P2 N0 M0 
Stage IIIa P3 N0 M0 
Stage IIIb P1– 3 N1 M0 
 P4 N0 M0 
Stage IV P4 N1 M0 
 Any P Any N and/or M1 
(Eur Echino Reg, 1998, WHO/OLE, 2001, Kern, 2003, 2006) 
 
 
1.5.1.3 Laboratory diagnosis for echinococcosis 
As a rule, routine laboratory haematology tests show non-specific results. Marked 
eosinophilia may however occur in cases of cyst rupture. Immunodiagnostic 
procedures for serum antibody detection are generally used for the aetiological 
confirmation of imaging structures suggestive for CE or AE for diagnosis or 
differential diagnosis in cases of uncharacteristic imaging findings. In clinical 
practice tests for detecting specific serum antibodies are of particular importance 
in the diagnosis of CE, and the detection of circulating antigens is less relevant 
(Siles-Lucas and Gottstein, 2001; Craig et al., 2003). 
Almost all immunodiagnostic methods have been used for human cystic or 
alveolar echinococcosis over the past 30 years. An intradermal test (Casoni’s test) 
was the first one used by Casoni from 1912. Casoni’s test, indirect 
haemaglutination assay (IHA), and immunoelectophoresis (IEP) had been used in 
Xinjiang (China)| from 1960s. The high false positive rate (between 12-67%) of 
Casoni’s test and also risk of allergic hypersensitivity was problematic. In the last 
10 years several new techniques have been applied for immunodiagnosis of 
CE/AE, such as lymphocyte proliferation responses, cytokine analyses, could 
apparently give more information about post-treatment follow-up studies. The 
detection of echinococcosis specific antibodies is also important and widely used 
in clinical and epidemiologic studies. However the sensitivity and specificity of 
tests are variable, due to the application of different antigens and test methods. 
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Currently, the ELISA and Western blot (immunoblot) have been the main assays 
for human CE using cyst fluid antigen and/or antigen B (Craig, 2003). For human 
AE, Em2 (or Em2plus) and Em18 are considered currently best antigens for 
immunodiagnosis (Gosstein 1993, 1996; Ito 1999). The benefits of serology for 
human CE/AE has been reviewed by several authors and including: confirmation 
of imaging/clinical evidence, identification of asymptomatic, infected individuals 
with no obvious cystic image, provision of long term epidemiological information, 
and provision of information on the state of the infection and the immune response 
against the parasites (Rogan and Craig, 2002). Even if the highly specific antigens 
and detection methods (IgG-ELISA or Western Blot) are used, antibodies may not 
be detectable in a certain proportion of patients with echinococcosis. For example, 
CE cyst in brain or eye, calcificated cysts or lesions, cyst with a thick cyst wall, 
single small cyst, paediatric CE, etc. as they may induce low or no antibody titres. 
Specific antibody detection is most valuable for human echinococcosis diagnosis 
and follow-up study compared to circulating antigen detection which is difficult to 
apply due to its lower sensitivity than other tools (Siles-Lucas and Gottstein, 2001; 
Craig et al., 2003). However, direct antigen detection in hydatid cyst fluid has been 
used to confirm the presence of a hydatid cyst at surgery or by fine-needle 
puncture inspiration (Craig et al., 1986; Wang et al., 2002). Sensitivity and 
specificity of serologic tests can be quite different in different labs or different 
areas even when using the same antigen and the same detection method. The 
main factors affecting a test will be the antigen quality, preparation and whether 
the detection method is adequately standardized and repeatable.  
 
1.5.2 Antigens in immunodiagnosis of human echinococcosis 
For the application of immunodiagnostic in human echinococcosis, diagnostic 
antigens should be easy to obtain and have relatively stable and higher sensitivity 
and specificity. Native antigens used for human CE serodiagnosis have been 
derived from E. granulosus hydatid cyst fluid, extracts of protoscoleces 
(excretory-secretory (ES) or somatic), and E. granulosus adult tapeworm, or even 
oncosphere stages (Carmena et al, 2006). Hydatid cyst fluid antigen of E. 
granulosus from livestock hosts has been the main antigen resource for human 
CE immunodiagnosis. Crude cyst fluid antigen, and the cyst fluid antigens, antigen 
B and antigen 5, have been used both in clinical diagnosis or surveys in endemic 
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areas (Rogan et al., 1991; Shepher et al., 1991; Lightowlers and Gottstein, 1995; 
Ortona et al., 2000; WHO/OIE 2001; Craig et al., 2003). Crude cyst fluid antigen 
(EgCF) has been widely used in all immunodiagnostic tools with high sensitivity, 
and also antigen B (EgB) with its higher specificity (Rogan et al., 1991, 1993, 1997; 
Liu et al., 1993; Craig et al., 2003; Zhang et al., 2003; Carmena et al., 2006). 
Antigen 5, which detected by immunoelectrophoresis, is less useful than antigen B 
for diagnostic purpose due to its lower sensitivity 44%-89% and cross reaction 
with other cestode, trematode and nematode infections (Yarzabal et al., 1977; Di 
Felice et al., 1986; Carmena et al, 2006). Crude antigen somatic extracts from 
protoscoleces (EgP) or adult worms (EgW) have been used for immunodetection 
in dogs and other carnivores, and also for antibody detection in human sera with 
82-90% sensitivity and 48-65% specificity respectively (Allan et al., 1992, Craig et 
al., 1995; Allan and Craig, 2006; Carmena et al, 2006). Excretory-secretory (ES) 
antigens from protoscoleces or adult stages also have been used for definitive 
host coproantigen ELISA tests and for human sera specific antibody detection 
(Allan et al, 1992; Benito et al., 2005; Carmena et al, 2005, 2006).  
Antigens used for human AE serodiagnosis are Em2, Em2 plus, EmP and Em18 
which have usually been derived from AE cyst metacestode or protoscoleces 
taken from experimentally infected rodents. Em2 plus is a mixture of native Em2 
and a recombined antigen (Em II/3-10) which has been used commercially with 
sensitivity 85% and specificity 95% (Gosstein 1993; Rogan and Craig, 2002). 
Immunoblot tests for identification of Em18 antigen are reported with a sensitivity 
range of 50-90% and specificities >95% (Ito et al., 1999). Em2 as a native 
carbohydrate rich laminated layer antigen is relatively easy to obtain, low cost and 
could be applied in several immunodiagnostic tests (Gosstein, 1993). The 
antigens EgCF, Ag5, EgP, EgB, Em2 and Em18 which have frequently been used 
in immunodiagnosis of human echinococcosis are reviewed here. 
1.5.2.1 Native crude E. granulosus Cyst fluid antigen (EgCF): 
Crude E. granulosus cyst fluid antigen (EgCF) from livestock hydatid cysts has 
been used for over 50 years and even now remains most widely used antigen 
preparation for almost all the specific antibody detection methods. Chordi and 
Kagan were the first to analyze serum antibody responses in human hydatid 
infection by gel immunodiffusion with EgCF of sheep origin. Hydatid cyst fluid from 
human CE cases was not suitable for diagnosis since there are human origin 
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proteins in cyst fluid such as human IgG. Hydatid cyst fluid from sheep is also the 
main source for antigen preparation (EgCF, Ag5, AgB) for ELISA and immunoblot 
for detection of total IgG / IgG subclasses or other Ig isotypes (IgM, IgE, IgA). 
Crude hydatid cyst fluid, EgCF, is a complex mixture of glycoprotein, lipoproteins, 
carbohydrates and salts, and contains metabolic products from both the 
metacestode and the host (mainly albumin and immunoglobulin) (Baveja et al., 
1997; Zhang et al., 2003). EgCF has a high sensitivity around 72%-96% for 
human CE in ELISA (Zhang, et al., 2003), but its specificity is variable with 
cross-reactions reported against other cestode (89%), nematode (39%) or 
trematode (30%) species (Eckert and Deplazes, 2004). Due to high sensitivity, 
EgCF antigen has been recommended by WHO for application of mass screening 
in endemic areas, especially when used together with ultrasound (WHO/OIE, 
2001; Carmena et al., 2006). Partially purified E. granulosus cyst fluid antigens 
were obtained through precipitation at low ionic strength (0.005M acetate buffer, 
pH 5, Oriol et al. 1971) or eluted after affinity column chromatography (against 
normal human sera coupled CNBr-activated Sepharose4B) (Zhang, 1999). E. 
granulosus cyst fluid antigens are also often used for the source of antigenic 
materials for animal intermediate hosts (ungulates, such as sheep and cattle) 
immunodiagnosis, but cross-reactions were also observed (Lightowlers and 
Gottstein, 1995; Zhang 2003). 
1.5.2.2 E. granulosus cyst fluid antigen 5 (Ag5) 
Ag5 (Capron et al., 1967) is a lipoprotein complex composed of 57- and 67-kDa 
components (Di Felice et al., 1986). Under reducing conditions 38 and 22-24 kDa 
subunits were further found (Lightowlers et al., 1989). Ag5 is thermolabile with 
high immunogenicity and forms a precipitation line in agar diffusion and 
immunoelectrophoresis assays known as Arc 5. Ag5 has been used widely in 
immunodiagnosis of human CE mainly with immunoelectrophoresis (Arc 5) and 
ELISA. Cross-reaction with other cestode, trematode and nematode infections 
were however observed using native Ag5 for serodiagnosis of human CE 
(Yarzabal et al., 1977; Di Felice et al., 1986; Carmena et al., 2006). The sensitivity 
and specificity of Ag5 ranged between 50-54% and 89-92% respectively (Barbieri 
et al., 1998; Gonzalez et al., 2000, Carmena et al., 2006). Ag5 have been 
considered less useful than antigen B for diagnosis of human cystic 
echinococcosis (Carmena et al., 2006) 
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Recombinant Ag5 (rAg5) and recombinant Ag5 38 kDa subunit (rAg5-38s) have 
been evaluated for CE serological diagnosis, but showed less diagnostic value 
than native preparations (Lorenzo et al., 2005; Camena et al., 2006). Synthetic 
peptide 89-122 showed variable sensitivity with different panels of patient sera 
(range 16-85%) with main cross-reaction against sera from alveolar 
echinococcosis patients (Chamekh et al., 1992; Barbieri et al., 1998, Gonzalez et 
al., 2000, Camena et al., 2006). 
1.5.2.3 E. granulosus cyst fluid antigen B (AgB) 
AgB is a major heat stable lipoprotein, and a component from hydatid cyst fluid 
(Oriol et al, 1971). It is a strongly immunogenic polymeric lipoprotein with a 
molecular weight of 120-160 kDa that dissociates under reducing conditions into 
8/12, 16, and 20/24 kDa subunits, suggesting that it consists of polymers of 8 kDa 
subunits (Lightowlers et al., 1989). The smallest subunit has proved the most 
useful target in diagnostic studies. A possible new antigen B (AgB) subunit (AgB4) 
was recently identified (Arend et al., 2004) and shows that AgB is encoded by a 
multigene family (Haag et al., 2006). Furthermore, AgB has some homology with 
molecules in E. multilocularis, and shares apparent structural similarities with, 
helix-rich hydrophobic ligand binding proteins (HLBPs) from other cestodes, 
together with fatty acid binding properties (Chemale et al., 2005). AgB can be 
detected in CE patient serum as circulating antigen, and used as an 
immunodiagnostic marker to identify cyst fluid removed from suspected human 
cases of suspected cystic echinococcosis (Craig et al., 1986; Wang et al., 2002). 
Antigen B appears to play an important role in the immuno biology of the parasite 
and probably parasite-host relationship (Shepherd et al., 1991; Rigano et al., 2001, 
2002; Zhang, 2003; Carmena et al., 2006). AgB has been regarded as the most 
specific antigen for human CE (>90%) currently available for immunodiagnosis of 
human CE. The only important cross reaction that may occur is with other cestode 
species primarily E. multilocularis and to a less extent with Taenium Solium 
(Maddison et al., 1989; Ito et al, 1999). Immunoblot detection of smallest subunit 
(8kDa) of AgB has proved the most overall useful subunit in diagnostic studies 
(Ortona et al., 2000). The sensitivity of native AgB for human CE varied between 
63-92%. Maddison et al (1989) reported 18% of human CE sera were specific 
antibodies negative against AgB, and 39% of human AE cases showed 
cross-reactivity with AgB.  
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Five major gene clusters named EgAgB1, EgAgB2, EgAgB3, EgAgB4 and 
EgAgB5 have now been identified in Antigen B (Shepherd et al., 1991; Fernandez 
et al., 1996; Chemale et al., 2001; Arend et al., 2004; Haag et al., 2004; Carmina 
et al., 2006).  
Recombinant AgB proteins, EgAgB1 and EgAgB2 have been cloned, expressed 
and assessed for serodiagnosis of human CE to give high specificity but lower 
sensitivity. Of them, EgAgB2 was shown to have best features in terms of 
diagnostic efficiency, and significantly higher than native AgB (Virginio et al., 2003), 
however another evaluation showed different results which had lower sensitivity 
and specificity (Lorenzo et al.2005). This might due to the different preparation of 
recombined antigen and the antigen stability might have some influence. Recent 
research showed antigen B is also expressed in E. multilocularis, where 5 cDNAs 
encoding 8kDa subunit monomers (EmAgB) named as EmAgB/1 to EmAgB/5 
(Mamuti et al 2004). The diagnostic value of native and recombinant AgB 
preparations and synthetic peptides of AgB subunit derived from this molecule in 
the immunodiagnosis of human CE were compared by Carmena et al (2006) 
(Table 1.7). 
Another interesting finding in human CE is a clear predominance of IgG4 antibody 
response for both native and recombinant AgB (Wen and Craig, 1994; Mcvie et al, 
1997; Daeki et al, 2000). Human IgG4 antibody production appears to be 
associated with hydatid cyst development, growth and disease progression or 
active disease (Wen et al., 1994; Roger and Craig, 2002). IgG4 detection with AgB 
has also been used for follow-up studies of treated CE cases (surgery or 
chemotherapy) (Rigano et al., 1995). This finding has important implications on 
the sensitivity of the immunodiagnostic test used in CE patients, the serological 
profile for IgG and IgG subclass antibodies may vary according to disease stage 
(e.g., Type 1-5), site and progression (Daeki et al. 2000). 
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Table 1.7: Main characteristics of antigens used for serodiagnosis of human 
cystic echinococcosis based on native, recombinant, or synthetic peptides 
of antigen B (AgB) 
Antigen No. of subjects tested 
 CE 
cases 
Other 
disease 
Healthy 
subjects 
Test Sensitivity (%) Specificity 
(%) 
Cross reaction Reference 
Native 
AgB 
210 79 47 IgG4 
ELISA 
63 81 AE, Cys. 
Schis. 
McVie et al. 
(1997) 
Native 
AgB 
90 88 28 IgG  
ELISA 
77 86 AE Barbieri et al. 
(1998) 
Native 
AgB 
90 86 28 IgG  
ELISA 
77 86 AE Gonz´alez-Sapien
za et al. (2000) 
Native 
AgB 
204 53 90 IgG  
ELISA 
73 100 None Ortona et al. 
(2000) 
Native 
AgB 
31 87 29 IgG  
ELISA 
77 82 AE, Schis. Tox Rott et al. (2000) 
Native 
AgB 
129 65 203 IgG  
ELISA 
60 93 Cys, Tox Virginio et al. 
(2003) 
Native 
AgB 
59 55 15 IgG  
ELISA 
80 77 AE, Cys Lorenzo et al. 
(2005a) 
Native 
AgB 
173 181 29 IgG IB 92 71 AE Ito et al. (1999) 
Native 
AgB 
87 339 200 IgG IB 60-71 98 AE, Cys Poretti et al. 
(1999) 
Native 
AgB 
204 53 90 IgG IB 73 100 None Ortona et al. 
(2000) 
rAgB8/1 210 79 47 IgG4 
ELISA 
65 91 AE McVie et al. 
(1997) 
rAgB8/1 31 87 29 IgG  
ELISA 
55 80 AE, Schis. Tox Rott et al. (2000) 
rAgB8/1 129 65 203 IgG  
ELISA 
84 91 Cys Virginio et al. 
(2003) 
rAgB8/1 59 55 15 IgG  
ELISA 
68 88 AE, Cys Lorenzo et al. 
(2005a) 
rAgB8/1 204 53 90 IgG IB 72 100 None Ortona et al. 
(2000) 
rAgB8/2 31 87 29 IgG  
ELISA 
84 98 Schis, Tox Rott et al. (2000) 
rAgB8/2 129 65 203 IgG  
ELISA 
93 99 Cys, Tox Virginio et al. 
(2003) 
rAgB8/2 59 55 15 IgG  
ELISA 
45 86 AE, Cys Lorenzo et al. 
(2005a) 
p65 90 88 28 IgG  
ELISA 
34-48 80-97 AE, Onch, 
Schis, Tox 
Barbieri et al. 
(1998) 
p65 90 86 28 IgG  
ELISA 
44 96 AE, Schis, Tox Gonz´alez-Sapien
za et al. (2000) 
P175 90 86 28 IgG  
ELISA 
49 94 AE, Schis, Tox Gonz´alez-Sapien
za et al. (2000) 
P176 90 86 28 IgG  
ELISA 
80 93 AE, Schis, Tox Gonz´alez-Sapien
za et al. (2000) 
P176 59 55 15 IgG  
ELISA 
63  83 AE, Cys Lorenzo et al. 
(2005a) 
P177 90 86 28 IgG  
ELISA 
38 92 AE, Schis, Tox Gonz´alez-Sapien
za et al. (2000) 
pGU4 90 88 28 IgG  
ELISA 
12-18 96-100 AE Barbieri et al. 
(1998) 
pGU4 90 86 28 IgG  
ELISA 
18 98 AE, Schis, Tox Gonz´alez-Sapien
za et al. (2000) 
r=recombinant; p=peptide; IB=immunoblot; AE=alveolar echinococcosis, 
Cys=cysticercosis; Schis=schistosomiasis, Tox=toxoplasmosis; Onch=Onchocerciasis) 
(Carmena et al, 2006) 
 
1.5.2.4 E. granulosus protoscolex extract (EgP) 
Antigenic differences have been found in a somatic extract of protoscoleces (EgP) 
from different species of intermediate hosts (Rafiei and Craig, 2002). Some 
research showed EgP sensitivity is similar to hydatid cyst fluid antigen (EgCF) and 
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little specificity (29.6%) in a dot-ELISA immunodiagnostic test of human CE (Qiao 
et al, 1999). Native EgP generally showed poorer specificity for human CE, some 
recombinant protoscoleces proteins exhibited higher levels of sensitivity (90-92%) 
and specificity (95-96%), particularly rEpC1 (Li et al, 2003) and rEgcMDH (Virginio 
et al., 2003). The real potential of EgP antigen for human immunodiagnosis still 
remains to be determined. 
1.5.2.5 E. granulosus adult worm extract (EgW) 
E. granulosus adult worm extract (EgW) has also been assessed for 
serodiagnosis of human CE (Ersfeld et al, 1997). Sensitivity of 82% and specificity 
65% in ELISA were observed with EgW. A range of low-molecular-weight 
antigenic proteins (12-45 kDa), being immunoprecipitated from in vitro-translated 
E. granulosus adult worm mRNA, was recognized by human CE sera (Ersfeld et 
al., 1997). 
1.5.2.6 E. multilocularis protoscolex antigen (EmP) 
Crude extract from supernatant of in vitro E. multilocularis protoscoleces was first 
demonstrated in 1988 by Auer et al. And an E. multilocularis protoscoleces extract 
(EMP) had been used for community screening and IgG/IgG subclass analysis 
with better specificity than whole E. multilocularis metacestode extract (EmCH). 
(Craig et al., 1992, 2000; Wen and Craig, 1994; Wen et al., 1995). Main 
cross-reactivity of EmP was 36% with sera from CE patient and 50% with sera 
from T. solium cysticercosis (Wen et al., 1995). Two low- molecular-weight (16- 
and 18- kDa) peptides from E. multilocularis protoscoleces were regarded as 
species-specific antigens later (Ito 1993, 1999). 
1.5.2.7 E. multilocularis  metacestode antigen (Em2) 
Em2 is a carbohydrate rich, affinity purified, highly species-specific native antigen 
which is extracted from E. multilocularis metacestode derived from experimentally 
infected animals (Gottstein et al., 1983, 1992). Em2 has been used successfully 
over a long period for immunodiagnosis of human AE with a sensitivity of 77-92% 
in ELISA in different endemic areas (Gottstain et al., 1992; Eckert et al., 1992). It 
has been confirmed as a PAS (periodic acid shifts) staining positive component 
from the laminated layer of E. multilocularis. It appears that Em2 could not 
differentiate between antibodies in progressive or inactive AE lesions so it may not 
be suitable for follow-up studies, however it can identify aborted infections in 
human (Gottstein et al., 1983, 1987, 1993; Bartholomat et al., 2000). Em2 shows 
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high specificity (95%) but has cross-reaction with some CE cases and other 
cestode species (Wen et al., 1995). The Em2plus ELISA, that was a combination 
of native Em2 with a recombinant protein designated II/3-10 (also termed Em10), 
increased the sensitivity for human AE to 97% (Gottstein et al, 1993). The 
Em2plus assay exhibited cross-reaction in 25.8% of CE cases) which was higher 
than the individual Em2 (5.6%) or 11/3-10 (6.5%), but limited cross-reactivity with 
other diseases (Gottstein et al., 1992). 
1.5.2.8 E. multilocularis protoscolex antigen (Em18) 
An 18-KD antigen from E. multilocularis protoscoleces (Em18) was first reported 
by Ito et al. (1993), as a highly species-specific (96.8%) and sensitive (97%) 
antigen with potential not only for differentiation of AE from either CE or other 
helminthes infections, but also for differentiation of active from inactive AE (Ito et 
al., 1993, 1995, 1997, 1999). A small degree of cross-reaction has been described 
with CE patient sera (Nirmalan and Craig, 1997; Ito et al., 1999; Ito, 2002). 
Subsequently, Em18 was shown to be a fragment of the C-terminal of Em10 and 
recombinant protein (rEm18) was recognized in ELISA and immunoblotting by 
87.1% and 90.3% respectively of 31 serum samples from AE patients, 
respectively (Sako et al, 2002). Recombinant Em18 ELISA and Em18 immunoblot 
assays have proved very accurate for differentiating AE from CE infection, with 
Em18 ELISA also being useful for evaluation of the efficacy of treatment in AE 
patients (Ito et al, 2002). Epitope mapping has indicated that the part of the 
recombinant Em18 antigen sequence important for detection of AE antibodies 
occur in the N-terminal half to two thirds of the entire sequence (Jiang, et al., 
2004). Em 18 was also shown to be present in E. granulosus and recognized by 
some CE cases (Wen et al., 1995; Nirmalan and Craig, 1997; Ito et al., 2003). 
 
1.5.3 Definitive host diagnosis: 
1.5.3.1 Parasitological diagnosis 
Canids play the most important role as the definitive host in the transmission and 
epidemiology of E. granulosus and E. multilocularis. Necropsy to identify the 
tapeworms in the small intestine is the best (gold-standard) and traditional way for 
confirmation of infection in definitive hosts, but is difficult, biohazardous and 
unethical to use routinely for either domestic dogs or sylvatic hosts (e.g. foxes) 
(Craig 2001; Zhang 2003, Allan and Craig 2006). Pre-mortem direct microscopic 
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detection of echinococcus (eggs or proglottides) in faeces may be carried out after 
purgation with arecoline salts. Purgation, should be 100% specific for 
Echinococcus Spp tapeworms due to direct morphological identification, however, 
it has several disadvantages: including importantly variable sensitivity (Wachira et 
al., 1990; Craig 1994), its complicated operation, time consuming, requirement for 
technical person, is bio-hazardous and may cause distress to some dogs and has 
a high failure rate (10-20%) (Craig, 1994; 2001; Lahmar et al., 2007). Eggs could 
be found in faecal samples using routine flotation in saturated saline or using clear 
adhesive tape to microscopic slide (Deplazes & Eckert 1988). Microscopically 
detection using canid faeces may also be difficult due to often absence of eggs 
from faeces, furthermore the morphologic structure under light microscopy of eggs 
is indistinguishable between Echinococcus and Taenia species (Euzeby, 1966; 
Craig et al., 1986; Aluja et al., 1987, Craig, 2001, WHO/OIE, 2001; Allan and Craig, 
2006).  
1.5.3.2 Serological diagnosis 
Serological tests to detect of adult E. granulosus tapeworm antibodies using a 
protoscoleces antigen in definitive host are considered unreliable for due to the 
lack of specificity and sensitivity. EgP is a crude somatic extract from E. 
granulosus protoscoleces, which has been used for detection of antibodies in the 
definitive host but lacked sensitivity (Gasser et al., 1988 and Gasser 1994, 
Carmena et al., 2006). Serological test for dogs was not widely carried due to 
variable sensitivity (40-90%) (Jenkins et a., 1990; Gasser et al., 1994); lower 
levels of specific antibody in 25-60% sera from dog with E. granulosus and 
cross-reactivity with other parasite species (Casser et al., 1988). 
Serological diagnosis to detect adult E. granulosus tapeworm antibodies with a 
protoscoleces antigen was assessed using experimental canine echinococcosis in 
Australia and showed initially 91.8% specificity and 72.7% sensitivity (Gasser et 
al., 1988). Further studies however exhibited lower sensitivity (40%) as observed 
in naturally infected dogs in Kenya (Jenkins et al., 1990) and in Uruguay (Craig et 
al., 1995). The potential application of antibody tests in definitive hosts might 
supply more information on community studies rather than individual diagnostic 
value (WHO/OIE, 2001).  
1.5.3.3 Coproantigen detection 
Sandwich ELISA for detection of parasite specific antigen in faecal samples 
 42
(coproantigens) using polyclonal antibodies against somatic or 
excretory/secretory antigens of adult E. granulosus has been developed and used 
in several specialized laboratories for transmission and epidemiologic studies in 
endemic areas (Allan et al., 1992; Deplazes et al., 1992; Craig et al., 1995). 
Echinococcus coproantigen has been observed to be very stable during the 
sampling, storing (at room temperature over several days), and detection. 
Coproantigen ELISA has been showed to have reasonable sensitivity (70% to 
95%) and high genus-specificity (>90%) against other parasites including Taenia 
spp in dogs, dingoes, and foxes, and coproantigen does not depend on the 
presence of eggs (Allan et al. 1992; Deplazes, 1992; Allan & Craig, 2006). E. 
granulosus coproantigen appeared to be associated with the parasite tegument or 
glycocalyx due to its components of large molecular weight (around 150 kDa to 
670 kDa) with carbohydrate moieties (Casaravilla et al., 2003, 2005; Elayoubi et 
al., 2003, 2004; Allan and Craig, 2006). Above ELISA coproantigen tests were 
asked professional laborotary and technitians, which should be carried out in 
standard reference laborotary. Then a rapid and easy method for using in rural 
field was needed to apply in endemic area. 
1.5.3.4 Copro PCR 
PCR amplification of DNA from faeses of foxes infected with E. multilocularis was 
developed by Bretagne et al (1993) and modified for epidemiological studies in 
Europe (Dinkel et al. 1998; Deplazes et al., 2003; Van der Giessen et al., 1999). 
Recently PCR (copro PCR) has also been developed and applied for specific 
detection of E. granulosus worm DNA from faeces of definitive hosts (Cabrera et 
al, 2002; Abbasi et al., 2003, Casulli et al., 2004, 2005; Stefanic et al., 2004, 
Varcasia et al., 2004; Reiterova et al., 2005). The PCR method should give more 
information and better chance of species-specific confirmation (Deplazes and 
Eckert, 2001; Abbasi et al, 2003) and even for environmental detection of 
Echinococcus eggs in soil samples (Shaikenov et al., 2004, Zhang and McManus 
2006). Application of coproantigen ELISA and copro-PCR to tests definitive host 
faecal samples have provided excellent tools for transmission or epidemiology 
studies, and for monitoring the progress of hydatid control Program (Deplazes and 
Eckert, 2001; Craig 2003; Craig et al., 2007; Huang et al., 2007). 
1.5.3.5 Adult Echinococcus spp antigens. 
A crude somatic extract from E. granulosus adult worms (EgWWE) has been 
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assessed as the basis coprodiagnosis of echinococcosis. EgWWE was used to 
boost rabbits to get polyclonal anti-EgWWE antibodies, and then were used for a 
double antibodies sandwich ELISA to detect coproantigens in definitive host 
faeces (Allan et al., 1992; Craig et al., 1995; Allan and Craig, 2006). This method 
considerable improved the sensitivity for detection of coproantigens of adult worm 
infection in dogs compared to antibody detection in serum (Craig et al., 1995). It 
has been widely applied in different geographical regions more than 10 years and 
confirmed its usefulness for epidemiological studies. The EgWWE preparation is a 
saline extract from adult tapeworm by removal of the non-gravid segments, 
homogenization and centrifugation. Rabbits were immunized with EgWWE and 
Freund’s complete or incomplete adjuvant after first boost. IgG fraction were 
purified from rabbit sera using a Protein A sepharose CL 4B column and 
subsequent elution using a low pH glycine buffer for affinity chromatography. Half 
of IgG was dialyzed against PBS for following conjugation with horseradish 
peroxidase and the other half dialyzed against bicarbonate-carbonate buffer to act 
as capture antibody in a coproantigen sandwich ELISA (Allan et al., 1992). 
Secretory-excretory (ES) antigens from adult E. multilocularis or E. granulosus 
have been investigated for specifically primarily in relation to coproantigen test 
development (Deplazes, et al., 1992; Allan et al., 1992, Malgor et al., 1997; 
Casaravilla et al., 2005; Huang et al., 2007). And recently ES antigens from 
protoscoleces of E. granulosus have been demonstrated for coproantigen ELISA 
and more effective with modifications (Carmena et al., 2005; Benito and Carmena, 
2005). 
 
1.6 Developments in immunodiagnostic assays 
There is a long of history using immunodiagnosis tests, and almost all 
immunodiagnostic methods have been assessed or used at the same time for 
detection of human echinococcosis (Table 1.8). Various results were observed in 
both sensitivity and specificity. Non-specific tests, like the Casoni intradermal test, 
the complement fixation test, the indirect haemagglutination test, and the latex 
agglutination test, the indirect immunofluorescence antibody test, 
immunoelectrophoresis (IEP), have now been largely replaced by the ELISA, and 
immunoblotting (IB) in well equipped laboratories for routine application. The 
diagnostic sensitivity and specificity of ELISA and IB in comparison to IEP in 
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detecting IgG antibodies to native or recombinant antigen B and a crude hydatid 
cyst fluid antigen in CE patient sera were compared. Hydatid cyst fluid fraction-IB 
gave the highest sensitivity (80%) followed by ELISA (72%) and IEP (31%), the 
diagnostic sensitivity decreased significantly in relation to hydatid cyst pathology 
(i.e. active vs. inactive cysts) (Ortona et al., 2000; Zhang et al., 2003). 
Recombinant and native EgB immunoblots (IB) had similar sensitivity (74%) but 
gave 20% of CE cases were false negative (Ortona et al., 2000). It has been 
suggested that combination of several defined antigens (including native or 
synthetic peptides may obtain more information about serological responses to 
this infection (Zhang et al., 2003). Antigen detection in the suspected hydatid cyst 
fluid samples for confirmation of E granulosus infection with ELISA or dot-blots 
has been tried to assess diagnosis of suspected CE during the surgery or PAIR 
(Craig, 1986; Wang 1997).  
In definitive hosts, serological tests were generally of low sensitivity and 
sometimes difficult to apply. In contrast, the coproantigen sandwich ELISA has 
been used successfully for mass screening of dogs. Confirmation of coproantigen 
ELISA positives, copro PCR for species differentiation is the current 
recommended approach for epidemiological and surveillance studies in canids 
(WHO/OIE, 2001; Eckert, 2003; Craig et al., 2003; Allan and Craig, 2006). 
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Table 1.8: Immunodiagnostic Tests used for human cystic echinococcosis 
Detection 
methods Technique References 
Complement Fixation Test, CFT Bradstreet, 1969 
Latex Agglutination Test, LA Williams and Prezioso, 
1970 
Agglutination, 
lysis 
Indirect Hemagglutination Test, 
IHA 
Varela-Diaz et al, 
1975a 
Immunoelectrophoresis, IEP Varela-Diaz et al, 
1975b 
Double Diffusion, DD Coltori and 
Varela-Diaz, 1978 
Counter Immunoelectrophoresis, 
CIEP 
Pinon et al, 1979 
Precipitation 
Diffusion In Gel-Enzyme-Linked 
Immunosorbent Assay, DIG-ELISA
Dematteis et al, 1989 
Radioimmunoassay, RIA Musiani et al.,1974 
Indirect Fluorescent Antibody Test, 
IFA 
Matossian et al., 1972 
Enzyme-linked Immunosorbent 
Assay, ELISA 
Craig, 1986 
Dot-ELISA Rogan et al., 1991 
Western Blot Maddison et al.,1989 
Dot Immuno-Gold Filtration Assay, 
DIGFA 
Fu et al., 2001; Feng et 
al.,2002; Chen et 
al.,2005 
Indirect 
antibody 
labeled 
Gold Immunochromatographic 
Assay, GICA 
Xue et al., 2005 
Casoni intradermal (ID) test Yarzabal et al., 1975; 
Gonlugur et al., 2005 
Skin tests 
Delayed intradermal reaction Todorov et al., 1979; 
Gonlugur et al., 2005 
Lymphocyte 
stimulation,cyto
kine assays 
Lymphocyte Transformation In 
Vitro 
ELISA 
Siracusano et al, 1988 
Coproantigen ELISA Allan et al., 1992; 
Deplazes et al., 1992 
DNA probe DNA hybridization and 
immunoelectrophoretic assay，
Immunoblotting 
Rishi and McManus, 
1987 
 
1.7 New tools for rapid diagnosis of hydatidosis / echinococcosis 
ELISA and immunoblot have confirmed efficacy and use in immunodiagnostic 
studies. They are relatively easy to set up in any laboratory but have the limitation 
of long assay-time especially in mass-screening community studies. A rapid 
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immunological diagnostic method that can be used in both the field and for initial 
differentiation of CE and AE at clinical level would be very useful (Craig et al., 
2000; Bartholomat et al., 2000; Wang et al., 2004). Rapid serological test formats, 
such as dot-ELISA have been assessed for both human CE and AE, and although 
useful when associated with mass ultrasound screening, were temperamental and 
subjective in reading (Rogan et al., 1991).  
Dot immuno-gold filtration assay (DIGFA) is a rapid immunodiagnostic test that 
uses colloidal gold conjugated antibody or antigen instead of enzyme or 
fluorescence conjugates (Valkirs and Barton, 1985; Beesley 1989; Chun and Chu, 
1989; Xiao et al., 1995; Reddy 2006). Antibody or antigen are attached on a 
nitrocellulose membrane, heparinized blood or serum applied, and colloidal gold 
conjugated anti-human antibodies give a color change to show positive or 
negative. The procedure is similar to ELISA, but uses an infiltration system with 
colloidal gold to give a rapid result.  
 
1.7.1 Colloidal gold preparation 
Colloidal gold, also called "nanogold", is a suspension (colloid-like) of 
sub-micrometre-sized particles of gold in a fluid formation. The liquid shows 
usually an intense red colour for particles less than 100 nm (Wessling et al, 1996). 
The gold particles themselves can come in a variety of shapes, e.g. spheres, rods, 
cubes, and caps are some of those frequently observed. 
Known since the ancient Roman times, colloidal gold was originally used as a 
method of staining glass as an intense red which the process was refined by 
Andreus Cassius and Johann Kunchel in the 17th century. In 1842, John Hershel 
found a method that used colloidal gold to record images on paper, called 
chrysotype (from the Greek word for gold). The first pure sample of colloidal gold 
was prepared in 1857 by Michael Faraday who used phosphorus to reduce a 
solution of gold chloride, which he called 'activated gold'. Faraday was also the 
first to recognize that the colour was due to the size of the gold particles. Modern 
scientific evaluation of colloidal gold did not begin until Michael Faraday's work of 
the 1850s (Mulvaney, 2003, Reddy, 2006). Colloidal gold has been widely applied 
in a wide variety scientific and technological fields, including electronics, 
nanotechnology due to its unique optical, electronic, and molecular-recognition 
properties, etc. (Rao et al, 1999, Mulvaney, 2003, Reddy 2006). 
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Generally, colloidal gold is produced in a liquid formular ("liquid chemical 
methods") by reduction (usually sodium citrate or sodium borohydride) of 
hydrogen tetrachloroaurate (HAuCl4). After dissolving HAuCl4 in distilled water, 
the boiled solution is rapidly stirred while a reducing agent is added. This changes 
Au3+ ions to reduce to un-ionized gold atoms. The solution becomes 
supersaturated when most gold atoms reduced, and residual gold gradually starts 
to precipitate as sub-nanometer particles while other rest of the gold atoms stick to 
the existing particles. The similar size of particles could be obtained if the solution 
is stirred vigorously enough. To prevent the particles from aggregating, some sort 
of stabilizing agent that sticks to the nanoparticle surface is usually added. They 
can be functionalized with various organic ligands to create organic-inorganic 
hybrids with advanced functionality (Beesley, 1989; Reddy 2006). 
Generally used sythenization methods for colloidal gold were sodium citrate 
reducing (Turkevich et al., 1951; Frens et al., 1970; Beesley 1989, Reddy 2006; 
Pong et al., 2007); organic reducing (like toluene) using tetraoctylammonium 
bromide (TOAB) (Brust et al. 1994-1998) and sonolysis (Zhang, et al., 2006) 
 
1.7.2 Colloidal gold based immunodiagnostic assays 
Colloidal gold conjugated antibody/antigen could be used in immunodiagnostic 
assays replacing enzyme or fluorescence dyes. Colloidal gold technique was first 
used in 1970s for immunological purpose in locating special antigen on the 
surface of cell through electric microscopy (Faulk and Taylor 1971; Horisberger et 
al., 1975). A dot immunogold infiltration assay (DIGFA) was used for detect HIV in 
1989 (Beesley 1989; Chun and Chu, 1989). This technique is basically involves 
the antigen or antibody attached to a nitrocellulose membrane with a filter tissue 
underneath with the target antibody / antigen be combined on the membrane (Fig.  
1.11). The procedure is similar to ELISA but using an infiltration system and 
colloidal gold provide a more rapid and reliable result.  
Another related technique is the immunogold chromatography assay (IGCA) 
which has been widely used for example in HCG hormone detection for early 
diagnosis of pregnancy (May 1991). Gold conjugate and sample are allowed to 
flow to the capture (antigen or antibody) on the nitrocellulose membrane through 
chromatography, reaction in precipitation as a line (Millipore corp 1996). Other 
colloidal dyes such as Palami Red (UK), Samaron Red (Hoechst F.R.G) etc. were 
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used as an alternative to colloidal gold particles for antigen detection 
immunoassay with dipsticks (Snowden and Hommel, 1991).  
Preparation of antibody-colloidal gold conjugate (Beesley, 1989) was using 
optimum volume of 1mg/ml antibody for conjugation with colloidal gold; and 
blocking with 1-10% BSA or gelatin or PEG 20,000 according different design; 
purification using centrifugation with different speed due to different size of 
colloidal gold; column chromatography to obtain the evenly size of gold particle. 
 
Dot Immuno-Gold Filtration Assay (DIGFA) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.16: The device for DIGFA. A: ready-to-use device; B: different 
components of this device, including a plastic bottom for backup, an absorbent 
pad for collecting all the liquid, a piece of NC membrane as a reaction barrier, and 
a top cap with a middle well. C: reactions occurred in DIGFA, with specific antigen 
binded to NC membrane (solid phase), specific antibody in patient’s sample would 
combined with this antigen, and a colloidal gold conjugated anti-Ig could bind to 
above combination and showed color to judge the reaction. 
 
DIGFA, using nitrocellulose (NC) membrane as a carrier which pre-coated antigen 
or antibody as a capture, is similar to immunoblot procedure excepted of a 
substrate step (Fig. 1.16). A sample (including antibody or antigen) dropped on the 
NC membrane followed by colloidal gold conjugate and washing buffer, 
antigen-antibody-conjugate would show red dot on the membrane and excessive 
reagents would filtrate through NC membrane to an absorbent tissue. Antigen or 
Top cap
NC membrane
Absorbent 
pad 
Bottom 
C 
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antibody in sample / conjugate would combined to the antibody/antigen on NC 
membrane when the solution past through NC membrane and thus was more like 
a concentration with affinity chromatography. This made the procedure rapid 
(about 5 minutes), and washing step through filtration became more simple and 
rapid. DIGFA became one of the point of care test (POCT) due to rapid and simple 
(no special device needed).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.17: Immunogold chromatography assay strip 
 
Immunogold chromatographic Assays, also called lateral flow assays or simply 
strip assays, have been developed for some time. This technique is based on an 
immunochromatographic procedure that utilizes antigen-antibody properties in a 
novel manner and provides rapid detection of analyte (Fig. 1.17) (Millipore corp 
1996). They possess four benefits of user-friendly format, very short time to get 
test results, long-term stability over a wide range of climates and relatively 
inexpensive to make. These characteristics render it ideally suited for on site 
testing by untrained personnel, rapid point of care testing, and testing in the field 
for various environmental and agricultural analytes. In addition, they provide 
reliable testing that might not otherwise be available to third world countries. The 
principle behind the test is straightforward. Basically, any ligand that can be bound 
to a visually detectable solid support, such as dyed microspheres, can be tested 
for qualitatively, and in many cases even semi-quantitatively. Some of the more 
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common lateral flow tests currently on the market are tests for pregnancy (May 
1991, Millipore corp 1996), strep throat , and chlamydia (Liu 2005; United States 
Patent 5393658; European Patent EP0258963; Shim et al., 2006). These are 
examples of conditions for which a quantitative assay is not necessary. 
The main advantages of immunogold techniques are rapid and efficient. The 
procedure is simple, cheap, and easy to apply and does not require a reader 
device or machine and therefore cheap. Sensitivity could also be comparable to 
ELISA if good quality controls have been included. Such test have been used for 
diagnosis in some parasite diseases, such as antibody detection circulating 
antigen in toxoplasmasis (Wang et al., 2007; Li et al., 2004; Tang and Zhou, 2004), 
schistosomiasis (Zhu et al., 2002; Wu et al., 2005), cysticercosis (Liu et al., 2001, 
2002), circulating antigen detection for Plasmodium falciparum (Moody, 2002; Li et 
al., 2004; Grobusch et al., 2004) and Plasmodium vivax, Wuchereria bancrofti and 
Leishmania spp (Yang, 2003, Zhu, 2002; Garcia et al., 2000;).  
Colloidal gold antibody conjugate based DIGFA or similar immuno- 
chromatographic assays have also become an acceptable rapid clinical bed-side 
detection method for drug screening and diagnosis of severe microbial and 
parasitic infections (Dar et al., 1994; Xiao et al., 1995; Dylan and Kevin, 1999; 
Feng et al., 2000; Garcia et al., 2000; Feng et al., 2002; Zhu et al., 2002; Sorell et 
al., 2002; Yang, 2003; Hujakka et al., 2003; Chen et al., 2005). Initial applications 
of DIGFA for human echinococcosis in China indicated good potential as a rapid 
test (Fu et al., 2000; Feng et al., 2002; Zhang et al., 2001). 
 
1.8 Aims and Objectives. 
Echinococcosis is highly endemic in northwestern China. In order to improve 
immunodiagnostic tests in support of community screening and for hospital use, 
this study tried to develop and standardize a dot immunogold filtration assay 
(DIGFA) with novel antigens for rapid serodiagnosis of human CE and AE, then 
compare the performance of DIGFA with a standard ELISA, and the diagnostic 
value included sensitivity, specificity, accuracy, positive and negative predictive 
value of DIGFA would be assessed in hospital diagnostic setting and in endemic 
community screenings in northwest China. This study also tried to develop an 
immunochromatographic assay (ICA) test that would be initial developed for rapid 
E.granulosus antigen detection in cyst fluid samples to identify / confirm that cysts 
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are of hydatid origin. Another ICA strip was to be disigned for rapid coproantigen 
detection in dog faeces. A series of epidemiological surveys using portable 
ultrasound and DIGFA test during 2002-2007 would be reported and risk factors 
for human echinococcosis would be analyzed for further understanding the 
epidemiological features, where in the counties of Habahe, Qinghe, Mulei, Hejing, 
Wenquan, Xinyuan, Nileke, Hoboksaier in Xinjiang Region; Xiji in Ningxia; Ganzi 
Tibetan Autonomous Prefecture in Sichuan Province; and Dangxiong and 
Dingqing in Tibet Autonomous Region (TAR) in northwestern China. This research 
has implications for further development of rapid tests in support of human and 
canine echinococcosis diagnosis and for surveillance of transmission in China and 
elsewhere. 
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Chapter 2. Materials and methods  
 
2.1 Study sites 
Serological studies for human echinococcosis were mainly undertaken in Xinjiang 
Hydatid Clinical Research Institute, First Teaching Hospital of Xinjiang Medical 
University, Urumqi, P. R. China. Most rapid test development for Echinococcus 
coproantigen detections and for human hydatid cyst fluid antigen test was carried 
in Salford University. Community studies in several regions were undertaken in 
Xinjiang, Ningxia, Sichuan and Tibet. 
 
2.2  Materials and methods for developing a rapid DIGFA test for hydatid 
disease 
2.2.1 Human serum samples 
Hospital human hydatid cases serum samples were collected from Xinjiang 
Medical University Hospital (XMUH) during 1998-2006; Chongqing Medical 
University, P. R. China. Blind test sera from Xinjiang Medical University Hospital 
(XMUH) Salford University (UK), Besancon University Hospital (France). 
Non-endemic control sera were collected from Greater Manchester hospital, UK 
(non-endemic area). 
Serum samples for community study were collected from endemic communities in 
northwest China screened by ultrasound (US). The screened communities were 
Qinghe, Hobukersaier, Wenquan, Xinyuan County and Bayinbuluk Pasture in 
Xinjiang; Xiji County in Ningxia, Ganzi County in Sichuan, and Dangxiong, 
Dingqing County in Tibet AR.  
2.2.2 Antigens for human Echinococcus antibodies detection 
Four native antigens were used for DIGFA test which included E. granulosus cyst 
fluid antigen (EgCF), crude somatic extract of E. granulosus protoscoleces (EgP), 
E. granulosus cyst fluid antigen B (EgB) and E. multilocularis metacestode antigen 
Em2. The first three antigens were made from hydatid cyst fluid and E. granulosus 
protoscoleces, which were obtained by aseptic aspiration from naturally infected 
sheep livers or lungs collected in abattoirs from different endemic areas of 
Xinjiang, P. R. China. Em2 was made from E. multilocularis larval metacestode 
masses which were obtained from experimentally infected gerbils (Meriones 
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unguiculatus) at XMU. The details for preparation of them were in Appendix I. 
The assay followed the standard indirect ELISA procedure for specific IgG 
detection with slight modification as used in the XMUH laboratory (Zhang et al., 
2001). Buffers used are detailed in Appendix 2. 
2.2.3 Development of multiple-antigen DIGFA for immunodiagnosis of 
human echinococcosis  
Colloidal gold and conjugate was made following laborotary protocols. Rapid dot 
immunogold infiltration assay (DIGFA) was then designed for rapd test which was 
including a test plate and three test buffers: buffer A, B and C. Stability of DIGFA 
were observed in different temperatures for over then one year. Test procedure 
was finally standarded. 
2.2.4 Comparison between DIGFA and ELISA 
Serum samples from a hospital panel were tested by DIGFA and ELISA tests. The 
difference of sensitivity and specificity was calculated by SPSS 16.0 software (at 
p<0.05 level). The sensitivity and specificity of each antigen in DIGFA and ELISA 
were assessed. 
2.2.5 Evaluation of diagnostic accuracy of DIGFA 
The sensitivity, specificity, accuracy, negative predictive value (NPV) and positive 
predictive value (PPV), Odds Ratio (OR), Youden index, Positive likelihood ratio 
(PLR) and Negative likelihood ratio (NLR) of DIGFA were assessed for evaluation 
of this diagnostic test in each serum panel (The TDR Diagnostic Evaluation Expert 
Panel, 2006). In addition the reproducibility of DIGFA was also assessed for 
measuring or was test the stability. 
True positives and negatives were previously determined by the gold-standard of 
clinical diagnosis with imaging (which was confirmed by surgery in hospital cases 
or ultrasound in the community studies). 
 
2.3  Materials and methods for Rapid immunochromatographic assay (ICA) 
test for direct detection of human E. granulosus cyst fluid antigen B (EgB) 
Human hydatid cyst fluid samples were collected from the First Teaching Hospital 
of Xinjiang Medical University.  
E. granulosus antigen B (EgB, from sheep cyst fluid) was prepared as Appendix I. 
Hyperimmune rabbit serum anti EgB sera was then made and prepared for 
capture and conjugated antibodies. Half of above rabbit anti-EgB IgG was 
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conjugated with colloidal gold. 
Direct and indirect DIGFA test for antigen detection in human hydatid cyst fluid 
were tried for the rapid test but did not perform very well. 
Immunochromatographic Assay (ICA) was then another better choice for antigen 
detection using a sandwich assay style approach. Therefore, an ICA test was 
designed to be composed of a sample pad, a conjugate pad, a NC membrane with 
test and control lines and an absorbent pad.  
Finally the ICA results were initially assessed. 
 
2.4  Dog faeces sampling and preparation for coproantigen test  
2.4.1  Study and sampling sites for canine echinococcosis 
Most research on diagnosis of canine echinococcosiswas undertaken in Salford 
University with the main faecal samples came from China. 
E. granulosus adult worms used for developing a rapid immunochromatographic 
assay (ICA) were obtained from experimentally infected dogs in Xinjiang 
Veterinary Research Institute, China.  
A panel of normal dog faeces was gain from a UK non-endemic area and 
experimental normal control non-parasite infected dogs from XMUH, China.  
Screening of owned dog was carried at the same time as the human 
echinococcosis surveys in northwestern China. Dog sampling occurred mainly in 
Habahe, Qinghe, Xinyuan, Bayinbuluk, Wenquan and Hoboksar counties in 
Xinjiang; Yushu County in Qinghai; Ganzi County in Ganzi Tibetan 
AutonomousPrefecture in Sichuan, and Dangxiong and Dingqing counties in Tibet 
AR.  
2.4.2  Matierials and methods for canine echinococcosis 
Matierials.  
E. granulosus adult worms used for developing a rapid immunochromatographic 
assay (ICA) were obtained from 9 experimentally infected dogs at Xinjiang 
Veterinary Research Institute, China. Required E. granulosus protoscoleces were 
collected freshly from hydatid cysts from sheep liver or lungs in a slaughter house 
in Xinjiang. The adult worms were collected and stored as described by Allan et 
al ,1992 and Craig, 1997. 
Faecal samples were prepared essentially as described by Allan et al. (1992).  
E. granulosus whole worm extract antigen (EgWWE) was prepared essentially 
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according to Allan et al. 1992.  
Preparation of hyperimmune rabbit antiserum was done according to the method 
described by Allan and Craig (1989) with a few small alterations.  
Sandwich ELISA test for canine coproantigen detection 
Preparation of capture and HRP conjugated rabbit anti-serum IgG was made 
according to the methods mentioned from Allan and Craig, 1989 and the 
conjugate was made via the method described by Wilson and Nakane (1978). 
Coproantigen ELISA procedure was used as described by Allan and Craig, 1989. 
Development of a rapid ICA coproantigen test  
A rapid sandwich ICA test were developed and optimized. Dog faecal samples 
were tested by ICA and ELISA for coproantigen detection. Results were compared 
and assessed with sensitivity and specificity with 95 confidence interval. Positive 
and negative predictive values were also determined. 
 
2.5 Community studies on echinococcosis in northwest China 
2.5.1 Study locations and communities 
The study was part of mass screening survey for echinococcosis in highly 
endemic areas of northwest China during 1998-2007. There included main study 
sites of Yili, Tacheng, Altai, Boertala and Bayinguoleng Prefectures in Xinjiang 
Uygur Autonomous Region; also collaborate work with -Guyuan Prefecture in 
Ningxia Hui Autonomous Region, Ganzi Tibetan Autonomous Prefecture in 
Sichuan, Lhasa and Chamdo Prefectures of Tibet Autonomous Region.  
2.5.2 Human echinococcosis screening 
i. Questionnaire including general information and relative risk factors history (see 
appendix). 
ii. Blood samples were collected from volunteers after the questionnaire and 
serological tests were did with Rapid DIGFA kit 
iii. Abdominal ultrasound scanning were did for all the volunteers and Images with 
CE or AE characters or suspected cases were recorded. 
iv. Serology follow-up were did by double check by DIGFA and/or US, or a chest 
X-ray for suspects. 
v. All the CE or AE detected cases that needed treatment were initially given 
albendazole tablets or surgical treatment. 
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2.5.3 Canine echinococcosis surveys  
Dog surveys by different teams were performed at the same time as 
community screening for human disease. A questionnaire (see appendix III) for 
dog owners included their host general information and dog’s details. Dog faecal 
samples were collected. 
 
2.6 Data analysis 
Data analysis was used to evaluate the immunodiagnositic tools and determine 
risk factors in epidemiological studies on echinococcosis.  
Chi-square tests were used to compare differences between rapid DIGFA and 
portable US scanning for human CE/AE; between rapid DIGFA and ELISA for 
human echinococcosis diagnosis; contribution differences among four different 
antigens; between rapid ICA and ELISA for coproantigen detection in dogs; and 
distributions of CE or AE in different locations/ethnic groups/ages/occupations. 
Univariate odds ratios were used to determine independent associations of risk 
factors in different areas and different variables (including dog owner, livestock 
owner, home slaughter, occupation, education, hygienic habits, etc.) 
Multivariate logistic regression was used to find adjusted odds rations to assess 
the relationship of diseases with different risk factors in different ethnic groups, 
different areas and find the key control points. 
All analyses performed using SAS 9.0, SPSS 16.0 and Epi info version 6.0.  
Statistical significance was set at alpha=0.05. 
 57
Chapter 3. Development and application of a rapid dot 
immunogold filtration assay (DIGFA) antibody detection kit for 
human CE and AE 
 
3.1 Introduction 
Echinococcosis is a worldwide zoonosis caused by the larval stages of tapeworms 
(cestodes) belonging to the genus Echinococcus (family Taeniidae). 
Echinococcus granulosus and Echinococcus multilocularis, which cause human 
cystic echinococcosis (CE) and alveolar echinococcosis (AE) respectively, are 
highly endemic in China (Wen and Yang, 1997; Craig, 2004). Both cause serious 
and potentially life-threatening diseases, the latter especially with high fatality 
rates and poor prognosis if not diagnosed and treated in the early stages (Zhou et 
al., 2000; WHO/OIE 2001; Craig et al., 2003). Mixed CE and AE cases are rare 
but have also been reported in China (Wen et al., 1992; Yang et al., 2006a; Yang 
et al., 2006b). Currently, mortality for human CE may vary between 0.2% and 
4.5%, and for human AE 10-15% (Wen and Yang, 1997; WHO/OIE 2001; 
McManus et al., 2003; Zhang et al., 2003).  
Early diagnosis of human echinococcosis is difficult because CE and AE patients 
usually have no signs or symptoms during the first few years of infection. Human 
echinococcosis commonly comes to the attention of clinicians because of 
non-specific clinical signs (e.g. upper abdominal pain, jaundice, allergic reactions) 
or due to incidental image findings of echinococcal cysts or lesions, or after 
specific mass-screening surveys by ultrasound and/or serology (WHO 1996; 
WHO/OIE 2001; Zhang and McManus, 2006).  
The frequent difficulty in obtaining a definitive diagnosis is one reason why 
immunological methods have played an important role of diagnosis of human 
echinococcosis (Wen et al., 1995, Rogan and Craig 1997, 2002; WHO/OIE 2001). 
Almost all traditional immunodiagnostic methods (e.g. Casoni intradermal test, 
complement fixation test, indirect haemagglutination test, indirect 
immunofluorescence antibody test, immunoelectrophoresis (IEP), and latex 
agglutination test), have now been replaced by the enzyme-linked immunosorbent 
assay (ELISA) and/or immunoblotting (IB) which are commonly performed in 
routine laboratory diagnosis of human echinococcosis (Rogan and Craig, 2002; 
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Craig et al., 2003). Hydatid cyst fluid lipoprotein antigen B (AgB) from E. 
granulosus, and Em2/Em2plus, and/or Em18 antigens from E. multilocularis, are 
currently considered to be the most specific native or recombinant antigens for 
immunodiagnosis of human CE and AE respectively (Gottstein et al., 1987; Ito, 
2002; Zhang et al., 2003; Carmena et al., 2005, 2006). 
Although ELISA and immunoblot are very useful laboratory tests for human 
echinococcosis, a rapid immunological method that can be used for initial 
diagnosis of clinically suspected CE or AE, and that could be applied in 
community screening, would be extremely convenient. Rapid serological test 
formats such as dot-ELISA have been previously assessed for both human CE 
and AE, and although useful in conjunction with mass ultrasound screening, they 
were temperamental and difficult to use and interpret (Zheng et al., 1986; Rogan 
et al., 1991; Eliades et al., 1998; Qiao et al., 1999; Craig et al., 2000). Dot 
immuno-gold filtration assay (DIGFA) is a rapid immunodiagnostic test similar to a 
‘pregnancy’ test that uses colloidal gold conjugated antibody or antigen instead of 
enzyme or fluorescence conjugates (Faulk and Taylor 1971; Horisberger et al., 
1975; May 1991; Chun and Chu 1989; Xiao et al., 1995). Antigens are attached on 
a nitrocellulose membrane, and serum or whole blood applied, followed by 
colloidal gold conjugated anti-human antibodies to give a desired color change to 
indicate a positive or negative reaction.  
In the current study a rapid DIGFA has been developed for human echinococcosis 
and assessed with four different native antigen-preparations including, E. 
granulosus crude hydatid cyst fluid antigen (EgCF), hydatid cyst fluid native 
antigen B (AgB), an E. granulosus protoscolex antigen extract (EgP), and an E. 
multilocularis metacestode laminated layer extract (Em2). The test was assessed 
in Xinjiang Medical University Hospital (Urumqi, northwestern China), which has 
treated over 6000 human echinococcosis cases in the last 40 years (Wen and 
Yang, 1997). The current study showed that the major advantages of DIGFA were 
rapidity, convenience, and ability to provide initial diagnosis and even 
differentiation of cystic and alveolar echinococcosis in approximately 80% of 
cases either in clinical or community screening settings. 
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3.2 Methods and Approaches 
3.2.1  Serum samples and echinococcosis patients 
3.2.1.1. Hospitalized hydatid patients 
Archived serum panels used in the initial laboratory development and 
standardization of the DIGFA, were available from 108 post-operative hepatic CE 
cases, 34 post-operative hepatic AE cases, and 101 healthy controls collected 
from Xinjiang Medical University Hospital (XMUH) during 1998–2000. In addition 
25 sera from cysticercosis (Taenia solium) patients were a gift from Prof. Y.H. Liu, 
Chongqing Medical University, P. R. China. (Table 3.1). 
A serum panel was also available to assess hospital-based diagnosis of DIGFA 
and compared with standard ELISA. It consisted of 857 CE sera including 717 
hepatic CE cases: among them, 516 ultrasound and/or surgery confirmed patients 
with less than 2 years post-surgery, 64 lung CE cases (diagnosed by X-ray or 
computerized tomography (CT)), 11 abdominal CE (diagnosed by ultrasound or 
CT), 18 multi-organ CE (diagnosed by ultrasound and CT) and 47 non-liver/lung 
CE cases (diagnosed by ultrasound, CT or magnetic resonance imaging (MRI)) 
(Table 3.2 and Fig. 3.1). In addition, sera from 42 liver AE cases and 1 mixed 
AE/CE case were assessed. In total 702 serum samples from non-hydatid disease 
patients were used as negative controls: non-parasite simple cystic disease 153, 
carcinoma 85, tuberculosis 28, solid or complicated space-occupying lesions 
(non-echinococcosis by imaging) 266, cirrhosis 6, abscess 13, cysticercosis 3, 
cholecystitis/gallstones 12, other patients treated in internal medicine (for 
hypertension, diabetes, and other clinical conditions) 88 and healthy individuals 5 
(Table 3.3). All samples were collected and tested in XMUH during the period 
1999–2006. For non-endemic controls, 35 sera from healthy people were collected 
from a hospital in Greater Manchester, UK, which is a non-endemic area. 
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Table 3.1: Hospital serum samples for developing and application of DIGFA 
serodiagnosis of human echinococcosis 
Duration Where CE AE Mixed 
CE/AE
Cysticercosis 
(Taenia 
solium) 
Normal 
control 
Total
1998-1999 XJMUHa 108b 34b 0 0 101 243 
1998 Chongqing 
Medical 
University c 
0 0 0 25 0 25 
1999-2006 XJMUH 857 42 1 0 702 1602
Total  965 76 1 25 803 1870
a: XJMUH means Xinjiang Medical University Hospital, Urumqi 830000, P. R. China 
b: hepatic CE or AE cases 
c: sera from cysticercosis (Taenia solium) patients were a gift from Prof. Y.H. Liu in 
Chongqing Medical University, P. R. China. 
 
 
Table 3.2: Hospital cystic echinococcosis cases in different organs in 
XJMUH (1999-2006) 
Organs Cases Percentage 
liver 717 83.7% 
lung 64 7.5% 
abdominal cavity 11 1.3% 
pelvic cavity 17 2.0% 
multi-organ 18 2.1% 
brain 5 0.6% 
spleen 6 0.7% 
kidney 5 0.6% 
bone 7 0.8% 
heart 3 0.4% 
thoracic wall 3 0.4% 
pancreas 1 0.1% 
Total 857 100% 
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Fig. 3.1: Hospital cystic echinococcosis cases in different organs in XJMUH 
(1999-2006) 
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Table 3.3: Hospital non CE/AE control cases in different disease in XJMUH 
(1999-2006) 
Clinical diagnosis Organs N Percentage 
Liver 154 21.9% 
Lung 4 0.6% 
Brain 5 0.7% 
Kidney 5 0.7% 
Spleen 5 0.7% 
Abdominal cavity 5 0.7% 
Pelvic 8 1.1% 
Multi-organ 5 0.7% 
Non-parasite cystic disease 
(n=196) 
Others 5 0.7% 
Benign 30 4.3% 
Malignant 49 7.0% 
Carcinoma 
(n=85) 
Unknown 6 0.9% 
Thoracic cavity or lung 22 3.1% 
Spine 3 0.4% 
Tuberculosis 
(n=28) 
Abdominal cavity 3 0.4% 
Solid or complicated 
space-occupying lesions (non 
echinococcosis by imaging) 
Liver, lung and others 266 37.9% 
Cirrhosis  6 0.9% 
Abscess Lung, liver etc. 13 1.8% 
Cysticercosis (T. solium) Brain 3 0.4% 
Cholecystitis /gallstones Gallbladder 12 1.7% 
Other internal medicine Diabetes, hypertension, 
etc. 
88 12.5% 
Normal Healthy individuals 5 0.7% 
Total  702 100% 
 
Blind test. Sera from 224 CE and 68 AE patients from Xinjiang Medical University 
Hospital (XMUH) confirmed by surgery and pathology were assessed. In addition, 
112 serum samples, including 33 AE, 18 CE, 32 cysticercosis (T. solium), 10 
schistosomiasis and 19 negative controls were available from Salford University 
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(UK), and 128 serum samples, comprising 11 CE, 72 AE and 45 negative controls 
were provided by Besancon University Hospital (France). All sera were labeled by 
number only and tested in XMUH and Salford University. 
Non-endemic control sera. 35 ‘normal’ (non echinococcosis) controls from 
healthy people were collected from Greater Manchester hospital, UK 
(non-endemic area). 
 
Serum sample preparation from hospital human hydatid cases 
All blood samples were collected through vein injection (3-5mL per person), 
allowed to clot for 1 hour under the room temperature, or mixed well with 
procoagulant reagent (Clot activator for quick clot in 5 mins, such as ‘increased 
silica act clot activator, silicone-coated interior’, which could be applied in 
“procoagulant tube” products, Zhejiang Gong-Dong Medical Plastic Company), 
centrifuged at 2000 rpm for 10 mins and aliquots 0.5ml/tube, stored at 4 °C for test 
within 2 days or -80 °C for long-term storage. 
 
3.2.1.2 Samples collection from community screening.  
Echinococcosis endemic communities in northwest China that were screened by 
ultrasound and serology were: Qinghe, Hobukersaier, Wenquan, Xinyuan County 
and Bayinbuluk Pasture in XUAR; Xiji County in Ningxia Hui Autonomous Region 
(AR); Ganzi County in Sichuan Province; and Dingqing County in Tibet AR (Feng 
et al., 2002, Chen et al., 2005, Wang et al., 2001, Yang et al., 2006a, 2006b). 
Based on ultrasound scan as the gold standard, serum samples from 160 CE and 
108 AE cases, and 2923 normal persons came from endemic communities in 
northwest China screened by ultrasound (US). Ultrasound normal cases with a 
previous history of echinococcosis surgery were not included in the ‘negative’ 
group. All persons included gave informed consent for their serum to be collected 
and assessed in the study. Ethical permission was granted by the Xinjiang Medical 
University Hospital Ethical Committee. 
 
3.2.2 Preparation of diagnostic antigens 
Native extracts of E. granulosus and E. multilocularis were used because they can 
be prepared relatively easily by most laboratories. Sheep hydatid cyst fluid and 
protoscoleces from E. granulosus were collected in Xinjiang Uygur Autonomous 
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Region (XUAR), China. Crude cystic fluid (EgCF) was partially purified by affinity 
chromatography using a normal human serum coupled to CNBr–Sepharose 4B to 
remove non-specific host reactive proteins from sheep hydatid cyst fluid (Rogan et 
al., 1991, Zhang et al., 2000). A crude somatic extract of E. granulosus 
protoscoleces (EgP) with >85% viability were harvested from fertile sheep hepatic 
hydatid cysts, prepared by ice cold homogenization and centrifugation (13,000 × g 
for 30 min at 4 °C) and partially purified by affinity chromatography as for EgCF 
(Zhang et al., 2000). E. granulosus cyst fluid antigen B (AgB) was purified from 
fresh sheep hydatid cyst fluid by precipitation, boiling, centrifugation and 
concentration by dialysis as previously described (Rogan et al., 1991, Rogan and 
Craig, 1997, Zhang et al., 2000 and Zhang et al., 2001). Experimental infections of 
gerbils (Meriones unguiculatus) after 3 months post-infection with E. multilocularis 
protoscoleces (in a metacestode homogenate suspension) were used to produce 
metacestode tissue for extraction of a laminated layer enriched antigen (Em2) by 
homogenization, centrifugation and affinity chromatography using rabbit anti-E. 
granulosus cyst fluid-IgG coupled CNBr–Sepharose 4B column (Gottstein et al., 
1983 and Zhang et al., 2001). (Details in appendix I). 
 
3.2.3 Development of a rapid DIGFA system for human echinococcosis 
A rapid dot immuno-gold filtration assay (DIGFA) was chosen for development an 
immunodiagnostic test for detection antibody of human echinococcosis, which 
could be easily used to replace Casoni test for initial diagnosis combined with 
ultrasound in the rural area. Several antigens were selected and applied with a 
DIGFA test for evaluation their sensitivity and specificity for human 
echinococcosis. This developed DIGFA test for human echinococcosis was 
applied in the patients from Xinjiang Medical University Hospital and the results 
were compared with standard ELISA.  
3.2.3.1 Diagnostic Antigens selection and preparation 
Several native antigens were generally used for antibody detection of human 
echinococcosis by ELISA or immunoblot, e.g., native Echinococcus antigens 
EgCF, EgP, Arc-5 and antigen B for CE, EmP, Em2 and Em18 for AE (see Chapter 
1). Combined different antigens might supply more information for diagnosis of 
human echinococcosis and obtain better sensitivity and specificity.  
Antigens were selected by materials available, easy preparation, sensitive and 
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specific for both CE and AE. Preparation of Echinococcus granulosus cyst fluid 
antigen (EgCF) and E. granulosus protoscoleses abstract (EgP) were studied by 
ELISA and dot immunoblot assay (DIBA) to obtain better sensitivity of human CE 
(Zhang et al., 2000). Meanwhile, more specific antigen B for human CE and Em2 
for AE were selected and tested by ELISA. 
Native extracts of E. granulosus and E. multilocularis were used because they can 
be prepared relatively easily by most laboratories. Sheep hydatid cyst fluid and 
protoscoleces from E. granulosus were collected in Xinjiang Uygur Autonomous 
Region (XUAR), China. Crude cystic fluid (EgCF) was partially purified by affinity 
chromatography using a normal human serum coupled to CNBr–Sepharose 4B to 
remove non-specific host reactive proteins from sheep hydatid cyst fluid (Rogan et 
al., 1991, Zhang et al., 2000). A crude somatic extract of E. granulosus 
protoscoleces (EgP) with >85% viability were harvested from fertile sheep hepatic 
hydatid cysts, prepared by ice cold homogenization and centrifugation (13,000 × g 
for 30 min at 4 °C) and partially purified by affinity chromatography as for EgCF 
(Zhang et al., 2000). E. granulosus cyst fluid antigen B (AgB) was purified from 
fresh sheep hydatid cyst fluid by precipitation, boiling, centrifugation and 
concentration by dialysis as previously described (Rogan et al., 1991, Rogan and 
Craig, 1997, Zhang et al., 2000 and Zhang et al., 2001). Experimental infections of 
gerbils (Meriones unguiculatus) after 3 months post-infection with E. multilocularis 
protoscoleces (in a metacestode homogenate suspension) were used to produce 
metacestode tissue for extraction of a laminated layer enriched antigen (Em2) by 
homogenization, centrifugation and affinity chromatography using rabbit anti-E. 
granulosus cyst fluid-IgG coupled CNBr–Sepharose 4B column (Gottstein et al., 
1983 and Zhang et al., 2001). (Details see appendix I). 
 
3.2.3.2 Preparation of colloidal gold and conjugate 
Preparation of colloidal gold 
Gold chloride (HAuCl4, 10%) was prepared with H2O using HAuCl4·3H2O, Gold (III) 
Chloride trihydrate, ACS reagent (Sigma G4022). Pure water 100mL in a 500mL 
glass flask was boiled in a microwave oven (around 90 seconds in 750W). 300 µL 
of 10% HAuCl4 was added until the solution was pale yellow and then boiled again 
and 7.5 ml 1% sodium citrate (fresh made) was added immediately. The flask was 
swirled quickly to mix the reagents well. The colour should change into wine red in 
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1-2 minutes. The colloidal gold was cooled at room temperature and then stored 
at 4°C with a foil cover until used for conjugate to antibody. 
 
Preparation of colloidal gold conjugate 
Goat anti-human IgG (Sigma I1886, USA; Sino-American Biotechnology Co, 
Luoyang, China) was diluted to 1mg/ml in 20mM Tris-HCl buffer, and 384µL of IgG 
solution added (determined by colloidal gold conjugate volume, see appendix 3) to 
10 mL of colloidal gold with 1 mL of 10mM borate buffer. The conjugate was 
allowed to combine at 4°C for over 45 minutes. Blocking buffer including 100mM 
Tris-HCl, 25% sucrose, 5% Gelatin (Sigma-Aldrich, G7765, from cold water fish 
skin) and 0.03% polyethylene glycol 20,000 (PEG, BDH Chemicals Ltd. Poole, UK) 
was added 2.95mL and mixed well to block unbound colloidal gold. The conjugate 
was then filtered through a 0.2µm syringe filter (Millipore, UK) and stored at 4°C 
within dark bottles (stable for up to 1 year). 
 
3.2.3.3 Building a Rapid dot immunogold infiltration assay (DIGFA) 
3.2.3.3.1 Composition of a DIGFA test Plate: 
The test components were set up in advance: plastic plate base plus filter tissue 
plus Nitrocellulose (NC) membrane (0.45µm pore size, Sartorius, Germany) plus 
top cap (Fig 2-2). 
Normal human sera control for test function diluted with pH 8.2 200mM Tris-HCl 
buffer (1:1 ratio) was added as one drop (1µL) onto the middle of the NC 
membrane ensuring that the pipette tip did not contact with the NC membrane; 
Antigen solutions EgCF, EgP, EgB, Em2 (the concentration of each was 
determined by chess-board check with CE or AE patient sera) were coated as a 
small dot (0.5 µL per dot) onto the 4 corners of the NC membrane, and allowed to 
dry completely. 
The test kit with antigens was vacuum-packed in an aluminium foil bag and stored 
at 4°C until used (stable for up to 1 year). 
 
3.2.3.3.2 Test buffers: buffer A, B and C 
Buffer A was a sample dilution buffer and also blocking buffer and consisted of 
20mM Tris-HCl, 1% Gelatin and 0.05% Tween 20. Washing buffer B was made up 
of 20mM Tris-HCl, 0.9% NaCl and 0.4% Tween 20. Buffer C was the colloidal gold 
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conjugated goat anti-human IgG (see above). 
 
3.2.3.3.3 Stability of DIGFA 
The test kit and buffers were stored at 37 °C for 2 weeks  and at room 
temperature (20-25°C) for 2 months with no change to test efficacy.  
The test result could be kept stable in 24 hours at 4°C and 20 minutes in room 
temperature. 
 
3.2.3.3.4 Test procedure  
Serum (20µL) was diluted with 5-drops (about 200 µL) of Buffer A. Whole blood 
(heparinized blood) was diluted 40 µL with 5-drops Buffer A and centrifuged at 
3000rpm for 3 min and the supernatant retained. Diluted sera or whole blood 
supernatant was added (100µL) to the well of NC membrane until absorbed. Then 
the NC membrane was added with 3 drops of washing buffer (Buffer B).  
Three drops colloidal gold conjugated goat anti-human IgG (Buffer C) was added 
until absorbed. Then the NC membrane was washed with 3 drops washing buffer 
(Buffer B) again. 
The membrane was read then (better in 5 minutes). Red or purple colour of an 
antigen dot means positive. 
 
 
 
 
 
 
 
 
Fig. 3.2: Left: the model of test kit; Right: procedure step by step, 3-5 
minutes in total.  
 
 
3.2.3.4 Optimization of DIGFA 
In general, DIGFA is using nitrocellulose (NC) membrane as a carrier which 
pre-coated antigen or antibody as a capture which is similar to immunoblot without 
Positive 
Buffer A
Sera 
Mix
Add on 
the plate 
Buffer B Buffer B Buffer C
Central well 
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substrate step (see Chapter 1). An immunoblot nitrocellulose (NC) membrane 
(pore size 0.45µm, Sartorius, German) was used in this study. Pretreatment with 
20% methanol of NC membrane made it operable to put into a frame of DIGFA kit 
since original NC membrane was crisp and easy to break. Additional treatment 
with 0.01% SDS and 0.01% Tween 20 were optional when the absorbance of 
antigens on NC membrane was not good enough due to storing for a longer time 
(eg. more than one year). 
Optimal concentrations of antigens were assessed by coated with different 
dilutions (1:2, 1:4, 1:8 and 1:16) and tested with serum samples of CE, AE cases 
and healthy individuals (Table 3.4). Finally EgCF 1:2、EgP 1:2、AgB 1:3、Em2 1:6 
were determined. Optimal concentration of colloidal gold conjugate (see Chapter 
2) was also determined by the same serum panel. 
The DIGFA kit was designed with a test working control (mixed sera of healthy 
individuals) in the central of a test well and four antigens at 4 corners. DIGFA 
procedure was carried out as described in Appendix. The DIGFA results were 
assessed usually as positive or negative spots (Fig. 3.3).  
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Table 3.4: Optimization of concentrations of antigens for DIGFA 
DIGFA results b Antigens a 
CE1 CE2 CE3 AE1 AE2 AE3 N1 N2 N3
EgCF original 3+ + 2+ 3+ + 2+ ± - - 
EgCF 1:2 2+ ± + 3+ ± - - - - 
EgCF 1:4 2+ ± ± 2+ - - - - - 
EgCF 1:8 - - - + - - - - - 
EgP original 3+ + 2+ 3+ + + ± - - 
EgP 1:2 2+ ± + 3+ + + - - - 
EgP 1:4 ± ± ± 2+ - - - - - 
EgP 1:8 - - - + - - - - - 
AgB original 3+ + 2+ 3+ ± + - - - 
AgB 1:2 2+ ± + 2+ ± - - - - 
AgB 1:4 2+ ± + + - - - -  
AgB 1:8 + - + - - - - - - 
Em2 original + + + 4+ + 3+ ± ± - 
Em2 1:2 ± ± ± 3+ + 2+ - - - 
Em2 1:4 ± - - 2+ + + - - - 
Em2 1:8 - - - 2+ ± + - - - 
a  The protein concentration of original antigens were ranged from 2-4mg/ml. 
b CE1,2 and 3 were serum samples of CE cases which showed strong, weak and middle 
positives by ELISA; AE1, 2 and 3 were serum samples of AE cases which showed strong, 
weak and middle positives by ELISA; ‘’+’’ was positives and ‘’-‘’ was negatives. 
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(i) 
 
 
 
 
(ii) 
 
 
 
 
 
Fig. 3.3: DIGFA test kit  
(i) Diagram of antigen dots: 
     Dot A is for EgCF, Dot B for EgP, Dot C for AgB and Dot D for Em2 antigens 
(ii) Actual DIGFA result after serum test (3 minutes) 
 (a) Serum positive CE case, (b) serum positive AE case, (c) negative control 
 
3.2.4  ELISA tests for detection of human serum antibodies 
Optimal dilutions of antigen extracts (5-15µg/ml) were determined by check-board 
titration using EgCF, EgP, EgB or Em2 antigens. Antigens were coated 100µl/well 
on to the 96-well microtitre plates (12well *8 line and frame, from Shanghai Kehua 
Bio Tech Co., China) with carbonated coating buffer (0.01M NaHCO3, pH9.6) and 
left at 4 ºC overnight. 
The microtitre plate was washed 3 times with 0.15M PBS (pH7.2) including 0.1% 
Tween20 (PBSTW) and then blocked 37ºC for 2 hours with a blocking buffer 
consisted of 0.15M PBS, 1% BSA (bovine sera albumin), 0.3% Tween20 and 
1.6% gelatin added to reduce non-specific binding. 
After washing the plate 3 times with PBSTW, sera was added 100µl/well at 1:100 
dilution in a sample buffer (0.15M PBS with 0.3% Tween20 and 3% normal sheep 
sera for 30 minutes at 37 ºC. Plate then washed as above. 
Horseradish peroxidase (HRP) conjugated goat anti-human IgG (Sigma A6029) at 
a b c
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100µL/well (1:8000 diluted according to manufactories instruction by a conjugate 
buffer including 0.15 M PBS, 0.3% Tween20 and 3% normal sheep sera) was 
added for 20 minutes at 37ºC. Plate then washed as above. 
Substrate of tetramethyl benzidine (TMB) (buffer A and B 50 µL/well respectively, 
TMB powder from BBI, Canada, imported by Shanghai Sangon Co, buffer A and B 
made according appendix 2) was added and incubated for 15 minutes at 37ºC. 
After final substrate incubation, the reaction was stopped after 15-20 minutes by 
adding 50 µl/well of stop buffer (0.5% sulfuric acid). 
Microtitre plate OD values for each well was read at 450nm using a microplate 
reader (Bio-Rad 550, USA). The positive-negative cut-off was the mean OD of 
control sera plus 3 SD, or 2.1 times the OD value of normal controls. The latter 
was used routinely in the XMU hospital ELISA microplate reader’s software 
programme. Buffers details were shown in Appendix II. 
 
3.2.5 Assessment of DIGFA in diagnosis of human CE and AE 
The sensitivity, specificity, accuracy, negative predictive value (NPV) and positive 
predictive value (PPV), Odds Ratio (OR), Youden index, Positive likelihood ratio 
(PLR) and Negative likelihood ratio (NLR) of DIGFA were assessed for evaluation 
of this diagnostic test in each serum panel (The TDR Diagnostic Evaluation Expert 
Panel, 2006). The reproducibility was tested in the same or different batch of 
DIGFA kit. The storing stability was determined by testing after storing at 37°C 2 
for 2 weeks and at room temperature (20-25°C) for 2 months. Comparisons of 
DIGFA with ELISA were carried out in initial development panel and hospital test 
panel. 
The definitions and formulations for above assessment indexes were as 
follows. 
i) Gold standard or reference standard means the best available test that is 
used as comparison and provided by professional authorities. Here the 
confirmed clinical diagnosis by ultrasound, X-ray, computerized 
tomography (CT), magnetic resonance imaging (MRI and/or surgery was 
used as gold standard. 
ii) Sensitivity (Se) means that the probability of test positives from truly 
infected individuals (true positive rate). Sensitivity= no. of test positives in 
infected individuals /no. of infected individuals *100% 
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iii) Specificity (Sp) means that the probability of test negatives from truly 
uninfected individuals (true negative rate). Specificity = test negatives in 
uninfected individuals/ uninfected individuals *100% 
iv) Accuracy means that the percentage of correct test results compared with 
the gold standard. Accuracy = (true positives + true negatives)/(infected + 
uninfected)*100% (the number of correct results divided by the total 
number of results) 
v) Negative predictive value (NPV) means the probability of a negative result 
accurately which indicates the absence of infection. NPV=true 
negatives/(true negatives + false negatives) 
vi) Positive predictive value (PPV) means the probability of a positive result 
accurately which indicates the presence of infection. PPV= true positives / 
(true positives + false positives) 
vii) 95% confidence intervals (CI): n
ppp )1(96.1 −±
 
viii) The diagnostic odds ratio (DOR) is a measure of the effectiveness of a 
diagnostic test. It is defined as the ratio of the odds of the test being 
positive if the subject has a disease relative to the odds of the test being 
positive if the subject does not have the disease. A DOR of exactly one 
means that the test is equally likely to predict a positive outcome whatever 
the true condition. Higher DOR are indicative of better test performance. 
Sensitivity Specificity 
Diagnostic Odds Ratio = 1 - Sensitivity × 1 - Specificity 
 
ix) Youden index is an index for accurate diagnosis, which shows the ability of 
the test could judge patient or non-patient. 
Youden index = Sensitivity + Specificity – 1 
 
x) Positive likelihood ratio (PLR) indicates the ratio between true positive rate 
and false positive rate, which explains the multiple between the probability 
of the test positives in patients and in non-patients. Higher PLR means 
better validity and valuable for clinical diagnosis. 
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True positive rate Sensitivity 
PLR = False positive rate = (1-Specificity) 
xi)  Negative likelihood ratio (NLR) is the ratio between false negative rate and 
true negative rate, which indicates the multiple between the test negative 
probability in patients and in non-patients. Lower NLR means better validity. 
False negative rate (1-Sensitivity) 
NLR = True negative rate = Specificity 
 
For the ELISA procedure, positive-negative cutoff value was determined as the 
mean optical density (OD) value of a panel of negative controls (n=35) plus three 
standard deviations (Table 3.5). Sensitivity and specificity were calculated using 
95% confidence intervals (CI) and significance values were also determined at the 
95% probability level.  
 
Table 3.5: Comparison of DIGFA and ELISA with non-echinococcosis human 
sera from non-endemic area  
DIGFA (n=35) ELISA (n=35) Antigens 
Positive* Negative Specificity Positive Negative Specificity
EgCF 6 29 82.9% 1 34 97.1% 
EgP 6 29 82.9% 0 35 100% 
AgB 0 35 100% 1 34 97.1% 
Em2 0 35 100% 1 34 97.1% 
* These positives in DIGFA all showed just suspectable with very poor positive. 
ELISA positives cutoff was mean OD of all samples add 3 times standard deviation. 
Cutoff-1 for EgCF: 0.570, EgP: 0.327, AgB: 0.303, Em2: 0.343 
 74
3.3  Results 
All the human serum samples were tested by the DIGFA and/or ELISA formats 
prepared in the Xinjiang Hydatid Clinical Research Institute, Xinjiang Medical 
University Hospital.  
 
3.3.1 Development and Initial validation of multiple Echinococcus antigens 
(EgCF, EgP, AgB and Em2) in DIGFA for human echinococcosis 
In preliminary assessment of archived serum samples the sensitivity of DIGFA for 
human CE (n=108) was 92.6%, 90.7% and 89.8% with EgCF, EgP and AgB native 
antigen preparations respectively. For human AE (n=34) the sensitivity of DIGFA 
was 91.1% for Em2 antigen. The specificity for CE with AgB antigen in DIGFA was 
88.1% with 95% confidence intervals (CI) (82.0%--94.2%), and for AE with Em2 
antigen was 93.6% with 95% CI (89.4%--97.8%). Cross-reactivity between human 
CE and AE for AgB antigen was 35.3% for AE, while cross-reactivity for Em2 with 
human CE was 7.4%. Cross-reaction in DIGFA with serum from cysticercosis 
patients was observed with all four antigens (60% and 56% with EgCF and EgP; 
8%, 16% respectively for AgB and Em2). There was no statistical difference 
between results observed using DIGFA versus the standard ELISA (p>0.05). Of 
the four different native antigen preparations the highest sensitivity occurred with 
antigen EgCF (92.6% for CE cases and 88.2% for AE cases) (Table 3.6).  
The reproducibility, or called reliability was checked by the same or different 
batches of DIGFA kits and 95.5% of reproducibility was obtained as 95% (Table 
3.7 and 3.8). The stability of DIGFA kits was confirmed by the same results 
obtained after 2 weeks at 37°C and 2 month at room temperature. 
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Table 3.6: DIGFA and ELISA results with multiple antigens (EgCF, EgP, AgB 
and Em2) for detection of confirmed human hepatic cystic (CE) or alveolar 
(AE) Echinococcosis. (n=268) 
CE cases a 
(n=108) 
AE cases a 
(n=34) 
Non-hydatid  
(n=101) 
Cysticercosis 
(n=25) 
Antigens  
DIGFA ELISA DIGFA ELISA DIGFA ELISA DIGFA ELISA
Positive 100 101 30 32 7 5 15 16 
Sensitivity 
(%) 
92.6 93.5 88.2 94.1 Cross-reaction 
(%) 
60 26.7 
EgCF 
Specificity 
(%) 
    93.7 95.1   
Positive 98 102 28 32 7 5 14 15 
Sensitivity 
(%) 
90.7 94.4 82.4 94.1 Cross-reaction 
(%) 
56 60 
EgP 
Specificity 
(%) 
    93.7 95.0   
Positive 97 99 12 10 4 3 2 3 
Sensitivity 
(%) 
89.8 91.7 35.3 29.4 Cross-reaction 
(%) 
8 12 
AgB 
Specificity 
(%) 
    96.0 97.0   
Positive 8 10 31 32 3 2 4 5 
Sensitivity 
(%) 
7.4 9.3 91.1 94.1 Cross-reaction 
(%) 
16 20 
Em2 
Specificity 
(%) 
    98.02 95.05   
Total 108 108 34 34 101 101 25 25 
a CE or AE cases were selected surgical confirmed samples – post-surgery, in Xinjiang 
Medical University Hospital(XMUH) 
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Table 3.7: Reproducibility in the same batch of DIGFA kits 
Sera 
Group 
Antigens No. 
Test 
positive 
Test 
negative 
Reproducibility 
(%) 
EgCF 22 21 1 95.5 
EgP 22 21 1 95.5 
AgB         22 21 1 95.5 
Positives 
(CE or 
AE) 
Em2 22 21 1 95.5 
EgCF 22 1 21 95.5 
EgP 22 1 21 95.5 
AgB 22 1 21 95.5 
Controls 
Em2 22 1 21 95.5 
 
 
Table 3.8: Reproducibility in different batch of DIGFA kits 
Sera 
Group 
Antigens No. 
Test 
positive 
Test negative Reproducibility (%)
EgCF2 22 20 2 90.9 
EgP2 22 21 1 95.5 
AgB 22 21 1 95.5 
Positives 
(CE or AE) 
Em2 22 21 1 95.5 
EgCF2 22 1 21 95.5 
EgP2 22 1 21 95.5 
AgB 22 1 21 95.5 
Controls 
Em2 22 1 21 95.5 
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3.3.2 Diagnostic evaluation of the rapid DIGFA in a hospital setting 
The DIGFA was applied for immunodiagnosis of clinical echinococcosis using a 
panel of sera (n=899, CE and AE) taken from patients that were treated in XMUH 
over the period September 1999 to April 2006. The DIGFA test had a lower 
sensitivity for CE (80.7%) compared with the initial laboratory based 
standardization study (p<0.01) for all CE patients combined including liver, lung, or 
other organs (Table 3.9 and 3.10). Specificity of DIGFA for CE was 93.4% 
(695/744 non-CE cases were negative) (Table 3.11). The sensitivity of DIGFA for 
human AE showed no statistical difference between the laboratories based study 
(91.1%) and the main hospital study (90.3%) (p>0.05) (Table 3.12). The sensitivity 
of DIGFA for CE in different organs was, 94.4% in multi-organ CE, 83.4% for 
hepatic CE, 80.7% for pulmonary CE, 80% for CE in the pelvic cavity, 70% for CE 
in the abdominal cavity, and 56.7% for CE in other organs (including heart, kidney, 
brain, spine, bone, subcutaneous). Significant statistical differences were 
observed between DIGFA and ELISA for serodiagnosis of CE. The ELISA 
exhibited lower sensitivity for hospitalized human CE cases (75.0%), but higher 
specificity (97.6%) compared to DIGFA (p <0.01). For human AE both ELISA and 
DIGFA had similar sensitivities (97.6% vs 92.9%) (p> 0.05) but different 
specificities (78.6.1% vs. 90.3%) (p<0.01) (Table 3.9, Table 3.12 and 3.12.1). 
Overall a false positive rate of 10.4% occurred with the DIGFA for sera from 
persons without echinococcosis. 
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Table 3.9: Comparison of rapid DIGFA and standard ELISA applications for 
serodiagnosis of human echinococcosis in hospitalized CE (n=857) or AE 
cases (n=42) using four native antigen preparations: E. granulosus cyst 
fluid (EgCF, AgB), E. granulosus proscoleces (EgP) and E. multilocularis 
(Em2). 
DIGFA ELISA Clinical 
Diagnosis N Ag Pos Neg Pos Neg Chi
2 p b 
857 EgCF 683 174 533 324 63.68 <0.01 
 EgP 631 226 437 420 93.5 <0.01 
 AgB 586 271 492 365 22.09 <0.01 
 Em2 146 711 290 567 63.78 <0.01 
 Any dota  692 165 643 214 8.13 <0.01 
CE: 
 
 Sensitivity 80.7% 75.0%   
42 EgCF 39 3 27 15 10.18 <0.01 
 EgP 39 3 27 15 11.18 <0.02 
 AgB 28 14 21 21 2.4 >0.05 
 Em2 35 7 33 9 0.31 >0.05 
 Any dot* 39 3 41 1 0.26 >0.05 
AE: 
 
 Sensitivity 92.9%  97.6%   
702 EgCF 63 639 27 675 15.39 <0.01 
 EgP 55 647 36 666 4.24 <0.05 
 AgB 21 681 28 674 1.04 >0.05 
 Em2 5 697 20 682 9.16 <0.01 
 Any dot* 73 629 72 630 0.01 >0.05 
Controls 
(non 
CE/AE) 
 Specificity 89.6%  89.7%   
Total 1601c 
Ag=Antigen, Pos=positive, Neg=negative 
a: means any antigen showed positive in positive column, and none antigen showed 
positive in negative column. 
b: means p value when compared DIGFA and ELISA, Chi-Square test and correction if 
one cell had expected count less than 5. (SPSS 16.0) 
c: Total tests included another mixed CE and AE case, which showed positive with four 
antigens in DIGFA and all positive exclude Em2 in ELISA. 
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Table 3.10: Comparison of rapid DIGFA and standard ELISA applications for 
serodiagnosis of human echinococcosis in hospitalized CE (n=857) or AE 
cases (n=42) (modified from Table 3-8). 
DIGFA ELISA 
Clinical 
Diagnosis N 
Positive b Negative
Sensitivity 
(%)  
(95% CI c)
Positive Negative 
Sensitivity 
(%) 
(95% CI) 
P 
CE 857 692 165 80.7 (78.1-83.3) 643 214 
75.0 
(73.5-76.5) <0.01
AE 42 39 3 92.9 (88.9-96.8) 41 1 
97.6 
(95.2-99.9) >0.05
AE/CE 1 1 0 100 1 0 100  
Controls a 702 73 629 10.4 d 72 630 10.4* >0.05
Total 1602 805 797  757 845   
a. Controls were defined as those free from either CE or AE infection. 
b. Positive means any one of the four antigen dots changing color. 
c. 95% confidence interval, 
n
ppp )1(96.1 −± , p means sensitivity or specificity, n 
means number.  
d. False positive rate in control group (non CE/AE). 
 
The diagnostic assessments were then analyzed by accuracy, PPV, NPV, 
diagnostic odds ratio, Youden Index, PLR and NLR. The accuracies of DIGFA 
were 84.7% ((692+629)/(857+702))for CE and 89.8% for AE ((39+629)/(42+702)), 
meanwhile the accuracies of ELISA  were 81.7% ((643+630)/(857+702)) for CE 
and 90.2% ((41+630)/(42+702)) for AE. PPV of DIGFA and ELISA for CE (90.5% 
and 89.9) was better than for AE (34.8% and 36.3%), however, NPV of DIGFA and 
ELISA for CE (79.2% and 74.6%) was lower than for AE (99.5% and 99.8%). DOR 
of DIGFA and ELISA for CE (36 and 13) was lower than for AE (112.7 and 354). 
Youden index of DIGFA and ELISA for CE (0.7, 0.65) was also lower than for AE 
(0.8, 0.87). And also DIGFA and ELISA for AE showed a better probability for true 
positives and true negatives than for CE with higher PLR and lower NLR results 
(Table 3.10.1). 
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Table 3.10.1: Assessments of rapid DIGFA and standard ELISA applications 
for serodiagnosis of human echinococcosis in hospitalized CE (n=857) or 
AE cases (n=42) 
CE AE  Assessments: 
DIGFA ELISA DIGFA ELISA 
i. Se (%)  (95%CI) 80.7 
(78.1-83.3)
75.0 
(73.5-76.5)
92.9 
(88.9-96.8) 
97.6 
(95.2-99.9)
ii. Sp (%) in Non CE or 
AE controls (95%CI) 
89.6 
(88.4-90.8)
89.7 
(88.6-90.8)
89.6 
(88.4-90.8) 
89.7 
(88.6-90.8)
iii. Accuracy 
(%)(95%CI) 
84.7 
(82.9-86.5)
81.7 
(79.8-83.6)
89.8 
(88.3-91.3) 
90.2 
(88.7-91.7)
iv. PPV (%) (95%CI) 90.5 
(89.1-91.9)
89.9 
89.1-91.9 
34.8 
32.4-37.2 
36.3 
33.9-38.7 
v. NPV (%)(95%CI) 79.2 
(77.2-81.2)
74.6 
(72.4-76.8)
99.5 
(99.2-99.8) 
99.8 
(99.6-100) 
vi DOR 36.0 13.1 112.7 354.2 
vii. Youden Index 0.703 0.647 0.825 0.873 
viii. PLR 7.76 7.28 8.93 9.48 
ix. NLR 0.22 0.28 0.08 0.03 
 
The diagnostic value was also assessed for DIGFA and ELISA antibody test 
against a single antigen and parallel combination (Table 3.10.2 and 3.10.2a for 
EgCF, Table 3.10.3 and 3.10.3a for EgP, Table 3.10.4 and 3.10.4a for AgB, Table 
3.11 for parallel combination) for CE. The generally lower Se, Sp, Accuracy, PPV, 
NPV, DOR, Youden Index and PLR were observed in DIGFA antibody against 
single antigen (EgCF, EgP and EgB) for CE compared to that against parallel 
combination, except a higher specificity (93.4%), PPV (92.3%) and PLR (10.36) 
was occurred in single antigen AgB (Table 3.11). 
 
Table 3.10.2: Sensitivity and specificity of EgCF antigen in DIGFA and ELISA 
for hospitalized CE cases 
DIGFA ELISA Clinical 
diagnosis N Positive Negative Positive Negative P value 
CE 857 683 174 533 324 <0.01 
Non-CE 744 102 642 54 690 >0.05 
Total 1601 785 816 587 1014  
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Table 3.10.2a: Assessments of EgCF antigen in rapid DIGFA and standard 
ELISA applications for serodiagnosis of human echinococcosis in 
hospitalized CE (n=857) or non-CE cases (n=744) 
EgCF for CE Assessments 
DIGFA ELISA 
Se (%)  (95%CI) 78.1  (76.1-80.1) 62.3  (59.9-64.7) 
Sp (%) in Non CE controls  (95%CI) 86.3  (85.4-87.2) 92.7  (91.4-94.0) 
Accuracy (%)  (95%CI) 82.8  (80.9-84.7) 76.4  (74.3-78.5) 
PPV (%)  (95%CI) 87.0  (85.3-88.7) 90.8  (89.4-92.2) 
NPV (%)  (95%CI) 78.7  (76.7-80.7) 68.0  (65.7-70.3) 
Odds ratio 24.7 21.0 
Youden Index 0.644 0.556 
PLR 5.701 8.534 
NLR 0.254 0.407 
 
Table 3.10.3: Sensitivity and specificity of EgP antigen in DIGFA and ELISA 
for hospitalized CE cases 
DIGFA ELISA Clinical 
diagnosis 
N 
Positive Negative Positive Negative 
P value 
CE 857 631 226 437 420 <0.01 
Non-CE 744 94 650 63 681 >0.05 
Total 1601 725 876 500 1101  
 
Table 3.10.3a: Assessments of EgP antigen in rapid DIGFA and standard 
ELISA applications for serodiagnosis of human echinococcosis in 
hospitalized CE (n=857) or non-CE cases (n=744) 
EgP for CE Assessments 
DIGFA ELISA 
Se (%)   (95%CI) 73.6  (71.4-75.8) 51.0  (48.5-53.5) 
Sp (%) in Non CE controls   (95%CI) 87.4  (85.8-89.0) 91.5  (90.1-92.9) 
Accuracy (%)  (95%CI)   80.0  (78.0-82.0) 69.8  (67.5-72.1) 
PPV (%)  (95%CI) 87.0  (85.3-88.7) 69.8  (67.5-72.1) 
NPV (%)  (95%CI) 74.2  (72.0-76.4) 87.4  (85.8-89.0) 
Odds ratio 19.3 11.2 
Youden Index 0.61 0.425 
PLR 5.841 6.0 
NLR 0.302 0.536 
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Table 3.10.4: Sensitivity and specificity of AgB antigen in DIGFA and ELISA 
for hospitalized CE cases 
DIGFA ELISA Clinical 
diagnosis 
N 
Positive Negative Positive Negative 
P value
CE 857 586 271 492 365 <0.01 
Non-CE 744 49 695 49 695 >0.05 
Total 1601 635 966 541 1060  
 
 
 
Table 3.10.4a: Assessments of AgB antigen in rapid DIGFA and standard 
ELISA applications for serodiagnosis of human echinococcosis in 
hospitalized CE (n=857) or non-CE cases (n=744) 
AgB for CE  Assessments 
DIGFA ELISA 
i Se (%)  (95%CI) 68.4  (66.8-69.9) 57.4  (54.1-60.7)) 
ii Sp (%) in Non CE controls
(95%CI) 
93.4  (91.6-95.1) 93.4  (91.6-95.1) 
iii Accuracy (%)  (95%CI) 80.0  (78.0-82.0) 74.1  (71.9-76.3) 
iv PPV (%)  (95%CI) 92.3  (91.0-93.6) 90.9  (89.5-92.3) 
v NPV (%)  (95%CI) 71.9  (69.7-74.1) 65.6  (63.2-67.9) 
vi Odds ratio 30.6 19.1 
vii Youden Index 0.618 0.508 
viii PLR 10.36 8.69 
ix NLR 0.338 0.456 
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Table 3.11: Assessments of multiple antigens and single antigen in rapid 
DIGFA applications for serodiagnosis of human echinococcosis in 
hospitalized CE (n=857) or non-CE cases (n=744) 
Assessments Multiple 
antigens 
EgB EgCF EgP 
Se (%)  (95%CI) 80.7   
(78.1-83.3)
68.4 
(66.8-69.9) 
78.1 
(76.1-80.1) 
73.6 
(71.4-75.8) 
Sp (%) in Non CE 
controls    (95%CI) 
89.6 
(88.4-90.8)
93.4 
(91.6-95.1) 
86.3 
(85.4-87.2) 
87.4 
(85.8-89.0) 
Accuracy (%) 
(95%CI) 
84.7 
82.9-86.5 
80.0 
(78.0-82.0) 
82.8 
(80.9-84.7) 
80.0 
(78.0-82.0) 
PPV (%)  (95%CI) 90.5 
89.1-91.9 
92.3 
(91.0-93.6) 
87.0 
(85.3-88.7) 
87.0 
(85.3-88.7) 
NPV (%)  (95%CI) 79.2 
(77.2-81.2)
71.9 
(69.7-74.1) 
78.7 
(76.7-80.7) 
74.2 
(72.0-76.4) 
Odds ratio 36.0 30.6 24.7 19.3 
Youden Index 0.703 0.618 0.644 0.61 
PLR 7.76 10.36 5.701 5.841 
NLR 0.22 0.338 0.254 0.302 
 
The diagnostic value was also assessed for DIGFA and ELISA antibody test 
against Em2 for human AE. Almost all the assessment parameters by single Em2 
were lower than parallel combination in both DIGFA and ELISA, except a higher 
specificity (90.3%) and accuracy (90.1%) for single Em2 in DIGFA (Table 3.12 and 
3.12a). 
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Table 3.12: Sensitivity and specificity of Em2 antigen in DIGFA and ELISA for 
hospitalized AE cases 
DIGFA ELISA Clinical 
diagnosis 
N 
Positive Negative Positive Negative 
P value
AE patients 42 35 7 33 9 >0.05 
Non AE 1559 151 1408 310 1249 <0.01 
Total 1601 186 1415 343 1258  
 
 
 
Table 3.12a: Assessments of Em2 antigen in rapid DIGFA and standard 
ELISA applications for serodiagnosis of human echinococcosis in 
hospitalized AE (n=42) or non-AE cases (n=1559) 
Em2 for AE Assessments 
DIGFA ELISA 
Sensitivity (%) 
(95%CI) 
83.3 
(72.1-94.6) 
78.6 
(66.2-91.0)) 
Specificity (%) in Non AE controls 
(95%CI) 
90.3 
(89.6-91.0) 
78.0%  
 (75.9-80.1) 
Accuracy (%) 
(95%CI) 
90.1 
(88.6-91.6) 
80.1 
(78.1-82.1) 
Positive predictive value (%) 
(95%CI) 
18.8 
(16.9-20.7) 
10.6 
(9.1-12.1). 
Negative predictive value (%) 
(95%CI) 
99.5 
(99.2-99.8) 
99.3 
(98.9-99.7) 
Odds ratio 46.4 13.0 
Youden Index 0.736 0.566 
Positive likelihood ratio 8.59 5.78 
Negative likelihood ratio 0.185 0.274 
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3.3.3 Comparison of DIGFA with different sources of serum samples from 
China, UK and France 
Double-blind test was carried out for DIGFA using serum stored in XMUH 
(Xinjiang, China), Salford University (UK) and Besanson University (France). A 
higher sensitivity and specificity was observed for both CE and AE in XMUH 
compared in Salford and Besancon (Table 3.13). There were cross reactions 
found in serum of cysticercosis and schistosomiasis (31.3% and 40%). 
 
Table 3.13: Blinding test for evaluation of DIGFA in the sera from China, 
Britain and France 
DIGFA 
Countries 
Clinical 
Diagnosis 
No.
Positive Negative
Sensitivity 
 (%) 
Specificity 
(%) 
China CE 224 216 8 96.4  
 AE 68 62 6 91.2  
 Normal 169 12 157  92.9 
Britain CE 18 13 5 86.7  
 AE 33 30 3 90.9  
 Cysticercosis 32 10 22 Cross-reaction 31.3% 
 Schistosomiasis 10 4 6 Cross-reaction 40% 
 Normal 19 2 17  89.5 
France CE 10 4 6 40  
 AE 73 57 16 78.1  
 Normal 45 2 43  95.6 
Total  701 412 289   
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3.3.4 Diagnostic evaluation of the DIGFA for endemic community hydatid 
mass screening in northwest China 
When DIGFA was used in conjunction with ultrasound in community mass 
screening studies, it showed good sensitivity for human AE (90.7%) but lower 
sensitivity for CE (71.8%). Overall specificity for CE was 78.1% and for AE was 
97.6% based on ultrasound abdominal screening as the gold standard. AgB 
antigen had the lowest sensitivity (51.3%) in DIGFA in comparison to ultrasound 
confirmed human CE (n=160), while Em2 antigen in DIGFA had a sensitivity of 
77.8% for ultrasound confirmed AE cases (n=108) (Table 3.14 to 3.16). Specificity 
of AgB for community detected human CE was 94.6% and Em2 for AE was 97.1% 
in this study (Table 3.14 and 3.15). AgB antigen in DIGFA gave high cross reaction 
68.6% (74/108) with community detected AE cases, while Em2 antigen cross 
reacted with 11.3% (18/160) of ultrasound confirmed CE cases. 
 
Table 3.14: Comparison of DIGFA test with abdominal ultrasound imaging in 
mass screening community studies in western China (data combined from 
Xinjiang, Ningxia, Sichuan and Tibet AR) 
Ultrasound No. EgCF  
Positive
EgP  
Positive
AgB  
Positive
Em2 
Positive 
All 
Negative
CE 160 112 88 82 18 45 
AE 108 95 83 74 84 10 
Normal 2923 641 462 91 70 2175 
CE 70% 55% 51.3% 11.3% 71.8%a Sensitivity 
For each antigen AE 87.9% 76.9% 68.5% 77.8% 90.7%b 
Specificity  78.1% 84.2% 96.9% 97.6% 74.4%c 
a. 95% CI of general sensitivity for CE was 64.9%-78.8%. 
b. 95% CI of general sensitivity for AE was 85.2%-96.2%. 
c. 95% CI of general specificity for both CE and AE was 72.8%-76.0%. 
d. Accuracy of DIGFA for CE was 74.3% ((160-45) + 2175)/(160+2923)) and for AE 
was 75.0% ((108-10)+2175)/(108+2923). 
e.  NPV of DIGFA for CE was 98.0% (2175/(2175+45)) and for AE was 99.5% 
(2175/(2175+10)).  
f. PPV of DIGFA for CE was 13.3% ((160-45)/((160-45)+(2923-2175)) and for AE 
was 11.6% ((108-10)/((108-10)+(2923-2175)). 
 
 
Evaluations of DIGFA test with abdominal ultrasound in community studies 
showed a lower sensitivity, specificity, accuracy, PPV, DOR, Youden Index and 
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PLR compared to hospitalized study, especially PPV (11.9% to 90.5%) (Table 
3.14.1 and 3.14.1a). 
 
Table 3.14.1: Assessment cross tab of DIGFA test with abdominal ultrasound 
CE imaging in mass screening community studies in western China (data 
combined from Xinjiang, Ningxia, Sichuan and Tibet AR) 
DIGFA 
Clinical diagnosis N 
Positive Negative 
CE 160 115 45 
Non-CE / Non HD 3031 / 2923 846 / 748 2185 / 2175 
Total 3191 / 3083 961 / 863 2230 / 2220 
 
Table 3.14.1a: Evaluations of DIGFA test with abdominal ultrasound CE 
imaging in mass screening community studies in western China (data 
combined from Xinjiang, Ningxia, Sichuan and Tibet AR) 
Assessments Multi-DIGFA for CE 
Se (%)  (95%CI) 71.895 / 71.895  (69.7-74.1 / 69.7-74.1) 
Sp (%) in Non CE/HD controls 
(95%CI) 
72.088 / 74.410  (69.9-74.3 / 72.2-76.6) 
Accuracy (%)  (95%CI) 72.078 / 74.278  (69.9-74.3 / 72.1-76.4) 
PPV (%)  (95%CI) 11.967 / 13.326  (10.4-13.6 / 11.6-15) 
NPV (%)  (95%CI) 97.982 / 97.973  (97.3-98.7 /97.3-98.7) 
DOR 6.612 /7.431 
Youden Index 0.439 /0.463 
PLR 2.577 /2.809 
NLR 0.389 /0.378 
 
The diagnostic value in community study was also assessed for DIGFA antibody 
test against a single antigen and parallel combination (Table 3.14.2 and 3.14.2a 
for EgCF, Table 3.14.3 and 3.14.3a for EgP, Table 3.14.4 and 3.14.4a for AgB, 
Table 3.15 for parallel combination) for CE. The lower sensitivities were observed 
in DIGFA antibody against single antigen (EgCF, EgP and EgB) for CE compared 
to against parallel combination (Table 3.15). 
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Table 3.14.2: Assessment cross tab of EgCF-DIGFA test with abdominal 
ultrasound imaging in mass screening community studies in western China 
(data combined from Xinjiang, Ningxia, Sichuan and Tibet AR) 
EgCF-DIGFA 
Ultrasound 
Positive Negative 
Total 
CE patients 112 48 160 
Non-CE / Non-HD 
control 
735 / 641 2296 / 2282 3031 / 2923 
Total-1 847 / 753 2344 / 2330 3191 / 3083 
 
 
 
Table 3.14.2a: Evaluations of EgCF-DIGFA test with abdominal ultrasound 
CE imaging in mass screening community studies in western China (data 
combined from Xinjiang, Ningxia, Sichuan and Tibet AR) 
Assessments EgCF-DIGFA for CE 
Se (%) (95%CI) 70 /70  (67.7 / 67.7 - 72.3 / 72.3) 
Sp (%) in Non-CE/HD controls 
(95%CI) 
75.75 / 78.07  (73.6 / 76.0 - 77.9 / 80.1) 
Accuracy (%)   (95%CI) 75.46 / 77.65  (73.3 / 75.6 - 77.6 / 79.7) 
PPV (%)  (95%CI) 13.22 / 14.87  (11.5 / 13.1 - 14.9 / 16.6) 
NPV (%)  (95%CI) 97.95 / 97.94  (97.3 / 97.2 - 98.6 / 98.6) 
Odds ratio 7.29 / 8.307 
Youden Index 0.458 / 0.481 
Positive likelihood ratio 2.886 / 3.192 
Negative likelihood ratio 0.396 / 0.386 
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Table 3.14.3: Assessment cross tab of EgP-DIGFA test with abdominal 
ultrasound CE imaging in mass screening community studies in western 
China (data combined from Xinjiang, Ningxia, Sichuan and Tibet AR) 
EgP-DIGFA 
Ultrasound 
Positive Negative 
Total 
CE patients 88 72 160 
Non-CE patients 545 2486 3031 
Non-HD control 462 2461 2923 
Total-1 633 2558 3191 
Total-2 550 2533 3083 
 
 
 
Table 3.14.3a: Evaluations of EgP-DIGFA test with abdominal ultrasound CE 
imaging in mass screening community studies in western China (data 
combined from Xinjiang, Ningxia, Sichuan and Tibet AR). 
Assessments EgP-DIGFA for CE 
Se (%)  (95%CI) 55 / 55 (52.5– 57.5 / 52.5-57.5) 
Sp (%) in Non CE/HD controls 
(95%CI) 
82.0 / 84.2  (80.1– 83.9 / 82.4 - 86.0) 
Accuracy (%)  (95%CI) 80.7 / 82.7  (78.7-82.6 / 80.8-84.5) 
PPV (%)  (95%CI) 13.9 / 16  (12.2– 15.6 / 14.2-17.8) 
NPV (%)  (95%CI) 97.2 / 97.2  (96.4– 98.0 / 96.3-97.8) 
Odds ratio 5.575 / 6.510 
Youden Index 0.37   / 0.392 
Positive likelihood ratio 3.059 / 3.480 
Negative likelihood ratio 0.549 / 0.534 
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Table 3.14.4: DIGFA test using AgB antigen for immunodiagnosis of CE in 
community mass screening studies (data combined from Xinjiang, Ningxia, 
Sichuan and Tibet AR) in comparison to abdominal ultrasound 
AgB-DIGFA 
Ultrasound 
Positive Negative 
Total 
CE patients 82 78 160 
Non-CE / Non-HD 
control 
165 / 91 2866 / 2832 3031 / 2923
Total 247 / 173 2944 / 2910 3191 / 3083
Sensitivity 51.3% (82/160), specificity 94.6% (2866/3031); Accuracy of AgB-DIGFA for CE 
was 92.4% ((82 + 2866)/3191). NPV of AgB-DIGFA was 97.4% (2866/2944). AgB PPV 
was 33.2% (82/247) in DIGFA. 
 
 
 
Table 3.14.4a: Assessments of antigen B by DIGFA for serodiagnosis of 
human echinococcosis in community CE (n=160) or non-CE/HD cases 
(n=3031/2923) 
Assessments AgB-DIGFA for CE (95%CI) 
Se (%)  (95%CI) 51.25/51.25  (0.488-0.5373/0.4878-0.537) 
Sp (%) in Non CE/HD controls
(95%CI) 
94.556/96.887  (0.9344-0.9567/0.960-0.977) 
Accuracy (%)  (95%CI) 92.385/95.621  (0.9108-0.9369 / 0.946-0.966) 
PPV (%)  (95%CI) 33.198/47.399  (0.3086-0.3553 / 0.449-0.499) 
NPV (%)  (95%CI) 97.350/97.319 (0.9656-0.9814 / 0.965-0.981) 
Odds ratio 18.26/32.717 
Youden Index 0.458/0.481 
PLR 9.414/16.462 
NLR 0.515/0.503 
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Table 3.15: Assessments of multiple antigens and single antigen in rapid 
DIGFA applications for serodiagnosis of human echinococcosis in 
community CE (n=160) or non-CE/HD cases (n=3031/2923) 
Assessments Multiple 
antigens 
EgB EgCF EgP 
Se (%) 71.89 /71.89  51.25/51.25  70 /70   55 / 55  
Sp (%) in Non CE/HD 
controls 
72.09 /74.41  94.56/96.89  75.75 /78.07 82.0 / 84.2
Accuracy (%) 72.08 /74.28  92.38/95.62  75.46 /77.65  80.7 / 82.7
PPV (%) 11.97 /13.33  33.2/47.4  13.22 /14.87  13.9 / 16  
NPV (%) 97.98 /97.97  97.35/97.32 97.95 /97.94  97.2 / 97.2
Odds ratio 6.61 /7.43 18.26/32.72 7.29 /8.31 5.57 / 6.51
Youden Index 0.44 /0.46 0.46/0.48 0.46 /0.48 0.37 / 0.39
PLR 2.58 /2.81 9.41/16.46 2.89/3.192 3.06 / 3.48
NLR 0.39 /0.38 0.51/0.50 0.4 / 0.4 0.55 / 0.53
 
The diagnostic value in community study was also assessed for DIGFA against 
Em2 for human AE. The DIGFA sensitivity by single Em2 (77.8%) were lower than 
parallel combination (90.7%) in community study (Table 3.14) and also lower than 
Em2 (83.3%) in hospitalized study. Meanwhile the higher specificity (97.1%), 
accuracy (96.5%) and PPV (48.8%) for single Em2 in DIGFA was found in 
community study (Table 3.16). 
 
Table 3.16: DIGFA test using Em2 antigen for diagnosis of AE in community 
mass screening studies (data combined from Xinjiang, Ningxia, Sichuan and 
Tibet AR) in comparison to abdominal ultrasound 
Em2-DIGFA 
Ultrasound 
Positive Negative 
Total 
AE patients 84 24 108 
Non AE 88 2995 3083 
Total 172 3019 3191 
Sensitivity 77.8% (84/108) (95% CI 70.0%-85.6%), specificity 97.1% (2995/3083) (95% 
CI 96.5%-97.6%) 
Accuracy of Em2-DIGFA for AE was 96.5% ((84 + 2995)/3191).  
NPV of Em2-DIGFA was 99.2% (2995/3019).  
Em2 PPV was 48.8% (84/172) in DIGFA. 
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3.3.5 False positives and negatives 
For clinically defined echinococcosis patient sera, there were in total 14.6% 
(131/899) false negatives in the DIGFA test and these were also negative in the 
standard ELISA (Table 3.9 and 3.10). Clinical features of false negative CE cases 
were collapsed, degenerated, necrotic (Type CE4), or consolidated cysts, or 
calcificated type cysts (CE5), or single, small univesicular cysts (Type CE 1), and 
also for small single cysts deep in organ locations (WHO/OIE 2001). A false 
positive rate of 10.4% (73/702) occurred in hospitalized persons in XMUH without 
echinococcosis, and these cases (including simple non-parasitic cysts, carcinoma 
or tuberculosis) showed no evidence of echinococcocal cysts or lesions by 
ultrasound or other imaging methods (X-ray or CT) (Table 3.17). Three T. solium 
cysticercosis cases treated in XMUH were all seronegative in DIGFA and ELISA. 
In addition, there were other 12 false negatives in the DIGFA test that were also 
negative in ELISA (Table 3.18). Clinical features of false negative CE cases 
indicated 12 patients had collapsed cyst, degenerated, necrotic, consolidated or 
calcified CE5 type cysts, or single, small size (Type CE 1) cysts, or cysts in a deep 
location in the organ or far away from blood vessels. Another 12 false positive 
cases from XJMUH appeared as patients with other diseases including 1 
cysticercosis, 3 carcinoma, 2 tuberculosis, 5 simple cyst cases and 1 lipoma case 
(Table 3.19). 
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Table 3.17: False positives occurred by DIGFA in 702 non echinococcosis 
sera from XMUH (1999-2006) 
Clinical diagnosis N DIGFA positives  
(false positive rate) 
Cystic disease 196 16 (8.2%) 
Carcinoma 85 11 (12.9%) 
Tuberculosis 28 8 (28.6%) 
Space-occupying lesions (non 
echinococcosis by imaging) 
266 29 (10.9%) 
Cirrhosis 6 1 (16.7%) 
Abscess 13 1 (7.7%) 
Cysticercosis (T. solium) 3 0 (0%) 
Cholecystitis /gallstones 12 1 (8.3%) 
Other medicinal disease 88 6 (6.8%) 
Normal 5 0 (0%) 
Total 702 73 (10.4%) 
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Table 3.18: Analysis influent factors in 12 false negative CE patients 
No. Sex Age DIGFA Results of surgery 
and pathology 
Clinical Remarks 
1 Male 50 (-) Single hydatid cyst in 
right lobe of liver 
Deep in inner liver, 
3 cm from surface 
of liver 
2 Male 25 (-) Single hydatid cyst in 
Ⅷ segment 
Full of yellow, sticky, 
necrotic fluid 
3 Female 27 (-) Single hydatid cyst in 
the peak of liver 
Adhere to phrenic 
muscle 
4 Male 69 (-) Single hydatid cyst in 
low lobe of right lung 
Inner cyst had 
infected, broken 
and necrosis 
5 Female 55 (-) Multiple hydatid cysts 
both in liver and lung 
Inner cyst had 
broken and 
degenerated 
6 Female 15 (-) Hydatid cyst in 
abdomen, malignant 
tumor in ovary 
Hydatid cyst had 
calcificated 
7 Male 9 (-) Alveolar hydatid in left 
lobe of liver 
child 
8 Male 68 (-) Single hydatid cyst in 
left lobe of liver 
Necrosis and 
consolidated 
9 Female 34 (-) hydatid cyst in thyroid 
gland 
Deep in thyroid 
gland 
10 Female 42 (-) Single hydatid cyst in 
lung 
Single 
11 Female 30 (-) Single hydatid cyst in 
right lobe of liver 
Deep in liver, the 
wall is thick, 
protoscleces were 
found in puncture 
12 Male 11 (-) hydatid  cyst in brain child 
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Table 3.19: Analysis influent factors in 12 false positive cases 
No. Sex Age 
 
DIGFA Results of surgery 
and pathology 
Clinical Remarks 
1 Male 41 (+) cysticercosis in brain Necrosed 
2 Male 41 (+) malignant tumor in 
mediastinum 
 
3 Female 63 (+) carcinoma of the lung  
4 Male 23 (+) granuloma in socket 
of the left eye 
 
5 Female 30 (+) peritonitis caused by 
tuberculosis 
 
6 Female 60 (+) cholelithiasis, multiple 
cysts in left lobe of 
liver 
 
7 Female 7 (+) cyst in mediastinum  
8 Male 66 (+) multiple cysts in 
kidney and liver 
 
9 Female 38 (+) carcinoma of the lung  
10 Male 32 (+) lipoma in upper lobe 
of lung 
 
11 Male 26 (+) cyst in  mediastinum  
12 Female 30 (+) pulmonary 
tuberculosis 
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3.4 Discussion 
Early diagnosis of human cystic echinococcosis (CE) and especially for alveolar 
echinococcosis (AE) could provide significant improvement in the quality of clinical 
management and treatment prognosis of both these zoonotic diseases (WHO/OIE, 
2001; Craig et al 2003). Diagnostic laboratory methods that are cheap, rapid and 
easy to use would be very useful for basic clinics in endemic rural areas and in 
support of mass screening programmes since most persons in the early stages of 
CE or AE are asymptomatic (Rogan and Craig, 1997, 2002; Craig et al., 2000, 
2003; WHO/OIE, 2001). Specific antibody detection appears most valuable for 
serodiagnosis of human CE or AE and has also shown promise in some 
post-treatment follow-up studies (Wen et al, 1995; Ito, 2002; Rogan and Craig, 
2002). Gold standard laboratory tests for human echinococcosis are currently 
based on ELISA or immunoblots using E. granulosus hydatid cyst fluid antigen B 
for CE, and E. multilocularis metacestode antigen Em2 or antigen Em18 for AE 
(Gottstein et al, 1983, 1987; Zhang et al., 2000, 2001; Rogan and Craig, 2002; Ito, 
2002; Craig et al., 2003; Carmena et al., 2006).  
Dot-ELISA rapid format has been applied in a few community based studies for 
human CE but has limitations since enzyme-conjugates are difficult to store and 
apply in field conditions (Zheng et al., 1986; Rogan et al., 1991; Qiao et al., 1999).  
Colloidal gold labeling techniques were first used in the 1970s to locate specific 
antigens on the cell surface using electron microscopy (Faulk and Taylor, 1971; 
Horisberger et al., 1975). “One-step pregnancy test strip” type tests are a good 
example of a colloidal gold based rapid diagnostic test (May, 1991; Millipore Corp, 
1996). A dot-immunogold infiltration assay (DIGFA) was first developed for 
serodiagnosis of HIV in 1989 (Chun and Chu, 1989; Spielberg et al., 1989). The 
procedure is similar to dot-ELISA but has the advantage of an infiltration system 
and use of colloidal gold conjugated IgG to give a more rapid, reliable and clear 
result. Colloidal gold antibody conjugate based DIGFA or similar 
immunochromatographic assays have also become an acceptable rapid clinical 
bed-side detection method for drug screening and diagnosis of several microbial 
and parasitic infections (Dar et al., 1994; Xiao et al., 1995; Dylan and Kevin, 1999; 
Feng et al., 2000; Garcia et al., 2000; Feng et al., 2002; Zhu et al., 2002; Sorell et 
al., 2002; Yang, 2003; Hujakka et al., 2003; Chen et al., 2005). Initial applications 
of DIGFA for human echinococcosis in China indicated good potential as a rapid 
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test (Fu et al., 2000; Feng et al., 2002; Zhang et al., 2001).  
The current study reports the most comprehensive assessment and application of 
a rapid DIGFA for quick serodiagnosis of human echinococcosis. We confirm that 
DIGFA exhibited the following features: (1) the test could give a reliable diagnostic 
result within 2--3 minutes using only 20μL of serum or 40 μL heparinized blood; (2) 
the test was able to detect human echinococcosis in approximately 80-93% of 
cases and differentiate human CE and AE in about 80% of confirmed cases; (3) 
the DIGFA procedure is simple and no special training was required and therefore 
it had practical value for support of both community mass-screening in conjunction 
with ultrasound, and for hospital based diagnostic confirmation of echinococcosis 
(Fu et al., 2000; Zhang et al., 2001; Feng et al., 2002; Chen et al., 2005).  
We developed this DIGFA test which acted as a qualitative immunological 
diagnostic method for detection antibody of human echinococcosis. Antigens used 
for DIGFA had been studied from 1980s and the preparation had been partially 
modified by our research group in Xinjiang Hydatid Clinical Research Institute 
from 1997 to 2000. Those antigens had been tested by ELISA and dog 
immunoblot assay (DIBA) and a sensitivity of 91% for EgCF in ELISA and DIBA, 
93% in ELISA and 91% in DIBA for EgP had been reported (Zhang et al., 2000). I 
had tried to apply DIBA for the community study in 1998 but the storing and 
application of enzyme conjugate became the main problems since no fridge or 
freezer available. And also the DIBA procedure was similar with ELISA and asked 
for at least 1 hour test time at room temperature. But the stability of antigens on 
the NC membrane kept effective for longer time (at least 2 months without special 
package) indicated that we might find another stable conjugate to develop a test 
for using in the rural area. Colloidal gold conjugate could be stable at 4°C in 
working dilution and had been successfully applied in DIGFA and other tests for 
some infection disease (e.g. HAV IgM for hepatitis, Feng et al., 2000). The four 
antigens were combined together in one test for obtain better sensitivity and also 
partially specific for differentiation of CE and AE. Optimization the concentration of 
four antigens could supply stable and reproductive results and commercial DIGFA 
kit had been allowed to apply in many hospitals in hydatid endemic area of 
northwest China for clinical diagnosis and community study. DIGFA kit with 4 
antigens was accepted since no special device needed, easy to perform and 
effective for both CE and AE. Other antigens had been tried to apply as well. 
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Native E. multilocularis crude abstract showed a higher false positive in normal 
controls in initial trial (not exactly calculated) and was given up. A recombined 
antigen B (r-AgB) was also regarded as a potential candidate antigen but need 
more work for that since initial poor sensitivity was observed due to lower 
concentration and poor stability. Em18 or recombined Em18 might also be 
optional antigens for future research and application in DIGFA for human AE. 
Based on a panel of 1601 serum samples from advanced CE or AE patients 
confirmed by imaging, pathology and/or surgery in Xinjiang Medical University 
Hospital (XMUH, Urumqi, China), and control sera, overall DIGFA sensitivity was 
80.7% (692/857) for human CE and 92.9% (39/42) for human AE. Specificity for 
echinococcosis (both CE and AE) was 89.6% (629/702); while E. granulosus 
antigen B specificity for CE was 93.4% (695/744), and E. multilocularis Em2 
antigen specificity for AE was 90.3%(1408/1559).  
When applied to community mass screening studies in western China (i.e. sites in 
Xinjiang, Ningxia, Sichuan, Tibet, see also Chapter 6), the Echinococcus DIGFA 
showed slightly lower sensitivity (71.8% for CE and 90.7% for AE) and specificity 
(74.4% for echinococcosis in general, 94.6% with antigen B for CE, 97.1% with 
Em2 for AE) compared with the hospital based DIGFA assessment. The DIGFA 
test was nevertheless extremely useful in these resource-poor settings as a 
combined diagnostic tool with ultrasound. Sera could be tested within 1 hour of 
ultrasound scan and up to 200 sera tested in one day. Diagnosis of CE or AE was 
confirmed in more than 80% of community detected cases and therefore 
facilitated efficient clinical treatment and assisted follow-up recommendations. 
Reasons for lower sensitivity of DIGFA in community (vs hospital settings) may be 
due to exposure without a detectable abdominal cyst lesion, involvement of sites 
not ultrasound detectable, and / or presence of small cysts or lesions, or 
degenerate, calcified, or necrotic cysts/lesions. The false negative rate for 
hospitalized CE cases was 19.3% (165/857) compared to 7.1% (3/42) for AE, 
while false positives occurred in 6.6% of CE (49/744), and in 9.7% (151/1559) of 
AE cases in XMUH. The DIGFA test could reliably differentiate CE and AE cases 
from each other around 80% of the time and an Em2 positive reaction appeared in 
17.1% (146/857) of CE case sera. The DIGFA results were comparable to those 
obtained with the standard ELISA (false negative for CE 25.0%, for AE 2.4%, false 
positive for both 10.3%), and in general the ELISA was less sensitive (p<0.01) but 
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exhibited comparable specificity with DIGFA for human CE. The AgB antigen 
preparation from E. granulosus and Em2 metacestode extract from E. 
multilocularis, showed reliable specificity (90.3% --97.1%) in DIGFA for CE or AE 
disease, and were comparable to other studies using traditional ELISA formats 
(Gottstein et al., 1983, 1987; Liu and Zhao, 1993; Poretti et al., 1999; Carmena et 
al., 2006).  
 
3.5 Summary 
In conclusion, a rapid 3 minute eye-read dot immunogold filtration assay (DIGFA) 
for serodiagnosis of human cystic (CE) and alveolar (AE) echinococcosis was 
developed in which 4 crude or semi-purified native antigens from E. granulosus 
(EgCF, EgP, AgB) and E. multilocularis (Em2) were utilized simultaneously. The 
overall sensitivity of DIGFA in a hospital diagnostic setting was 80.7% for human 
cystic echinococcosis (CE) (n=857) and 92.9% for human alveolar echinococcosis 
(AE) (n=42). The E. granulosus protoscoleces (EgP) and crude cyst fluid (EgCF) 
extracts provided high sensitivity for the test; while E. granulosus partially purified 
antigen B (AgB) and E. multilocularis antigen (Em2) ensured specificity 
comparable to standard ELISA. Highest specificity was 93.4% with AgB extract for 
CE, and 90.3% with Em2 antigen for AE when CE vs AE cross-reactivity was 
excluded. Anti-AgB antibodies were present in 35.5% of AE cases and anti-Em2 in 
7.4% of CE cases. In endemic communities in northwest China screened for 
echinococcosis, the sensitivity of DIGFA ranged from 71.8% to 90.7% in 
comparison to abdominal ultrasound; specificity for CE using AgB was 94.6% and 
for AE using Em2 was 97.1%. The DIGFA format was used successfully in 
conjunction with ultrasound for mass screenings to identify or confirm 
asymptomatic CE and AE cases in co-endemic communities in western China. 
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Chapter 4. Development and application of a rapid antigen 
detection method in cyst fluid for human CE 
 
4.1  Introduction 
Crude E.granulosus cyst fluid antigens (EgCF) and antigen B or are present in 
E.granulosus cyst fluid. Therefore, detection of antigen B or EgCF with 
immunological methods can be used to identify / confirm that cysts are of hydatid 
origin.  
Generally we did not get cyst fluid from confirmed CE patients before operation is 
not usually tested or available. Diagnosis of CE is usually already made for most 
cases using imaging techniques with or without serological confirmation. However 
testing cyst fluid could be helpful in some special situations. PAIR treatments for 
those CE cases who were not suitable for surgery (as elder, poor healthy status or 
unwilling for a surgical operation) and as a less medical alternative to surgery， 
was developed in Italy and China (Felice et al., 1990, 1997, 2000; Wang 1994; 
Wen 1997). A cyst fluid antigen test could confirm the diagnosis of CE and 
following PAIR or albendazole treatment could be useful to those cases. Another 
requirement can be for the differential diagnosis for non-specific fluid such as the 
lavage fluid under bronchoscopy, or other cyst fluid from cystic lesions in the liver, 
eyes or other organs. The use of ELISA and a rapid dot-ELISA have been applied 
to test cyst fluid for hydatid origin (Craig, et al., 1986; Paul et al., 1997; Wang et al., 
2002). The latter just needs 10 minutes and this was really useful for clinical 
practice. However, shelf-life of enzyme labeled antibody, could be limited as it was 
easily degraded.  
Rapid tests with colloidal gold techniques have been widely applied in clinical 
laboratory diagnosis for urine HCG, sera HBsAg, and some initial screening for 
drugs, etc. The advantages of colloidal gold tests is their speed and easy to 
operate. This kind of ‘bedside’ detection test was designed for rapid identification 
of hydatid cyst fluid in the current study for potential use during surgery and/or 
PAIR for CE. 
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4.2  Methods and approaches 
4.2.1  Preparation of antigen, rabbit anti sera and conjugate 
i) Antigen preparation: E. granulosus antigen B (AgB, from sheep cyst fluid) was 
prepared (details shown in Appendix I). 
 
ii) Preparation of rabbit anti antigen B: Rabbit anti AgB IgG was prepared by 
boosting rabbit with AgB. AgB 0.5 ml and complete Freund’s adjuvant (Sigma 
F5881) 0.5ml were mixed evenly to emulsify and kept overnight at 4oC. A New 
Zealand rabbit, approximate 2kg, was injected subcutaneously in multiple sites on 
the back and intramascular injection in the thigh with this emulsion. After 10-14 
days, another emulsion of mixed EgB 0.5ml and incomplete Freund’s Adjuvant 
0.5ml (Sigma F5506) was injected into the rabbit as above, followed by once a 
week for 2-3 weeks until antibody titers were sufficiently raised. One week after 
the last boost, the rabbit was anesthetized and bled from the heart or cervical 
artery. The blood was stored at room temperature for 1 hour; the clot separated 
and then at 4 °C overnight, centrifuged 2000 g for 10 minutes and the serum 
supernatant collected. Approximately 40-50 ml of rabbit anti-sera could be 
collected finally, and stored at -80°C. An IgG fraction prepared from rabbit 
anti-sera by Protein A column affinity chromatography. A protein A Sepharose CL 
4B column (Pharmacia) was prepared with PBS following the manufactures 
instructions. 1 ml serum was added to a 10 ml column and subsequent elution of 
IgG using a low pH glycine buffer (0.2M glycine/HCl + 0.5M NaCl, pH3.0). After 
dialysis against 500 vol. PBS, the IgG fraction was reconcentrated by an Amicon 
ultra filtration cell with YM10 membrane (Amicon Corp, MA, USA) to a final 
concentration of 8.6 mg/ml, which was determined by spectrophotometry at 
280nm.  
Capture antibody: Half of above rabbit IgG anti-EgB was diluted to 5µg/ml with 
BCB (pH9.6) for use in ELISA, and diluted to 2mg/ml with 20mM Tris-HCl (pH 8.5) 
for the colloidal gold rapid test as a capture antibody. 
Conjugate: Half of above rabbit anti-EgB IgG was conjugated with colloidal gold. 
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iii) Conjugate Procedures: 
(1) Preparation of colloidal gold and conjugate. 
Preparation of colloidal gold was the same as the procedure for DIGFA for human 
serology test as described in section 3.2.  
Colloidal gold conjugated rabbit anti-EgB IgG was prepared similar to section 3.2 
but with 5% BSA blocking buffer and purification through the following procedures. 
The conjugate was centrifuged at 2000g for 30 minutes to remove some bigger 
particles. The conjugate solution was concentrated in a dialysing tube covered 
sucrose powder until one third of original volume. The concentrated conjugate 
was coupled to a Sephadex G200 column (1g for a volume 15-20ml) column, and 
eluted with 2% BSA 20mM Tris-HCl. Since uneven sizes of colloidal conjugate 
would have different pass speed, the middle part of the elute with a deep wine red 
colour was collected to get similar size (40nm) conjugate. The final volume of 
conjugate was around 4ml. The OD value was checked at a wavelength of 570nm. 
The conjugate was diluted with conjugate buffer to lower an OD value of 0.7. 
 
(2). Determination of the optimized labeling volume of IgG: 
The colloidal gold, IgG and 10%NaCl were mixed in order in small eppendor tubes; 
the optimal volume of IgG was selected according to the better color change point 
(Table 4.1). 
 
Table 4.1: The trial for optimizing the volume of IgG to conjugate with 
colloidal gold. 
Reagents Tube 1# Tube 2# Tube 3# Tube 4# Tube 5# Tube 6#
Colloidal gold 100 μl 100 μl 100 μl 100 μl 100 μl 100 μl 
IgG 1mg/ml 0.4 μl 0.8 μl 1.6 μl 3.2 μl 6.4 μl 12.8 μl 
10%NaCl 10 μl 10 μl 10 μl 10 μl 10 μl 10 μl 
Results Grey Grey Grey-red Purple red Red Red 
 
The optimized volume of IgG was 3.2 μl in 100 μl colloidal gold in this test. And 
practical optimized volume of IgG was 3.2*120%=3.84 μl for 100 μl colloidal gold. 
 
(3). Conjugation procedure was same with goat anti human IgG conjugate with 
colloidal gold which was described in Chapter 2. The conjugate used for DIGFA 
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was not needed to be purified again but should be done for ICA tests. The 
blocking buffer for conjugate used in ICA was 5% BSA blocking buffer. Then the 
conjugate was centrifuged under 2000g for 30 minutes, the suspension was 
concentrated to 1/3 of original volume by polyethylene glycol (PEG) 4000 and 
then purified by pass through Sephadex G 200 column. The combined collections 
were test OD value under 570nm wavelength and the results was 1.3.  
 
4.2.2 Optimizing capture, conjugate, blocking reagents, sample buffer and 
washing buffer 
The optimal capture dilution for ICA was determined by continuous dilution 
method and final capture was 2mg/ml. The conjugate (non-dried) was 20μl per 
strip; the sample buffer was PBS with 0.3% Tween-20. 
Solution A and B for DIGFA were prepared as described in Appendix III.  
 
4.2.3 Detection methods. 
(1). Direct dot immunogold filtration assay:  
Preparation of immunogold kit and reagents. The kit with NC membrane was the 
same as DIGFA used for human serology (in section 3. 2). A control dot was goat 
anti rabbit IgG (2mg/ml), and a test dot was rabbit anti sheep EgB IgG. Sample 
dilution buffer A and washing buffer B were prepared as the same as section 3.2.  
Add 8~10ul sample to the middle of the hole with NC membrane, then add 
Solution A 2 drops, Solution B 3 drops, Solution C 4 drops, Solution B 3 drops. The 
results can be read in 3 minutes. This assay was just used as an initial trial and 
not for formal test. 
(2.) Indirect DIGFA (sandwich method): Coated rabbit anti AgB IgG to NC 
membrane until dried completely. Add 2 drops Solution A, then 50~100ul sample 
in the hole, then Solution B 3 drops, Solution C 4 drops, Solution B 3 drops. The 
appearance of a red colour on the test dot indicated a positive reaction and 
presence of antigen B in the tested cyst fluid sample. 
(3). ICA (immuno chromatography assay) strip:  
Because the original hydatid cyst fluid might be mixed with bile or other host 
contaminants, the DIGFA results did not perform very well due to poor 
background. Furthermore the DIGFA set up was not good for a sandwich design 
test. Immunochromatographic Assay (ICA) became the better choice for antigen 
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detection using a sandwich assay style approach. Therefore, an ICA test was 
designed to be composed of a sample pad, a conjugate pad, a NC membrane with 
test and control lines and an absorbent pad. 
NC membrane with test and control line: The NC membrane used in the ICA test 
was different to that used in the DIGFA. General blotting NC membrane with pore 
size 0.45μm was tried but failed to function due to its smaller pore size. A 
commercial Whatman Immunopore FP was chosen finally due to a more 
acceptable flow speed. For a quality control reagent, goat anti-rabbit IgG (affinity 
purified, from Chemicon International Inc., UK), at a concentration of 2.18mg/ml, 
was diluted to 0.5-2mg/ml to act as a control line. Final optimal concentration was 
2mg/ml. The test line was rabbit anti-EgB IgG diluted to 0.5-4mg/ml with a final 
optimal concentration of 2mg/ml. Capture buffer for dilution of both control and 
test IgG captures was 10mM Tris-HCl, 3% ethanol, pH 8.2.  
Conjugate Pad. Colloidal gold conjugated rabbit anti-EgB IgG were prepared as 
above and absorbed to a glass fiber or cellulose based membrane (Whatman 
rapid 27) (15-20μl per test depending on the width of pad). Left to dry at 37ºC for 2 
hours or freezer-dried overnight. Conjugate dilution Buffer for adjusting conjugate 
to optimal ratio was 20mM Tris-HCl containing 2% BSA, 10% sucrose, 0.1% 
Tween 20. 
Sample pad. A Whatman 3MM sample pad was soaked in 0.1M PBS with 0.6% 
Tween 20 and 1% gelatin  and left to dry at 37ºC for 2 hours or freezer-dried 
overnight. 
Finally, Rabbit anti AgB IgG was coated on the NC membrane (Millipore HF 180) 
as a capture (protein conc: 2mg/ml) and goat anti rabbit IgG (affinity purified, by 
Chemicon International, Inc) as a quality control (2mg/ml). The strip was made 
with the absorbent pad (Whatman 3MM) above, NC membrane in middle and 
sample pad at the bottom end. In the test tube, 20μl PBS with 0.3% Tween-20, 
20μl cyst fluid, and 20μl colloidal gold labeled rabbit anti AgB IgG was added in 
order. Then the strips were plugged into the test tube, the liquid would go up until 
the absorbent pad in 5-10 minutes. 
 
4.3  Results 
4.3.1 AgB detection trial in cyst fluid with indirect DIGFA 
In total of 26 confirmed CE cyst fluid samples from human and livestock or rodents 
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were tested, just 3.9% (1/26) was false negative, 1 could not be read due to poor 
situation of cyst fluid sample. The sensitivity was 92.3%. The specificity was not 
calculated since sample number was too fewer (Table 4.2).  
 
Table 4.2: AgB detection in different hydatid cyst fluid isolates with DIGFA.  
CF Origin No. of samples Positive Negative 
Human 4 3 1 
Sheep 7 0 0 
Horse 9 8 1* 
Buffalo 2 2 0 
Bovine 1 1 0 
Cotton rat 2 2 0 
Gerbil 1 1 0 
Negative(L.C.R) 2 0 2 
Total  28 24 4 
*: The sample looked yellow; it may be contaminated with bile and looked difficult to 
filtrate. 
Sensitivity=Positive number in positive samples/positive samples*100% 
                 =24/26 *100%             =92.3% 
 
4.3.2 ICA for human cyst fluid samples 
Different concentration of Tween 20 could reduce the background of the ICA test. 
The following results showed 0.6% Tween 20 could be better for this method 
(Table 4.3 and Fig. 4.1). 
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Table 4.3: First trial of ICA strips with different conc. of Tween 20 for AgB in 
cyst fluid 
Results No Sample 
0.3% Tw20 0.6% Tw20 
B1-1 Liver CE CF (female, 12y, 8/00), T3 ++ ++ 
B1-2 Liver CE CF (male, 14y, 10/00, Qinghe), T1 + + 
B1-3 Liver CE CF (female, 17y, 10/00), T3 +++ ++ 
B1-4 Liver CE CF (male, 27y, 7/00,), T3,  ++ + 
B1-5 CE CF (male, 34y, 4/99), T1 + + 
B1-6 Liver CE CF (male, 61y, 5/99, Huang 
Yuntang), T1 
+ ++ 
B1-7 Liver non-parasite CF (male, 56y, 25/7/00) Suspicious - 
B1-8 Liver non-parasite CF (male, 7/00) - - 
B1-9 CE CF (male, 10y, 7/00), T1 Poor + + 
B1-10 CE CF (male, 26y, 7/00), T1 + + 
B1-11 CE CF (female, 27y, 7/00), T3 + ++ 
B1-12 CE CF (female, 12y, 8/00), T3 + ++ 
B1-13 872, fluid from residual cavity (7/00) Suspicious - 
B2-N PBS with 0.6% Tween 20 - - 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.1: First trial of ICA strips with different conc. of Tween 20 for AgB in 
cyst fluid (left half with 0.3% Tween 20 and right half with 0.6% Tween 20 in 
the sample buffer).  
 
Control line 
Test line 
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A total of 23 cyst fluid samples from Xinjiang, China were used for initial trial of ICA 
strips. The result showed all 22 confirmed human CE cyst fluid samples were 
positive, 1 cyst fluid from residual cavity were suspicious (Table 4.4 and Fig. 4.2). 
 
Table 4.4: Trial of ICA strips for AgB in human cyst fluid 
No Sample Results 
B3-1 CE CF (female, 27y, 7/00),  ++ 
B3-2 Human CE CF2 91 + 
B3-3 Human CE CF2 91 + 
B3-4 Human CE CF2 91  + 
B3-5 HU CE CF, X264 + 
B3-6 CE CF (female, 27y, 7/00), T3, ② ++ 
B3-7 CE CF (female, 27y, 7/00), T3, ④ ++ 
B3-8 872, fluid from residual cavity (7/00) Suspicious
B3-9 HU CE CF, X264 + 
B3-10 Human CE CF2 91 + 
B3-11 Human CE CF2 91 + 
B3-12 Liver CE CF (male, 61y, 5/99), T1④ ++ 
B3-13 Liver CE CF (male, 61y, 5/99, Huang Yuantang), T1② ++ 
B3-14 Human CE CF2 91 + 
B3-15 Liver CE CF (male, 61y, 5/99), T1③ + 
B3-16 Liver CE CF (female, 12y, 8/00), T3② ++ 
B3-17 Liver CE CF (female, 12y, 8/00), T3③ ++ 
B3-18 Liver CE CF (female, 12y, 8/00), T3② ++ 
B3-19 Chinese human cyst fluid, 2000 ++ 
B3-20 Chinese human cyst fluid, 2000 ++ 
B3-21 Human CF ++ 
B3-22 Human CF ++ 
B3-23 Human CF ++ 
N Sample buffer - 
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Fig. 4.2: Trial of ICA strips for AgB in human cyst fluid (samples details see 
Table 4.4.)  
 
A total of 109 human CE cyst fluid samples were collected in Xinjiang Medical 
University Hospital and 6 fluid samples from non-parasite cysts, were tested with 
the ICA strips. The results showed the sensitivity was 93.58% (95% CI 
91.23-95.93%) and the specificity was 100% (except the samples with color or 
contamination) (Table 4.5 and 4.5a). 
 
Table 4.5: Sensitivity of ICA strips for AgB in human cyst fluid 
Samples No. of Sample ICA Positive (%) 
CE cyst fluid 109 102 (93.58) 
Non-CE sample 6 0 
Total 115 102 
 
Control line Test line
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Table 4.5a: Assessments of ICA strips for AgB in human cyst fluid 
Assessments AgB-ICA for CE cyst fluid (95%CI) 
Sensitivity (%) 93.58 (91.23-95.93) 
Specificity (%) in Non CE controls 100  
Accuracy (%) 93.91 (91.68-96.14) 
Positive predictive value (%) 100  
Negative predictive value (%) 46.15 (41.51-50.80) 
Youden Index 93.58 (91.29-95.86) 
 
4.4  Discussion 
Identification of cyst fluid as being of hydatid origin is of use for clinical 
requirements especially for unconfirmed cyst pathology. The use of immunological 
methods to detect hydatid antigen B since it could be more useful for cyst fluid 
identification than other antigens such as crude E. granulosus cyst fluid antigen. 
Antigen 5 has also been assessed by previous research (Paul et al., 1997). ELISA 
has been a traditional and practical tool for antigen detection, especially with 
double antibody sandwich methods. AgB ELISA and AgB Dot-ELISA have been 
confirmed useful and effective (Craig et al., 1986; Wang et al., 2002). 
Colloidal gold techniques in this study have been confirmed as a simple rapid and 
functional method for detecting hydatid antigens in cyst fluid, either was DIGFA or 
ICA approaches. Results were readable after only several minutes. This then 
could be useful for hydatid diagnosis during the surgical or percutaneous 
procedures. Generally the two methods had similar sensitivities but practical 
aspects were really different. ICA is easy to be made since the strips could be 
easily coated with an antibody line and cut into strips by a Bio-Dot machine. And 
DIGFA is more complicated since the NC membrane should be pre-set in the plate 
to fix its position to apply the dots. A disadvantage of DIGFA in our study was poor 
background because the cyst fluid might be turbid or contaminated by bile 
leakage. 
The initial trial with the ICA test showed satisfactory sensitivity (93.6%) and 
accuracy (93.9%) but specificity was not so accurate 100% (6/6) due to less 
non-parasite cyst fluid or some given up cyst fluid samples with contamination. 
The advantages of an ICA test for cyst fluid identification were rapid, simple and 
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effective. It could be used as an instant test during the surgical treatment or PAIR 
and enable differential diagnosis with other cyst pathologies. 
The ICA test however was still in an initial developing stage and not a well 
rounded final product. For developing this method in the future, some further 
assessment is required. The purification of rabbit anti AgB IgG could be improved 
to a better capture and conjugate. Using recombined AgB as a stimulant to boost 
rabbit, or recombined antibody for AgB due to phage antibody library technique. 
More samples testing and development of this method to test both cyst fluid and 
sera will be preceded in the future research. 
 
4.5 Summary 
A rapid immuno chromatographic assay (ICA) for hydatid cyst fluid identification 
was initially developed with a rabbit anti AgB IgG as the capture and colloidal gold 
labeled rabbit anti AgB IgG as the conjugate. A satisfactory sensitivity (93.6%) 
and accuracy (93.9%) was observed. The ICA test however was still in an initial 
developing stage and need to be improved to a well rounded final product. 
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Chapter 5.  Development and application of a rapid sandwich 
ICA (Immuno Chromatographic Assay) coproantigen detection 
for canine echinococcosis 
 
5.1 Introduction 
Carnivores play the most important role as a definitive host in Echinococcus 
transmission. Therefore, diagnosis and treatment of definitive hosts become a 
major point for prevention and control for echinococcosis in endemic areas 
including China (Craig et al., 2000, 2006, 2007; Ito et al., 2003). 
Carnivores, especially dogs, are infected in a domestic lifecycle after eating 
livestock offal infected with Echinococcus granulosus cysts that contain 
protoscoleces. Protoscoleces evaginated and attach to the epithelium wall of dog 
small intestine with suckers and rostellar hooks (Ding and Wen 2000; WHO/OIE 
2001). Protoscoleces develop to the adult tapeworm stage after evagination, 
elongation (day 1), formation of first proglottid (day 11-14), genital rudiment 
division and first segment fully formed (day 14-17), rudimentary testes appear and 
second proglottid begin to form (day 17-20), two-segmented worm (day 20-28), 
male and female genitalia fully mature (day 28-33), ovulation and fertilization in 
terminal proglottid, 3-4 segments (day 33-37); gravid with embryonated eggs, 3-5 
segments (day 37-45) (WHO/OIE 2001). 
The gold standard for detection of adult Echinococcus worms in dogs is based on 
morphological check after necropsy of the small intestine and proglottid check 
under microscopy. But necropsy could not be accepted as a routine diagnostic 
approach for domestic dogs, and can only be used for selected sampling in 
research and possibly dog slaughter (for foods in some areas). Proglottid check 
could be accepted easily but the sensitivity is generally lower for light infection. 
Microscopy for eggs can not differentiate Echinococcus from other taeniid eggs. 
Arecoline purgation can be very useful for pre-mortene diagnosis of Echinococcus 
for in dogs, but its time consuming, biohazards and may lack sensitivities (Craig, 
1997; WHO/OIE, 2001). Coproantigen ELISA and copro-PCR therefore became 
more important for general detection assays in epidemiological survey and control 
projects (Craig et al, 1995, 1996; Sakai et al., 1995; Eckert et al, 1997). The 
satified sensitivities (84%-95%) and very high specificities (>95%) of coproantigen 
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ELISA were reported (Allan et al., 1992, Deplazes et al, 1992, 1999; Sakai et al., 
1995; Fraser et al, 2002). A disadvantage of these two assays was the 
professional technical aspects, cost and instruments.  
The aim of this research was to develop a rapid test for initial screening of dog 
fecal samples so that the first check could be carried on dogs in the field and rural 
endemic areas. 
 
5.2  Methods and approaches 
Experimental infected dogs: Protoscoleces of E. granulosus were collected 
from freshly hydatid cysts from sheep liver or lungs in an official slaughter house in 
Xinjiang. Then the protoscoleces were packed within dog food (sheep intestine) 
and feed to 9 dogs which had been treated with praziquantel 1 week before 
infection. Each dog received above 80,000 protoscoleces by oral dosing. Dog 
faecal samples were collected every 2 day until necropsy. Infection periods were 
20-, 34- and 53 days respectively. Three dogs were post-mortem at 20 days after 
infection and 2 of them were confirmed infected with E. granulosus worms in their 
intestine. Three dogs were post-mortem 34 days, and the remaining 3 were killed 
53 days after infection; all were confirmed infected. Intestines of dogs were 
removed at necropsy as described by Allan et al (1992) and put into 37℃ saline. E. 
granulosus adult worms were washed out from intestinal wall using warm 
physiological saline, washed by decantation and collected into tubes with saline 
and frozen at -80 ºC immediately (Craig, 1997) for further developing the IGCA 
rapid test. 
Faecal Samples:  A total of 163 faecal samples were collected during the 
infection from 0 days to 53 days from above E. granulosus experimental infected 
dogs in Xinjiang Veterinary Research Institute, China. And 158 faecal samples 
among them were extracted for DNA which would be used for Copro PCR test. 
The normal controls were from Britain non-endemic area and experimental 
controlled non-parasite dogs in XMUH (n=30). Faeces were stored at -80 ºC for a 
week and then transferred to -20 ºC.  
Faecal samples for coproantigen sandwich ELISA and rapid ICA test were 
prepared essentially as described by Allan et al. (1992). This method involved 
mixing faecal material (~2gm) with an equal volume of 0.15 M PBS containing 
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0.3% Tween 20 (Sigma). The samples were then vigorously shaken by hand or 
shaker to produce a homogeneous mixture. Faecal samples were then 
centrifuged at 3000rpm for 30 minutes at room temperature and supernatants 
were aliquoted for later testing. If sample were not tested in 2 days they were 
frozen at -20ºC/-80ºC. 
The application of rapid coproantigen tests were carried on feces samples from 
communities including Hoberkesaier, Bayanbulake County in Xinjiang. 
5.2.1 Preparation of adult worm antigen (EgWWE) 
E. granulosus adult worms came from Xinjiang Medical University. They were 
obtained from experimentally infected dogs with E. granulosus protoscoleces from 
sheep hydatids and necropsied at 20-, 34- and 53- days after infection.  
E. granulosus whole worm extract antigen (EgWWE) was prepared essentially 
according to Allan et al. (1992) by selection of the non-gravid segments (could be 
done under a microscope), which were then washed three times in sterile 0.15 M 
phosphate-buffer saline (PBS) (pH 7.2) for at least 30 minutes. The worms in PBS 
were frozen and thawed at -80ºC / room temperature, then homogenised on ice 
using a hand held glass homogenizer. To the homogenate 5ml of PBS plus 
protease inhibitors 0.1M Phenylmethanesulfonyl fluoride (PMSF) was added, and 
then the preparation was ultrasonicated (60sec, 40W, 80%pulse) on ice. This 
extract was centrifuged at 12 000g for 30 mins at 4 ºC and the supernatant was 
removed and aliquot to use as an antigen (EgWWE), frozen at -20°C. Protein 
concentration of EgWWE was measured by Bradford Assay (Allan and Craig, 
1992). 
Above EgWWE from worms with 20-, 34- and 53-day infection, were checked with 
a SDS-PAGE and western blot (Fig. 5.1). The gel and blotting showed 
EgWWE-34D and -53D owned similar protein bands with standard EgWWE 
control but EgWWE-20D had stronger reactions. Their protein concentrations 
were tested by ultraviolet spectrophotometry which checks OD value of 1:30 
dilution antigen under 280nm wavelength. The result showed OD value was 0.038, 
0.040 and 0.124 respectively and calculated protein concentration was 
0.844mg/ml, 0.889mg/ml and 2.756mg/ml using the formulation OD×30/1.35. 
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Fig. 5.1: Western-Blot and SDS Page results for EgWWE antigens. 
1. Protein marker; 2. EgWWE control; 3. Eg immature worm antigen (20 days after 
infection); 4. Eg mature worm antigen (34 days after infection); 5. Eg adult worm antigen 
(53 days after infection); 6. Eg mature worm antigen 1:62.5 (protein conc 0.1mg/ml); 7. Eg 
adult worm antigen 1:125 (protein conc 0.1mg/ml); 8. EgWWE H (homogenized); 9. 
EgWWE NH (none-homogenized); 10. EgWWE H;8-10. EgWWE from different sources. 
The antibody used for blot was HRP conjugated rabbit specific anti-EgWWE IgG. 
 
5.2.2 Preparation and purification of rabbit anti E. granulosus (EgWWE) 
antibodies 
The preparation of hyperimmune antiserum was produced according to the 
method described by Allan and Craig (1989) with a few small alterations.  
A hyperimmune rabbit antiserum was obtained by the following steps. First boost 
was using the injections consisted of intramuscular and subcutaneous of a rabbit 
with 0.5ml (250µg protein) EgWWE in 0.5ml Freund's complete adjuvant (Sigma). 
This was followed by a second boost 10-14 days after first one, and then other 2-3 
boosts at 7-10 days intervals, using 0.5ml EgWWE in 0.5ml Freund's incomplete 
adjuvant (Sigma) from second boost. Prior to each injection, approximately 0.5ml 
blood from an ear vein was separated and serum tested for antibody levels using 
a standard ELISA (EgWWE as a capture, goat anti-rabbit IgG-HRP as a 
conjugate). The rabbit was then killed and bled-out 7-10 days after the third or 
fourth boost when satisfactory antibody level (>1:30,000 titre) occurred. Blood was 
allowed to clot for 1 hour at room temperature and overnight at 4 °C before being 
centrifuged at 3000rpm and serum removed. Serum was used within 2 days or 
stored at -80°C until used. 
 
1 12 23 34 45 56 67 78 89 910 10
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5.2.3 Preparation of horseradish peroxidase (HRP) conjugates 
An IgG fraction was then isolated from above hyperimmune rabbit for use in 
ELISA. This was achieved by passage of the sera through a protein A sepharose 
CL 4B column (Pharmacia, Sweden) and subsequent elution using a low pH 
glycine buffer (0.2M glycine/HCl + 0.5M NaCl, pH3.0). After dialysis against 500 
vol. PBS, the IgG solution was re-concentrated by vacuum dialysis to a final 
concentration of 6-8 mg/ml, which was determined by spectrophotometry at 
280nm (Allan and Craig, 1989). 
The hyperimmune serum IgG was divided into equal portions, one was dialysed 
with 0.15M PBS (pH7.2) for use as capture antibodies, and another part dialysed 
with 0.01M BCB buffer (pH9.6) for conjugation to horseradish peroxidase (HRP, 
type VI, Sigma P6782), via the method described by Wilson and Nakane (1978). 
Conjugation to HRP procedure: HRP (Sigma P6782) was dissolved in pure H2O 
with a ratio of 1:2 (w/w) with IgG (e.g. 1ml 8mg/ml IgG would using 4 mg HRP). 
Fresh prepared 0.1M sodium periodate (NaIO4) was added to the HRP solution 
with a ratio 200μl per ml and mixed well to become a blue-green solution and 
covered with foil (to prevent light) for 20 minutes at room temperature. The above 
solution was dialyzed against 0.001M sodium acetate buffer pH4.4 overnight at 
4°C, then the pH was raised to 9.5 by adding 20μl/ml freshly prepared 0.2M 
sodium carbonate/bicarbonate buffer (BCB) pH 9.6. Additional volume of 0.05M 
BCB was added to bring the volume of the IgG solution to the same as the HRP 
solution. Immediately, the HRP and IgG solutions were mixed together and gently 
stirred for 2 hours at room temperature in a foil covered tube. 
Finally, 0.1ml/ml fresh prepared sodium borohydride (NaBH4, 4mg/ml) was added 
to the conjugation solution and mixed well for 2 hours at 4oC. Finally the conjugate 
solution was dialyzed against 0.15M PH7.4 PBS, overnight at 4oC and aliquoted 
and store at -80oC. 
 
Coproantigen ELISA 
The optimal dilutions for capture IgG antibody and HRP conjugated antibodies 
were obtained by checker-board titration. There ranged from 5-10µg/ml for 
capture antibody. 
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A 96-well Immulon 4 microtitre plate (Product code M129AIV-50, Dynex 
Technologies Ltd, UK) was coated with capture antibody -- rabbit anti-EgWWE 
IgG (diluted with 0.05M NaHCO3 / Na2CO3 buffer pH9.6) 100µL/well, 2 wells 
should be left as blank controls (not antibody, faeces or conjugate solution added) 
and covered with cling film and left at 4ºC overnight. Plates were washed with 
PBS (0.1% Tween 20), and blocked with 100 μl/well of PBS with 0.3% Tween 20 
for 1 hour at room temperature. 
 
Supernatant from a faecal sample (see section 2.5.2) was diluted 1:1 in PBS 0.3% 
Tween 20 and 50µL/well added to 50µL/well of heat-inactivated foetal calf sera 
(FCS, to prevent non-specific reaction) already in each well and incubated at room 
temperature for 1 hour. Positive and negative control faecal samples were 
included in each plate and all the samples including controls were tested in 
duplicate.  
 
Faecal samples were discarded from the plate into 10% bleach. Plates were 
washed 3 times with PBS (0.1% Tween 20), and then 100 µL/well of conjugate 
(HRP-IgG anti-EgWWE, diluted with PBS 0.3% Tween 20) added at optimal 
concentration, and incubated at room temperature for 1 hour.  Plates were 
washed 3 times with PBS (0.1% Tween 20). Then a substrate of tetramethyl 
benzidine (TMB microwell peroxidase system, Catalog no 50-76-00. Dynex Ltd. 
UK) was added at 100 µL/well including blank wells for 20 mins. OD values were 
determined initially at 630nm by microplate reader; after addition of stopping 
buffer (1M phosphoric acid at 50µL/well) was final ODs were read at 450nm if 
necessary. 
 
5.2.4 Preparation and purification of colloidal gold conjugate 
5.2.4.1. Colloidal gold: 
10% HAuCl4, were prepared with H2O using HAuCl4·3H2O, Gold (III) Chloride 
trihydrate, ACS reagent, Sigma G4022. 100 ml pure H2O was brought to boil on a 
heat board or in a microwave. Then 10% HAuCl4 300 µL was added and back to 
boil again. Add 7 ml 1% Sodium citrate into above hot solution quickly. Keep 
boiling for more 10 minutes with stirring evenly on a heat board or just shake the 
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bottle quickly to mix the reagents well. The colour would be changed into wine red 
in 1-2 minutes. Cool in room temperature and store at 4°C with foil covered. 
 
5.2.4.2 Optimized antibody concentration for gold conjugate  
1 ml of Colloidal gold were first added into each tube, then followed by different 
volumes antibody (8 μl, 16μl, 32μl, 64μl, 128μl respectively) and 100μl 10% NaCl 
at last. Observe the colors of each tube after 1 hour. The 3rd one with 32μl 
antibody showed red-purple which just changed to red from black or dark purple. 
 
A rabbit anti- EgWWE antigen was prepared as described in Section 2.5.2. Sera 
was taken out and then purified through Protein A column to obtain IgG. A part of 
IgG was conjugated with HRP as described in general protocol using NaIO4 which 
have details in 5.2.3, in order to use it as secondary antibody in the sandwich 
ELISA. Another part of the rabbit IgG was conjugated with colloidal gold.  
 
 
 
 
 
 
 
 
 
 
Fig. 5.2. Experiment for optimizing the antibody conc. to be labelled with 
colloidal gold. Antibody was added into 1ml colloidal gold for conjugate with 
different volumes (8 μl, 16μl, 32μl, 64μl, and 128μl) from left to right. The tube was 
selected when the color of liquid was just turned into purple-red from black or 
purple. Above result showed the third one with 32μl volume was that we needed. 
Then the optimal concentration of antibody for 1ml colloidal was expected as 
32*120=38.4μl for the conjugation. 
 
5.2.4.3 Procedure for Anti-EgW Gold Conjugate: 
Mixed 10 ml Colloidal Gold with 1 ml 0.2 M Sodium borate first and then added 
0.384ml 1mg/ml rabbit anti-EgW IgG prepared in 20 mM Tris-HCl. Kept above 
mixture at 4 °C for 45 minutes or 1 hour. Add 440 µL 5% PEG 20,000 and 2.94ml 
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Blocking buffer (certain concentration of sucrose, Gelatin and BSA in 200mM 
Tris-HCl). The initial conjugate was then filtered with 0.2 µm pore size syringe filter 
and stored in dark at 4°C. 
5.2.4.4 Conjugate purification: 
Above conjugate was centrifuged in 2000rpm for 30 minutes to get rid off some 
bigger particles. Then the supernatants were concentrated in a dialysing tube with 
covered PEG 4000 until final one third of original volume left. 
A Sephadex G200 column was prepared with 1g Sephadex G200 powder for a 
volume 15-20ml. Concentrated conjugate was coupled with the column, and 
eluted with 2% BSA 20mM Tris-HCl. The middle part of conjugate with deep wine 
red colour was collected due to different sizes of colloidal conjugate which would 
have different pass speed to get similar size conjugate. The final volume of 
conjugate was around 4ml. OD value was tested under the wavelength 570nm. 
The final conjugate was diluted to lower the OD value to the optimal 0.7 with a 
conjugate buffer. 
 
5.2.5 Development of Immunochromatographic Assay (ICA) 
Preparation for ICA test 
A rabbit anti- EgWWE antigen was prepared as described (section 5.2.1).  
Sera was taken out and then purified through Protein A column to obtain IgG. A 
part of IgG was conjugated with HRP as described in general protocol using NaIO4 
in order to use it as secondary antibody in the sandwich ELISA. Another part of the 
rabbit IgG was conjugated with colloidal gold.  
Colloidal gold was prepared by the reduction of gold chloride with citric acid; 
protein could be combined were test with rabbit anti-EgWWE IgG and 10% NaCl. 
Colloidal gold conjugate anti-EgWWE IgG was prepared using 1mg/ml IgG in 20 
mM Tris-HCl buffer, and combined 120% of optimal volume  to the suspension of 
borate buffer balanced colloidal gold (pH>8.0), at 4ºC for 1 hour. Blocking buffer 
(5%BSA, 100mM Tris-HCl, sucrose, gelatin and PEG 20, 000) was added drop by 
drop, mixed and filtered through a 0.2μm membrane, then stored at 4ºC in the 
dark. 
The last concentrate could be changed by ultracentrifuge to individual design, the 
purification methods would be talked in following paragraph. 
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ICA test kit designed for coproantigen detection 
ICA test kit was essentially a kind of dipstick or strip-test. With the NC membrane 
in the middle, a sample pad, conjugate pad and downstream an absorbent pad, 
were in proper order and pasted to a commercial plastic back  
(Whatman, China) (Fig. 5.3). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.3: ICA test strip 
 
An ICA test kit consists of the following downstream membrane or pads on a 
plastic backup: an absorbent pad, a strip of NC membrane with capture, a 
conjugate pad and a sample pad at the bottom (Fig. 5.4). 
The NC membrane used in ICA test was different with that used in the DIGFA 
approval. General blotting NC membrane with pore size 0.45µm was tried but 
failed to absorb reagent due to its smaller pore size. A commercial Millipore 
HiFlow Plus HF 18004 NC membrane was finally chosen due to better flow speed 
and reaction time. 
A quality control line of affinity purified goat anti-rabbit IgG (Chemicon 
International Inc., UK), at a concentration of 2.18mg/ml, was diluted to 0.5-2mg/ml 
to act as a control line. Final optimal concentration was 2mg/ml. 
Sample 
Pad
Conjugate Pad
NC membrane
Absorbent Pad
Test line (capture IgG) 
Quality control line (sheep anti-rabbit 
IgG)
Bottom, immerse in faecal supernatant 
Top 
Upstream 
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Rabbit anti-EgWWE IgG at a concentration of 0.5-4mg/ml (optimal concentration 
was 2mg/ml) was used as capture antibody diluted in 10mM Tris-HCl, 3% ethanol, 
pH 8.2. 
Colloidal gold conjugated rabbit anti - EgWWE IgG was coated (approximately 
32µg/ml, 2µl per test) on the conjugate pad (Millipore, based on glassfibre 
membrane). The dilution of colloidal gold conjugate was determined by titration 
with positive control (EgWWE antigen 1:100) and negative dog faecal samples.  
A Millipore sample pad made of cellulose was soaked in a Tris-HCl buffer 
including some surfactants such as Tween 20, PEG 20,000, and 2% BSA to 
decrease the nonspecific reaction and dried at 37°C for over 2 hours. 
A Whatman 3MM chromatographic membrane was used as absortent pad. 
 
The ICA procedure was simple to carry out. The sample pad of the strip was first 
immersed in the faecal supernatant in a tube. The absorbed faecal supernatant 
then met with the pre-coated conjugate and antigen-antibody combined together if 
coproantigen existed in the faecal sample. The mixture was then upstream again 
on the NC membrane and reacted with capture antibody (double antibodies 
sandwich). The red color on test line would appear if coproantigen existed. Excess 
conjugate should go up and combine with the third antibody to act as a quality 
control line. All the excess liquid would be absorbed into the top absorbent pad to 
leave the reaction area for clear reading. The procedure could be carried out in 5 
to 20 minutes depending on the different type of NC membrane and utilizes. 
 
 
 
 
 
. 
 
 
 
 
Fig. 5.4: ICA coproantigen strips were prepared to test 
 
Absorbing Pad
NC membrane 
Control line 
Test line 
Conjugate Pad
Sample Pad 
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5.2.6 Copro PCR for experimental infected dogs 
5.2.6.1 Faecal DNA extraction 
5.2.6.1.1 Preparation 
Enough 2ml & 1.5ml tubes and collecting topless tubes (for DNA collection at end 
of procedure) were autoclaved before extraction.Tips for loading gels only were 
autoclave as well. Samples were labeled properly. Plenty of PBS was prepared 
with 1 tablet PBS adding 200ml H2O. Bleach pot was prepared for used tips and 
samples. The Sonitech water bath was warm to 70°C--90°C for eggs lysis. PCR 
sample were stored in ethanol. Medical torgue depnessors were prepared for 
holding faecal samples. 
 
5.2.6.1.2 Procedures: 
Bottles of 12*10ml were labeled and added about 1/3 volume PBS. Tubes 
(12*50ml) were labeled and added 2.5-3ml percoll per tube, then added PBS until 
42.5 ml, put a deposable sieve on the top. 1-2g faeces were weighted and put into 
the above 10ml-bottle and mixed with PBS. Then the mixture was poured on the 
sieve on the above tubes. Then the tube top was stewed and the tube was 
centrifuged at 3600-3660 rpm for 30 minutes. The sieve and faeces were thrown 
away and the supernatant was collected for next procedure. Operation for stool 
DNA was then carried out from Step 2 in manufacture’s protocol (QIAamp DNA 
Stool Handbook) and the last DNA eluate stored at -20°C. 
 
5.2.6.2 Copro PCR procedure （Abbasi, 2003; Boufana et al, 2008 ） 
The primers was as follows: Eg1121a 5′-GAATGCAAGCAGCAGATG-3′ 
(upstream) and Eg1122a 5′-GAGATGAGTGAGAAGGAGTG-3′ (downstream). 
First to calculate how much PCR solution would be needed which 49ul last 
solution + 1ul DNA for each sample. For 50 μl reaction solution, it was made by 
21.25μl H2O, 25μl X2 buffer 9, 0.5μl 1mm dNTP, 0.5μl 1μm Pra, 0.5μl 1μm Prb, 
1μl 2% Formamide, 0.25μl 1.25μ Taq, and then 1μl DNA solution. Turn on the UV 
light before start to work and bring ice back. PCR tubes were put on the rack and 
then put on the icebox. All the solutions were added one by one to a 2ml tube. Add 
1μl DNA to the bottom of PCR tube. Taq could be taken out only the last step. 
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Mixed them in a rotor and aliquoted to the PCR tubes, the mineral oil could be add 
on the top. Then all the tubes were capped, marked label on the top. Sample box 
was taken out from the UV box, and DNA sample did before. PCR machine which 
need to preheat before starting. The coproPCR was runned with the profile of 5 
minutes at 95°C for 1 cycle, 1 minute at 95°C+1minute at 55°C + 10 seconds at 
72°C for 35 cycles, then 10 minutes at 72°C for 1 cycle. 
 
PCR Gel preparation: 
0.5% TBE buffer 100ml was added agarose 1.5g, heated by a microwave oven for 
3 minutes, was cooling down with water bath in 0.5 hours, poured into the gel 
cassette with 2 drops Ethidium Bromide (0.6mg/ml, 5μl per 100ml). 
1 drop Blue one and 10μl DNA sample were mixed and then added to the well, at 
the same time 5μl DNA marker was added in another line. 
 
5.3 Results 
5.3.1 Sandwich ELISA test for canine coproantigen  
5.3.1.1 Test dog faecal samples with sandwich ELISA 
A total of 163 fecal samples from E. granulosus experimental infected dogs were 
used for copro ELISA. The time-curve of coproantigen ELISA showed the 
positivity and sensitivity were higher following the infection time. The samples with 
the infection time fewer than 28 days presented the lower OD value than the cutoff 
(0.318), and after that time, almost all the samples showed positives. First 
copropositive occurred by 28dpi (Fig. 5.5). 
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Fig. 5.5: Mean OD value of Coproantigen sandwich ELISA in E. granulosus 
experimental infected dogs. (Cutoff=N+3*SD=0.318) 
 
5.3.1.2 Coproantigen ELISA tests for screening dog-faecal samples from 
community survey in western China.  
The results showed that 3 stronger positive in 21 samples (14.3%) from Habahe 
and 3 positive in 41 samples (7.3%) from Yushu (Table 5.1). The positive rate in 
Yushu was lower than we expected. I tested them again with other reagents, but 
got the similar results with before. I thought that the reason might be relevant with 
the condition of the faecal samples’ collection, dilution and storage. The samples 
were collected 2 years ago, the diluted ratio looked different in different samples, 
and they were stored at 4°C for 2 years. 
 
Table 5.1: Coproantigen ELISA tests for screening dog-faecal samples from 
endemic communities in Xinjiang (X) and Qinghai (Q) of China. 
Communities No. Positive (%) Negative 
Habahe(X) 21 3 (14.29) 18 
Yushu(Q) 41 3 (7.32) 38 
Hoboksar(X) 76 36(47.4) 40 
Hejing(X) 40 9(22.5%) 31 
Total 178 41 (23.03) 127 
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5.3.2 Diagnostic evaluation of immunogold chromatographyic assay (IGCA) 
for experimental dogs 
96 faecal samples from E. granulosus experimental infected dogs were also 
tested by rapid IGCA assay as for the ELISA test. The results showed the 
sensitivity was increased followed by infected days as well and had significant 
difference in four different infection period (P<0.01) (Table 5.2(a) and 5.2(b)). The 
initial IGCA result presented a little lower sensitivity compared with ELISA 
(P>0.05). The specificity was 100% (30/30 for non-infected control group) in 
ELISA and 93.33% (28/30) in IGCA.  
 
Table 5.2(a): Comparison of coproantigen ELISA and IGCA rapid test for E. 
granulosus experimental infected dogs 
Positives Negatives Sensitivity (%)
Samples No. 
ELISA IGCA ELISA IGCA ELISA IGCA 
Non-infected 30 0 2 30 28 - - 
1-20days 30 4 2 26 28 13.3 6.7 
21-34days 20 10 8 10 12 50 40 
35-53days 16 16 15 0 1 100 94 
Total 96 30 27 66 69 45.5 42.4 
 
Table 5.2(b): Statistical result for comparison of coproantigen ELISA and 
IGCA rapid test 
 
ELISA & 
ICA 
Time courses with 
ELISA 
Time courses with 
ICA 
Chi-square 0.099 56.592 54.696 
P 0.753 0.000 0.000 
 
5.3.3 Copro PCR results for experimental infected dogs 
A total of 158 DNA samples were extracted from feces from above E. granulosus 
experimental infected dogs. The positive rate was not so good since the fecal 
sample had stored for near 8 yrs ago. But the interesting result was the clear 
positive zones occurred in sample No 93 and No. 155 which were fecal samples 
from two 20-day infected dogs (Fig. 5.6). 
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Fig. 5.6: No. 93# and 155# showed all positives within double check with 
Copro PCR (Abbasi’s methods) for experimental infected dogs. 
Lanes: fist and last lane were 100-bp molecular DNA ladder, second and third lanes from 
right were negative and positive control, the other lanes were different DNA samples from 
dog faeces. 
(a) No. 93# (20 days post infection) had one positive lane in 133bp and No. 155# (20 days 
post infection) had another strong bands. 
(b) No. 93# had two obvious positive bands and NO. 155# had a weak positive in its 
second band. 
 
5.4 Discussion 
The dog is a key host in the life cycle of Echinococcus, not just for E. granulosus, 
but also for E. multilocularis since it has been confirmed to be infected with E. 
multilocularis (Craig et al., 1992, 2000, 2003, 2005; Shi, 1995; Vuitton et al., 2003). 
Serological tests for dog infection were effective but not so sensitive because 
serum antibodies may be present from recent infection even if there is no current 
infection (Craig, 1997). Eggs as the infective source for livestock and human, exist 
within segments of adult worms and in dog feces. Eggs are however difficult to be 
differentiated from other taeniid cestode eggs under the microscope. Arecoline 
purgation is useful to show presence of adult worms after purgation and has been 
applied in mass screening (Gemmell, 1973; Craig et al., 1995; Budke et al., 2005; 
Lahmar et al., 2007, 2009). However unsuccessful purgation might cause missed 
infections and light infections may not be detected (Craig et al., 1995; Schantz et 
al., 1995; Fraser et al., 2002; Budke et al. 2005). The autopsy of dogs is a gold 
standard for infection but can not usually be accepted or recommended (Craig et 
al., 1997; Eckert et al., 1997; WHO/OIE, 2001; Fraser et al, 2002).  
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Coproantigen sandwich ELISA has been widely accepted as a laboratory 
detection method for canine echinococcosis (Allan et al., 1992; Craig et al, 1995; 
Deplazes et al, 1992, 1997; WHO/OIE, 2001; Fraser et al, 2002). One of the most 
common used antigens for raising antibodies was whole worm extract of E. 
granulosus (EgWWE) and the sensitivity and specificity was generally over 85% 
(Allan et al, 1992; Deplazes et al., 1992, 1999). The extracts of E. granulosus 
include somatic protoscoleces, excretoary / secretory (E/S) extract of E. 
granulosus protoscoleces, and the FPLC fraction from EgWWE were all used for 
find a more specific antigen to be used as a boost for coproantigen ELISA (Allan et 
al., 1992; Craig et al., 1995, 1996; Deplazes 1992, 1999; Sakai et al., 1995; 
Frazer et al., 2002; Elayoubi et al., 2004). Monoclonal antibody for EgWWE was 
also another attempt to gain more specific result (Kohno et al., 1991, 1995; Sakai 
et al., 1995; Malgor et al., 1997; Zhang et al., 2003). Copro-PCR was developed 
for differential diagnosis of E. granulosus and E multilocularis by amphyzation of 
species specific DNA (Dinkel et al, 1998; Frazer et al., 2002; Abbasi, 2003; 
Boufana et al, 2008, 2012).  
This Chapter reports the first initial development and assessment of a rapid IGCA 
for coproantigen detection for effective screening of dog infections. The sensitivity 
of IGCA was not as good (94%) compared with coproantigen ELISA (100%) in 16 
experimental 35-53 dpi dogs. This might be due to several possibilities. Polyclonal 
antibody was used as the capture and detection antibody, but a good monoclonal 
antibody was difficult to obtain against a purified antigen. Then the detection 
system was very important, IGCA is a rapid test, based on eye-reading so its 
sensitivity and specificity were generally lower than for coproantigen ELISA. Thus 
it might be best used as an initial screening tool in the field.  
The E. granulosus experimental time-course infection of dogs was subjected to 
faecal screening. ELISA and IGCA showed that coproantigen level appeared to 
increase from day 16 after infection and were clearly detected after day 24 dpi by 
both ELISA and IGCA. This might be thought to correlate when the first segment 
of worm formed in that period (i.e. day 14-17) and two segmented worm (day 
20-28) (WHO/OIE, 2001). And the DNA of E. granulosus was amplified from dog 
faeces from 20 days after infection. Copro DNA has been detected in 
experimentally infected dogs in other studies pre-patency (Lahmar et al., 2010). 
DNA might be associated with cell turnover from the worm surface and/or lost / 
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degraded worms or proglottids from 20-28 dpi. 
The copro ELISA was also applied to screen faeces of dog sampled in endemic 
communities in Xinjiang and Qinghai. The initial trial had been used in some 
community studies and a mean positive rate of 23% (41/178) was obtained. The 
samples from Hobokersaier and Hejing showed relative higher positives (47.4% 
and 22.5%) compared to Habahe and Yushu Counties, and also we confirmed the 
higher human CE prevalence in epidemiological studies in these two counties in 
Xinjiang (see Chapter 6). 
These results suggested that copro tests (coproantigen ELISA, IGCA, copro-PCR) 
might be sensitive for canine echinococcosis from 20 days after infection. The use 
of monoclonal antibody for surface antigen of E. granulosus adult worm had been 
shown to have effective results in other research work (Zhang et al., 2003) and 
this could be helpful for both coproantigen ELISA and IGCA. And the IGCA might 
be potential. 
 
5.5 Summary 
A rapid IGCA of coproantigen detection for dog infections was initially developed 
and assessed. The sensitivity of IGCA was 94% in 16 experimental 35-53 dpi 
dogs. ELISA and IGCA showed that coproantigen level appeared to increase from 
day 16 after infection and were clearly detected after day 24 dpi by both ELISA 
and IGCA. The copro ELISA was also applied to screen faeces of dog sampled in 
endemic communities in Xinjiang and Qinghai. The initial mean positive rate of 
23% (41/178) was obtained. The samples from Hobokersaier and Hejing showed 
relative higher positives (47.4% and 22.5%).The results suggested that copro 
tests (coproantigen ELISA, IGCA, copro-PCR) might be sensitive for canine 
echinococcosis from 20 days after infection.  
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Chapter 6. Epidemiological studies and risk factor analysis for 
echinococcosis in northwestern China 
 
6.0.1 Introduction 
The areas including Wenquan County, Bayinbuluke (Hejing County), Xinyuan 
County and Hoboksar Mongol Autonomous County in Xinjiang, Xiji County in 
Ningxia, Ganzi County in Sichuan, Dangxiong County and Dingqing County in 
Tibet (Fig. 6.0.1) were considered as suspected endemic areas for human 
echinococcosis (Menghebat et al., 1993; Guo et al., 2001; Bai et al., 2002; Feng et 
al., 2002; Huang et al., 2002; Bao et al., 2003; Tang et al, 2003; Budke et al., 2005; 
Li et al., 2005, 2010; Wang et al., 2005, 2006; Yang et al., 2006; Chu et al., 2010; 
Pang et al., 2010). But the limitations of above studies showed just Casoni test 
was a serological tool, or just ultrasound result without serology, the relative risk 
for local people not sure, and ever no general information (ie. Tibet). A 
comprehensive epidemiology model included ultrasound for abdominal 
echinococcosis with serology (DIGFA), and questionnaires for risk factor analysis, 
was nessessary for mass human screening of these endemic areas. Furthermore, 
the performance evaluation of DIGFA for community study could be assessed for 
further understanding the epidemiological features. 
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Fig. 6.0.1: Community studies for echinococcosis in 8 Counties of 
Northwest China 
Hoboksar Wenquan 
Xinyuan Bayinbuluke 
Xiji
GanziDingqingDangxiong 
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6.0.2 General methods for community studies  
 
6.0.2.1 Study locations and communities 
The study was part of mass screening survey for echinococcosis in highly 
endemic areas of northwest China during 1998-2007. There included main study 
sites of Yili, Tacheng, Altai, Boertala and Bayinguoleng Prefectures in Xinjiang 
Uygur Autonomous Region; also collaborate work with -Guyuan Prefecture in 
Ningxia Hui Autonomous Region, Ganzi Tibetan Autonomous Prefecture in 
Sichuan, Lhasa and Chamdo Prefectures of Tibet Autonomous Region. Most 
populations in these area included Kazakh, Mongolian, Hui, Han and Tibetan 
ethnic groups, many of them were nomadic or semi-nomadic and a few farmers 
(Table 6.0.1 and Table 6.0.2). 
During each community screening, local administrative support from local hospital, 
Center of Disease Control, Public Health Office and local government was 
obtained. All the procedures during screening were explained to individuals 
through local language translators according to ethical standards under the 
directions of Xinjiang Medical University Hospital Ethics Committee.  
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Table 6.0.1: General information of studied communities on echinococcosis 
in Northwestern China 
Prefectures 
Counties 
/Communities 
Populationa Ethnicb Longitude Latitude Altitudec 
Bayinguoleng 
Hejing 
/Bayinbulak 
14310 Mongolian 82°27’-86°17’ 42°18’-43°34’ 2400m 
Boertala 
Wenquan 
/Angelige 
10618 
Han, 
Mongolian, 
Kazak 
81°02′--81°08′ 44°51′--44°57′ 1030-1250m
Yili 
Nileke 
/Wulasitai 
9098 Kazak 81°58-84°58′ 43°25′-44°17′ 800-4590m
 Nileke  /Musi 10145 Kazak   700-900m 
 
Xinyuan 
/Nalati 
27000 Kazak 83°10′-- 84°25′ 43°15′-- 43°40′ 900-4275m
 
Xinyuan 
/Turgen 
12000 Kazak 83.27 43.41 900-1120m
Tacheng Hoboksaier 50000 Mongolian 84°37´--87°20´ 45°20´--47°12´ 1292m 
Altai Qinghe 55096 
Kazak, 
Mongolian
90°37 46°71 900-3659m
 Habahe 79050 Kazak 85°31 ～87°19 47°42 ～49°09 440-3248m
Guyuan Xiji 471000 Hui 105°20′—106°04′ 35°35′—36°14′ 1688-2633m
Ganzi Ganzi 56000 Tibetan 99°08′——100°25′ 31°24′——32°54′ 3325-5688m
Lhasa Dangxiong 41918 Tibetan 90°45′—91°31′ 29°31′—31°04′ 4200-7111m
Chamdo Dingqing 60000 Tibetan 94°39′-96°17′ 31°01′-32°21′ 3300-6328m
Shannan Qusong 20000 Tibetan 92°11 29°3’ 4200 
a. Population got from government statistics (2003 or 2005) and indicated 
communities or counties if not specialize commune. 
b. Main ethnic groups in these areas. 
c. Mean altitude or low-highest altitude above sea level. 
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Table 6.0.2: Community mass screening sites for human echinococcosis by 
XMUH in China during 1998-2007 
Province or 
Autonomous 
Region 
Prefecture County Commune Survey period 
No of 
screened
Xinjiang Bayinguoleng Hejing1 Bayanbuluke 
2004-8, 
2004-10 1398 
 Boertala Wenquan2 Angelige Oct-05 1292 
 Yili Xinyuan3 Narati Oct-03 1815 
  Xinyuan Turgen May-05 1841 
  Nileke4 Wulasitai Apr-04 2044 
  Nileke Musi May-05 1851 
 Changji Mulei5  2002.3 962 
 Altai Habahe6  1998-9, 2002-5 1648 
  Qinghe7  2001-10,2002-5 1134 
 Tacheng Hobuksaier8  2007-3,2007-10 1325 
Ningxia Guyuan Xiji9  2002.10 945 
Sichuan Ganzi Ganzi10  2006-4 1685 
Tibet Shannan Qusong11  2003-8 722 
 Lhasa Dangxiong12  2006-10 557 
 Chamdo Dingqing13  2007-11 232 
Ethnic groups were mainly 1. Mongolian; 2. Han, Kazak, Mongolian; 3. Kazak; 4. Kazak; 5. 
Kazak; 6. Kazak; 7. Mongolian and Kazak; 8. Mongolian; 9. Hui; 10. Tibetan; 11. Tibetan; 
12. Tibetan; 13. Tibetan. 
 
All the community studies shown here were conducted from 1998 – 2007 in 
Xinjiang (Fig. 6.0.2). Also other community studies including assessment at a 
rapid serology test were carried out in Xiji County, Ningxia Hui Autonomous 
Region in 2001 and 2002; in Ganzi County, Ganzi Tibetan Autonomous Prefecture 
of Sichuan Province in 2006, in Qusong (2003, just ultrasound and DIGFA results, 
no questionnaires), Dangxiong (2006) and Dingqing (2007) Counties, Tibet 
Autonomous Region.  
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Fig. 6.0.2: Community screening sites for echinococcosis in Xinjiang Uygur 
Autonomous Region, China 
 
6.0.2.2 Human echinococcosis screening 
i. Questionnaire  
Each person was asked by the registering person to answer a questionnaire (2 
sides) and was given a registration number. Generally questionnaires were 
completed with the help of local translators. Questionnaire included the following 
information request: 
      a. General information including gender, age, ethnic, occupation, income, 
address 
      b. Risk factors history: dog owner, fox/wolf contact, livestock ownership, 
home slaughter, health education (see Appendix VI). 
 
ii. Blood samples and serology 
Most people voluntary donated 3-5ml of venous blood for immunological testing. 
The blood collection procedures were undertaken using strict standard operations 
by a registered nurse with a single-use disposable syringe or vacuum blood 
collection tube. The blood samples were centrifuged at 2000g for 10 minutes after 
Habahe n=1648
(1998,2002) 
Qinghe n=1134 
(2001,2002) 
Mulei n=962  
Xinyuan n=3656
 (2004,2005)
Nileke n=3895 
(2004,2005) 
Bayanbulak n=1398
Wenquan n=1292
Hoboksar n=1325 
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1 hour or 10 minutes if using procoagulant tube. Sera were collected into 
1.5ml/0.5ml capped tubes. Rapid DIGFA was carried out in the field and the 
results provided to participant the same day. Sera were stored at -20°C for ELISA 
test later in the XMUH laboratory. Sera were random selected for clinically normal 
and DIGFA negatives, and all ultrasound positives and/or DIGFA positive cases. 
 
iii. Abdominal ultrasound scanning 
People were scanned by abdominal ultrasound (US) operated by an experienced 
registered sonographer (from XMUH) using a portable ultrasound scanner 
(Sonoline SX Siemens, Germany; or LOGIQ Book XP, USA). Images with CE or 
AE characters or suspected cases were recorded, and for CE cyst were graded 
Type I, II, III, IV, V according to WHO classification (WHO/OIE 2001). For AE liver 
lesions were classified using the PNM system (EurEchinoReg, 1998, WHO/OIE, 
2001, Kern, 2003, 2006) 
 
iv. Serology follow-up 
Sero-diagnostic results were compared with the US result. Double checks for 
serology (DIGFA) were performed if one was positive but another showed 
negative. Sero-negative but US positives were regarded as true positive (US 
results as ‘gold’ standard). Sero-positive but US negatives were double check by 
US also arranged to have a chest X-ray. Sero-positives without abdominal or 
chest cysts or lesions were recorded for follow-up management study. 
 
v. Treatment of CE or AE cases 
All the CE or AE detected cases that needed treatment were initially given 
albendazole tablets for 3-6 months. A few CE cases that were not suitable for 
surgery were given fine-needle puncture aspiration injection reaspiration (PAIR) 
treatment under US guidance in a local hospital (e.g. Habahe County in Xinjiang). 
Cases with cysts or lesions that could be surgically removed, received surgical 
treatment performed by the professional surgeon group from XMUH that follow-up 
the community screening. Both medical, PAIR or surgical treatment were free to 
patients and supported by Chinese governmental funds, cooperation funds (e.g. 
NIH) and/or the Chinese Song Qingling Charity Fund Committee. 
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6.0.2.3. Canine echinococcosis surveys  
Dog surveys by different teams were performed at the same time as 
community screening for human disease. A questionnaire (see Appendix VII) for 
dog owners included general information, the number of dogs owned and history 
of ownership, hunting practices, health behaviors (washing hands before eating, 
etc.). Dog faecal samples were collected from the freshest faeces on the ground 
or taken with a plastic loop from the rectum (Fig. 6.0.3). Faecal sample was 
divided into one tube with PBS (0.3% Tween 20, 5% formal saline), and another 
tube with 95% or 100% ethanol (for future copro-PCR test), sealed and stored at 
room temperature during the field work and then -20ºC in the laboratory later. 
 
 
 
 
 
 
 
Fig. 6.0.3: Left: rapid DIGFA test for human serum in the field; Right: dog 
faecal sampling by loops.  
 
6.0.2.4. Data analysis 
Data analysis was used to evaluate the immunodiagnositic tools and determine 
risk factors in epidemiological studies on echinococcosis.  
Chi-square tests were used to determine the distributions of CE or AE in different 
locations/ethnic groups/ages/occupations. 
Univariate odds ratios were used to determine independent associations of risk 
factors in different areas and different variables (including dog owner, livestock 
owner, home slaughter, occupation, education, hygienic habits, etc.) 
Multivariate logistic regression was used to find adjusted odds rations to assess 
the relationship of diseases with different risk factors in different ethnic groups, 
different areas and find the key control points. 
All analyses performed using SAS 9.0, SPSS 16.0 and Epi info version 6.0.  
Statistical significance was set at alpha=0.05. 
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6.1 Community study in Wenquan County, Boertala Mongol 
Autonomous Prefecture, Xinjiang 
6.1.1 Introduction to study site 
Wenquan County is located within the west of Boertala Mongol Autonomous 
Prefecture, west of Xinjiang Uygur Autonomous Region, P.R.China, at longitude 
81º02’- 81º08’E and latitude 44º51’- 44º57’N, elevation is 1030-1250 metre above 
sea level (Fig 6.1.1). It contains an area of 5,900 km2. According to the 2002 
census, it has a population of 70,000. 
Wenquan County was reported as a high endemic area for CE which showed 185 
CE cases (191.8 cases per 100,000 populations) during 1981-1990 (National 
Hydatid Disease Center of China, Menghebat et al., 1993). Sheep infection with 
echinococcosis was 84.6% in Wenquan County (Li et al., 2005). 
 
Fig. 6.1.1: Wenquan County in Boertala Mongol Autonomous Prefecture, 
Xinjiang Uygur Autonomous Region, P. R. China 
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A community study on echinococcosis was carried out in 2005 in Angelige 
Commune of Wenquan County, 16 Km from Wenquan County Center (Fig. 6.1.2). 
Angelige Commune is a semi- agriculture and semi-pastoral area, covered 617 
Km2 of which 120000 acres pasture and 12850 acres agriculture land. The 
population of 10618 consisted of 3204 households in 16 villages, comprising 
Mongolian, Han, Uygur, Kazakh, Hui and other 9 ethnic groups. The dominant 
ethnic group was Mongolian, Kazak and Han. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6.1.2: Community study site- Angelige Commune, for human 
echinococcosis in Wenquan County（44° 59′ 0″ N, 81° 4′ 0″ E; 5663.7 km2; 
1:60,000） 
 
6.1.2 Results 
6.1.2.1 Mass screening 
In this study 1293 residents (12.2% of the commune population) were screened in 
four agriculture villages (Bureletunge, Erantuoergan, Tuoli and Angeligebuhu) and 
two livestock husbandry villages (Benbutu and Tuosihuertu). Each person was 
registered (plus questionnaire), screened by abdominal ultrasound and 
serological test with vein blood. The screened people included 604 males and 688 
females, with ages from 12 to 81 years (average 36 years), and ethnic groups 
comprised by  Mongolian 189 (14.7%), Kazakh 175, Hui 142, Han 734, Uygur 47 
and other ethnics 5. Their occupations were farmers 697, herdsmen 170, and 
students 330, others 95 (cadres, businessmen, etc.). 
Angelige Wenquan 
Kazakhstan 
Huocheng BoleSailimu 
L k
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6.1.2.2 Ultrasound and Serological prevalences of human echinococcosis 
Ultrasonographic scan showed 13 active cystic echinococcosis (CE) cases (1% 
prevalence in 1292) including 6 that had a previous surgical history. There were 
another 11 individuals with a previous surgical history of CE but with no 
recurrence sign on ultrasound scan. No human AE cases were found in this 
survey. Echinococcus antibodies serological test using DIGFA showed a 15.3% 
(197/1288) seropositive rate in total. All 24 (1.86%) CE cases were analyzed for 
distribution and risk factors. 
i) Prevalence by gender, ethnicity and occupations. (Table 6.1.1) 
More female CE cases (15/24, 2.18%) were found by ultrasound in this study, 
even no statistical difference in genders (p>0.05). But females showed higher 
seropositives (17.4%) than males (13%) (p<0.05)..  
The main ethnic groups had a similar ultrasound prevalence of CE from 1.1% to 
3.4% (p>0.05). And Han and Mongolian ethnic groups had higher seropositives 
than other ethnic groups (p<0.05). 
Occupation as farmers or herdsmen, dog or livestock owners appeared as the 
main risk factors for human ultrasound CE in this study (p<0.05). There were also 
significant differences in seroprevalence between occupation groups (p<0.05). 
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Table 6.1.1: Human ultrasound CE prevalence and seropositivity by gender, 
ethnic group and occupation in Wenquan County (Xinjiang) 
 
Ultrasound Serology 
  
No. CE CE%
Chi- 
Square
p 
No. Positives P% 
Chi- 
Square
p 
Gender Male 604 9 1.5%   602 78 13.0   
 Female 688 15 2.52   686 119 17.4   
 Total 1292 24 1.9% 0.84 0.36 1288 197 15.3 4.770 0.029
Ethnicity Han 734 8 1.1%   730 127 17.4   
 Hui 142 4 2.8%   142 18 12.7   
 Mongolian 189 5 2.7%   189 32 16.9   
 Uygur 47 1 2.1%   47 5 10.6   
 Kazak 175 6 3.4%   175 15 8.6   
 Others 5 0 0   5 0 0   
 Total 1292 24 1.9% 0.00 0.14 1288 197 15.3 11.034 0.026
Occupation Farmer 697 18 2.6%   695 96 13.8   
 Herdsman 170 4 2.4%   170 18 10.6   
 Student 330 1 0.3%   329 64 19.5   
 Others 95 1 1.1%   94 19 20.2   
 Total 1292 24 1.9% 0.00 0.04 1288 197 15.3 10.230 0.017
 
 
ii) Prevalence by age and locations. 
Human ultrasound CE prevalence (2.03%-3.6%) in the 20-50 years people were 
higher than other age groups (P<0.05). Seropositivities was observed increase in 
the over 20 year group (p<0.05) (Table 6.1.2). 
Agriculture village residents had a similar ultrasound CE prevalence compare to 
residents in livestock husbandry villages (p>0.05). Seroprevalences were different 
with ultrasound prevalence at village level and there were differences between all 
villages (p<0.05). (Tables 6.1.3). 
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Table 6.1.2: Human ultrasound CE prevalence and serological positives by 
DIGFA in different age groups in Wenquan County (Xinjiang) 
 
Ultrasound DIGFA serology Age 
group No CE Prevalence 
Chi 2 p 
N Positives P（%） 
Chi 2 p 
＜20 347 1 0.29%   346 65 18.8   
20- 148 3 2.03%   148 15 10.1   
30- 250 9 3.6%   249 30 12.2   
40- 221 5 2.26%   220 28 12.7   
50- 165 2 1.21%   164 27 16.5   
60- 113 2 1.77%   113 21 18.6   
70- 48 2 4.17%   48 11 22.9   
Total 1292 24 1.86% 0.000 0.034 1288 197 15.3 12.711 0.048
 
 
Table 6.1.3: Human CE prevalence and seropositivity in different villages in 
Wenquan County (Xinjiang) 
 
Ultrasound DIGFA serology 
Villages 
No. CE Prevalence
Chi 2 P 
No Positives P (%) 
Chi 2 P 
Bureletunge 195 1 0.51%   193 25 12.95   
Eranhaergan 245 7 2.86%   245 50 20.41   
Tuoli 201 6 2.98%   201 18 8.96   
Angeligebuhu 270 2 0.74%   270 46 17.04   
Benbutu 57 1 1.75%   57 5 8.77   
Tuosihuertu 128 5 3.91%   128 16 12.50   
Others 112 2 1.79%   111 21 18.92   
Town 84 0 0   83 16 19.28   
Total 1292 24 1.86% 0.000 0.107 1288 197 15.30 17.414 0.015
 
 
6.1.2.3. Analysis of risk factors for human CE in Wenquan County 
From all the questionnaires, 69.4% (896/1292) of people raised livestock, and 
57.8% (747/1292) owned dogs in which 32.8% (245/1292) owned dogs more than 
5 yrs. Both females 368 (49.4%) and males 197 (26.4%), and both 181 (24.2%) 
 141
reported close contact with dogs. There were 597 (79.9%) people said they fed 
animal offal to dogs, and 135 (18.1%) people reported that they applied dog 
faeces to fertilize their gardens. A total of 135 (18.1%) people reported that they 
used dogs for livestock herds; 617 (47.8%) people raised dogs and livestock at 
the same time; and 816 (63.2%) people said they had the habit to slaughter 
livestock at home. Only 295 (22.8%) people thought they knew something about 
echinococcosis. People who owned dogs had a higher CE prevalence than those 
without dogs (p<0.05) and people who owned livestock showed the same 
difference (p<0.05) (Table 6.1.4) 
 
Table 6.1.4: Relationship between livestock and dog ownership with risk of 
human CE in Wenquan County 
Ownership CE Non CE Total 
Ultrasound
Prevalence
Chi p 
Dog        
Yes 19 728 747 2.54%   
No 5 540 545 0.92%   
Total 24 1268 1292 1.86% 0.0165 0.0366 
Livestock       
Yes 22 874 896 2.46%   
No 2 394 396 0.51%   
Total 24 1268 1292 1.86% 0.0079 0.0137 
 
Multivariate analysis of risk factors of human CE was carried out for three 
variables including ethnic, occupation and dog ownership (Table 6.1.5). 
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Table 6.1.5: Multivariate analysis of risk factors of human CE in Wenquan 
County (Analysis of Maximum Likelihood Estimates) 
                                           
Parameter 
Variable 
DF Estimate Standard Error Chi-Square
Pr > 
ChiSq 
Hazard 
Ratio 
Ethnic 1 -0.80443 0.45509 3.1246 0.0771 0.447 
Occupation 1 0.64717 0.51837 1.5587 0.2119 1.910 
Dog 1 1.04214 0.51186      4.1452      0.0418   2.835 
Analysis of Maximum Likelihood Estimates 
                                Standard          Wald 
Parameter    DF    Estimate     Error      Chi-Square    Pr > ChiSq 
Intercept     1     -4.6775      0.3835      148.7668        <.0001 
Dog owner   1      1.0605      0.5071        4.3731        0.0365 
Occupation   1     -0.6076      0.2527        5.7835        0.0162 
 
ln(P/1-P)=-4.6775+1.0605x1-0.6076x2; 
 
OR＝dog owner/non dog owner＝exp (1.0605) =2.887, and OR for occupation 
(farmer & herdsman/others) was 1.837. These 2 factors could be the main risk 
factor for local human echinococcosis. 
 
6.1.3 Discussion (Wenquan County, Xinjiang) 
Wenquan County has been known an endemic area of CE from 1950s. Hospital 
records showed 185 CE cases (19.18 per 100,000 pop in 1990) in Wenquan 
County from 1951-1990 (National Hydatid Disease Center of China, 1992), with 
had 67 cases of CE were reported during 1987-1989 (Wu, 1994). An ultrasound 
survey of students in Wenquan County indicated a prevalence of 0.4% (22/5550) 
in 2003, which was similar to our study (0.3%, 1/330). Echinococcosis in livestock 
and dogs were very high in Wenquan County, i.e. 71.5% (1492/2083) in sheep 
and 54.8% (17/31) in dogs (Dang et al., 1997).  
Although the Xinjiang provincial authorities had applied a control programme for 
echinococcosis since late 1980s, human CE cases still occurred in western 
Xinjiang. The total prevalence of confirmed human CE (new and existing cases) in 
Angelige Commune of Wenquan County, in Boertala Mongolian Autonomous 
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Prefecture  (western Xinjiang, China), was 1.86% (24/1292) in the current study. 
No alveolar echinococcosis (AE) cases were found during this study but a case 
report of AE existed (from Prefecture Hospital records). The youngest CE case in 
the current study was 16 yrs old and the average age of all 24 CE cases was 41.3 
yrs. A total of 13 new cases were detected. New young case meant the 
transmission of echinococcus granulosus was still active in this area. 
Human CE prevalence usually resulting from the presence of an active dog-sheep 
cycle, close contact with dogs and livestock, and human behavior, which 
contribute to main risk factors for human CE infection (Craig et al., 1994, 2000, 
2004, 2007, Eckert et al., 2000; WHO-OIE, 2001; McManus et al., 2003; Schantz 
et al., 2003; Budke, 2006, Yang et al., 2006). Occupations as farmers or 
herdsmen, and the dog or livestock ownership were the main risk factors for 
human CE in Wenquan County. Farmers had similar prevalence with herdsmen 
since they also raised livestock and dogs, as well as Herdsmen. The same 
reasoning applies for different ethnic groups because Han were engaged with 
livestock husbandry as well as Mongolian and Kazakh groups. Local people’s 
lifestyle around dogs and livestock might be the main reason for active E. 
granulosus life cycle.  
Dogs were considered very important for most rural people in Xinjiang. Muslim 
people did not eat dog meat and Mongolians were forbidden to kill dogs under 
Buddhism beliefs. Eggs in dog faeces could cause contamination because of 
faeces in public areas or from faeces fertilization of gardens. Poor hygiences such 
as non-washed hands after touching dogs or poor contaminated surroundings 
possibly also contribute to infection. Home slaughter was very common in 
Wenquan with 79.9% of persons reported to give infected offal to their dogs. In 
addition, poor knowledge of CE (<25%) might have also contributed to the 
transmission likelihood over many years. 
From above observation, CE infection in humans and an active dog-sheep cycle 
appeared to be ongoing in Wenquan County. Progress in the National 
Echinococcosis Control Programme had been carried in northwest China since 
2007, based on dog treatment (with praziquantel) and health education in selected 
endemic areas. Further follow-up after the control programme should be assessed 
through dog and human prevalence and disease burden. 
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6.2 Community study in Bayinbuluke Town, Hejing County, 
Bayinguoleng Mongol Autonomous Prefecture, Xinjiang 
 
6.2.1 Introduction to study site 
Bayinbuluke (means 'abundant spring' in Mongolian) Grassland, located at 
longitude E82°27’-86°17’and latitude N42°18’-43°34’, is a main pasture area (the 
second largest grassland in China) in Hejing County, Bayinguoleng Mongol 
Autonomous Prefecture (Fig. 6.2.1). The well-known Swan Lake is located in the 
prairie. In fact it has many small lakes and is the only nature reserve for swans in 
China. Bayinbuluke is in northwest of Hejing County and Yanqi Basin, 
southeastern Yili Valley, south side of Tianshan mountain, with mean elevation 
2390-2500 meters (4000-5000 meters for mountains around), and covering 
23,868 km2 area. Local populations was 14,310, including 9945 herdsmen and 
95% of them were Mongolian. Main livestock were cattle, yak, horses, sheep and 
camels (760,000 totals). 
Bayinguoleng Mongol Autonomous Prefecture was recorded as a high endemic 
area for cystic echinococcosis which had 1412 hospital CE cases were reported 
during 1950-1990 (National Hydatid Disease Center of China, by Menghebat et al., 
1993). Hejing County was one of counties with high endemic for human CE in 
Bayinguoleng Mongol AP which showed 334 CE cases and 120.3 cases per 
100,000 populations during 1981-1990. A serological and ultrasound survey in 
other communes/towns showed 1.18% (21/1785) human CE prevalence (Gu et al., 
1991). A pilot study by ultrasound indicated 6.6% (20/300) human echinococcosis 
(unpublished data, personal communicate) in Bayinbuluke Town. And a case of 
human AE was reported in Hejing County (Zhang et al., 2000). 
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Fig. 6.2.1: Hejing County in Bayinguoleng Mongol Autonomous Prefecture, 
Xinjiang Uygur Autonomous Region, P.R.China 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6.2.2: Community study sites in Bayinbuluke Area of Hejing County, 
Xinjiang, P. R. China （1：1, 550,000） 
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A community study for echinoccosis by ultrasound and serology was carried on in 
2 communes and one pasture of Bayinbuluke Town in 2004 (Fig. 6.2.2). In total 
1398 people were screened including 597 (42.7%) males and 801 (57.3%) 
females; age from 7 to 82 years old (average 29 years); ethnic groups included 
Mongolian 1377 (98.5%), Uygur 6 (0.43%) and Han 15 (1.07%); occupations 
included herdsmen 826 (59.1%), farmers 16 (1.14%), cadres 129 (9.2%), students 
407 (29.1%) and others 20 (1.43%). And 30 dogs from Bayinbuluke were checked 
by autopsy. 
 
6.2.2 Results 
6.2.2.1 Prevalence of CE and AE by ultrasound in human 
A total of 60 CE (including 1 case combined with a confirmed CE cyst and a query 
AE lesion), 3 AE cases were detected by ultrasound. There were 18 of 45 
individuals with a previous history of surgery for CE that they showed normal 
images in this study. So the overall prevalence of human CE was 5.6% (78/1398), 
AE was 0.2% (3/1398) in Bayinbuluke in this survey.  
i) Ultrasound prevalence by gender and age. 
No significant difference was found between male and female for CE, AE or both 
(p>0.05). CE cases occurred in age range 7-68 yrs old with mean age 34.3 yrs 
and AE cases from 26-82 yrs old with average 45.3 yrs. Differences among age 
classes showed > 10 yrs had higher prevalence for both CE and AE (p<0.05) 
(Table 6.2.1). 
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Table 6.2.1: Human echinococcosis prevalence by genders and ages in 
Bayinbuluke Town 
For gender analysis of CE: Pearson Chi-Square Value2.893 Asymp. Sig. (2-sided) 0.089 
For gender analysis of AE, Pearson Chi-Square Value2.241 Asymp. Sig. (2-sided) 0.134 
Fisher's Exact Test Exact Sig. (1-sided) 0.188 
For gender analysis of both CE&AE, Pearson Chi-Square Value1.895 Asymp. Sig. 
(2-sided) 0.169 
For Ages analysis: Fisher's Exact Test, Table Probability (P)    1.112E-06, Pr <= P    
0.0341 
 
ii) Ultrasound prevalence by ethnicity. 
No significant differences were found between different ethnic groups (p>0.05) for 
both CE and AE in Bayinbuluke (Table 6.2.2). 
 
Table 6.2.2: Ultrasound CE and AE prevalence by ethnic group in 
Bayinbuluke Town 
Ethnic groups No. CE (%) AE (%)
Mongolian 1377 78(5.7) 3 (0.2%)
Uygur 6 1(16.67) 0 
Han 15 0(0) 0 
Total 1398 79(5.7) 3 (0.2%)
Fisher's Exact Test: Table Probability Pr <= P     0.3419 
 
iii) Ultrasound prevalence by occupation. 
Most people were involved with livestock husbandry and farming was very limited. 
Herdsmen had a higher prevalence than other occupations (p<0.01) (Table 6.2.3).  
Male Female Total Ages  
(-ys) No CE (%) AE (%) No CE (%) AE (%) No CE (%) AE (%)
<10 27 0(0) 0 26 1(3.9) 0 53 1(1.9) 0 
11~20 198 11(5. 6) 0 226 4(1.8) 0 424 15(3.5) 0 
21-30 146 13(8.9) 0 220 12(5.5) 2(0.9) 366 25(6.8) 2(0.5%)
31-40 131 10(7.6) 0 159 5(3.1) 0 290 15(5.2) 0 
41-50 62 3(4.8) 0 94 3(3.2) 1(1.1) 156 6(3.8) 1(0.6) 
51-60 22 2(9.1) 0 51 9(17.6) 0 73 11(15.1) 0 
>60 11 2(18.2) 0 25 4(16) 0 36 6(16.7) 0 
Total 597 41(6.9) 0 801 38(4.7) 3(0.4) 1398 79(5.7) 3(0.2) 
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Table 6.2.3: Ultrasound CE and AE prevalence by occupation in Bayinbuluke 
Town 
Occupations No. CE (%) AE (%) 
Herdsman 826 63(7.6) 3(0.4) 
Farmer 16 0 0 
Cadre 129 1(0.8) 0 
Student 407 14(3.4) 0 
Others 20 1(5) 0 
Total 1398 78(5.6) 3 (0.2) 
Fisher's Exact Test for CE: Table Probability (P)    1.032E-06 Pr <= P  5.516E-04 
For both CE and AETable Probability (P)    9.159E-07, Pr <= P 3.945E-04 
 
6.2.2.2 Serological prevalence by DIGFA 
Serological assay with DIGFA showed 24.54% positive (293/1194) among people 
who had the vein blood test. Female showed the higher positive rate (29.2) than 
male (p<0.01) (Table 6.2.4 and Fig. 6.2.3). 
 
Table 6.2.4: Serum screening by DIGFA in Bayinbuluke 
Male Female Total 
Ages 
No Positives (%) Screened Positives (%) No Positives (%)
≤10 16 2 12.5 17 3 17.7 33 5 15.15 
11- 156 17 10.9 186 19 10.2 342 36 10.53 
21- 121 23 19.01 199 68 34.2 320 91 28.44 
31- 111 23 20.72 143 57 39.9 254 80 31.5 
41- 55 16 29.09 86 29 33.7 141 45 31.91 
51- 21 3 14.29 49 21 42.9 70 25 35.71 
>60 11 3 27.27 23 8 34.8 34 11 32.35 
Total 491 87 17.72 703 205 29.2 1194 293 24.54 
Chi-Square Tests for gender Pearson Chi-Square Value20.485 Asymp. Sig. (2-sided) 
0.000 
Chi-Square Tests for ages, Pearson Chi-Square Value57.085 Asymp. Sig. (2-sided) 0.000 
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Fig. 6.2.3: Seropositives by gender and age groups in Bayinbuluke (n=1194). 
 
6.2.2.3 Risk factors for human CE 
People being a dog owner had a higher ultrasound CE prevalence (6.1%, 76/1245) 
than those who did not have dogs (2%, 3/153) (p<0.05) (Table 6.2.5). The same 
situation occurred in people who had livestock around. Persons with livestock 
ownership had a higher CE prevalence (5.7%, 78/1369) than those without 
livestock (3.5%, 1/29), but no statistical difference was found (p>0.05) (Table 
6.2.5).  
 
Table 6.2.5: Dog/Livestock ownership and human hydatid disease (CE, AE). 
Dog ownership Livestock ownership 
Ultrasound 
No. 
(%) Yes No Chi p Yes No Chi p 
CE 
79 
(5.7%) 
76 
(6.1%) 
3 
(2.0%)
0.01 0.04
78 
(5.7%)
1 
(3.5%) 
0.31 1.00
AE 
3 
(0.2%) 
2 
(0.2%) 
1 
(0.6) 
0.26 0.29
3 
(0.2%)
0 0.32 1.00
Non HD 
1316 
(94.1%) 
1167 
(93.7%) 
149 
(97.4%)
  1288 28   
Total 1398 1245 153   1369 29   
For hydatid cased including CE and AE, Chi value was 0.0274 and P was 0.0697. 
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The varieties, which included gender, age, occupation, ethnic groups, dog owner, 
livestock owner, wildlife contact and home slaughter, were selected for risk factor 
analysis and valuated as Table 6.2.6. Others in ethnic group included Uygur ethnic 
(n=6) and Han ethnic (n=15); in occupation group included farmers (n=16), cadres 
(n=129) and others such as businessmen, housewives (n=20). 
 
Table 6.2.6: Analysis variables and valuation for hydatid disease in 
Bayinbuluke 
Variables Valuation 
Gender 1＝Male, 2＝Female 
Ethnic 1＝Mongolian, 2＝others 
Occupation 1＝Herdsmen, 2＝Students, 3＝others 
Dog ownership 1＝Yes, 2＝No 
Wild life contact 1＝Yes, 2＝No 
Livestock ownership 1＝Yes, 2＝No 
Home slaughter 1＝Yes, 2＝No 
 
The single factor logistic regression analysis showed that the dog ownership was 
probably the most import risk factor for human ultrasound CE (OR=2. 298) in 
Bayinbuluke in the current study (Table 6.2.7). The other relative risk factors might 
be age, wildlife contact and home slaughter. 
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Table 6.2.7: CE prevalence and univariate logistic regression analysis for 
Bayinbuluke 
Factor Prevalence (%) OR value (95%CI) 
Age  5.7（79/1389） 1.028（1.013-1.043） 
Gender Male 6.9（41/595） 0.679（0.431-1.070） 
 Female 4.8（38/794）  
Ethnic Mongolian 5.7（78/1368） 0.827（0.110-6.242） 
 Others 4.8（1/21）  
Occupation Herdsmen 7.5（63/839） 0.442（0.245-0.799） 
 Student 3.5（14/404） 0.171（0.41-0.707） 
 Others 1.4（2/146）  
Yes 6.0（75/1242） 2.298（0.828-6.376） Dog ownership 
No 2.7（4/147）  
Yes 6.3（45/711） 1.280（0.809-2.024） Wild Life contact 
No 5.0（34/678）  
Yes 4.7（44/927） 0.608（0.384-0.962） Livestock 
ownership No 7.6（35/462）  
Yes 6.1（44/720） 1.179（0.747-1.862） Home slaughter 
No 5.2（35/669）  
 
The single factor logistic regression analysis was also used for CE seropositive 
prevalence and suggested more risk factors involves included age, gender, 
occupation, dog owner, wildlife contact, livestock and home slaughter (Table 
6.2.8). 
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Table 6.2.8: Univariate associated with CE seropositives for hydatid disease 
in Bayinbuluke 
Factor Prevalence (%) OR value (95%CI) 
Age 14.2(198/1392) 1.033(1.023-1.044) 
Gender   
Male 9.9(59/595) 1.919(1.386-2.657) 
Female 17.4(139/797)  
Ethnic   
Mongolian 14.2(195/1371) 1.005(0.293-3.444) 
Others 14.3(3/21)  
Occupation   
Herdsmen 19.0(160/842) 1.568(0.940-2.616) 
Student 4.7(19/404) 0.330(0.169-0.643) 
Others 13.0(19/146)  
Dog ownership   
Yes 14.6(182/1245) 1.402(0.815-2.411) 
No 10.9(16/147)  
Wildlife contact   
Yes 17.2(123/714) 1.673(1.229-2.279) 
No 11.1(75/678)  
Livestock ownership   
Yes 14.8(138/930) 1.167(0.843-1.617) 
No 13.0(60/462)  
Home slaughter   
Yes 16.5(119/722) 1.476(1.087-2.005) 
No 11.8(79/670)   
 
Multivariate logistic regression analysis of CE ultrasound prevalence showed 
students and wildlife contact were main risk factors in Bayinbuluke (Table 6.2.9). 
And multivariate logistic regression analysis of seropositives showed female and 
wildlife contact were risk factors (Table 6.2.10). 
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Table 6.2.9: Multivariate logistic regression analysis for CE ultrasound 
prevalence in Bayinbuluke 
Variable Ｂ Ｓ．Ｅ． Wald value Ｐ value ＯＲ value (95％ＣＩ)
Constant -4.965 0.819 36.765 0.000 0.007 
Age 0.026 0.01 6.893 0.009 1.026（1.007-1.046）
Occupation      
Herdsmen   5.897 0.053  
Students 1.784 0.736 5.871 0.015 5.951（1.406-25.188）
Others 1.753 0.811 4.674 0.031 5.771（1.178-28.273）
Livestock 
ownership -2.954 0.781 14.293 0.000 0.052（0.011-0.241）
Wildlife 
contact 2.628 0.783 11.251 0.001 13.841（2.981-64.266）
 
Table 6.2.10: Multivariate logistic regression analysis of possible risk 
factors for CE seropositive in Bayinbuluke 
Variable Ｂ Ｓ．Ｅ． Wald value Ｐ value ＯＲ value (95％ＣＩ)
Constant -2.921 0.379 59.427 0.000 0.054 
Age 0.013 0.007 3.652 0.056 1.013(1.000-1.026) 
Gender 0.586 0.17 11.863 0.001 1.796(1.287-2.507) 
Occupation      
Herdsmen   17.813 0.000  
Students -1.221 0.301 16.494 0.000 0.295(0.164-0.532) 
Others -0.426 0.264 2.614 0.106 0.653(0.390-1.095) 
Livestock 
ownership -0.859 0.459 3.498 0.061 0.424(0.172-1.042) 
Wildlife 
contact 0.937 0.463 4.097 0.043 2.551(1.030-6.320) 
 
6.2.3 Discussion (Bayinbuluke, Hejing County, Xinjiang) 
The Mongolian population in Xinjiang mostly lives in two Mongolian Autonomous 
Prefectures (Bayinguoleng and Boertala) and one Mongolian Autonomous County 
(Hoboksaier). But Bayinbuluke in Bayinguoleng AP has the highest proportion of 
95% population is Mongolian and this relatively rare since the ethnic group move 
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widely and commonly (Zhang, 1995). Mongolian lifestyle is more close to Tibetan 
with communities at higher altitude (2400 meters), Buddhism religion, mainly work 
as herdsmen. Both CE and AE were all endemic in Tibetan areas such as western 
Sichuan, north Qinghai and Tibet AR (Qiu et al, 1995, 2000; Wang et al., 2000;  
Budke et al, 2005; Li et al., 2006, 2010). Human CE prevalence was also higher in 
Inner Mongolian AR (Zhang et al., 1996; Tao et al, 2011). In Xinjiang, higher CE 
prevalence in Mongolian communities in Hoboksar has been reported (Wang et al., 
2005, 2006; Chu et al., 2007, 2010). We now show that human CE was also very 
serious in Bayinbuluke. This could be an active area for transmission of E. 
granulosus since younger people (<10 years) were found to have a higher 
ultrasound prevalence (1.9%) and seropositive rate (15.2%). Poor health 
education and low socioeconomic level were a limitation for local people to go 
outside and get medical attention.  
The domestic dog as a definitive host of E. granulosus appears to be the main risk 
factor for local people for both CE and AE. We found most dogs were not tied 
during day and night, and the dogs ran around tents even the open area for 
cheese dried in the sun (Fig. 6.2.4). Dog faeces could be found anywhere even 
near the stream used for drinking and washing. Livestock slaughter in the street is 
common and small cysts in sheep liver are thrown to any nearby dogs (Fig. 6.2.5 
and Fig. 6.2.6). 
Twenty dogs (66.7%) were found infected with E. granulosus after necropsy from 
30 dogs in Bayinbuluke. The high prevalence in dogs suggested that the active 
transmission of E. granulosus in Bayinbuluke. People in this area, whatever 
gender, age, occupation, inevitably lived in an area of high endemically for E. 
granulosus. Unfortunately they did not understand the risk since health education 
was very limited. 
Human AE cases were reported rarely but existed in Hejing County (Hu 1993; 
Zhang et al., 2000). In the current study 3 AE cases and a suspicious CE and AE 
mixed infection were found by ultrasound in Bayinbuluke and also a dog was 
reported to have a mixed infection with E. granulosus and E. multilocularis (Zhang 
et al., 2006). This suggested that the transmission of E. multilocularis existed in 
Bayinbuluke and the domestic dog was involved in the life-cycle of E. 
multilocularis. The sylva lifecycle of E. multilocularis in Bayinbuluke is probably 
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similar to the Tianshan Mountains because human AE cases were previously 
reported in Ili Valley (Zhou et al., 2000; Gao et al, 2005; Dingmulati et al., 2005).  
The suggestion from this survey, health education around hydatid disease should 
be given to local people as soon as we can. Local dogs should be registered and 
treated with praziquentel twice a year. People should prohibit their dogs close to 
their water source and foods, and do not give a suspicious livestock organ to dogs. 
These suggestions had been reported to local government and they now have a 
policy to have parts of herdsmen moving to other area under the high land and 
training for other occupation such as agriculture, worker, etc.; so that to escape of 
overgraze, poor education and bad medical concern. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6.2.4: A dog close to a sheet with sun-dried cheese (August, 
Bayinbuluke). 
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Fig. 6.2.5: Untied dogs in a yard, they came to scavenge after home 
slaughter (October, Bayinbuluke). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6.2.6: A sheep slaughtered in the town center of Bayinbuluke, infected 
liver was thrown to dogs nearby. 
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6.3 Community study in Xinyuan County, Yili Kazakh 
Autonomous Prefecture, Xinjiang 
 
6.3.1 Introduction to study site 
Xinyuan County, also called Künes County (43° 27′ 4″ N, 83° 8′ 52″ E), is a county 
situated within Yili Kazakh Autonomous Prefecture (AP) and located in the east of 
Ili Valley in the north part of West Tianshan Mountains in Xinjiang (Fig. 6.3.1). It 
contains an area of 7,581 km2. According to the 2002 census, it has a population 
of 290,000 Most Kazakh people in China live in Yili Kazakh AP. Narati Town 
located in the east end of Xinyuan County, 60 km and local population was 25,986. 
As one of the world's four largest grasslands, Narati is located in the hinterlands of 
the Tianshan Mountains, to the east of the Ili River Valley, covers a total area of 
400 square kilometers, with an altitude of 1,800 meters. Turgen Commune is 42 
km from Narati with 8,490 populations. Surveys for human echinococcosis were 
planned and carried out during 2003 to 2005 (Fig. 6.3.2). 
Fig. 6.3.1: Xinyuan County (pink ?) in Ili Kazakh AP of Xinjiang, China 
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Fig. 6.3.2: Narati Town and Turgen Commune in Xinyuan County (1:650000). 
 
6.3.2 Results 
A total of 3691 residents accepted the questionaire survey, a portable ultrasound 
check and sera test. This included 1838 persons in Narati Town and 1853 persons 
in Turgen Commune. The mean age was 33 yrs old with youngest 8 yrs and oldest 
90 yrs old. The ratio of male to female was 0.93: 1. In total 7 ethnic groups were 
screened of which Kazak was 69.06%. The proportion of people whose 
occupation was herdsman was 39.1% and agricultural peasant was 33.89%.   
6.3.2.1 Ultrasound prevalence of human echinococcosis and seropositives 
in Xinyuan 
56 CE and 11 AE cases were diagnosed by abdominal ultrasound which gave 
1.52% CE prevalence (56/3691) and 0.3% AE prevalence (11/3691). The 
youngest CE case was 11 yrs old and oldest was 72 yrs old. Kazakh CE cases 
were 85.71%, herdsmen and peasants were 85.71%. The CE prevalence by 
ultrasound was 1.74% in Narati Town and 1.29% in Turgen Commune, which no 
significant difference was found (p>0.05). The human AE prevalence was 0.32% 
and 0.27% in Narati and Turgen respectively. 
A total of 933 people (25.28%) were seropositives by DIGFA The youngest was 11 
yrs old and oldest was 86 yr old; and Kazak proportion was 71.81%, herdsmen 
and peasants were 74.38%. Seropositive rate was 19.15% in Narati Town and 
31.33% in Turgen Commune, the later was higher (p<0.05). 
Xinyuan County 
Narati Town 
Turgen 
C
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i.) Ultrasound and seropositive CE prevalence by genders and age 
No significant differences was found in different genders on ultrasound prevalence 
of CE (p>0.05) which the CE prevalence was 1.69% in male and 1.36% in female. 
The seropositive rate was 23.31% in males and 27.11% in females, which was 
significant higher in females (p<0.05) (Table 6.3.1). 
There was no difference of CE ultrasound prevalence in different age groups 
(P>0.05), the highest prevalence was 2.56% in 40-50 yrs old group. No obvious 
difference was found in different age groups (p>0.05). Seropositive rate increased 
with age and the highest was 30.08% in over 60 yrs old group (Table 6.3.1, Fig. 
6.3.3, Fig 6.3.4).  
 
Table 6.3.1: Ultrasound and seropositive prevalence of human CE by 
genders and age in Xinyuan County 
US CE Serology 
Distribution No. Positives 
(%) 
2χ P 
Positives (%) 
2χ  P 
Gender          
Male 1780 30 (1.69) 415 (23.31) 
Female 1911 26 (1.36) 
0.65 0.42
518 (27.11) 
7.02 0.01
Ages    
<20 942 9 (0.96) 227 (24.10) 
20～ 696 16 (2.30) 168 (24.14) 
30～ 917 10 (1.09) 221 (24.10) 
40～ 546 14 (2.56) 141 (25.82) 
50～ 354 5 (1.41) 105 (29.66) 
60～ 236 2 (0.85) 
10.69 0.06
71 (30.08) 
8.42 0.14
Subtotal 3691 56 (1.52) － － 933 (25.28) － － 
US: ultrasound 
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Fig. 6.3.3: Comparison of seropositive rate in different ages and genders in 
Xinyuan County 
 
 
 
Fig. 6.3.4: Ultrasound and seropositive prevalence for human CE in different 
ages in Xinyuan County 
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ii.) Ultrasound CE and seropositive prevalence by ethnic group and 
occupations 
The prevalence of CE by ultrasound was 1.60% in Han, 1.72% in Mongolian, 
1.57% in Kazak echnic group and which no difference was found (p>0.05). The 
seropositive rate was 19.65% in Han, 21.26% in Mongolian, 26.28% in Kazak. 
Significant difference was found (p<0.05) in seropositives among different ethnic 
groups (Table 6.3.2).  
The highest seropositive rate was 27.60% in farmers and herdsmen, then 25.03% 
in students, but no statistical difference (p>0.05). Cadres had the highest CE 
prevalence of 5.45%, and then was herdsmen 1.80%. Statistical difference was 
showed in this study. The highest CE prevalence by occupation was cadre, 
herdsmen, students, peasants and others (including worker, businessmen, soldier, 
housewife and slaughterers) (Table 6.3.2 and Fig. 6.3.5). 
 
Table 6.3.2: Seropositives and prevalence (by US) of human CE in different 
ethnic groups/ occupations / Townships in Xinyuan  
Ultrasound Serology 
Distribution No. 
CE (%) 
2χ  P Positives (%) 
2χ  P 
Ethnic groups        
Han 626 10 1.60 123 19.65 
Mongolian 174 3 1.72 37 21.26 
Kazakh 2549 40 1.57 670 26.28 
Others 342 3 0.88 
1.06 0.79
103 30.12 
17.59 0.00
Occupations          
Herdsmen 1443 26 1.80 21.73 0.00 352 24.26 5.96 0.20
Farmer 1251 12 0.96   342 27.60   
Students 812 9 1.11   201 25.03   
Cadres 165 9 5.45   33 21.15   
Others 20 0 0.00   5 25.00   
Towns          
Narati 1838 32 1.74 1.23 0.28 352 19.15 72.75 0.00
Turgen 1853 24 1.29   581 31.35   
Subtotal 3691 56 1.52 － － 933 25.28 － － 
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Fig. 6.3.5: The comparison of human CE prevalence by occupations in Narati 
and Turgen of Xinyuan 
 
iii.) Dog and livestock ownership 
The proportion of residents who owned dogs and livestock was higher in Narati 
Town (76.85%, 1412/1838 for dog and 92.9%, 1707/1838 for livestock) than 
Turgen Commune (71.2%, 1320/1853 for dog and 67.1%, 1244/1853 for livestock) 
(p<0.01) (Table 6.3.3). The highest proportion of dog ownership was occurred in 
the Mongolian ethnicity which was 81.61% compared tp 75.56% in Kazakh 
(p<0.01) (Table 6.3.3). Herdsmen and students had higher seropositive 
prevalence (14.8% and 13.2%) compared to farmers, cadres and other 
occupations in Narati Town. Meanwhile the highest seropostive prevalence 
occurred in farmers (25%) and other occupations (businessmen, housewife, etc.) 
in Turgen Commune (Fig. 6.3.6). 
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Table  6.3.3: Dogs and livestock owning by different ethnic residents in 
Narati and Turgen in Xinyuan 
People with dogs/livestock ownership（%） 
 No. Dogs 
ownership
Livestock 
ownership 
Both 
owner Non-owner
Town 
Narati 1838 1412(76.82) 1707(92.87) 1381(75.14) 135(7.34) 
Turgen 1853 1320(71.24) 1642(88.61) 1244(67.13) 100(5.40) 
Chi  14.77 19.90   
p  0.000 0.000   
Ethnic groups 
Han 626 419(66.93) 527(84.19) 390(62.30) 60(9.58) 
Mongolian 174 142(81.61) 159(91.38) 141(81.03) 11(6.32) 
Kazakh 2549 1926(75.56) 2346(92.04) 1885(73.95) 147(5.77)
Others 342 245(71.64) 317(92.69) 242(70.76) 17(4.97) 
Chi  25.71 38.72   
p  0.000 0.000   
Total 3691 2732(74.02) 3349(90.73) 2625(71.12) 235(6.37)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6.3.6: The comparison of seropositives for human CE by occupation in 
Narati and Turgen of Xinyuan 
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6.3.2.2 Risk factors for human CE in Xinyuan County 
i) Risk factors and their evaluation 
In this study, dependant variable for risk factors of human CE infection was 
designated by seropositives, and independant variable was risk factors. Positive 
and negative were assigned as 1 and 0 respectively. The assignment of risk 
factors is shown in Table 6.3.4, Univariate and multivariate logistic regressive 
analysis was calculated (Table 6.3.5). 
 
Table 6.3.4: Assignment of risk factors for human CE in this study 
Variable Assignments 
Towns 0=Narati Town，1= Turgen Town 
Genders 0=Male，1=Female 
Ethnic groups 0=Others，1=Han，2=Mongolian，3=Kazakh 
Occupations 0=Others，1=Herdsmen，2=Farmers，3=Students，4=Cadres
Dogs owner 0=No，1=Yes 
Livestock 
owner 
0=No，1=Yes 
Home slaughter 0=No，1=Yes 
 
Analysis of Univariable Logistic regression of risk factors related with human CE, 
which showed four risk factors had statistical differences (p<0.05) (Table 6.3.5). 
These risk factors were areas, genders, ages and ethnic groups (Regression 
coefficient>0, OR>1). 
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Table 6.3.5: Analysis of Univariate Logistic regression of risk factors related 
with human CE 
Variables 
Regression 
coefficient 
Standard 
Error 
2χ  P OR 
95% 
confidence 
interval of OR
Township 0.66  0.08  71.61 0.00 1.93 1.66-2.25 
Genders 0.20  0.08  7.00 0.01 1.22 1.05-1.42 
Ages 0.01  0.00  6.57 0.01 1.01 1.00-1.01 
Ethnic 
groups 
－ － 17.44 0.00 －  － 
Han 0.10  0.21  0.22 0.64 1.10 0.73-1.67 
Mongolian 0.38  0.11  11.72 0.00 1.46 1.18-1.81 
Kazakh -0.19  0.13  13.37 0.00 1.76 1.30-2.39 
Occupations － － 5.94 0.20 －  － 
Herdsmen -0.03  0.52  0.00 0.95 0.97 0.35-2.68 
Farmers 0.12  0.52  0.05 0.82 1.13 0.41-3.13 
Students -0.01  0.52  0.00 0.98 0.99 0.35-2.75 
Cadres -0.29  0.55  0.27 0.60 0.75 0.25-2.21 
Dog owners 0.03  0.09  0.10 0.76 1.03 0.87-1.22 
Livestock 
owners 
-0.06  0.13  0.20 0.65 0.94 0.73-1.22 
Home 
slaughers 
0.05  0.21  0.06 0.81 1.05 0.70-1.57 
 
The logistic regression analysis of the multiple factors for risk factors related with 
human CE showed that five variable which came into the multiple factors 
regressive model. In this model, different areas, genders, ages, ethnic and 
occupation were risk factors (Table 6.3.6). 
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Table 6.3.6: The multivariate logistic regression analysis for risk factors 
related with human CE 
Variables 
Regression 
coefficient 
Standard 
Error 
2χ  P OR 95% CI
a of 
OR 
Township 0.79 0.11 54.24 0.00 2.20 1.78-2.71 
Genders 0.20 0.08 6.11 0.01 1.22 1.04-1.42 
Ages 0.01 0.00 8.74 0.00 1.01 1.00-1.02 
Ethnic groups － － 9.63 0.02 － － 
Han -0.20 0.22 0.84 0.36 0.82 0.53-1.26 
Mongolian 0.05 0.12 0.20 0.66 1.06 0.83-1.35 
Kazakh 0.39 0.16 5.91 0.02 1.48 1.08-2.03 
Occupations － － 18.07 0.00 － － 
Herdsmen 0.55 0.54 1.07 0.30 1.74 0.61-4.97 
Farmers 0.28 0.53 0.28 0.59 1.33 0.47-3.75 
Students 0.67 0.54 1.54 0.21 1.96 0.68-5.69 
Cadres -0.13 0.56 0.06 0.81 0.88 0.29-2.62 
Dog owners 0.05 0.10 0.27 0.60 1.05 0.87-1.28 
Livestock 
owners 
-0.08 0.14 0.34 0.56 0.92 0.69-1.22 
Home 
slaughers 
-0.02 0.22 0.01 0.93 0.98 0.64-1.51 
a. CI means confidence interval. 
 
6.3.3 Discussion (Xinyuan, Xinjiang) 
Xinyuan County located between N 43°03′ to 43°41′ and E82°28′ to 84°56, 196km 
from Yining City, 495km from Urumqi. It is geographically surrounded by 
mountains in east, north and south, with the west opened as Yili Valley crossing 
the border to Kazakstan. Its altitude above sea level is between 792 to 4261 
meters where east part is higher and west part is lower. The climate in Xinyuan 
belongs to continental semi-drought area, so it is easy to be affected by humid 
airstream from west to east and become the character of relatively warm winter 
and cool summer in Xinyuan. Annual amount of precipitation is 270 to 800 mm, 
fewer flatlands and more mountain areas, and difference between east and west 
is higher than it between north and south. Annual sun period is 2400 to 2700 
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hours, from a total of 8144 km2 of Xinyuan, 470 km2 is natural pasture and 535 
km2 agriculture land. Productive of grass had good quantities and the number of 
livestock was in the second position in county level in Xinjiang with average 
population 1 million annually (http://www.xinyuan.gov.cn). 
The ultrasound and seropositives prevalence of human CE in Xinyuan County 
which was presented here, was close to Gongliu County, Yining County and 
Nileke County where also belongs to Yili Valley region. Those counties had similar 
geographical characters, which show highland pasture surrounded by forest; and 
with ethnic Kazak population, similar life styles and business structure. In addition, 
from hospital records we could find human CE cases had increased during last 50 
years (Gao et al., 2005; Dingmulati et al., 2005). So that we could suggest that the 
transmission of E. granulosus is still in an active life cycle and was not well 
controlled. 
A total of 1.52% ultrasound CE prevalence (56/3691), 0.3% AE prevalence 
(11/3691) and 25.28% seropositives by DIGFA were reported in the current study. 
85.71% CE cases were Kazakh, herdsmen and peasants. Seropositive rate was 
19.15% in Narati Town and 31.33% in Turgen Commune, the later was higher 
(p<0.05). No significant differences were found on ultrasound prevalence of CE 
between males and females. However the seropositive rate in males (23.31%) 
was significant higher than in females (27.11%) (p<0.05). There was no difference 
of ultrasound CE prevalence and seropositive rate in different age groups (p>0.05). 
Significant difference was found in seropositives among different ethnic groups 
with the highest 26.28% in Kazak (p<0.05). Herdsmen and students had higher 
seropositive prevalence (14.8% and 13.2%) compared to farmers, cadres and 
other occupations in Narati Town. Meanwhile the highest seropostive prevalence 
occurred in farmers (25%) and other occupations (businessmen, housewife, etc.) 
in Turgen Commune. 
The proportion of residents who owned dogs and livestock was higher in Narati 
Town than Turgen Commune (p<0.01). The highest proportion of dog ownership 
was occurred in the Mongolian ethnicity which was 81.61% compared tp 75.56% 
in Kazakh (p<0.01). Different areas, genders, ages, ethnic and occupation were 
risk factors for human CE in current study. 
This high CE endemic status might due to poor veferinary public health. The 
check and treatment for dogs seemed not to work and no dogs were registered 
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officially. As the most important definite host of E. granulosus, dogs undoubtedly 
became the main risk factor and other factors such as home slaughter, livestock 
and poor hygiene habits etc. were also related to dog infection and transmission. 
Traditional husbandry was practiced by most people and they relied on dogs for 
herding livestock and guarding their yards. Generally people did not have the dog 
tied all of the time. The local climate of wet, cold weather appears suitable for 
Echinococcus eggs surviving in pasture or around the village. Occupations which 
were more close to dogs had more chance to be infected, but farmers were 
herding livestock as well in many villages and generally they had same risk of CE 
as herdsmen. Even mostly Kazakh populations in Xinyuan, but other ethnic 
groups such as Han, Hui, Uygur, had a similar chance to be infected since they 
had same life-style and habits. 
Human AE was relatively sporadic in Xinjiang compared to CE. Higher prevalence 
(3.9/100,000) was observed in Altai Mountain (Zhou et al., 2000). 79 cases of 
human AE in 4486 hydatid disease records during 1957 and 1997 were treated in 
Xinjiang Medical University Hospital (Qiu et al., 1999). A total of 84 hospital AE 
cases were recorded between 1993-2003 in Ili valley (Gao et al., 2005) and 
0.636% (13/2044) human AE prevalence were observed in a community survey in 
Nileke County of Ili valley (Zhumabai et al., 2005). Human AE prevalence (0.3%) 
of Xinyuan County in this study showed no significant statistical difference (p>0.05) 
compared to 0.64% in the nearby Nileke County (Zhumabai et al., 2005). The 
transmission of E. multilocularis might be similar in these two counties because 
they all located in the Ili Valley of Tianshan Mountains. A sylvatic cycle is 
maintained in Xinjiang with red fox (Vulpes vulpes) as the main definitive host, 
microtines (voles) as main intermediate host (WHO/OIE, 2001; Ding and Wen, 
2000). Domestic dogs were involved in E. multilocularis transmission in nearby 
Bayinbuluke pasture in Xinjiang. So the close contact with dog might be one of the 
main risk factors for human AE in this case. 
The knowledge of how to prevent and control of E. granulosus and E. 
multilocularis infection seems very poor for local people. So public health 
education through TV programme, broadcast, handbook etc, might be helpful to 
local people to understand the transmission and get to prevent by better hygiene, 
correct methods for livestock offal and dog feces, and they could accepted the test 
and prazquentel treatment for dogs. 
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6.4 Community study in Hoboksar Mongol Autonomous County, 
Tacheng Prefecture, Xinjiang 
 
6.4.1 Introduction to Study Site 
Hobukesaier (Hoboksar) Mongol Autonomous County is a county situated in the 
Xinjiang Uyghur Autonomous Region and is under the administrative jurisdiction of 
the Tacheng Prefecture (Fig. 6.4.1). It has an area of 28,799 km² with a population 
of 50,000. Hoboksar is located northwest board of Jungger Basin, 495 km from 
Urumqi, with low mountain ranges (altitude above 1000 metre) in the north, 
Gurbantunggut Desert in the south and piedmont alluvial plain in the middle. Its 
climate belongs to north temperate zone continental drought weather, with 
average annual temperature 3.0ºC and annual rainfall 142 mm.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6.4.1: Hoboksar Mongol Autonomous County in Tacheng Prefecture, 
Xinjiang Uygur Autonomous Region, P.R.China 
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A community study was carried out in five communes/pastures ie. Narenhebuk 
and Bustunge Pastures, Tiebukenwusan, Chagankuke and Bayinaowa 
Communes) in Hoboksar Mongol Autonomous County in 2007 (Fig. 6.4.2). 
 
Fig. 6.4.2: Community study sites in Hoboksar Mongol Autonomous County, 
Tacheng Prefecture, Xinjiang Uygur AR (1:1,200,000) 
 
6.4.2 Results 
A total of 1339 residents accepted questionnaire, abdominal ultrasound and 
serological test by DIGFA. Population sample (age ranged from 6 to 77 years, 
median 31years) comprised 42.57% (593)male and 53.55% (746) female, with 
ethnic groups as Han 121 (9%), Mongolian 574 (42.9%), Kazakh 620 (46.3%), 
and others 24 (1.8%). Their occupations included farmers 491(36.7%), herdsmen 
260 (19.4%), students 477 (35.6%), Cadres 76 (5.7%), and others 35 (2.6%). 
Communes screened were Tiebukenwusan (n=460), Narenhebuke (n=248), 
Chagankuke (n=268), Bayinaowa (n=240), Busitunge (n=119) and others (n=4). 
6.4.2.1 Ultrasound Prevalence 
Of 1339 volunteers who were checked by abdominal ultrasound, 68 (5.1%) were 
confirmed to have CE, 2 (0.1%) to have AE, and 12 (0.9%) to have isolated 
calcification lesions. 
i) Prevalence by communes: 
There were significant differences of CE prevalence among different communes 
(p<0.01). Narenhebuke Pasture showed the highest CE prevalence of 9.3%, and 
Narenhebuk
Tiebukenwusan Chagankule Bayinaowa
Busitunge 
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followed by Tiebukenwusan and Chagankuke (Table 6.4.1).  
 
Table 6.4.1 Human CE or AE prevalence by abdominal ultrasound in 
Hoboksar Mongol Autonomous County, Tacheng Prefecture, Xinjiang Uygur 
Autonomous Region, P.R.China 
Communes Populations Screened CE(%) AE(%) Calcification(%) Normal
Tiebukenwusan 3524 460 23(5) 1(0.2) 7(1.5) 429 
Narenhebuke 2374 248 23(9.3) 0 5(2) 220 
Chagankuke 4320 268 13(4.9) 0 0 255 
Bayinaowa 2460 240 4(1.7) 0 0 236 
Busitunge 2268 119 2(1.7) 1(0.8) 0 116 
Others  4 3 0 0 1 
Total  1339 68(5.1) 2(0.1) 12(0.9) 1257 
For CE prevalence in 5 different communes: Chi-Square Value18.3328 Prob 0.0011 
 
ii) Prevalence by gender, ethnic and occupation 
Females showed similar CE prevalence to males. Just 2 AE cases were identified 
both females. Mongolian and Han ethnic people had higher CE prevalence 
compared to Kazakh (p<0.01). Farmers and herdsmen presented higher CE 
prevalence than other occupations (p<0.01) (Table 6.4.2). 
 172
Table 6.4.2: Human CE or AE prevalence in three communes in northwest 
Hoboksar  
  Ultrasound  
    N CE(%) AE(%) Calcification 
Male 593 29(4.9) 0 7(1.2) Gender 
Female 746 39(5.2) 2(0.3) 5(0.7) 
  Total 1339 68(5.1) 2(0.1) 12(0.9) 
Han 121 11(9.0) 1(0.8) 1(0.8) 
Mongolian 574 34(5.9) 1(0.2) 7(1.2) 
Kazakh 620 20(3.2) 0 4(0.6) 
Ethnic 
groups 
Others 24 3(12.5) 0 0 
 Total 1339 68(5.1) 2(0.1) 12(0.9) 
Farmers  491 30(6.1) 1(0.2) 3(0.6) 
Herdsmen 260 22(8.5) 1(0.4) 7(2.7) 
Students 477 8(1.7) 0 0 
Cadres 76 4(5.3) 0 2(2.6) 
Occupation 
Others 35 4(11.4) 0 0 
  Total 1339 68(5.1) 2(0.1) 12(0.9) 
For genders, Pearson Chi-Square Value.078, Asymp. Sig. (2-sided) 0.780 
For ethnic, Pearson Chi-Square Value12.048 Asymp. Sig. (2-sided) 0.007 
For occupations, Pearson Chi-Square Value19.748a Asymp. Sig. (2-sided) 0.0002 
 
iii) Prevalence by age group 
Higher CE prevalence occurred in the > 20 age groups (p<0.01) (Table 6.4.3) 
 
Table 6.4.3: Human CE or AE prevalence in different age groups in 
community study in north Hoboksar Mongol Autonomous County  
Ages N CE (%) AE (%) Calcification (%) Normal
<20 502 10 (1.99 ) 0 (0.00)  1 (0.20)  491 
20- 353 28 (7.93 ) 1 (0.28)  6 (1.70)  318 
40- 374 25 (6.68 ) 0 (0.00)  3 (0.80)  346 
60- 110 5 (4.55 ) 1 (0.91)  2 (1.82)  102 
Total 1339 68 (5.08) 2 (0.15)  12 (0.90)  1257 
CE prevalence: Chi-Square Value was 17.9491 Prob was 0.0005 
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6.4.2.2 Serological prevalence by DIGFA 
The rapid DIGFA test results showed females had a higher seropositive rate 
(22.56%) than males (17.41%, p<0.05). Han and Mongolian ethnic group had 
higher seropositives than Kazakh and other ethnic groups (p<0.01). Herdsmen 
and farmers showed higher seropositive rate than students, cadres and other 
occupations (p<0.01) (Table 6.4.4). 
 
Table 6.4.4: Serological prevalence by gender /ethnic group /occupation in 
Hoboksar.  
 No. test Positive Positive % Negative Chi P 
Genders       
Male 580 101 17.41  479   
Female 727 164 22.56  563 5.2825 0.0215
Ethnic groups 
Han 118 42 35.59  76   
Mongolian 559 129 23.08  430   
Kazakh 606 89 14.69  517   
Others 24 5 20.83  19 31.5574 <0.0001
Occupation 
Farmers 484 139 28.72  345   
Herdsmen 254 66 25.98  188   
Students 463 33 7.13  430   
Cadres 
&others 106 27 25.47  79 77.7538 <.0001
Age (yrs)       
<20 488 33 6.76  455   
20-39 348 101 29.02  247   
40-59 363 106 29.20  257   
60- 108 25 23.15  83 90.043 0000 
Total 1307 265 20.28  1042   
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Table 6.4.5:  Human ultrasound CE and AE prevalence and seropositive 
prevalence by education level in Hoboksar 
Ultrasound DIGFA 
Education 
N CE (%) AE (%) N Positives (%)
Illiteracy 58 6 0 58 21 
Primary school 595 24 1 580 112 
Middle school 510 27 0 499 92 
High school 140 7 1 135 35 
College and over 36 4 0 35 5 
Total 1339 68 2 1307 265 
(Education level: 2χ b=1.692, Pb＞0. 05; 2χ 血=13.462, P血=0.009) 
For CE prevalence Pearson Chi-Square Value7.453 Asymp. Sig. (2-sided) .114 
For seropositives Pearson Chi-Square Value13.928 Asymp. Sig. (2-sided) .008 
 
6.4.2.3 Risk factors for human CE 
Human CE related risk factors, including ethnicity, age, sex, occupation and 
personal status on hygiene were analyzed under multifactorial logistic regression. 
The main risk factors that were significantly associated with CE were ages  
(OR=7.6, 95%CI: 2.481-23.579) and home slaughtering of livestock (OR=3.2,   
95%CI: 1.297-7.809). Herdsmen had the highest prevalence of CE in all of the 
occupations in this study (Table 6.4.6). 
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Table 6.4.6 Univariable Logistic regression analysis for risk factors of 
human CE in Hoboksar 
Variables Prevalence (％) OR (95%CI) 
  Male 29/593 (4.9) 1.073（0.655- 1.757）Gender 
  Female 39/746 (5.2)  
  Han 11/121 (9.0)  
  Mongol 34/574 (5.9) 1.429(.367-5.562) 
  Kazakh 20/620 (3.2) 5.562(0.645-7.986) 
Ethnic 
  Others  3/24 (12.5) 4.286 (1.181-15.556)*
Herdsmen 22/260 (8.5)  
  Farmer 30/491 (6.1) 1.396 (0.451-4.318) 
  Students 8/477 (1.7) 1.983 (0.657-5.986) 
  Cadres 4/76 (5.3) 7.565 (2.158-26.510)*
Occupation 
  Others 4/35 (11.4) 2.323 (0.546-9.886) 
  ～20 10/502 (1.99 )  
  20～ 28/353 (7.93 ) 2.343 (0.785-6.996) 
  40～ 25/374 (6.68 ) 0.553 (0.208-1.468) 
Age (years) 
  60～ 5/110 (4.55 ) 0.665 (0.248 1.779)
  Yes 51/942 (5.41)  0.782 (0.446-1.371) Dog owner 
  No 17/397 (4.28 )  
  Yes 63/1276 (4.94 ) 1.660 (0.643-4.283) Livestock owner 
  No 5/63 (7.94 )  
  Yes 42/885 (4.75 ) 1.219 (0.738-2.016) Home slaughter 
  No 26/454 (5.73 )  
  Yes 15/315 (4.76 ) 1.092 (0.607-1.965) Stray dogs 
  No 53/1024 (5.18 )  
  Tap water 34/533 (6.38 )  
  Deep well 1/96 (1.04 ) 1.129 (0.582-2.190) 
  Shallow well 20/528 (3.79 ) 7.308 (0.941-56.733) 
Drinking water 
  River or stream 13/182 (7.14 ) 1.954 (0 .951-4.013) 
  Yes 65/1298 (5.01 ) 1.498 (0.450-4.980) Wash hand 
before eating   No 3/41 (7.32 )  
  Yes 35/822 4.26  1.533 (0.940 -2.500) Drink unboiled 
water   No 33/517 6.38   
  Yes 21/617 3.40  1.976  (1.168 - 3.344)* 
Eat uncooked 
vegetables 
  No 47/722 6.51   
 
Three variables were chosen since they seemed to have significant differences for 
CE. There were ethnicity, occupation and eating of uncooked vegetables, which 
were selected for multivariable logistic regression. The analyzed results showed 
that Han, Mongolian and Kazak groups had a lower CE prevalence risk than other 
ethnic group included Uygur, Hui and Xibo ethnic. Farmers and students had a 
lower risk than other occupations but herdsmen and cadre had a slighting higher 
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risk, eating uncooked vegetables did not show any significant differences (Table 
6.4.7).  
 
Table 6.4.7: Multivariable Logistic regression analysis for risk factors of 
human CE in Hoboksar 
95.0% C.I.for EXP(B)
Risk Factor B S.E. Wald Sig. Exp(B)
Lower Upper 
Ethnic   15.690 0.001    
ethnic(1) -1.368 0.700 3.821 0.051 0.255 0.065 1.004
ethnic(2) -2.119 0.650 10.638 0.001 0.120 0.034 0.429
ethnic(3) -2.195 0.645 11.583 0.001 0.111 0.031 0.394
Occupation   12.929 0.012    
Occupation(1) -.159 0.659 0.058 0.809 0.853 0.234 3.101
Occupation(2) 0.076 0.681 0.012 0.912 1.079 0.284 4.100
Occupation(3) 0.279 0.747 0.140 0.709 1.322 0.306 5.717
occupation(4) -1.535 0.745 4.244 0.039 0.215 0.050 0.928
uncookveg(1) -0.474 0.287 2.740 0.098 0.622 0.355 1.091
Step 1a 
Constant -0.418 0.828 0.255 0.614 0.658   
 
6.4.3 Discussion (Hoboksar, Tacheng Prefecture, Xinjiang) 
Geographical CE distribution of human CE in Hobokesar showed that three 
southwest communes had higher prevalence than others in the north. CE 
prevalence by ultrasound in Narenhebuke (23/248, 9.3%) was higher than a 
previous report in same area which was 49/1844, 2.7% (Wang et al., 2001). 
Similarly in the current study CE prevalence in Mongolians was 5.9% (34/574), 
which was higher than the 2.7% (34/1267) recorded by Wang et al (2001). This 
difference might be caused a smaller sample for both Narenhebuke and 
Mongolian populations in the current survey.  
In Hoboksar females had a significant higher seropositive rate than males 
(P<0.05). That might due to close contact with dogs since female had more 
responsibility to feed dogs and to clean the yards where dogs and livestock are 
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kept. Generally however females and males had no difference for CE prevalence 
in other areas of Xinjiang, and also in a previous study in Hobokesar (Wang, 2001). 
Persons younger than 20 years old had a significantlly lower CE prevalence and 
seropositives rate than other age groups and seropositives increased with ages. 
Students, which for most part were younger than 20 yrs old had the lowest CE 
ultrasound prevalence and sero prevalence compared to other occupation groups. 
Education was also analyzed in this study with higher CE seropositive rate in 
persons who just had a primary school level. This might indicate that lower 
education level had more risk of exposure, not definitely. This could be caused by 
different health education levels or different level of knowledge about 
echinococcosis and its transmission, or different (closer) behavior of young 
children with dogs.  
Mongolian and Han ethnic groups showed higher CE ultrasound and sero 
prevalence compared to Kazakhs in the current study. Wang et al. (2001) found no 
significant difference for CE among Mongolian and Kazak groups, but higher for 
Han. That might be because in this study we had more Kazakhs and fewer 
Mongolian registered. As for Han residents, they have a similar life-style with local 
Mongolians and Kazakhs and also kept close contact with dogs as well.  
Risk factors for human CE were not so obvious in this study in Hoboksar County. 
That may be due to local people having similar life-styles and living in similar 
circumstances with dogs and livestock. The overall CE ultrasound prevalence in 
Hoboksar was high (5.1%) for Xinjiang, and similar with that we obtained in 
Bayinbuluke (5.7%), but much higher than in for Wenquan (1.86%) and Xinyuan 
(1.57%) areas. 
The youngest CE patient in the Hoboksar study was a 6-year old child. This 
suggested that E. granulosus was still in higher transmission status in this area 
since new cases occurred in young children (age group <20).  
The main activity in Hoboksar County is livestock production and 93.5% families 
raised livestock. Furthermore, 75.4% of families slaughtered their livestock in their 
yards. Dogs as guards or for herding livestock are essential for the local people, 
and 63% of people owned dogs (average 2 dogs per family). Untied dogs could go 
anywhere. People have more chance to be contacted with the skin, fur and feces 
of dogs and livestock. This suggested that people might have specific sera 
antibodies of E. granulosus since they kept contact with tools or materials and 
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surrounding infected by E. granulosus eggs. 
The distribution of human CE in southwest Hoboksar was high, but two human AE 
cases were also found in this study. Transmission of E. multilocularis may occur 
between the red fox and small mammals in this area (Lin et al., 1993; Zhou et al., 
2000). The high CE prevalence could affect local economic development due to 
livestock loses and human health loses. Prevention could be focus on dog 
management including routine testing and anthelmintic treatment, strengthen 
slaughter hygiene supervision, also to strengthen health education especially for 
children and students, and improve the general hygiene situation. At the same 
time, survey and treatment of cases and routine prevalence monitoring, which had 
been confirmed effective for prevention, are important for any effort to reduce 
human echinococcosis especially human CE. 
 
6.4.4 Discussion ---Community studies on human echinococcosis in XUAR, 
China 
Echinococcosis is a zoonosis with a worldwide distribution caused by adult or 
larval stages of tapeworms (cestodes) belonging to the genus Echinococcus 
(family Taeniidae) (Zhou et al., 2000; WHO/OIE 2001; Craig et al., 2003). The two 
major species of medical and public health importance in northwestern China are 
Echinococcus granulosus (E.g) and Echinococcus multilocularis (E.m), which 
result in cystic echinococcosis (CE) and alveolar echinococcosis (AE) in humans 
(Wen and Yang, 1997; Craig 2004, Xu et al., 2007; Bud). Both can be considered 
as life-threatening diseases, the latter especially with high fatality rates and poor 
prognosis if careful clinical treatment is not available in early stages. Mortality for 
human CE varied between 0.5% and 4.5%, and for human AE between 10-15% 
(Wen and Yang, 1997; WHO/OIE 2001; McManus et al., 2003; Zhang et al., 
2003).  
Xinjiang Uygur Autonomous Region (XUAR) is in the northwestern China with a 
population of 22 million people. A total of 21,560 hospitalized CE cases in China 
were recorded in Xinjiang from 1950-1990 (Jiang, 1991), over 1965 CE cased 
from 1993 to 2004 (Chai et al. 2004; Dinmurati et al.2005; Gao et al. 2005. Wang 
et al., 2008). Human CE cases have been recorded all over the region, which 
consisted of all of 12 prefectures including 5 minority ethnic autonomous 
prefectures. Main CE endemic area may focus on the North of Xinjiang from the 
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Tianshan Mountain to Altai Mountain including Bayinguoleng Mongolian 
Autonomous Prefecture, Yili Kazak Autonomous Prefecture, Tacheng Prefecture, 
Altai Prefecture, Changji Prefecture and Hami Prefecture. Hospital records 
indicated 16,663 cases of CE were treated surgically in Xinjiang from 1951 to 
1991 (National Hydatid Disease Center of China, 1993). Wei et al reported that 
human CE was more endemic in Tianshan Mountain (2.23%, 47/2103) and Altai 
Mountain (2.28%, 41/1420) than in Kunlun Mountain (0.6%, 6/1000) based on a 
cross –sectional survey including 4 community populations from 4 counties (Wei 
1994). Community screening data showed 2.22% (45/2044) CE prevalence in 
Wulasitai Commune of Nileke County, Yili Valley (Zhumabai et al., 2005); 4.5% 
(34/755) and 1.91% (17/889) in Habahe County (Song et al., 1999; Zhao et al., 
2003), 5.78% (31/536) in Qinghe County (Zhao et al., 2003), Altai Prefecture; 
2.4% (49/1844) in Hobukesar County, Tacheng Prefecture (Wang et al., 2001). 
Seven thousand two hundred and fifty-five CE cases have been treated in Xinjiang 
Medical University Hospital since 1957 and the annual cases curve showed a 
remarkable increase during the last decade (hospital record). 1126 hospitalized 
CE cases were registered in north 4 counties in Tacheng Prefecture (Qi et al., 
1995). 1965 CE cases were reported in Yili Valley which consists of 8 counties and 
1 city from 1993 to 2003 (Gao et al., 2005). 
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To further understand the geographic and ethnic distribution of human 
echinococcus infection (CE and AE) in Xinjiang, our team conducted series fine 
designed epidemiological studies in 7 counties including 6 natural villages in 5 
prefectures. A questionnaire including demographic and economic information 
and risk factors (dog owner, fox/wolf contact, homeslaughter, health education etc.) 
need to be completed at first, followed by ultrasound plus serologic tests with a 
rapid DIGFA and/or ELISA tests randomly selected subjects from each fields. 
Human hydatid survey and control model can be modified as an system which 
including basically population data, initial trial in a small group, formal survey 
(ultrasound plus serological tests), chemotherapy and/or surgical treatment, 
health education and continuous control programme. The overall results showed 
that CE were high endemic and AE were sporatic in all these counties of Xinjiang 
(Table 6.4.11 and Fig. 6.4.3). 
 
Table 6.4.11: The ultrasound prevalence of human CE and AE in field 
screening studies in Xinjiang (1998-2007) 
Counties No CE cases CE prevalence AE AE prevalence
Wenquan 1292 24 1.86% 0 0.00%
Hejing 1398 78 5.58% 3 0.21%
Xinyuan 3691 56 1.52% 11 0.30%
Hoboksaier 1339 68 5.08% 2 0.15%
Nileke 3908 94 2.41% 16 0.41%
Habahe 1644 51 3.10% 0 0.00%
Qinghe 536 31 5.78% 0 0.00%
Subtotal 13808 402 2.91% 28 0.20%
For CE, Pearson Chi-Square Value1.073E2 Asymp. Sig. (2-sided) 0.000; 
For AE, Fisher's Exact Test Value3.852 Sig. 0.262, 99% Confidence Interval (0.250, 
0.273) 
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Fig. 6.4.3: The ultrasound prevalence of human CE and AE in field screening 
studies in Xinjiang (1998-2007) 
 
 
Field works in above four counties in Section 6.1 to 6.4, which included Wenquan, 
Hejing, Xinyuan and Hoboksar, were put together to find the differences between 
them. The main findings appeared as follows. The ultrasound CE prevalences 
were different in different counties, which were higher in Hejing and Hoboksar 
counties (Table 6.4.12-6.4.13). There was no gender difference in human CE 
prevalence in Xinjiang (Table 6.4.14). In contrast females were 1-2 times higher 
CE than males on Tibet Plateau (Wang et al, 2000, Li et al., 2005, 2010). 
Mongolians were the main ethnic group with Echinococcus infection, with 
prevalence as high as 5.19% (Table 6.4.15). Persons with occupation as 
herdsmen and farmers, aged 20-60 years old should have greater risk than other 
occupation groups (Table 6.4.15 - 6.4.17). Dog and livestock ownership had given 
more risk for human CE. A total of 23 human AE cases were reported in above 
four counties including 5 cases in three Mongolian dominated communities 
(Hejing, Wenquan and Hoboksar). There were no statistical differences for 
ultrasound AE between three Mongolian dominated counties (Table 
6.4.12-6.4.13).  
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Table 6.4.12: Echinococcosis prevalence by ultrasound in 3 Mongolian 
dominated communities of Xinjiang 
County/ Commune No. HD ( %) AE (%) CE(%) 
Hejing / Bayanbuluke 1398 82 (5.87) 3 (0.21) 79(5.6) 
Wenquan / Angelige 1292 24 (1.86) 0 24(1.86) 
Hoboksar 1339 70 (5.23) 2 (0.15) 68 (5.08) 
Total 4029 176(4.27) 5 (0.12) 171(4.24) 
For HD, Pearson Chi-Square Value29.365 Asymp. Sig. (2-sided) 0.000 
For CE, Pearson Chi-Square Value27.208 Asymp. Sig. (2-sided) 0 .000 
For AE, Fisher's Exact Test Exact Sig. (2-sided) 1.000 
 
Table 6.4.13: Ultrasound Echinococcosis prevalence of Mongolian in 3 
Mongolian dominated communities in Xinjiang 
Communities No. HD(%) AE(%) CE(%) 
Hejing/Bayinbuluke 1377 81(5.88%) 3 (0.21) 78(5.6) 
Wenquan/Angelige 189 5(2.65%) 0(0) 5(2.65) 
Hoboksar 574 34(5.92) 1 (0.17) 33(5.75) 
Total 2140 120(5.61) 4(0.19) 116(5.42) 
For HD, Pearson Chi-Square Value3.437 Asymp. Sig. (2-sided) 0.179 
For CE, Pearson Chi-Square Value3.120 Asymp. Sig. (2-sided) 0.210 
For AE, Fisher's Exact Test Value0.242 Sig1.000 
 
Table 6.4.14: CE prevalence comparision of different genders in 4 counties 
of Xinjiang 
Male Female Subtotal 
Counties 
N CE (%) N CE (%) N CE (%) 
Wenquan 604 9 (1.49) 688 15 (2.18) 1292 24 (1.86)
Hejing 597 41 (6.87) 801 38 (4.74) 1398 79 (5.65)
Xinyuan 1780 30 (1.69) 1911 26 (1.36) 3691 56 (1.52)
Hoboksar 593 29 (4.89) 746 39 (5.23) 1339 68 (5.08)
Subtotal 3574 109 (3.05) 4146 118 (2.85) 7720 227 (2.94)
Male CE* counties Pearson Chi-Square 53.98, Asymp. Sig. (2-sided) 0.000 
Female CE * counties Pearson Chi-Square Value 42.09, Asymp. Sig. (2-sided) 0.000 
County * CE Pearson Chi-squarevalue90.11, Asymp. Sig. (2-sided) 2.08E-19 
Gender * AE Pearson Chi-squarevalue0.21,Asymp. Sig. (2-sided) 0.647925 
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Table 6.4.15: Ultrasound CE prevalence by ethnic group in four counties in 
Xinjiang 
Ethnic N CE (%) 
Han 1496 29 1.94 
Kazak 3344 66 1.97 
Mongolian 2314 120 5.19 
Others 566 1 2 2.12 
Subtotal 7720 227 2.94 
Pearson Chi-Square Value58.426 Asymp. Sig. (2-sided) 0.000 
 
Table 6.4.16: Ultrasound CE prevalence by age group in four counties in 
Xinjiang 
Age N CE CE% 
＜20 2268 36 1.59 
20- 3020 106 3.51 
40- 1889 68 3.60 
60- 543 17 3.13 
Total 7720 227 2.94 
Pearson Chi-Square Value20.929 Asymp. Sig. (2-sided) 0.000 
 
Table 6.4.17: Ultrasound CE prevalence by occupation in four counties in 
Xinjiang 
Occupation No. CE Prevalence 
Farmer 2455 60 2.44 
Herdsman 2699 115 4.26 
Student 2026 32 1.58 
Others 540 20 3.70 
Total 7720 227 2.94 
Pearson Chi-Square Value32.859 Asymp. Sig. (2-sided) 0.000 
 
The development of Dot Immuno-Gold Filtration Assay (DIGFA) for serological 
studies in hospitals and communities shared promise (Fu et al, 2000, Feng et al., 
2002, Chen et al, 2005, Feng et al., 2010). Compared with standard ELISA test 
using the same antigens, the DIGFA test showed higher sensitivity especially for 
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detection of CE T1, T2, T3 types (Chapter 3).  
A network for detection, treatment and control of human echinococcosis has been 
established in Xinjiang in the period of 2005-2006, which consists of the first 3 
sentry hospitals. A total of 29 hospitals were included in the network by the end of 
2008. Training, related scientific research, regular surveillance data collection 
have been done through the network. Official Appointed Hospitals for Human 
Echinococcosis were defined as two parts: one as Surgical Instruction Hospitals 
including the 1st Affiliated Hospital of Xinjiang Medical University and the 1st 
Affiliated Hospital of Medical College in Shihezi University, the other as Official 
Appointed Surgery Treatment Hospitals in Xinjiang such as Yili Friendship 
Hospital, Changji Prefecture Hospital and Wusu City Hospital et al., (see details in 
map). Distant tele-medical consultation for hydatid patients by National surgical 
aid programme was located in the 1st Affiliated Hospital of Xinjiang Medical 
University in April 2008 and well done for hydatid patients all over Xinjiang. 
National Training Programme for hydatid has been activated for mainstay staff of 
those Official Appointed Hospitals of Xinjiang since 2008 and continued in 2009, 
which included in serological diagnosis and imaging, surgical treatment if needed. 
Training video of hydatid intervention financially supported on the surgical aid 
programme for hydatid control and free charged for education and training in the 7 
endemic provinces and Autonomous Regions under the financial aids from 
Chinese Government. Consultations for the Official Appointed Hospitals in China 
were performed by MOH (Ministry of Health). In addition, Surgical Consultation 
Group for hydatid patients had been worked in Guyuan Hospital in Ningxia, 
Tianzhu Tibetan Autonomous County Hospital in Gansu, Ganzi Prefecture 
Hospital in Sichuan, Xilinguole Prefecture Hospital in Inner Mongolia, Xining CDC 
Centre in Qinghai, Wuzhong City Hospital in Ningxia and Shannan Prefecture 
Hospital in Tibet between 2008~2009 (see Fig. 6.4.4). 
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Fig. 6.4.4: Map of the sentry county hospitals all over Xinjiang Uygur 
Autonomous Region, P.R.China 
   3 counties in 2005/2006  
   5 counties in 2007 
   21 counties in 2008 
● 7 Official appointed hospitals in other endemic provinces or autonomous regions 
and 15 official appointed hospitals in Xinjiang. 
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6.5 Community study in Xiji County, Guyuan Prefecture, Ningxia 
Hui Autonomous Region (2002) 
6.5.1 Introduction to study site 
Xiji County in southern Ningxia Hui Autonomous Region (Fig. 6.5.1), is situated to 
the west Liupanshan Mountains, with longitude E105°20’-106 °04’, latitude N 
35°35’-36°14’, elevation 1688~2633 metres, and part of the hinterland of Loess 
Plateau in the middle reaches of the Yellow River. Xiji County is located 63 
kilometers from east of Guyuan City, 391 kilometers from the capital Yinchuan City 
in Ningxia, 459 kilometers (km) from Xian and 270 km from Lanzhou, and about 
2200 km from Urumqi. The Region covers 3143.85 square kilometers. The climate 
is a typical continental climate being sub-humid and semi-arid. It has an annual 
sunshine time of 2322 hours, with an average annual temperature of 5.3°C and 
100-150 days frost-free period, an average annual rainfall around 400 mm. There 
are owns 3 towns, 16 communes, 306 villages, and the total population of 471,000, 
of which 255,000 Hui Moslem ethnic group are biggest munorities (54.3%) 
(http://www.nxxj.gov.cn). 
 
 
 
Fig. 6.5.1 Xiji County of Guyuan Prefecture, Ningxia Hui Autonomous Region, 
P.R.China 
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6.5.2 Results 
6.5.2.1 Ultrasound Prevalence  
Following an ultrasound based survey a total 36 (3.81%) CE cases and 57 (6.04%) 
AEcased were detected in addition another 14 (1.48%) with queried and 40 
persons (4.23) showed isolated calcifications on portable ultrasound (Tabel 6.5.1). 
This region therefore had a high prevalence of human AE as well as CE. 
i) Prevalence by gender 
No difference between males and females was found in human CE prevalence by 
ultrasound in this study in Xiji (P>0.05). But as for AE prevalence in Xiji, the 
situation looked quite different since females had significantly higher prevalence 
(7.7% vs. 4.4.9%, P<0.05) 
 
Table 6.5.1: Prevalence comparison of human CE and AE in different 
genders in Xiji County, Ningxia 
Gender N CE (%) AE ( %) Query (%) Calcification (%) Normal
Male 490 19 (3.88) 22 (4.49) 4 (0.82) 20 (4.08) 425 
Female 455 17 (3.74) 35 (7.70) 10 (2.20) 20 (4.39) 373 
Subtotal 945 36 (3.81) 57 (6.04) 14 (1.48) 40 (4.23) 798 
For CE,  Chi-Square Tests Pearson Chi-Square Value.013 Asymp. Sig. (2-sided) 0.910 
For AE, Chi-Square Tests Pearson Chi-Square Value4.269a Asymp. Sig. (2-sided) 0.039 
 
ii) Prevalence by age 
There were significant differences for human CE and AE among different age 
groups (P<0.01).No CE or AE cases detected by ultrasound occurred in ages 
younger than 10 yrs old. The ultrasound prevalence of both CE and AE increased 
with age (Table 6.5.2). 
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Table 6.5.2: Ultrasound prevalence of human CE and AE by age in Xiji 
County 
Age N CE (%) AE (%) Query (%)
Calcification 
(%) 
Normal (%)
<10 33 0 (0) 0 (0) 0 (0) 1 (3.03) 32 (96.97)
10- 372 1 (0.27) 0 (0) 1 (0.27) 7 (1.88) 363 (97.58)
20- 127 3 (2.36) 1 (0.79) 0 (0) 9 (7.09) 114 (89.76)
30- 149 6 (4.03) 6 (4.03) 3 (2.01) 7 (4.70) 127 (85.23)
40- 114 5 (4.39) 20 (17.54) 3 (2.63) 8 (7.02) 78 (68.42)
50- 95 12 (12.63) 16 (16.84) 3 (3.16) 5 (5.26) 59 (62.11)
60- 55 9 (16.36) 14 (25.45) 4 (7.27) 3 (5.45) 25 (45.45)
Total 945 36 (3.81) 57 (6.03) 14 (1.48) 40 (4.23) 798 (84.44)
Chi-Square Tests For CE Pearson Chi-Square Value58.715 Asymp. Sig. (2-sided) 0.000 
Chi-Square Tests for AE Pearson Chi-Square Value1.161E2 Asymp. Sig. (2-sided) 0.000 
 
iii) Prevalence by ethnic groups 
No statistics differences were found between Han and Hui ethnic groups for CE or 
AE ultrasound prevalence (p>0.05) (Table 6.5.3).  
 
Table 6.5.3: Ultrasound prevalence of human CE and AE by ethnicity in Xiji 
County 
Ethnicity N AE AE(%) Chi p CE CE(%) Chi p 
HAN 428 27 6.31%   20 4.67%   
HUI 517 30 5.8% 1.591 0.207 16 3.09% 0.106 0.745
Total 945 57 6.05%   36 3.81%   
 
iv) Prevalence by occupation 
 
Agriculturalist showed higher prevalence of CE (5.59%) and AE (10.06%) 
compared to students (p<0.01). Other occupations which included cadres, 
businessmen and housewife, etc., showed high CE and AE prevalence (10% and 
6% respectively) (Table 6.5.4). 
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Table 6.5.4: Ultrasound prevalence of human CE and AE by occupation in 
Xiji County, Ningxia 
Occupation N CE (%) AE (%) Query (%)
Calcification 
(%) 
Normal 
(%) 
Peasant 537 30 (5.59)  54 (10.06) 12 (2.23) 31 (5.77)  410 (76.35) 
Student 358 1 (0.28)  0 (0.00) 1 (0.28) 6 (1.68)  350 (97.77) 
Others 50 5 (10.00) 3 (6.00) 1 (2.00) 3 (6.00)  38 (76.00) 
Subtotal 945 36 (3.81)  57 (6.03) 14 (1.48) 40 (4.23)  798 (84.44) 
For CE Pearson Chi-Square Value22.032 Asymp. Sig. (2-sided) 0.000 
For AE Pearson Chi-Square Value38.322 Asymp. Sig. (2-sided) 0.000 
 
6.5.2.3 Serological prevalence by DIGFA 
Females showed higher seropositivity (21.32%, 97/455) than males (12.65%, 
62/490) for DIGFA test (p<0.01). Seropositive rate increased with age (p<0.01) 
and was over 30% seropositives in people older than 50 yr old (Table 6.6.5). 
 
Table 6.5.5: Seropositive comparison for human echinococcosis antibodies 
in different genders/ages in Xiji County, Ningxia 
 N Positives (%) Negatives (%) Chi p
Gender   
Male 490 62 12.65 428 87.35  
Female 455 97 21.32 358 78.68 12.660 0.000
Age   
<10 33 0 0.00 33 100.00  
10- 372 42 11.29 330 88.71  
20- 127 15 11.81 112 88.19  
30- 149 20 13.42 129 86.58  
40- 114 33 28.95 81 71.05  
50- 95 31 32.63 64 67.37  
60- 55 18 32.73 37 67.27 57.202 0.000
Subtotal 945 159 16.83 786 83.17  
 
There was no significant statistical difference between Han and Hui echnic group 
for human serology prevalence (p>0.05) (Table 6.5.5). Peasants had a higher sero 
prevalence (20.9%, 112/537) compared to students (10.3%, 37/358) (p<0.01) 
(Table 6.5.6), however the ‘other’ occupation group included cadre, businessmen 
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and housewife had a higher seropositive prevalence of 20% (10/50). 
 
Table 6.5.6: Seropositive comparison of human echinococcosis antibodies 
in different ethnic groups in Xiji County, Ningxia 
 N Positives (%) Negatives (%) Chi p
Ethnic    
Han 428 72 16.82 356 83.18  
Hui 517 87 16.83 430 83.17 0.000 0.998
Occupation    
Peasant 537 112 20.86 425 79.14  
Student 358 37 10.34 321 89.66  
Others 50 10 20.00 40 80.00 17.37 0 .000
Subtotal 945 159 16.83 786 83.17  
 
 
6.5.3 Discussion (Xiji County, Ningxia) 
Xiji County is located in the south mountainous area of Ningxia Hui AR and whose 
hospital records showed the hydatid patients incidence (combined cased of CE 
and AE) to be 4.62 per 100,000 from 1994-2001 (Zhao et al., 2001; Yang et al., 
2006). The CE prevalence in Xiji by mass screening using ultrasound was 
reported 1.61% (18/1078) (Li et al., 2005), 1.96% (71/3629) (Yang et al., 2006), 
and 3.81% (36/945) in the current study. The CE prevalence in females showed 
no difference with males in some studies (Yang, 2006, and this study), or more 
female CE cases in other reports (Yang et al., 2006; Zhao et al., 2003). 
Furthermore, a higher seropositive rate in females was found in the current study. 
This suggested that females had the same or higher risk than males for CE 
infection. Other reports showed that the Hui ethnic group had a higher hydatid 
prevalence than the Han group (Yang, et al., 2006; Zhao et al, 2003; Li et al., 
2005), but no difference was found in our study. That might be due to local people 
living in the same endemic environment and having similar hygienic habits, and 
there were more people from Han- only areas in others reports. Peasants as 
agriculturalists had the highest CE prevalence of all occupations in all studies here. 
This suggested that peasants had more direct contact with the dog-livestock cycle 
of E. granulosus compared with other occupations.  
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Human AE prevalence has been known to be high in Xiji County since the late 
1980s. Local red fox population peaks occurred in that time and might have 
increaded E. multilocularis transmission together with increased dog population in 
1980s. Human AE prevalence was higher than CE in Xiji in this study and Yang’s 
report (Yang, et al., 2006). All AE cases in the current study were over 20 year old 
age. Most of them were provided albendazole treatment since they were late 
stage cases and possibly too late to be treated by surgical resection.  
Suggestions for prevention and control of echinococcosis in Xiji County should be 
focus on improving public health education level and dog management. A new 
policy had been carried out in poor mountainous areas in Xiji which moved people 
to relative rich flatlands in recent two years (from 2011). It would be interesting to 
carry out assessment of Echinococcus transmission in those translocated 
communities. 
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6.6 Community study in Ganzi County, Ganzi Tibetan 
Autonomous Prefecture, Sichuan 
6.6.1 Introduction of Study Site 
Ganzi County (also called Garze), is one of 18 counties in Ganzi Tibetan 
Autonomous Prefecture (TAP), Sichuan Province, P.R.China (Fig. 6.6.1). Ganzi is 
located northwest of Ganzi TAP, upper reaches of Yalong River, with longitude 
E99°08′-100°25′, latitude N31°24′——32°54′, elevation 3325-5688 metres, covers 
7303 square kilometers. Ganzi County had a population of 57,557 in 2006 which 
are mostly Tibetans (54867, 95.3%) involved with livestock husbandry. About 
48.5% of the county is pasture area with agriculture in 31.9% of valley area 
(mainly in Laima and Tuoba Communes), and 19.6% of area classed as 
semi-pasture and semi-agriculture areas. Ganzi County owns comprising 1 town 
and 21 communes (villages). The weather is dry and cold, with an average annual 
temperature of 5.6°C, ranging from -4.4°C in January and 14.4°C in July. The 
frost-free period is 35-75 days, annual rainfall 636.5 mm and annual sun time 
2640.8 hours. An epidemiological survey in Ganzi County was carried out in May 
2006 (Fig. 6.6.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6.6.1: Ganzi County (red dot) in Ganzi Tibetan Autonomous Prefecture 
(yellow) in Sichuan Province, southwestern China. 
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Fig. 6.6.2: Map of Ganzi County (1:350000) 
 
6.6.2 Results 
In total 1655 individuals were screened by portable ultrasound, which including 
723 males and 942 females, ages ranged from 1 to 86 years old and average age 
was 38 yrs old. Among them, a total of 1578 individuals were also screened by 
serological DIGFA test (see Section 6.0). 
 
A total of 13 CE and 30 AE cases were found by ultrasound and 39 isolated 
calcification cases were detected as well. Among them, 10 CE and 26 AE cases 
came from 7 and 10 communes in Ganzi County and other 3 CE and 4 AE cases 
came from Dege and Shiqu Counties (Table 6.6.1). 
Datongma 
Rongbach
Tuoba 
Shengkan
Yalong 
Donggu 
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Table 6.6.1: Human CE or AE cases were detected in the community study in 
Ganzi County, Ganzi Tibetan Autonomous Prefecture, Sichuan Province, P. 
R. China 
Area Communes Populations Screened CE AE Calcifications Normal 
Chengguan Ganzi  10602 519 4 8 7 500 
(Yalong) Gala 1989 214 0 0 2 212 
Shengkang Nanduo 1336 24 0 1 0 23 
 Shengkang  2068 78 1 1 2 74 
 Gonglong  1505 121 0 0 1 120 
 Zhake 3019 136 1 3 3 129 
Rongbacha Laima 3279 65 1 0 3 61 
 Xise 2233 85 0 1 2 82 
 Kagong  1510 32 0 0 1 31 
 Renguo 1685 35 0 0 1 34 
Tuoba Sexidi 2114 21 0 1 0 20 
 Tuoba  2610 74 0 0 0 74 
 Si’e 2802 19 0 0 1 18 
 Tingka 1936 65 0 1 2 62 
 Xiaxiong 2237 110 1 2 10 97 
Donggu Sitongda 2566 1 0 0 0 1 
 Duoduo 1309 0 0 0 0 0 
 Nike 1501 0 0 0 0 0 
Datongma Chazha 2687 5 1 2 1 1 
 Dade 2597 0 0 0 0 0 
 Kalong 2358 0 0 0 0 0 
 Chalong 1760 16 1 6 1 8 
Dege County  29 2 4 1 22 
Shiqu County  4 1 0 0 3 
Baiyu County  2 0 0 0 2 
Xinlong County  2 0 0 0 2 
Others  8 0 1a 1 6 
Total   1665 13 30 39 1582 
a : query 
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i) Ultrasound and seropositive prevalence by region. 
There were no significant differences for human CE or AE ultrasound prevalence 
in different areas of Ganzi County (P>0.05) (Table 6.6.2). But lower sero 
prevalence was found in Tuoba Commune compared to other areas (P<0.01) 
(Table 6.6.3). 
 
Table 6.6.2: Human CE or AE prevalence by abdominal ultrasound in three 
different areas (excluding Datongma) of Ganzi County 
Areas CE AE Query Calcification Normal Total 
Chengguan 4(0.5%) 9(1.2%) 0(0) 9(1.2%) 735 757 
Rongbacha 3(0.5%) 5(0.9%) 0(0) 13(2.4%) 531 552 
Tuoba 1(0.3%) 4(1.4%) 0(0) 13((4.5%) 271 289 
Total 8(0.5%) 18 (1.1%) 0(0) 35 (2.2%) 1537 1598 
For CE Pearson Chi-Square Value0.171 Asymp. Sig. (2-sided) 0.918, Fisher's Exact Test 
Table Probability (P) 0.1055 , Pr <= P 1.0000 
For AE Pearson Chi-Square Value 0.440 Asymp. Sig. (2-sided) 0.802, Fisher's Exact 
TestTable Probability (P) 0.0391  Pr <= P  0.7791 
 
Table 6.6.3: Human serological positives by DIGFA in three different areas 
(excluding Datongma) of Ganzi County. 
Areas Positives (%) Normal Total 
Chengguan 164 (23.10) 546 710 
Rongbacha 149 (28.22) 379 528 
Tuoba 105 (8.46) 168 273 
Others 23 (35.38) 42 65 
Total 441 (27.98) 1135 1576 
Pearson Chi-Square Value23.382 Asymp. Sig. (2-sided) 0.000 
 
ii) Relationship of ultrasound with serology. 
Using ultrasound as gold standard, the sensitivity of DIGFA in this study was 80% 
for CE and 92.8% for AE. Also 37.8% (14/37) of calcification lesions showed a 
seropositive reaction. The specificity of DIGFA for echinococcosis was 72% in this 
study (Table 6.6.4). 
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Table 6.6.4: Human serological positives by DIGFA in CE, AE, query, 
calcification and normal cases of Ganzi County, Ganzi Tibetan Autonomous 
Prefecture, Sichuan Province, P.R.China 
Positives 
Ultrasound 
EgCF EgP EgB  Em2 Any dot
Negative Total 
CE 8 
(80%) 
8 
(80%) 
7 
(70%) 
1 
(10%) 
8 
(80%) 
2 
(20%) 
10 
AE 24 
(85.7%) 
24 
(85.7%)
25 
(89.3%)
25 
(89.3%)
26 
(92.8%)
2 
(7.1%) 
28 
Query 1 
(100%) 
1 
(100%) 
1 
(100%)
1 
(100%)
1 
(100%) 
0 1 
Calcification 12 
(32.4%) 
14 
(37.8%)
5 
(13.5%)
4 
(10.8%)
14 
(37.8%)
23 
(62.2%) 
37 
Normal 325 
(21.7%) 
379 
(25.3%)
90 
(6%) 
42 
(2.8%) 
392 
(26.1%)
1108 
(73.9%) 
1500 
Total 370 
(23.5%) 
426 
(27.0%)
128 
(8.8%) 
73 
(4.6%) 
441 
(28.0%)
1135 
(72.0%) 
1576 
 
iii) Prevalence and seropositives by gender 
Females had a higher CE ultrasound prevalence, 1.2% (11/942) than males (0.3%, 
2/723, p<0.05) but there was no significant difference between females and males 
for AE prevalence (both 1.8%) (Table 6.6.5). Also females had a seroprevalence 
of 31.38% (279/889) which was significantly higher than males (23.58%, 162/687) 
(p<0.01) (Table 6.6.6). 
 
Table 6.6.5: Human CE or AE prevalence in different genders by abdominal 
ultrasound in community study in Ganzi County, Ganzi Tibetan Autonomous 
Prefecture, Sichuan Province, P.R.China  
Gender CE AE Query Calcification Total 
Male 2(0.3%) 13(1.8%) 1(0.1%) 15(2.1%) 723 
Female 11(1.2%) 17(1.8%) 0 24(2.5%) 942 
Total 13(0.8%) 30(1.8%) 1(0.1%) 39(2.3%) 1665 
CE: Pearson Chi-Square Value4.193 Asymp. Sig. (2-sided) 0.041 
Ae&gendersPearson Chi-Square Value0.000 Asymp. Sig. (2-sided) 0.992 
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Table 6.6.6a: Serological positives in different genders by DIGFA test in 
community study in Ganzi County, Ganzi Tibetan Autonomous Prefecture, 
Sichuan Province, P. R. China  
Seropositiveagainst antigen Areas 
EgCF EgP EgB Em2 Any dot 
Negative Total
Male 130(18.9%) 157(22.8%) 51(7.4%) 30(4.4%) 162(23.6%) 525(76.4%) 687 
Female 240(27.0%) 269(30.2%) 77(8.7%) 43(4.8%) 279(31.4%) 610(68.6%) 889 
Total 370(23.5%) 426(27.0%) 128(8.8%) 73(4.6%) 441(28.0%) 1135(72.0%) 1576 
 
Table 6.6.6b: Serological positives in different genders by DIGFA test in 
community study in Ganzi County, Ganzi Tibetan Autonomous Prefecture, 
Sichuan Province, P.R.China  
 
DIGFA Male Female Total 
Positives 162 (23.58%) 279 (31.38%) 441 (27.98%) 
Negatives 525 610 1135 
Total 687 889 1576 
Pearson Chi-Square Value11.708 Asymp. Sig. (2-sided) 0.001  
 
iv) Ultrasound prevalence and seroprevalence by age. 
Human CE ultrasound cases were 0.78% (13/1665) in Ganzi County which 
occurred in >20 years old group in the current study. Human AE ultrasound cases 
were 1.8% (30/1665) and happened in all age groups. There were no significant 
difference by age groups for both CE and AE (p>0.05) (Table 6.6.7).  
 
Table 6.6.7: Human CE or AE prevalence in different age groups by 
abdominal ultrasound in community study in Ganzi County, Ganzi Tibetan 
Autonomous Prefecture, Sichuan Province, P.R.China 
Age CE(%) AE(%) Query Calcification Normal Total 
0-19 0 0.00 1 0.35 0 0.00 5 1.74 282 288 
20-39 5 0.81 9 1.45 0 0.00 11 1.77 595 620 
40-59 4 0.71 16 2.83 0 0.00 13 2.30 533 566 
60- 4 2.09 4 2.09 1 0.52 10 5.24 172 191 
Total 13 0.78 30 1.80 1 0.06 39 2.34 1582 1665 
Fisher's Exact Test for CE prevalence, Monte Carlo Sig. (2-sided) 0.082 
Pearson Chi-Square for AE prevalence Value7.327 Asymp. Sig. (2-sided) 0.062 
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There was significant difference for seroprevalence between age groups (p<0.05). 
Age >40 years old groups had a higher seropositive rate (30.9%-31.8%) 
compared to other age groups (24.2%-26.8%) (Table 6.6.8). 
 
Table 6.6.8: Serological positives in different age groups by DIGFA test in 
community study in Ganzi County, Ganzi Tibetan Autonomous Prefecture, 
Sichuan Province, P. R. China  
Age Positives (%) Negative Total 
0-19 72 (26.77) 197 269 
20-39 144 (24.20) 451 595 
40-59 170 (31.84) 364 534 
60- 55 (30.90) 123 178 
Total 441(28.0%) 1135(72.0%) 1576 
Chi-Square Tests Pearson Chi-Square Value9.103 Asymp. Sig. (2-sided) 0.028 
 
v) Ultrasound prevalence by ethnic group 
All CE cases in the current study were Tibetan ethnic group. Meanwhile 27 AE 
cases were Tibetan (1.8%) and other 3 AE cases were Han ethnic (1.6%). There 
was no significant differences between ethnic groups for both CE and AE (p>0.05) 
(Table 6.6.9). 
 
Table 6.6.9: Human CE or AE prevalence in different ethnic groups by 
abdominal ultrasound in community study in Ganzi County, Ganzi Tibetan 
Autonomous Prefecture, Sichuan Province, P. R. China 
Ethnic Normal CE AE Query Calcification Total 
Tibetan 1393 13(0.9%) 27(1.8%) 1(0.1%) 38(2.6%) 1472 
Han 185 0 3(1.6%) 0 1(0.5%) 189 
Hui 1 0 0 0 0 1 
Qiang 2 0 0 0 0 2 
Yi 1 0 0 0 0 1 
Total 1582 13(0.8%) 30(1.8%) 1(0.1%) 39(2.3%) 1665 
For CE, Chi-Square TestsContinuity Correction Value.767 Asymp. Si g. (2-sided) 0.381 
For AE, Chi-Square TestsContinuity Correction Value.000 Asymp. Sig. (2-sided) 1.000 
 
vi) Ultrasound prevalence by occupation 
Other occupations (businessmen, housewife, etc.) had the highest ultrasound CE 
prevalence (3.7%, 3/73) and followed by herdsmen (1.4%, 2/115), farmers (0.9%, 
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7/750) and cadres (0.3%, 1/300) (p<0.05). However, Herdsmen were found to be 
the highest ultrasound AE prevalence (6.4%, 9/115) (p<0.01) (Table 6.6.10). 
 
Table 6.6.10: Human CE or AE prevalence in different occupations by 
abdominal ultrasound in community study in Ganzi County, Ganzi Tibetan 
Autonomous Prefecture, Sichuan Province, P.R.China 
Occupations Normal CE AE Query Calcification Total 
Farmers 750 7(0.9%) 11(1.4%) 0(0) 14(1.8%) 782 
Herdsmen 115 2(1.4%) 9(6.4%) 0 14(10%) 140 
Farmer & 
Herdsmen 
75 0 1(1.3%) 0 3(3.8%) 79 
Cadres 300 1(0.3%) 5(1.6%) 0 3(1.0%) 309 
Students 269 0 1(0.4%) 0 3(1.1%) 273 
Others 73 3(3.7%) 3(3.7%) 1(1.2%) 2(2.4%) 82 
Total 1582 13(0.8%) 30(1.8%) 1(0.1%) 39(2.3%) 1665 
For CE, Fisher's Exact Test Value9.690 Monte Carlo Sig. (2-sided) .041 
For AE, Fisher's Exact Test Value17.221 Monte Carlo Sig. (2-sided)0 .002 
 
6.6.3 Discussion (Ganzi County, Ganzi Tibetan Autonomous Prefecture, 
Sichuan) 
Ganzi County in Tibetan Sichuan was known as a high endemic area for both 
human CE and AE (Qiu et al., 2000). The ultrasound prevalence of CE was 
reported as 0.91% (25/2748) and AE 1.42% (39/2748) (Qiu et al., 2000). More 
extensive survey in Ganzi and Aba TAP during 2001-2008 showed a human 
ultrasound prevalence of 3.2% for CE, 3.1% for AE and 0.04% for dual infection 
(both CE and AE) (Li et al., 2010), By district that study obtained a prevalence of 
CE 0.91%(5/549), AE 3.83% (21/549), dual infection 0% in Kalong; CE 2.61% 
(16/614), AE 6.35%(39/614) ie, total prevalence 8.96% in Chalong; CE 2.59% 
(3/116), AE 2.59% (3/116) and total 5.17% in Chaza; CE 1.63% (2/123), AE 3.25% 
(4/123) and total 4.88% in Dade (Li et al., 2010). Dual infection (CE & AE) 
occurred in Shiqu and Seda Counties in that study (Li et al., 2010). 
The current study showed that the ultrasound prevalence in Ganzi County was 
0.8% (13/1665) for CE and 1.8% (30/1665) for AE which is similar to the previous 
study of Qiu et al. (2000). The distribution of human CE indicated that females, 
persons older than 20 years and occupation as herdsmen were risk factors. This 
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was similar to previous studies (REF). The highest prevalence of AE occurred in 
the 40-59 years age group in the current survey. 
Echinococcosis in the Tibetan population had been confirmed to have high 
endemicity in northeast Tibet AR, southeast Qinghai and western Sichuan. The 
reason could be variable since both CE and AE were all in very high prevalence in 
same area. E. granulosus which is transmitted through a dog-livestock cycle 
exists in most pastoral area in western China. The higher endemic areas for CE 
included Xinjiang, Inner Mongolian, Gansu, Ningxia, Qinghai, Tibet and west 
Sichuan. Furthermore, E. multilocularis which is transmitted primarily in wildlife 
cycles such as rodents - fox, also has high transmission in western Sichuan. A 
similar situation of co-endemic CE and AE areas was also in Ningxia but the later 
changes in dog ownership and expansion of agriculture has reduced numbers of 
new AE cases after that period (Pleydell et al., 2010). Such high AE prevalences 
might suggest the E. multilocularis transmission was very common. Dogs infected 
with E. multilocularis, which might occurr through dogs predating small mammals 
such as plateau pika, become the key role for human infection. Dog ownership is 
very common in Tibetan populations since household guard and livestock herding 
are needed for their pastoral lifestyle. Stray dogs were also very common in these 
areas because Tibetan monks and local people would like to feed them according 
their religious beliefs. Poor hygiene habit may also contribute to the high infection 
rate. Unwashed hands, eating with hands, living close to dogs, are all risk factors 
commonly in Tibetan areas.   
Using ultrasound as gold standard, the sensitivity of DIGFA in the curren study 
was 80% for CE and 92.8% for AE; meanwhile the specificity of DIGFA for 
echinococcosis was 72%. Also 37.8% (14/37) of calcification lesions showed a 
seropositive reaction. Lower sensitivity (70%-80%) and fewer false positives (6% 
for AgB and 2.8% for Em2) occurred when using single antigen for diagnosis in 
the current study. The paralleled combination of four antigens could supply more 
information for immunodiagnosis than single antigen test. 
Ultrasound and the DIGFA serological test were easy to carry out in rural areas of 
Ganzi County since the local hospital owned a portable ultrasound and had a 
clinical laboratory. But basic training should be a regular work for local hospital 
since their staff was fewer and always moved to other areas. Residents’ health 
education was also a big problem since not all parents sent their children to school. 
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Traditional behavior of local people might request in their asking help from the 
local temple but not the hospital. Higher prevalence in local residents might 
suggest that develop the health education programme in Tibetan teaching 
systems so that the students could tell people to get medical check and treatment 
in time. 
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6.7 Community study on echinococcosis in Dangxiong County, 
Lhasa Prefecture, Tibet Autonomous Region, P.R.China 
 
6.7.1 Introduction 
Dangxiong County (also called Damxung) is one of seven counties of Lhasa 
Prefecture (Fig. 6.7.1), Tibet Autonomous Region (TAR), P.R. China. Dangxiong is 
located 90°45’ -- 91°31’ E and 29°31’--31°04’ N, in the middle of Tibet AR and by 
the side of the Lhamo Namco Holy Lake, 170 kilometres north of Lhasa City, and 
borders with Naqu Prefecture (Fig. 6.7.2). The elevation of Dangxiong is over 
4200m and the top peak of Nyainqentanglha Mountain is 7111m. The county 
covers an area of 10,036 square kilometres with a population of 41,918 (2003). 
 (http://www.lasa.gov.cn/gb1/diqu/dangxiong/index.htm).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6.7.1: Lhasa Prefecture in Tibet Autonomous Region, P.R. China 
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Fig. 6.7.2. Damxung (Dangxiong) County located in north of Lhasa 
Prefecture, Tibet AR 
 
Dangxiong County has 98.8% Tibetan population in its 6 communes and 2 towns, 
including 7442 house-holds in total of which 6312 house-holds (37,616, 92.73% of 
total population) owned livestock. Damxung means "selected pasture" in the 
Tibetan language. The county depends on livestock breeding, and the many 
domestic animals include goats, sheep, yaks, cattle and horses. Average annual 
temperature is 1.3°C, the mean temperature in the coldest month (January) is 
-10.4°C and the warmest in July l0.7°C; lowest temperature -32.5°C (16th of 
January, 1981) and highest 26.5°C (8th of June, 1995). The annual amount of sun 
is around 2880 hours, and annual rainfall is 456.8mm. In the area, the Tibetan fox 
(Vulpes ferrilata), wild yak (Bos grunniens), wild ass (Equus), Blue Sheep 
(Pseudois nayaur), and small mammals such as plateau pikas (Ochotona 
curzoniae) and marmot (Marmota himalayanus) are common in Dangxiong 
County. ‘’Winter-worm’’ or Chinese caterpillar fungus, Xuelian, Fritillaria, and other 
valuable traditional Chinese/Tibetan medicines are commercially important and 
part of local production.  
Tibet AR is a known endemic area for human CE (Gong, 2001; Jiang 2003; Moh, 
2005). A skin test survey (Casoni’s test) carried out in Dangxiong and 
Mozugongka (Maizhokunggar) Counties, identified 734/20160 (3.65%) Casoni 
positives of which 48 CE cases were confirmed by ultrasound; 33/48 CE cases 
were given surgical treatment (Hu et al., 1999).  
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In the current study, a community survey including questionnaire registration, 
ultrasound scanning and rapid serological test (DIGFA, see Chapter 3) were 
carried out in two communes (Wuma and Ningzhong) and one town (Yangbajin) in 
Dangxiong County in October 2006 (Fig. 6.7.3). Self-selected volunteers from the 
county (n=557) included 212 males and 345 females, 532 came from above areas, 
and 25 from other communes excluding Namucuo (Namco) Commune. In total 
488 people agreed to provide 2-3ml venous blood per person for rapid antibody 
DIGFA test, and 165 among those were also tested by standard ELISA in Urumqi. 
Among the ultrasound confirmed CE cases, 11 cases were given surgical 
treatment and albendazole post-surgery in Lhasa City Hospital by a surgical group 
comprising the First Teaching Hospital of Xinjiang Medical University and Lhasa 
City Hospital. In total 39 cases with active CE cysts were give albendazole tablets 
for 6 month treatment courses. Surgical and chemotheraphy treatment were 
financially supported by China Soong Ching Ling Foundation (Beijing, China). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6.7.3: Main screened communes and town in Dangxiong County, Lhasa 
Prefecture, TAR 
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6.7.2 Results 
6.7.2.1 Prevalence of of human CE in Dangxiong County, Lhasa Prefecture, 
Tibet AR 
In total 55 (9.87%) human CE cases were detected in 557 people from Dangxiong 
County. More CE cases was identified in Wuma (10/89, 11.2%) and Ningzhong 
(29/295, 9.83%) communes than Yangbajin (8/148, 4.8%) (Table 6.7.1). Of the 
cases, 33 CE cases were first identified in a previous screening by another study 
in 2003 (unpublished) and those persons came over for further check and 
treatment (5 of them did not have an ultrasound CE image this time and they did 
not accept any treatment during 2003-2006, they were considered as non CE 
cases). Our study also showed 26 (5.6%) cases of human CE in 463 screened 
people, were not included all the follow-up of CE cases found in 2003. In total 13 
CE cases had evidence of effective for surgical treatment (without active cystic 
lesion by ultrasound) among 27 CE cases that had a historic CE surgery in Lhasa 
or other hospitals (local county hospital could not do CE surgery). More CE cases 
occurred in females 11.6% (40/345) than in males 7.1% (15/212) (Table 6.7.2 and 
Fig. 6.7.4). The youngest (7 yrs old) and oldest (85 yrs old) CE cases were 
females; the 7-yrs old had an operation during our survey, the 85-yrs old was too 
ill to be moved and presented with many large CE cysts (max cyst size 14.2 cm, 
full of her whole abdominal cavity and only part of right liver lobe could be seen 
under ultrasound). This latter case was given oral albendazole for a 6-month 
course.  
No human AE cases were identified during the current survey in Dangxiong 
County. 
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Table 6.7.1: Dangxiong population and ultrasound CE prevalence by the 
community/town. 
Commune/Town Population a No CE 
CE surgery 
history 
Prevalence 
(%) 
Dangquka Town 4182 5 3 3 - 
Yangbajin Town 4348 148 8 4 4.8 
Wuma Commune 5793 89 10 4 11.2 
Gongtang Commune 5147 7 2 1 - 
Ningzhong 
Commune 
7879 295 29 
13 9.8 
Geda Commune 3719 1 1 ABZ - 
Longren Commune 3810 12 2 2 - 
Namucuo Commune 4291 0 0 0 - 
Total 39169 557 55 27 9.6 
a Commune/town population data was based on local data in 2000. 
 
Table 6.7.1a: Ultrasound CE prevalence by communes/town Crosstabulation 
Communes/Town 
Ultrasound 
Wuma Ningzhong Yangbajin Others
Total 
CE 10 29 8 8 55 
Non CE 79 266 140 17 502 
Total 89 295 148 25 557 
Pearson Chi-Square Value17.260 Asymp. Sig. (2-sided) 0.001 
 
Table 6.7.2: Ultrasound CE prevalence by age and gender 
Male Female Ages 
(yrs) 
No 
No CE Normal No CE Normal 
<20 74 31 1(3.2%) 30 43 4(9.3%) 39 
20-39 233 78 9(11.5%) 69 155 17(11.0% 138 
40-59 169 68 4(5.9%) 64 101 12(11.9%) 88 
≥ 60 81 35 1(2.8%) 34 46 7(15.2%) 39 
Total 557 212 15(7.1%) 197 345 40(11.6%) 305 
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Table 6.7.2a: Ultrasound CE prevalence by gender Crosstabulation 
Gender 
Ultrasound 
Male Female
Total 
CE 15 40 55 
Non CE 197 305 502 
Total 212 345 557 
Pearson Chi-Square Value3.013, Asymp. Sig. (2-sided) 0.083 Continuity Correction 2.526, 
p 0.112 Fisher's Exact Test Exact Sig. (2-sided) 0.107 
 
Table 6.7.2b: Ultrasound CE prevalence by age group crosstabulation 
Ages 
Ultrasound 
0-19 20-39 40-59 >=60 Total 
CE 5 26 16 8 55 
Non CE 69 207 153 73 502 
Total 74 233 169 81 557 
Chi-Square Tests Pearson Chi-Square Value 1.272  Asymp. Sig. (2-sided) 0.736 
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Fig. 6.7.4: Ultrasound CE prevalence by age- and gender in Dangxiong 
County, Lhasa Prefecture, Tibet AR. (n=55) 
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6.7.2.2. Serological prevalence by DIGFA 
In total 488 serum samples were tested by rapid DIGFA during the survey within 
one hour of ultrasound scanning. The results showed 17 (32.7%) sero-positives in 
52 CE cases, including 12 positives in 23 ‘’active’’ CE type 1 to type 3, 1 positive in 
16 ‘’non active’’ CE type 4-5, and 4 positives in 13 post operative cases (4 
positives were provided surgical treatment in 2003 and 2005) (Table 6.7.3 to 
6.7.4). An ELISA test was carried out in Urumqi which had higher sensitivity than 
DIGFA (Chapter 3), and showed 43 (86%) seropositives of 50 CE cases (Table 
6.7.5). However the specificity of ELISA 78.3% (90/115) was lower than DIGFA 
(96.8%, 422/436) (Table 6.7.3 and Table 6.7.5). There was a single Em2 positive 
in DIGFA (0.2%, 1/488) but in ELISA12.1% (20/165). Em2 seroprevalence by 
DIGFA in Dangxiong (0.2%) was lower than in Dingqing County of Changdu 
Prefecture (11.2%, 22/195) in all screened people. However Em2 positive 
responses occurred in 4.2% (7/165) of ultrasound negative CE/AE persons in 
Dingqing County. 
 
Table 6.7.3: Rapid DIGFA serological test result in Dangxiong County, Lhasa 
Prefecture, Tibet AR 
Antigens DIGFA results CE (n=52) 
Non CE 
(n=436) 
Total 
EgCF Positive 16 13 29 
 Negative 36 423 459 
EgP Positive 16 11 27 
 Negative 36 425 461 
EgB Positive 15 6 21 
 Negative 37 430 467 
Em2 Positive 1 0 1 
 Negative 51 436 487 
Any antigen Positive 17 14 31 
 Negative 35 422 457 
Total  52 436 488 
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Table 6.7.4: Serological positives in different CE types in Dangxiong County, 
Lhasa Prefecture, Tibet AR 
Serological test by DIGFA and positives 
CE 
types a 
No 
No 
EgCF 
Positive
EgP 
Positive
EgB 
Positive
Em2 
Positives 
Anyone 
positives
T1 8 7 4 5 4 1 5 
T2 12 12 4 4 4 0 4 
T3 4 4 3 3 2 0 3 
T4 12 12 1 1 1 0 1 
T5 5 4 0 0 0 0 0 
Others b 14 13 4 3 4 0 4 
Total 55 52 16 16 15 1 17 
a. CE ultrasound classification according WHO/OIE, 2001 
b. ultrasound imagines including normal or residual cavity after human CE surgery, 4 
cases showed positives in this group were all got surgery treatment in 2003 and 2005. 
 
Table 6.7.5: Serological test by ELISA in Dangxiong County, Lhasa 
Prefecture, Tibet AR 
Antigens ELISA results CE (n=50) 
Non CE 
(n=115) 
Total 
EgCF Positive 18 2 20 
 Negative 32 113 145 
EgP Positive 39 14 53 
 Negative 11 101 112 
EgB Positive 25 0 25 
 Negative 25 115 140 
Em2 Positive 15 5 20 
 Negative 35 110 145 
Any antigen Positive 43(86%) 25 63 
 Negative 7 90(78.3%) 97 
Total  50 115 165 
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Table 6.7.6: Serological positives by ELISA in different human CE types in 
Dangxiong County, Lhasa Prefecture, Tibet AR 
Serological test by ELISA and positives 
CE types 
a 
No 
No
EgCF 
Positive 
EgP 
Positive
EgB 
Positive
Em2 
positives
Anyone 
positives 
Positive 
rate (%)
T1 8 6 3 5 5 3 5 62.5% 
T2 12 11 6 11 8 5 11 91.7% 
T3 4 4 3 4 4 2 4 100% 
T4 12 12 4 8 5 4 11 91.7% 
T5 5 4 1 1 0 0 1 20% 
Others b 14 13 1 10 3 1 10 71.4% 
Total 55 50 16 16 15 1 42 76.4% 
a. CE ultrasound classification according WHO/OIE, 2001 
b. ultrasound imagines including normal or residual cavity after human CE surgery, 4 
cases showed positives in this group were all got surgery treatment in 2003 and 2005. 
 
6.7.2.3. Risk factors for human CE in Dangxiong County, Lhasa Prefecture, 
Tibet AR 
Several potential risk factors were analysed for human CE including sex, age, 
occupation, dog and livestock ownership, home-slaughter, education and income 
levels, knowledge about CE, and hygiene habits (Table 6.7.2, Tables 6.7.7 to 
6.7.11). For occupation, 49 CE cases (9.7%) occurred in herdsmen (504, 90.5% in 
total 557 surveyed people) and 6 cases (11.3%) in 53 other occupations but with 
no statistical differences between them (P>0.05) (Table 6.7.7). The results also 
showed no statistical difference between CE prevalence and age, income, 
education level, or water source (Table 6.7.2, Table 6.7.7 to 6.7.9, Table 6.7.11). 
However, dog ownership was a significant risk factor (p<0.01) (Table 6.7.10). 
Individual hygiene habits reported was not show the true situation, such as just 
110/557 person said they did not washing hand before eating; generally it was 
higher by observation. Drinking unboiled water was another risk factor, 47 (12.2%) 
CE cases found in 380 people who drunk unboilded water (P<0.01%) (Table 
6.7.10). Eating uncooked vegetables did not show a significant risk since most 
vegetables were in fact transported from other areas. 
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Table 6.7.7: Ultrasound CE prevalence by occupation in Dangxiong County 
Occupations CE Non CE Total 
Herdsmen 49 457 506 
Farmer 1 3 4 
Cadre 1 7 8 
Students 2 23 25 
Others 2 12 14 
Total 55 502 557 
 
 
Table 6.7.7a: Ultrasound CE prevalence by occupation Crosstabulation 
Occupation 
Ultrasound 
Herdsmen Others Total
CE 49 6 55 
Non CE 457 45 502 
Total 506 51 557 
Chi-Square Tests Pearson Chi-Square Value 0.225  Asymp. Sig. (2-sided) 0.635 
Continuity Correction 0.052.819 Fisher's Exact Test Exact Sig. (2-sided) 0.622 
 
 
Table 6.7.8: Ultrasound CE prevalence by education level 
Education level CE Non CE Total 
Illiteracy 33(9.1%) 330 363(65.2%) 
Pre-school children 1 1 2(0.4%) 
Primary school 20(11.5%) 154 174(31.2%) 
Middle school and over 1(5.5%) 17 18(3.2) 
Total 55(9.7%) 502 557 
Chi-Square Tests Pearson Chi-Square Value 0.372 Asymp. Sig. (2-sided) 0.542 
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Table 6.7.9: Ultrasound CE prevalence by income 
Income level CE Non CE Total 
<2000 12 123 135 
2000-5000 17 191 208 
>5000 26 188 214 
Total 55(9.7%) 502 557 
Chi-Square Tests Pearson Chi-Square Value 2.069 Asymp. Sig. (2-sided) 0.355 
 
Table 6.7.10: Ultrasound CE prevalence correlation with dog ownership 
 Total CE Non CE Chi p 
Dog ownership      
Yes 422 52(12.4%) 370   
No 135 3(2.2%) 132 11.724 0.001 
Livestock ownership      
Yes 531 55(10.4%) 476   
No 26 0(0%) 26 1.938 0 .097 
Home slaughter      
Yes 514 54(10.5%) 460   
No 43 1(2.3%) 42 2.135 0 .108 
Water source      
Tap 4 0 4   
Well 38 3 35   
River and stream 515 52 463 0.121* 0.728 
Total 557 55(9.7%) 502   
 Chi-Square Tests did by combined Tap and well water as cleaner water source and 
compared with river and stream. 
 
Table 6.7.11: Ultrasound CE prevalence by drinking unboiled water crosses 
tabulation 
Drink unboiled water 
US 
Yes No 
Total 
CE 47(12.2%) 8(4.6%) 55(9.7%) 
Non CE 337 165 502 
Total 384 173 557 
Pearson Chi-Square Value7.772a Asymp. Sig. (2-sided) 0.005 
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6.7.3 Discussion (Dangxiong County, Lhasa Prefecture, Tibet AR) 
A human CE ultrasound prevalence of 5.6%-9.7% was obtained in Dangxiong 
County, which is quite high even for northwest China. CE is also endemic in other 
Tibetan areas around Tibet AR, for example in adjoining Qinghai, Gansu and 
Sichuan Provinces (Craig, 2003; Schantz et al., 2003; Wang et al., 2006; Moh, 
2005; Li et al., 2005, 2010). A mass screening study in three Tibetan Autonomous 
Prefectures of Qinghai province showed 6.5% (243/3703) human CE prevalence 
(Schantz et al., 2003). Prevalence of CE from 1.8% to 4.0% was reported in three 
Tibetan prefectures around Qinghai Lake (Wang et al., 2006) and higher human 
CE prevalence (7.55%) occurred in the south high plateau of Qinghai Province 
(Wang et al., 2000). High CE endemic areas in Sichuan Province showed 4.8% 
(60/1291 in 1998) to 6.8% (216/3199 in 2005) in Shiqu County, 2.04% in Baiyu 
and Seda County, 0.91% (25/2748 in 1998) in Ganzi County, all in Ganzi Tibetan 
Autonomous Prefecture of Sichuan Province (Qiu et al., 2000; Yu et al., 2005; Li et 
al., 2005, 2010). Hospital cases in Aba Tibetan and Qiang Autonomous Prefecture 
in Sichuan showed human CE endemic in this eastern Tibet plateau area 
including counties of Aba, Rangtang, Hongyuan, Ruoergai and Xiaojin (Chen and 
Qiu, 1996; Renzhen et al., 2006; Liu 2006). Human CE was also shown endemic 
in all 7 prefectures in Tibet AR, especially higher in ‘’livestock husbandry’’ areas, 
such as Naqu, Changdu, Lhasa, Shannan (recorded CE cases near or over 100). 
Naqu Prefecture is a high CE endemic prefecture in TAR with the most hospital 
CE cases reported (n=709) for the Tibet AR (Gong et al., 2001).  
Interestingly no human AE cases were confirmed in this community study in 
Dangxiong County. The one sero-positive for Em2 by DIGFA 0.2% (1/488) was 
confirmed ultrasound image with CE not AE. Furthermore, in 12.1% (20/165) Em2 
positives by ELISA, 14 were CE cases, 1 had a CE surgery history and 5 were 
‘normal’. Thus it would appear that human AE is rare or not present in Dangxiong 
County of TAR. Tibetan foxes (Vulpes ferrilata) and small mammals however 
appeared common around Dangxiong County, but despite this transmission of 
Echinococcus multilocularis was not found in the current study since no human AE 
cases and no hospital records proven. The Em2 sero positive rate was low (0.2%) 
in the DIGFA and is probably due to false positives and cross-reaction with CE 
cases. Hunting rodents or small mammals by dogs was not observed in this study 
but was quite common in known AE endemic areas of the eastern Tibetan plateau 
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eg. Qinghai and Sichuan (Qiu et al., 1995, 2000; Wang et al., Wang et al., 2000; Li 
et al., 2005, 2010). 
Possible risk factors for CE included gender (female), dog and livestock 
ownership, practise of home-slaughter, using stream/river water and drinking 
un-boiled water. Most Tibetan people were involved with livestock husbandry in 
Dangxiong since most areas were not suitable for agriculture at an elevation over 
4200 metres. Dog-livestock cycle for transmission of E. granulosus exists and is 
probably maintained since an average 1-3 dogs are owned per household and 
14.5 livestock owned per person (total of 232,996 yak, 302,505 sheep, 145,223 
goats and 8,063 horses in Dangxiong in 2004). This study showed 422/557 
(74.8%) people owned at least 1-3 dogs and some with a long history of dog 
owning (at least 371 people more than 10 years). Home slaughter was popular 
and feeding of offal to dogs was a normal practice for most people. Most owned 
dogs were not tied and stray dogs were common. Most people in rural areas of 
Dangxiong were still drinking stream or river water (515/527, 92.5%) rather than 
tap water or from wells. Drinking un-boiled water was common (68.9%), and 
actually boiling water is difficult due to the high elevation and lack of fuel. Dog 
ownership and drinking un-boiled water were main risk factors in this study in 
Dangxiong (p<0.01). More CE cases in females might be due to their being the 
main dog care person (414/421, 98.3%) in most families, and also their special 
role in routine life (general around the house). Male CE prevalence in the 20-40 
years old group was however similar with females, but females exhibited a higher 
prevalence in all age groups.  
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6.8 Community screening in Dingqing County, Chamdo 
Prefecture, Tibet Autonomous Region, P.R. China 
 
6.8.1 Introduction 
Dingqing, also called Dengqen, Temgchen, is one of 11 counties in Changdu 
(Chamdo, Qamdo) Prefecture (one of six prefectures) of Tibet Autonomous 
Region (TAR), People’s Republic of China (Fig. 6.8.1 and 6.8.2). Its location is in 
west of Changdu Prefecture, northeast of Tibet AR, 800 kilometers from Lhasa, 
boundary with Leiwuqi (Riwoqe) County of Changdu Prefecture from east; with 
Baqing, Suo County of Naqu Prefecture from west; with Luolong (Lhorong), 
Bianba (Banbar) County of Changdu Prefecture from south; with Zaduo and 
Nangqian County in Qinghai Province from north. The average elevation of 
Dingqing is 4000 meters (lowest 3500m in southeast (Luohe Village in Nujiang 
River valley) and highest Bujagangri mountain top is 6328m) above sea level, with 
longitude 94°39’ - 96°17’, latitude 31°01’ - 32°21’, 11,365 km2 including most 
grazing lands, just 110,000 acres agriculture land and 6.7% under forest covering. 
The annual amount of sun time is around 2450 hours, annual rainfall is 641mm, 
average temperature annually is 3.1 C; the highest recorded temperature in 
summer (July and August) is 27 C and the lowest is minus 25 C in winter (January 
and Febrary). (http://www.xzdingqing.com) 
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Fig. Fig. 6.8.1: Changdu (Chamdo, Qamdo) Prefecture in Tibet Autonomou 
Region, P.R. China 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6.8.2: Dingqing (Dengqen, Temgchen) County in Changdu Prefecture, 
Tibetan AR, P.R.China 
 
Qinghai Province
Sichuan 
Province 
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Population of Dingqing County was 60,000 in 2003 and 62440 in 2006, over 99% 
Tibetan. Most residents (62143) worked as herdsmen and farmers in 2 towns and 
11 communes, 65 villages of Dingqing County. Main kinds of livestock in northwest 
Dingqing County are yak, cattle, yak-cattle cross breeds, sheep, goats, horses, 
donkeys, and mules. Main agriculture products are barley, wheat and peas from 
southeast of Dingqing. About 60% population had been involved with traditional 
herb ‘’winter worm’’- yartsa gunbu (Cordyceps sinensis; caterpillar fungus) 
collection in the last few years. Domestic dogs and stray dogs are very numerous 
around towns or villages (approximate 1-3 per household). Among the widespread 
small mammals are: plateau pikas (Ochotona curzoniae), Tibetan fox (Vulpes 
ferrilata), red fox (Vulpes vulpes), Himalayan marmots (Marmota himalayana), and 
Tibetan woolly hares (Lepus oiostolus).  
In total 94 human cystic echinococcosis (CE) cases have been recorded in 
Changdu Prefecture before 1994 (Luo and Zhao, 1994) and 709 cases all over 
Tibet AR including 623 from Naqu Prefecture from 1996-2000 (Ze, 2001). 12 
cases of alveolar echinococcosis (AE) were first reported in 1993 (Peng, 1988; 
Yixi, 1992; Luo, 1993; Pu, 1999) in patients involved Lhasa, Naqu and Changdu 
Prefectures. Community screening in Naqu Prefecture and Dangxiong County in 
Lhasa Prefecture however did not find evidence for new AE patients. But during a 
visit to Changdu Prefecture Hospital in 2006, CT scan images with typical AE 
lesions were found by a hydatid research team from Xinjiang Medical University 
Hospital. A pilot screening in a village of Jiangda County in Changdu Prefecture 
found CE cases but no evidence for AE.  
6.8.2 Materials and Methods 
A pilot community study was performed in Dingqing County of Changdu 
Prefecture located between Naqu and Changdu (both AE case reported area) for 
estimate the prevalence of AE in humans in November 2007 by Xinjiang Hydatid 
Clinical Research Institute (XHCRI) and Tibet AR CDC. From five villages of Seza 
Commune, one village of Buta Commune and one village of Dingqing town (see 
Fig. 6.8.3), 232 volunteers came for screening by a questionnaire, serology and 
ultrasound scanning. Seza Commune, locates about 40 km from west of Dingqing 
Town, 31°32’32.3’’ N, 90°16’05.1’’ E. Its mean elevation over 3927m where has 
969 household and population 7761 in 5 villages who work for agriculture, 
‘winter-worm’ collection and livestock production. 122 people were screened in all 
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5 villages. Buta Commune, locates in northwest of Seza, 1704km2, 1928 
population in 2 villages called Ruta and Buta. 61 people (all herdsmen) from Ruta 
Village (20km from Seza, N 31°47’47.5’’，E 095°21’21.5’’, mean elevation 4390m) 
were screened. Dingqing Town is the center of Dingqing County, where has 8665 
population in 7 villages and engaged in agriculture and livestock production. 49 
people (all herdsmen) from Butuo Village (20km from Dingqing Town, N 
31°32’10.4’’，E 95°35’4.2’’, mean elevation 4273m) were screened. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6.8.3: Screened communes/town in Dingqing County, Chamdo 
Prefecture, Tibet AR 
 
6.8.3 Results 
6.8.3.1 Ultrasound prevalence of human CE and AE. 
Totally 232 people were registered by questionnaire in Dingqing County and 
screened by ultrasound and 195 persons accepted serology testing. In total, 11 
CE (4.7%), 11 AE (4.7%), 1 mixed CE and AE (0.1%) and 1 suspected AE (0.1%) 
were diagnosed by ultrasound. In total of 67 (34.3%) were seropositive in 195 
individuals. Both CE and AE prevalence in females (6.5% and 7.5%) were higher 
than in males (3.2% and 2.4%) however no statistical difference were showed 
between males and females for both CE and AE (p>0.05, Table 6.8.1). All CE and 
Sezha 
Buta 
Dingqing 
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most AE (10/11) cases were occurred in the age groups 20 to 60 years old though 
this was no statistical different (p>0.05, Table 6.8.2 and Table 6.8.2a). Most cases 
of CE (10/11), all AE (11) cases, 1 mixed CE/AE, and the suspected AE occurred 
in farmers and herdsman. However there was no statistical differences between 
occupations (p>0.05) (Table 6.8.3). 
 
 
 
Table 6.8.1: Prevalence of CE or AE by sex by ultrasound diagnosis in 
Dingqing County, Chamdo Prefecture, Tibet AR 
Ultrasound diagnosis 
Gender Normal CE AE Mixed Query 
Total 
Male 116 4(3.2%) 3(2.4%) 1(0.8%) 1(0.8) 125 
Female 92 7(6.5%) 8(7.5%) 0 0 107 
Total 208 11(4.7%) 11(4.7%) 1(0.4%) 1(0.4%) 232 
Pearson Chi-Square for CE=0.759, p value=0.383; Pearson Chi-Square for AE= 2.150, p 
value= 0.143. 
 
 
 
Table 6.8.2: Prevalence of CE or AE by sex and age by ultrasound diagnosis 
in Dingqing County, Chamdo Prefecture, Tibet AR 
Male Female 
Ages 
Total CE AE Others Normal Total CE AE Others Normal 
Total
0-10 3 0 0 0 3 7 0 0 0 7 10 
11-20 11 0 0 0 11 6 0 0 0 6 17 
21-30 33 2 1 0 30 18 0 1 0 17 51 
31-40 27 1 0 2a 24 29 4 3 0 22 56 
41-50 25 0 2 0 23 23 2 2 0 19 48 
51-60 9 1 0 0 8 11 1 1 0 9 20 
61-70 10 0 0 0 10 11 0 1 0 10 21 
71-80 3 0 0 0 3 4 0 0 0 4 7 
81- 0 0 0 0 0 2 0 0 0 2 2 
Total 121 4 3 2 112 111 7 8 0 96 232
a. including 1 mixed CE/AE,1 suspected AE 
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Table 6.8.2a: Age- CE Cross tabulation 
US result Age 
CE Non CE 
Total 
0-25 1 50 51 
26-50 9 122 131 
51- 2 48 50 
Total 12 220 232 
The SAS: 33% of the cells have expected counts less than 5. Chi-Square may not be a 
valid test. Fisher's Exact Test, Table Probability (P)=0.0389, Pr <= P 0.4824 
 
Table 6.8.3: Prevalence of CE or AE by occupation with ultrasound 
diagnosis 
Occupation Normal CE AE 
Mixed 
CE/AE
Suspected Total 
Farmer 103 5 4 1 1 114 
Herdsman 87 5 7 0 0 99 
Cadre 3 0 0 0 0 3 
Student 12 0 0 0 0 12 
Others 3 1 0 0 0 4 
Total 208 11 11 1 1 232 
For CE: The SAS System: 60% of the cells have expected counts less than 5. Chi-Square 
may not be a valid test. Fisher's Exact Test: Table Probability (P)=0.0204, Pr <= P 0.4416 
For AE: The SAS System: 60% of the cells have expected counts less than 5. Chi-Square 
may not be a valid test. Fisher's Exact Test: Table Probability (P)= 0.0481; Pr <= P 0.6334 
 
The CE cases mainly came from Seza and Buta communes and one case from 
Dingqing town. All the AE cases and the mixed CE/AE, came from Seza and Buta 
communes. (Table 6.8.4) No statistical differences were found for human CE 
prevalence between the three communes/town (p>0.05) but the ultrasound 
prevalence of human AE in Buta (7/61, 11.5%) was significantly higher than in 
Seza (4/122, 1.6%) and Dingqing (0%) (p<0.05). 
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Table 6.8.4: Prevalence of CE and AE in 3 communes/town of Dingqing 
County, Changdu Prefecture, Tibet AR 
Communes 
/Town 
Normal CE AE Mixed 
CE/AE 
Suspected 
AE 
Total 
Seza 110 6(4.9%) 4(1.6%) 1(0.8%) 1(0.8%) 122 
Buta 50 4(6.6%) 7(11.5%) 0 0 61 
Dingqing 48 1(2.0%) 0 0 0 49 
Total 209 11(4.7%) 11(4.7%) 1(0.4%) 1(0.4%) 232 
Chi-Square Tests for CE 2 cells (33.3%) have expected count less than 5. The minimum 
expected count is 2.53.Pearson Chi-Square Value1.298 Asymp. Sig. (2-sided) 0.523, 
 
6.8.3.2 Serological (DIGFA) test results 
DIGFA test gave 9/10 seropositives in CE cases of which 7/10 seropositive 
against antigen B. Seropositive AE cases were 10/11 versus antigen Em2. 
However in abdominal ultrasound negative individuals, 9/172 was seropositive 
against antigen B and 7/172 seropositive against antigen Em2 (Table 6.8.5). The 
serological positive prevalence was higher than the abdominal ultrasound CE or 
AE prevalence (p<0.01) (Table 6.8.5a and 6.8.5b). 
 
Table 6.8.5: Serological (rapid DIGFA) results in Dingqing County 
Antigens DIGFA  
results 
CE 
(n=10) 
AE 
(n=11)
Mixed CE / 
AE (n=1) 
Query 
(n=1) 
Normal 
(n=172) 
Total 
EgCF P 9 10 1 0 47 67 
 N 1 1 0 1 125 128 
EgP P 8 10 1 0 38 57 
 N 2 1 0 1 134 138 
EgB P 7 7 1 1 9 25 
 N 3 4 0 0 163 170 
Em2 P 4 10 1 0 7 22 
 N 6 1 0 1 165 173 
Any one P 9 10 1 1 48 69 
 N 1 1 0 0 124 126 
Total  10 11 1 1 172 195 
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Table 6.8.5a: Ultrasound (CE) and serology crosstabulation 
 Serology (DIGFA) 
US positive negative Total 
CE 10 1 11 
Non CE 59 125 184 
Total 69 126 195 
Chi-Square Tests1 cells (25.0%) have expected count less than 5. The minimum 
expected count is 3.89. Pearson Chi-Square Continuity Correctionb Value13.251 Asymp. 
Sig. (2-sided) 0.000 Fisher's Exact Test Exact Sig. (2-sided) 0.000 
 
Table 6.8.5b: Ultrasound (AE) prevalence and DIGFA crosstabulation 
DIGFA 
Ultrasound
Positive Negative
Total 
AE 11 1 12 
Non AE 58 125 183 
Total 69 126 195 
Chi-Square Tests. 1 cells (25.0%) have expected count less than 5. The minimum 
expected count is 4.25 Pearson Chi-Square Continuity Correctionb Value15.190 Asymp. 
Sig. (2-sided) .000 Fisher's Exact Test Exact Sig. (2-sided) .000 
 
6.8.3.3 Risk factors for CE or AE 
Occupation, education level, income level, dog and livestock ownership, and 
home slaughter were analyzed by independent test for risk factors vesus CE or 
AE. No statistical differences were found (p>0.05) by occupation, dog and 
livestock ownership, and home slaughter groups (Table 6.8.3, Table 6.8.6 to Table 
6.8.10). Most CE (10/11) and AE (9/11), mixed CE/AE and the suspected AE 
cases occurred in only 189 dog owners and 194 livestock owners (Table 6.8.7, 
6.8.8). Illiteracy and low income were the main risk factors especially for AE 
(p<0.05) (Table 6.8.6 and 6.8.7).  
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Table 6.8.6: Ultrasound prevalence of human CE or AE by different 
education level in Dingqing County 
Ultrasound diagnosis 
Educations 
Normal
CE AE 
Mixed 
CE/AE Suspected Total
Children under 
school 
5 0 0 0 0 5 
Illiteracy 110 7 10 1 1 129 
Primary school 83 4 1 0 0 88 
Middle school 5 0 0 0 0 5 
High school 2 0 0 0 0 2 
College and above 1 0 0 0 0 1 
Unknown 2 0 0 0 0 2 
Total 208 11 11 1 1 232 
 
 
Table 6.8.6a: Ultrasound CE/AE prevalence by education level 
Education Total CE AE HD Nomal 
Non educated 134 7(6.0%) 11(8.2%) 18 116 
Primary school and over 98 4(4.1%) 1(1.0%) 5 93 
Chi  0.4116 5.9634 4.3986  
p  0.5212 0.0146 0.0360  
Total 232 11 12 23 209 
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Table 6.8.7: Ultrasound prevalence of human CE or AE by different income 
Ultrasound diagnosis 
Income 
Normal CE AE 
Mixed 
CE/AE Suspected Total 
<2000 RMB 144 9 11 1 1 166 
2000-5000 RMB 55 2 0 0 0 57 
>5000 RMB 9 0 0 0 0 9 
Total 208 11 11 1 1 232 
For CE, The SAS System: 33% of the cells have expected counts less than 5. Chi-Square 
may not be a valid test. Fisher's Exact Test, Table Probability (P) =0.1395, Pr <= P 0.8372. 
For AE, Fisher's Exact Test: Table Probability (P)=0.0160; Pr <= P 0.0835 
 
Table 6.8.7a: Ultrasound hydatid disease (HD) by income (1) 
Income HD Non HD Total 
<2000 21 145 166 
2000-5000 2 55 57 
>5000 0 9 9 
Total 23 209 232 
The SAS System Chi-Square = 5.0009 p=0.0820; Fisher's Exact Test  Table Probability 
(P)=0.0109; Pr <= P 0.1107 
 
Table 6.8.7b: Ultrasound hydatid disease (HD) by income (2) 
Income HD Non HD Total 
<2000 21 145 166 
>2000 2 64 66 
Total 23 209 232 
The SAS System Chi-Square =4.8938  p =0.0270 
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Table 6.8.8: Independent test for dog /livestock ownership with ultrasound 
prevalence of human CE or AE 
 Total 
Normal CE AE 
Mixed 
CE/AE Suspected 
Dog ownership 
Yes 189 168 10 9 1 1 
No 43 40 1 2 0 0 
Chi   0.2316 0.2989   
P   0.7011 1.0000   
Livestock ownership 
Yes 194 173 10 9 1 1 
No 38 35 1 2 0 0 
Chi   0.139 0.000   
P   0.709 1.000   
Total 232 208 11 11 1 1 
For HD, Fisher's Exact Test, Table Probability (P)=0.1897; Two-sided Pr <= P 0.5835 
 
 
Table 6.8.9: Ultrasound CE /AE prevalence by home slaughter 
crosstabulation 
Home slaughter
Ultrasound 
Yes No 
Total Chi p 
CE 11 169 180 0.715 0.398 
Non CE 1 51 52   
Subtotal 12 220 232   
AE 8 172 180 0.332 0.565 
Non AE 4 48 52   
Subtotal 12 220 232   
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Table 6.8.10: Ultrasound CE/AE prevalence by dog & livestock ownership 
Dog & livestock ownership 
US 
Yes No 
Total Chi p 
CE 11 160 171   
Non CE 1 60 61 1.242 0.265
Subtotal 12 220 232   
AE 9 162 171   
non AE 3 57 60 0.000 1.000
Subtotal 12 219 231   
 
 
6.8.4 Discussion (Dingqing County, Changdu Prefecture, TAR) 
Human CE is probably endemic throughout Tibet AR, but especially in Naqu, 
Lhasa, Shannan and Chamdo Prefectures (Guo et al., 1994; Luo and Zhao, 1994; 
Gong et al., 2001; Jiang, 2002; Zhou and Xi, 2004; Yin and Wang, 2007). In 1990s, 
94 cases of human echinococcosis were reported in Chamdo hospital and 68 
human CE cases were specifically recorded recently (Yin and Wang, 1997). In the 
present study, an initial investigation of clinical echinococcosis cases was carried 
out in the hospitals in Changdu, and in total 68 cases of hydatid disease and 4 AE 
was found originating from Changdu Prefecture (Fig. 6.8.4). 
Current pilot study confirmed the ultrasound prevalence was 4.7% (11/232) for CE 
and 4.7% (11/232) for AE in Dingqing County. Seza and Buta Communes are 
close to Yushu Prefecture of Qinghai Province where both human CE and AE 
were known to be endemic (Schantz et al., 2003). Our study showed most human 
CE and AE cases came from these two communes, except one CE case which 
originated from a village of Dingqing town. Most CE (7/11) or AE (8/11) cases were 
females with ages from 21 to 60 although there was no statistical difference 
probably because the screened population was limited. 
 
 227
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6.8.4: Human echinococcosis distribution in Changdu Prefecture 
(including Dingqing County), Tibet AR.  
HD meant hydatid cases (recorded not clear CE or AE);  
Four AE cases were diagnosed retrospectively from CT images by Xinjiang Clinical 
Research Institute. 
 
One case of mixed CE/AE was found in this study, who was male, 33 years old, 
and a herdsman, non-educated with an annual income less than 2000RMB (～
£200). Ultrasound images showed one 10.5cm x 10cm solid AE lesion, one 8.5cm 
x 8cm CE cyst and 2 smaller CE cysts in his liver. The rapid DIGFA test gave a 
strong positive against all the four antigens (EgCF, EgP, AgB and Em2). 
Possibel risk factors which might related to human CE in Dingqing County of 
Changdu Prefecture (TAR), included occupation, education level, income, dog or 
livestock ownership, and home slaughter, however no statistical differences were 
found (P>0.05). The main reasons might due to the following points: (1) screened 
population limitation; (2) transmission (dog-livestock) existed and the environment 
for human life might be contaminated. The main risk of CE for local people might 
due to several reasons. (1) Dog and livestock ownership were common and stray 
dogs everywhere, that life cycle for Echinococcus granulosus might take eggs all 
around those area. Feeding offals of livestock to dogs (68.5%, 159/232) and home 
Qinghai Province 
Sichuan Province 
HD17, AE3 
HD1
HD7
HD13 
HD1 
HD3
HD 5 
HD3 
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HD8 
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slaughter (77.6%, 180/232) were common in Dingqing County. (2) Their water 
source was mainly from streams (207/232, 89.2%) which might give more chance 
of egg dispersion. (3) Unhealthy hygienic habits, for example 81.9% (190/232) 
screened people said they did not have the habit of washing hands before eating. 
(4) Lower education level and income level: 57.8% (134/232) people never had 
any education, and 71.5% (166/232) had a lower annual income less than 2000 
RMB (280 US$). 
General putative risk factors for human AE suggested that education and income 
level had some influence (p<0.05). The life-cycle of Echinococcus multilocularis 
could be maintained between theTibetan fox (Vulpes ferrilata) and plateau pikas 
(Ochotona curzoniae) as definitive host and intermediate host respectively in 
Dingqing County. The landscape is like dry steppe and treeless in Dingqing 
County and this was typical Tibetan fox habitat and dietary analysis showed 95% 
pika (O. curzoniae) and small rodents (Pitymus, Alticola, Cricetelus) in 113 fox 
scat samples from north west Tibet (Schaller 1998). The traditional ‘winter-worm’ 
collection in Spring might be another chance to bring people to rural areas where 
foxes lived and contact with E. multilocularis eggs from fox faeces. Furthermore 
hunting foxes was restricted in recent years. Dogs as a potential definitive host of 
E. multilocularis might exist due to owned and stray dogs hunting small mammals 
but the questionnaire responses showed no evidence (copro PCR would 
performed in future to identify dog’s infections). Same risk factors as water source, 
hygienic habits for CE might relate to AE infections as well. 
The curren study had confirmed both CE and AE were endemic in Dingqing 
County, Changdu Prefecture, Tibet AR. Prevention and control for CE and AE 
might be difficult due to lower education level and income and poor hygienic habits. 
Treatment of dogs is also difficult since lots of stray dogs existed. Possibly more 
health education about CE or AE given to school students, dog treatment with 
governmental support could be helpful for improving this situation. 
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6.9 Discussion --- Community studies on human echinococcosis in Tibet 
Autonomous Region, P.R.China 
The Tibet Autonomous Region (TAR) is situated in south-western area of the 
People's Republic of China, bordered to the north by Qinghai Province and 
Xinjiang Uygur Autonomous Region from northwest, Sichuan and Yunnan 
Province to the east, and neighbouring with Myanmar, India, Bhutan and Nepal to 
the south. Known as the "roof of the world'', the Tibet Autonomous Region forms 
the major part (47%) of the Qinghai-Tibetan Plateau (2.5 million square 
kilometres). Its varied topography is composed of three different natural areas: the 
northern Tibet Plateau (two-thirds of the autonomous region) is situated among 
the Kunlun, Tanggula, Kangdese and Nyainqentanglha mountains; the southern 
Tibet Valley is located between the Kangdese and Himalayan Mountains, and is 
drained by the Yarlung Zangbo River and its tributaries; the eastern Tibet Canyon 
is formed by mountains extending east-west before turning south-north that 
belongs to the Hengduan Mountain Range.  
TAR has an average elevation over 4000 metres above sea level, 1.22 million 
square kilometres and a population of 2.81 million (lowest population density, 2.3 
inhabitants per square kilometre) (China Statistical Yearbook 2007). The regional 
capital is Lhasa. Tibet AR is the largest Tibetan region in China. Tibetans account 
for 96% of the region's population. Other groups are Han, Hui, Mongolian, Monba, 
Lhoba, and others. The total number of Tibetan in China (TAR, Qinghai, Sichuan 
Gansu and Yunnan) is approximate 6 million. 
Tibet Autonomous Region is divided into one prefecture-level city and six 
prefectures. The prefecture-level city is Lhasa, and the prefectures are Naqu 
(Nagqu), Ali (Ngari), Linzhi (Nyinchi), Changdu (Qamdo), Shannan and Rikaze 
(Xigazê). 
Human cystic echinococcosis (CE) has been known to be endemic in the TAR 
since 1987 (Hu et al., 1987), but has continuously been present among of the 
predominant nomadic pastoral population on the Tibetan plateau for hundred of 
years. Mass screening programme for echinococcosis, principally using portable 
ultrasound for abdominal CE or AE, have been undertaken in several Tibetan 
Autonomous Counties and Prefectures outside the TAR in Qinghai and Gansu 
Province and in western Sichuan Province (Schantz et al., 2003; Bai 2002; Li et al., 
2005, 2010). These studies revealed a significant very high prevalence of both CE 
 230
and AE in Tibetan communities in Sichuan and Qinghai with mean prevalence of 
4-6% and ranges 1-15% for CE or AE. In 2004, the Chinese Ministry of Health 
(MoH) carried out a nation-wide assessment of 8 parasitic diseases including 
echinococcosis (MoH, 2005). The overall ultrasound prevalence (2.4%) by ethnics 
was in Tibetan communities of TAR, northwest Sichuan and Qinghai province. 
Hospital records in TAR showed 709 cases of human CE from three hospitals 
(Naqu Prefecture Hospital, 1st and 2nd Peoples Hospital of TAR) from 1996-2000 
(Gong et al., 2001). In total 623 CE cases were originally from Naqu Prefecture 
and 76 from Lhasa (35), Shannan (22), Changdu (10), Linzhi (8), Rikaze (4), Ali (2) 
and other areas (5). 94 cases of echinococcosis (not differentiated as CE or AE) 
were reported in Changdu Prefecture (Luo and Zhao, 1994), and 116 (1995-2004), 
155 (to 2007) or 268 (1988-2002) cases in Shannan (Liao et al., 2003; Peng et al., 
2005, Cai et al., 2007).  
Several community studies have been carried out in different areas of TAR. 
Immunodiagnostic positive (Casoni) rate in Tibet AR was 34.9% in a survey in 
1988-1991 (Guo et al., 1994). One survey in Dangxiong and Mozugongka County 
of Lhasa Prefecture in 1999 showed 48 cases of cystic echinococcosis from 734 
Casoni’s test positive individuals in a test population of 20160 (Hu et al., 1999). In 
Naidong County of Shannan Prefecture 81 cases of CE from 3379 individuals 
were detected by ultrasound, IHA and clinical features (Zhou and Xi, 2005). 
It appears that a hot spot of human AE occurs in northwest Sichuan and 
southwest Qinghai which burden eastern TAR (Wang et al., 2005; Li et al., 2005) 
although there is very little information on human AE in TAR itself. Human AE 
cases in Tibet AR were first reported in 1987 (1 AE and 174 CE in 1960-1983 in 
Tibet AR Peoples Hospital) (Hu et al., 1987). Then 2 AE cases (history identified in 
1977) were found from Changdu Prefecture (Peng, 1988). Since then, 12 cases of 
human AE were reported in hospitals in Lhasa and originally from Lhasa, Naqu 
and Changdu. After that, 2 cranial AE were reported (Pu, 1999; Yixi Jiacuo, 2001) 
and 3 hepatic AE cases were appeared in a CT image study in Linzhi (Duan et al., 
2006).  
The current studies of records in the People’s Hospital of Changdu Prefecture 
(TAR), and a pilot community study in Dangxiong County of Lhasa Prefecture, and 
Dingqing County of Changdu Prefecture (eastern TAR) (2006, 2007), was 
undertaken by Xinjiang Hydatid Clinical Research Institute with cooperation with 
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the Centre of Disease Prevention and Control (CDC) of Tibet AR. Community 
surveys including questionnaire registration, ultrasound scanning and rapid 
serological test were performed in Dangxiong County in October 2006 and in 
Dingqing County in November 2007. Volunteered people from Dangxiong were 
557 and form Dingqing County were 232, they came for screening by a 
questionnaire, serology and ultrasound scanning. In total 55 (9.87%) human CE 
cases were detected in 557 people, and no human AE cases were identified 
during the current survey in Dangxiong County. Meanwhile, 11 CE (4.7%), 11 AE 
(4.7%), 1 mixed CE and AE (0.1%) and 1 suspected AE (0.1%) were diagnosed 
by ultrasound from 232 people in Dingqing County. 
Human CE and AE cases were recorded in all of 7 prefectures in Tibet 
Autonomous Region (Table 1, 2). First reported hospital echinococcosis cases in 
the People’s Hospital of Tibet AR (in Lhasa city) were 174 CE and 1 AE through 
1960-1983 but without original patients address (Hu et al., 1987). And serological 
survey (not mentioned, but main possibility was by Casoni at that period) in Tibet 
AR showed average 34.9% positive (Guo et al., 1994). In the past 20 years, 
human CE cases recorded in hospital were over 100 in Naqu (623), Shannan 
(258), Changdu (94+10+68=172) and not sure in Lhasa (because hospital cases 
in Lhasa might came from other prefectures due to Lhasa as capital in Tibet AR, 
which showed 174 CE cases from 1960-1988 and 162 CE (35 from Lhasa) in 2 
regional hospitals, 80 CE cases from an Armed Police Hospital) (Hu et al., 1987; 
Cirendawa and Wang, 2000; Gong et al., 2001; Zhou et al., 2002; Liao et al., 2003; 
Peng et al., 2005; Yu, 2006; Cai et al., 2007). Cases reported in Rikaze, Linzhi an 
Ali were very limited but might not really rare in those areas since 9 vagina CE 
cases (7 cases had hepatic CE and 2 had uterus CE) were reported in Rikaze, 
and 18 hepatic CE in a CT scan imagine analysis in Linzhi Prefecture Hospital 
(Hou et al., 2005; Duan et al., 2006). 
The human CE cases in above reports and papers in Tibet AR were reviewed in 
Table 6.9.1. 
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Table 6.9.1: Human cystic echinococcosis recorded in Tibet Autonomous 
Region, P.R.China 
 
Human AE prevalence was not as high as CE in Tibet AR. After first reported in 
1987, other reports showed 2 cases from Changdo (Peng 1988), 12 cases (3 from 
Lhasa, others from Naqu and Changdu) (Yixijiacuo, 1992; Luo et al., 1993), 2 
cases cranial AE (Pu 1999; Yixijiacuo et al., 2001), and 3 AE cases diagnosed by 
CT images in Linzhi (Duan et al., 2006). 
The human AE cases in above reports and papers in Tibet AR were reviewed in 
Table 6.9.2. 
 
Hospital CE Community 
Prefecture Duration cases Refs County CE case Refs 
Naqu 1996-2000 623 Gong et al., 
2001 
   
Lhasa 1996-2000 35 Gong et al., 
2001 
Mozugongka 
/Dangxiong 
48/20160 
(0.2%) 
Hu et al., 
1999 
    Dangxiong 55/557 
(9.9%) 
2006 
Changdu  94 Luo and Zhao, 
1993 
Dingqing 11/232 
(4.7%) 
2007 
 1988-1995 70 Lan et al.,1999    
 1996-2000 10 Gong et al., 
2001 
   
  68 Yin et al., 2007    
Shannan 1996-2000 22 Gong et al., 
2001 
Naidong 81/3379(2.4%) Zhou et al., 
2004 
 1995-2001 80 Zhou et al., 
2002 
 7/1631(0.4%), 
16 query 
Shen et al., 
2004 
 1995-2004 116 Peng et al., 
2005 
Qusong 11/722(1.5%) 2003  
 1988-2002 268 Liao et al., 
2003 
   
 1999- 59 Yu, 2006    
  155 Cai et al., 
2007 
   
Linzhi 1996-2000 8 Gong et al., 
2001 
   
  18 Duan et al., 
2006 
   
Rikaze 1996-2000 4 Gong et al., 
2001 
   
  9 Hou et al, 
2005 
   
Ali 1996-2000 2 Gong et al., 
2001 
   
Not sure 1960-1983 174 Hu et al, 1987    
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Table 6.9.2: Human alveolar echinococcosis recorded in Tibet Autonomous 
Region, P.R.China 
 
Several community study using ultrasound and serology also found 48 CE cases 
in Lhasa, 81 echinococcosis cases in Naidong County and 11 CE cases in 
Qusong County, of Shannan (Table 6.9.1) (Hu et al., 1999; Zhou et al., 2005). No 
AE cases were found in community studies which have been published. 
Prevalence of human CE by ultrasound were 9/722 (1.2%), 55/575 (9.9%) and 
11/232 (4.7%) in Qusong, Dangxiong and Dingqing and highest was in Dangxiong 
(p<0.01) (Table 6.9.3). Prevalence review of human CE and AE in Tibet AR 
showed higher CE prevalences occurred in Naqu, Shannan, Changdu and Lhasa; 
and AE cases were mainly from Changdu, Linzhi and Lhasa (Table 6.9.4). 
Hospital AE Community 
Prefectures 
Duration cases
References 
County AE case 
References
Not sure  1 Hu, 1987    
Lhasa, Naqu, 
Shannan and 
Changdu 
1960-1992 12 Luo et al.,1993    
Not sure  1 Pu, 1999    
Sichuan Origin  1 Yixijiacuo, 2001    
Changdu 1977 2 Peng, 1988 Dingqing 11/232 2007 
 2006 4 
Hospital CT 
imagines 
   
Linzhi  3 
Duan et al., 
2006 
   
Tibet AR     2.76% MoH, 2005 
Total  23   11  
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Table 6.9.3: Community studies for human echinococcosis by ultrasound in 
Qusong, Dangxiong and Dingqing Counties (2003-2007) 
Counties 
Population 
(2003)a 
No. of 
screened
CE  AE 
mixed 
CE/AE
Query  
Serological 
positives 
Qusong 20,000 722 9(1.2%) 0 0 2(0.3%) 55/722(7.6%) 
Dangxiong 41,918 557 55(9.9%) 0 0 0 31/488(6.4%) 
Dingqing 60,000 232 11(4.7%) 11(4.7) 1(0.4%) 1(0.4%) 69/195(35.4%) 
Total 121,918 1511 75(4.96%) 11 1 3 155/1405(11.0%)
a. Prevalence of human CE in local population was 45/100,000in Qusong, 131.2/100,000 
in Dangxiong, 18.3/100,000 in Dingqing and AE prevalence was 18.3/100,000 in Dingqing 
just from this study. 
Chi-Square Tests Pearson Chi-Square Value49.646a Asymp. Sig. (2-sided) 0.000 
 
Table 6.9.4: Prevalence review of human CE and AE in Tibet AR 
CE AE 
Prefecture 
Population 
(2005) a 
Confirmed 
cases b 
Prevalence 
(1/100,000) 
Confirmed 
cases 
Prevalence 
(1/100,000) 
Lhasa 540,500 138 25.5 3 0.6 
Naqu 401,871 623 155.0 ?  
Ali 86,277 2 2.3   
Rikaze 662,146 13 1.96   
Linzhi 158,167 26 16.4 3 1.9 
Shannan 325,063 268 c 82.4 ?  
Changdu 606,444 182 30.0 17 2.8 
Tibet AR 2,770,000 1242 44.8 34 1.2 
a. population from http://www.xizang.gov.cn until the end of 2005. 
b. Hospital cases and ultrasound confirmed community cases excluding some cases 
surgical treated in the recorded hospital in the same period if community studies showed 
exactly. 
c. The actual human CE cases in Shannan might be more than 268 (at least other 20 were 
recorded in Lhasa’s hospital), but the data from same hospital were overlapped in 
different papers, and community study’s data did not published on formal magazines, so 
just choose the most records as a reference. 
 
Human CE cases were found in all seven prefectures of Tibet AR (Gong, et al., 
2001, Table 6.9.1 and 6.9.4) with most hospital cases in Naqu, Shannan, Changdu, 
Lhasa and Linzhi Prefectures. Community studies in Naqu, Lhasa, Changdu and 
Shannan Prefectures showed highest prevalences by ultrasound (Moh, 2005 and 
Table 6.9.1). Distribution of human CE cases was mainly located in southeast, 
east, north and northwest part of Tibet AR, where were located close to the areas 
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known as high endemic areas, such as southwest of Qinghai, northwest Sichuan 
Provinces. Previous reports showed that the highest ultrasound prevalence rate 
for human CE in China were occurred in Tibetan pastoral communities of eastern 
Tibetan plateau including southwest Qinghai and northwest Sichuan Provinces 
(Qiu et al., 1999; Schantz et al., 2003; Craig et al., 2004; Moh, 2005).  
Transmission of E. granulosus in Tibet AR might be due to the distribution of 
numbers of its major definitive host (dog) and intermediate hosts (domestic 
livestock mammals, such as sheep, yak, goats, cattle, etc.) (WHO/OIE, 2001, 
Craig, 2004). Numerous dogs were found in Tibet AR, especially in pastoral areas, 
which had many uses, such as guard, herd, farm dog, temple dog and also are a 
suitable companion dog. And adult worms of E. granulosus were found in the 
intestine of dogs in Naqu, Tibet AR (E. granulosus infections were reported 
common in yak, cattle, sheep and goat in Tibet AR (Liu et al., 1994; Zhang et al., 
1994; Nimaciren, 1998, Lan et al., 1999). 
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Chapter 7. General discussion 
 
Echinococcosis is listed as one of the neglected diseases in the world (WHO, 
2006). It is difficult to control in many countries due to poor efficacy and prolonged 
policies or lack of financial support. The vague definition which called hydatid 
disease for both CE and AE, was widely used in general discussion and scientific 
papers in western China for many years, although the first AE case was reported 
in China in 1965. In fact, the transmission lifecycle, clinical diagnosis and 
treatment are really different between CE and AE. Exact distribution of CE and AE 
are necessary for differentiating the epidemiological characters between these 
two kinds of disease and implement efficient prevention and control measures. 
A series of epidemiological surveys in this thesis showed there was different 
prevalence of human CE and AE at regional, prefectural and county level, even 
local town or commune level. The overall ultrasound prevalence of human 
echinococcosis in western China was 3.3% (619/18766), with CE 2.73% 
(513/18766) and AE 0.56% (106/18766) respectively (Table 7.1). Over 80% of 
human echinococcosis we detected was CE in this study, and CE cases were 
more than AE cases in most of our study sites. This means CE was endemic in all 
the study sites, and some counties had relatively higher CE prevalence over 5%. 
These high endemic areas were: Hejing and Hoboksar in Xinjiang, Xiji in Ningxia, 
Dangxiong and Dingqing in Tibet AR.  
The prevalence of human AE was however rather different. There was large 
variation in AE prevalence among different counties, for example sporadic AE 
cases in Xinjiang and high prevalence (>3%) in some counties in Ningxia, Sichuan 
and Tibet AR. The remarkable data was a relatively centralized focus of human AE 
cases reported in Shiqu County of Ganzi Tibetan Autonomous Prefecture in 
Sichuan in recent few years (Li et al., 2006, 2010). Dingqing County in Tibet AR is 
now reported from the current study as an AE endemic area for the first time. The 
reason might due to its close location and similar transmission ecological 
landscape with other AE endemic area such as Yushu Tibetan AP in Qinghai and 
Shiqu County in Sichuan. 
We also found the prevalence in one location or place might change from one 
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period to another time. The temporal change of echinococcosis transmission has 
been considered by ecologists and they found landscape changes might cause 
increase in small mammal populations and eventually outbreak of AE since the 
life-cycle of E. multilocularis will be favoured by suitable small mammal and fox 
habitats (Giraudaux, et al, 2006).  
 
Table 7.1: Echinococcosis prevalence by ultrasound in northwestern China 
(current study) 
Province/
AR 
Prefecture County 
Town/ 
Commune
Survey
Year
Number HD (%) AE (%) CE (%)
Xinjiang Altai Habahe  2002 1644 51 3.10 0 0.00 51 3.10
  Qinghe  2002 1134 31 2.73 0 0.00 31 2.73
 Changji Mulei  2002 991 3 0.30 0 0.00 3 0.30
 Bayinguoleng Hejing Bayinbuluke 2004 1398 82 5.87 3 0.21 79 5.65
 Boertala Wenquan Angelige 2005 1292 24 1.86 0 0.00 24 1.86
 Yili Xinyuan Narati 2003 1838 38 2.06 6 0.33 32 1.74
   Turgen 2005 1853 29 1.35 5 0.32 24 1.29
  Nileke Wulasitai 2004 2044 58 2.84 13 0.64 45 2.20
   Musi 2005 1851 20 1.08 0 0.00 20 1.08
 Tacheng Hoboksar  2007 1339 70 5.23 2 0.15 68 5.08
Ningxia Guyuan Xiji  2002 945 93 9.84 36 3.81 57 6.03
Sichuan Ganzi Ganzi  2006 1665 43 2.58 30 1.80 13 0.78
Tibet Dangxiong   2006 557 55 9.87 0 0.00 55 9.87
 Dingqing   2007 208 22 10.58 11 5.29 11 5.29
Total     18766 619 3.30 106 0.56 513 2.73
HD = hydatid diseases cases in total (CE and AE) 
For CE, human behavior was more focused on since the transmission of E. 
granulosus usually depends on dog-livestock cycle which is more affected by 
human themselves. CE was found to be endemic in husbandry or pastoral 
dominated areas, such as in western China. On the other hand, the environmental 
factors such as cold climate and grassland landscape might be suitable for 
Echinococcus egg survival (Ding et al., 2000; Wen et al., 2010; WHO/OIE, 2001). 
This natural dog-livestock ecology balance for E. granulosus also has human 
interference such as feeding dogs with the infected offal of livestock. Human 
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infections were determined by local parasite burden in dogs which could result in 
environmental contamination with eggs. As a consequence CE also occurred in 
persons who did not have close contact with dogs or livestock. People who owned 
dogs and livestock however might have more risk due to their actions and close 
proximities to the transmission system of CE. This occupation or gender risk might 
not come from herding itself. Some studies found human or dog infection risk were 
not really highest in pastoral areas versus settled communities (Wang et al, 2004; 
Wang et al, 2001, 2005). The limitation of livestock and dogs might give more 
chance to keep them close to each other and obtain high density parasite burden. 
Poor hygienic habits are another aspect of human infection with CE. Washing 
hands before eating was not common in children and also many adults since they 
did not feel the danger of unseen eggs existing in the surrounding areas. 
Uncooked or even unwashed vegetables are another potential egg source due to 
some people fertilizes their gardens with dog faeces (WHO/OIE, 2001). Another 
contamination came from drinking water. Streams became the main water source 
in the wild field for herds and this could be contaminated by dog faeces.  
Some general government policies have asked the herdsman to settle down 
rather than have a traditional nomadic life. The fencing for livestock might not 
decrease the incidence of CE since the close contact might cause higher parasite 
density in the limited space. But it could be resolved if routine dog administration 
could be carried out seriously, such as copro-detection and regular helminthicide 
treatment (Wang et al., 2004; Wang et al., 2001, 2005). 
Risk factors for human CE could be related with three directions including genetic 
susceptibility, environment and lifestyle-related. Genetic factors are difficult to 
show e.g. family cases, though some studies suggest familial clustering (Musui et 
al., 1989). So the other two aspects became very important. For example of 
environment, farm with livestock husbandry and pastures (where have dog-sheep 
cycle), home slaughter is popular, relative cold weather, open water sources, etc. 
Lifestyle-related risk factors for CE from the current study suggests occupation as 
a herdsman or farmer, owning dogs, poor hygiene habits, ethnic as nomadic 
people (i.e. Mongol, Kazakh, Tibetan, etc.) (Table 7.2) 
For human AE in Xinjiang, patients occasionally appeared in Tianshan and Altay 
Mountains areas. With red fox (Vulpes vulpes) as the main definitive host, 
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microtines (voles) as main intermediate host, a sylvatic cycle is maintained in 
Xinjiang (Ding et al., 2000; Wen et al., 2010; WHO/OIE 2001). Other endemic 
areas, the Tibetan fox (Vulpes ferrilata) and Plateau Pika (Ochotona curzoniae) 
might act as two important hotst in E. multilocularis transmission. Domestic dogs 
were involved in E. multilocularis transmission in many areas (Ganzi in Sichuan, 
Bayinbuluke in Xinjiang), which their roles might be a reason for relative 
centralized AE cases in those areas. So the close contact with dog might be one 
of the main risk factors for human AE in this case. Human behaviour could be also 
involved in the AE transmission such as fox hunting, fox skin handling, playing 
with dog and poor hygiene habits (WHO/OIE 2001). However there were very 
significant in current study. 
Rapid serological colloidal techniques have been widely applied in clinical practice. 
We developed a DIGFA colloidal gold test for hospital and epidemiological 
investigations on human echinococcosis. This real time bedside detection was 
easy to be operated by technicians. Comparable assessments for these 
developed potential commercial diagnostic tools have been done in many 
infectious diseases (Dar et al., 1994; Xiao et al., 1995; Dylan and Kevin, 1999; 
Feng et al., 2000; Garcia et al., 2000; Feng et al., 2002; Zhu et al., 2002; Sorell et 
al., 2002; Yang, 2003; Hujakka et al., 2003; Chen et al., 2005). Generally these 
rapid tests were more recommended for mass screening since they had the 
easy-to-use trait. The limitation of these tests was mainly for quality check rather 
than quantities measure. 
Two basic types of colloidal gold assays developed in the current study were 
DIGFA and ICA, which have been applied in commercial products for human 
echinococcosis in China. They have similar detection principle, which has antigen 
coated on the nitrocellulose membrane, then sera and colloidal gold labeled 
second antibody was reacted with antigen. They are similar to an indirect ELISA. 
The sensitivity and specificity was influenced by antigens, second antibody, and 
the size of colloidal gold and level of labeling. A purified E. granulosus cyst fluid 
antigen was used in ICA kit made in China and another recombined Em18 in 
another ICA product in Japan. We used a crude extract of E. granulosus cyst fluid, 
a crude antigen from E. granulosus protoscoleces, antigen B and a metacetode 
extract from E. multilocularis tissue and protoscoleces Em2 in our DIGFA kits. 
This kind of combination could give different reactive strengthen with parallel 
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multiple antigens and supply more information for same patient (Feng et al., 2010). 
The overall sensitivity of DIGFA was 80.7% for human CE (n=857) and 92.9% for 
human AE (n=42) in a hospital diagnostic setting, and ranged from 71.8% to 
90.7% in comparison to abdominal ultrasound in the community screening. 
However the higher specificity occurred in both settings which were 93.4% and 
94.6% with AgB for CE, and 90.3% and 97.1% with Em2 for AE (Feng et al., 
2010). 
New techniques and detection tools were developed through many years hard 
work. Molecular and immunological diagnostic tools has been applied in research 
laboratory and partially supplied to hospitals and survey group for both human and 
dog (or wild canids). An initial rapid ICA for coproantigen detection had been 
carried out in the current study. The 94% sensitivity of ICA in 16 experimental 
35-53 dpi dogs was reported. ELISA and IGCA showed that coproantigen level 
appeared to increase from day 16 after infection and were clearly detected after 
day 24 dpi by both ELISA and IGCA. The current results suggested that copro 
tests (coproantigen ELISA, IGCA, copro-PCR) might be sensitive for canine 
echinococcosis from 20 days after infection. And that would be also helpful to 
evaluate the efficacy of control policy.  
The epidemiological studies showed E. granulosus with dog-sheep lifecycle was 
high endemic in seven northwest provinces/autonomous regions including 
Xinjiang, Gansu, Ningxia, Qinghai, Tibet and Inner Mongol where livestock 
husbandry were prevalent and dog owning were popular. The prevalence of CE 
was different at county-level and generally pastures areas higher than agriculture 
areas. The distribution of AE was really complicated since higher prevalence 
occurred in Zhang and Min Counties of Gansu, Xiji County of Ningxia, Guoluo and 
Yushu Tibetan Prefectures of southeastern Qinghai, and Ganzi Tibetan Prefecture 
of Sichuan. The transmission of E. multilocularis would be relative with 
populations of wild carnivores and density of rodents which could form the 
lifecycle. The landscapes of endemic areas should be suitable for those wild 
animals to survive. But the population of wild animals and land usage might be 
dynamic and change through different time period. So the distribution of human 
AE cases was usually as a sporadic status in other areas such as Tianshan 
Mountain and Altay Mountain in Xinjiang.
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The control programme for echinococcosis was first started in Xinjiang from end of 
1980s. But non-continued financial support did not provide long term intervention. 
The next focus on echinococcosis was an initial prevention plan for 
echinococcosis since a serious endemic report of national parasite disease 
investigation was sent to the National Ministry of Health in 2005. Echinococcosis 
was not a neglected disease in China at that time. Hydatid disease was 
internalized into the range of national major infectious diseases with free 
treatment in highly endemic counties. Most endemic counties were internalized as 
‘’prevention and control programme county’’. For example, 30 counties became 
‘’prevention and control programme county’’ and 24 hospitals became the 
appointed hospitals for surgical treatment of echinococcosis in Xinjiang by the end 
of 2011. Hydatid patients in those counties could obtain medicine treatment free of 
charge and RMB 8000 yuan (£800) for their surgical treatment from Special Funds 
for Echinococcosis. And medical staff and CDC staff in those counties and 
hospitals could receive professional training and technique direction free of 
charge through this control plan. On the other hand, financial support was 
supplied to those counties including health education for residents, treatment plan 
for dogs and management for livestock slaughter. All those policies could be very 
helpful for practical prevention and control in high endemic areas even the 
complicated administration system existed. 
New techniques and detection tools were developed through many years hard 
work. Molecular and immunological diagnostic tools has been applied in research 
laboratory and partially supplied to hospitals and survey group for both human and 
dog (or fox and wolf). And that would be also helpful to evaluate the efficacy of 
control policy. Improvement of operation path has been successfully studied and 
carried out in clinical practice such as ‘’complete resection of hydatid cyst ‘’. New 
formulations of albendazole and other antihelminth drugs were developed and 
commercial available for assistant medicine treatment of patient. And the 
fundamental research on mechanism of transmission, infection model, 
immunological defense etc., had been evolved in research centers or institutes in 
Shanghai, Sichuan, Qinghai, Ningxia, Gansu and Xinjiang. 
The aetiology and infection route of human echinococcosis are clear but the 
transmission path or model needs to be established based on GIS technique or 
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mathematic model from dog infection. The diagnostic tool and vaccination for 
sheep are also available although the applications of them are still limited due to 
personal monetary outcome needed. In order to eliminate the preventable disease 
in northwest China, more effort is expected to be paid on developing 
comprehensive, effective, feasible policy, strategies and measures, as well as 
effective implementation and evaluation systems.  
Conclusions and recommendations 
Rapid diagnostic tests including DIGFA for human echinococcosis, ICA for cyst 
fluid identification and for coproantigen detection had been developed and 
evaluated through this study. DIGFA for human echinococcosis has been formally 
registered in National FDA of China and commercially used for hospitals and 
community studies from 2010. Results showed accepted sensitivity for above 
rapid test in hospital setting and also community studies. The rapid tests had been 
confirmed effective, and valuable for clinical diagnosis and community screening. 
But the rapid tests had the limitied diagnostic accuracy which the clinical diagnosis 
must combined imaging results. The false negative and false positive needed to 
be follow-up with same rapid test or other tests (ie. ELISA, western blot).   
Furthermore, new tools or techniques could be applied to improving the diagnostic 
accuracy and validity based on the above assays.  
A series of epidemiological surveys including the current study showed the overall 
ultrasound prevalence of human echinococcosis in western China was 3.3%, with 
CE 2.73% and AE 0.56% respectively. The transmission of E. granulosus and E. 
multilocularis might be involved with dog-livestock, fox or domestic dog and small 
mammal lifecycle in Xinjiang, Ningxia and Tibetan Plateau (Ganzi of Sichuan and 
Tibet AR). The risk factors for human CE could be relative with ethnic group, 
occupation, dog ownership and homeslaughter in the current study. 
However, we found that the control of echinococcosis was still difficult in above 
survey areas. In order to eliminate hydatid disease in Xinjiang, or extending to the 
whole country, more efforts can be expected for the payment of the development 
of comprehensive, effective, feasible policy, prevention and control strategies and 
evaluative system, as well as effective implementation.  
It would be very important to establish an administration system for control of 
human echinococcosis. This system should have several fields to be free from 
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existing risk factors. Dog control would be firstly responsible for registering all the 
information for local dogs including their birth/death, drug taken and faecal test 
and follow-up. Livestock control would be in charge of regular control of possible 
infected organs both in city slaughter and countryside. Thirdly, human control 
including hospital, CDC and public health education branch would be focused on 
prevention, diagnosis, treatment and follow-up observation for local population. 
Additionally, good hygiene habits and friendly home education formulation would 
be helpful to control of Echinococcus infections in humans and animals in Xinjiang, 
and gradually extended in northwestern China, and further more in all over the 
country. 
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Appendix
I. Preparation of antigens for human Echinococcus antibodies detection  
I.1 Native E. granulosus cyst fluid antigen (EgCF) 
Hydatid cyst fluid was obtained by aseptic aspiration from naturally infected sheep 
livers or lungs collected in abattoirs from different endemic areas of Xinjiang, P. R. 
China. The cyst fluid was centrifuged at 3000rpm for 30 minutes, and then 
supernatant was dialyzed against 0.15m PBS (pH 7.2) overnight at 4ºC. Dialyzed 
cyst fluid supernatant was then affinity purified against normal human IgG 
chromatographic column (DEAE, diethylaminoethyl) coupled cyanogens bromide 
activated Sepharose 4B (CNBr-4B, Sigma). The affinity absorbed cyst fluid 
supernatant was concentrated with an Amicon ultra filtration cell using YM10 
membrane (Amicon Corp, MA, USA). 
The protein concentration of EgCF antigen was estimated by spectrophotometric 
absorption at 280nm and 260nm (2.493mg/ml, from a calculation for the 
concentration of protein (1.55*A280-0.76*A260), Stoscheck et al., 1990)).  
 
Hydatid cyst fluid (EgCF) purification procedure with immunoabsorbent 
chromatography: 
• Human immunoglobulin was prepared from normal human serum samples 
from XJMU (laboratory confirmed without any other infection, e.g. HIV, HAV, 
HBV, HCV, TB) by precipitating with 40% saturated ammonium sulfate in 
normal saline for 3 hours at 4ºC, centrifuged 3000rpm for 20 minutes; 
centrifuged pellets was re-dissolved in saline and the saturated ammonium 
sulfate precipitation repeated; last pellets were dissolved with original volume 
of 0.02M PBS and dialyzed against 0.02M PBS, with a change of dialyzing 
buffer at least 3 times and  left overnight at 4ºC. 
Preparation of a DEAE column used the appropriate amount of DEAE 
cellulose and in a 200ml glass beaker; washed DEAE three to four times with 
large volume pure water, the DEAE was mixed with water by stirring and then 
put aside for 1 hour. Water were poured off and DEAE immersed in 0.5N 
NaOH (15ml per germ of DEAE), mixed well and equilibrated 30 minutes, 
filtered and washed with water until pH to about 7. DEAE immersed in 0.5N 
HCl and treated the same as above; repeated immersion in 0.5N NaOH again 
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and treated the same way. Finally DEAE was immersed in 0.1 M pH 7.4 PB, 
over night. A quarter volume of 0.1 M pH 7.4 PB added in a column tube, and 
DEAE was poured into until suitable volume; equilibrated with PB to get same 
pH 7.4. 
Dialyzed normal human Ig with 0.1M pH 7.4 PB, overnight at 4 ºC; added IgG 
on the DEAE column, eluted with 0.1M pH 7.4 PBS, collected the flow through 
to get ion-exchange purified human Ig. Dialyzed against with 0.1M pH 8.0 
PBS at 4ºC overnight before the coupling. 
? Coupling human Ig to CNBr-4B sepharose 
One gram of CNBr-4B was swollen in 10-5 HCl solution on a glass filter and 
washed for 15 minutes; approximately 200ml solution was added. 
Immediately after washing, a solution of normal human Ig which was adjusted 
pH to 9.0 was added to be coupled at room temperature for 2 hours. Blocked 
with 0.2M glycine for 2 hours. Washed with 5 volumes 0.2Mol/L pH 9.0 
NaHCO3 (0.1Mol/L NaCl). The column was ready for use. 
? Crude centrifuged EgCF was passed through the Ig-CNBr sepharose column 
slowly (1ml/min flow speed), washed through with 0.01Mol/L pH7.4 PBS; and 
eluted with 0.1 M glycine-HCl buffer (pH 2.4). Partially purified EgCF was 
collected in tubes containing 1Mol/L NaHCO3 for neutralizing the solution; 
dialyzing against 0.01M pH 7.4 PBS. This EgCF preparation absorbed against 
normal human serum was aliquoted (0.5ml/tube) and stored at -80°C until 
used. 
 
Anti-EgCF IgG preparation: 
  - A rabbit was hyperimminised with native E. granulosus cyst fluid antigen 
(EgCF) as described by Gottstein 1983. 
  - Rabbit serum was taken when the specific antibody titre in rabbit was high 
enough (>10,000, tested with ELISA: capture was native antigen EgCF to the 
microtitre plate, conjugate was HRP conjugated goat anti – rabbit IgG and TMB as 
substrate) 
  - IgG from rabbit sera was purified by precipitation with saturated ammonium 
sulfate and DEAE ion-exchange chromatography column as described above. 
 
 
 277
I.2 Native crude somatic extract of E. granulosus protoscoleces (EgP) 
E. granulosus protoscoleces were harvested by aseptic aspiration from fertile E. 
granulosus hydatid cysts from naturally infected sheep in Xinjiang. Protoscoleces / 
brood capsule suspension was centrifuged and washed by pH7.2 PBS 3 times. A 
crude somatic extract was prepared by freeze / thaw twice at -70ºC and room 
temperature followed by ultrasonic treatment at 70w, 5ms (JY92-II sonicator, 
Ningbo Xinzhi Bio-Tech Co, China), allowed to stand for 1 hour at 4 °C and then 
centrifuged at 10000 rpm for 30 min. The supernatant was partially purified by 
affinity immunosorbent chromatography - affinity purified with normal human Ig 
coupled CNBr-activated Sepharose4B (Sigma) column as described above. 
Supernatants were concentrated with an Amicon ultra filtration cell with YM10 
membrane (Amicon Corp, MA, USA). The protein concentration of the EgP extract 
was estimated by spectropherometric absorbance OD value at 280nm/260nm 
wavelengths. 
 
I.3  Native E. granulosus cyst fluid antigen B (EgB) 
E. granulosus hydatid cyst fluid was obtained from naturally infected sheep in 
Xinjiang, P. R. China and EgB antigen prepared as described by Oriol et al. (1971) 
and Rogan et al (1989). Approximately 200mL of sheep hydatid cyst fluid was 
centrifuged at 3000 rpm for 10 min at 4°C, the supernatant was then dialyzed 
against H2O, followed by 0.005M, pH5.0 acetate buffer overnight at 4 °C. The 
dialyzed cyst fluid was centrifuged at 15000 rpm at 4 0C for 60 minutes and the 
supernatant discarded. The precipitate was re-suspended in 20mL 0.2M pH 8.0 
PBS and 40% saturate ammonium sulfate added and left for 1 hour to cause 
precipitation. The precipitate was centrifuged and the supernatant boiled in a 
water bath for 15 min, cooled then centrifuged at 15000 rpm at 4 0C for 60 minutes 
and the pellet discarded. This supernatant should be enriched for antigen B and 
was further concentrated with an Amicon ultra filtration cell with YM10 membrane 
(Amicon Corp, MA, USA) (Rogan et al., 1993, Zhang 1999). The protein 
concentration of antigen B was estimated by spectrophotometric absorbance at 
280nm and 260 nm wavelengths. The final concentration of stock EgB was 
0.522mg/ml. Aliquots of EgB were stored at -80°C until used. 
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I.4  Native E. multilocularis metacestode antigen Em2 
E. multilocularis larval metacestode masses were obtained from experimentally 
infected gerbils (Meriones unguiculatus) at XMU. The larval mass was broken 
completely by homogenization (food processor) and mixed with 0.15M pH7.2 PBS. 
This crude homogenizate was freeze/thawed at -80ºC for 3 times, then 
centrifuged at 10,000 rpm for 30 minutes at 4°C and the supernatant dialyzed 
against 0.15M pH 7.2 PBS to get crude E. multilocularis (Em) antigen. Crude 
antigen was passed through a CNBr-Sepharose4B column containing rabbit 
anti-EgCF IgG and eluted a buffer of 5M MgCl2. The eluate was enriched with 
Em2 antigen from the laminated membrane. The concentration of Em2 extract 
was estimated by OD value at 280/260 nm wavelengths (Gottstein et al., 1983; 
Zhang et al., 2000). 
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II. Main buffers used for human serodiagnostical ELISA  
Coating buffer: pH 9.6 
Na2CO3                   1.85 g 
NaHCO3                  2.73 g   
MgCl2⋅6H2O             3.04 g 
               ddH2O        add to  1000 mL   
 
20×PBS storing buffer: 
              NaCl                             160 g 
              Na2HPO4⋅12H2O            58 g 
              KH2PO4                                        4 g         
              KCl                                  4 g 
              ddH2O    add up to    1000 mL 
 
PBS buffer: 
             20×PBS          50 mL 
             ddH2O           950 mL 
 
20×PBST buffer 
             20×PBS         300 mL 
             Tween-20          3 mL 
 
Washing buffer 
            20×PBST buffer                   25 mL 
            ddH2O                add up to 500 mL 
 
Blocking buffer 
            20×PBST                            20 mL 
            BSA                                      4 g 
            Gelatine                                8 mL 
            ddH2O              add up to  500 mL 
 
 280
Sample dilution buffer 
            20×PBST                           20 mL 
            Normal Sheep sera            15 mL 
           Thiomersal                       0.04 g  (C9H9HgNaO2S) 
            ddH2O             add up to  400 mL 
 
Conjugate dilution buffer 
    PBST                                  480 mL 
    Enzyme stable reagent     0.25 g (a production from a Chinese Company) 
    Normal sheep sera        15 mL(3%)  (from healthy sheep) 
    Proclin 300               0.25 mL  (a stable reagent for antigen/antibody) 
 
Substrate buffer A : 
             Citric acid                      7.3 g 
             EDTA                             0.15 g  
             Mannitol                          30 g 
             ddH2O                             475 mL 
       Wait for 1hr, then 
             TMB／DMSO                 150 mg / 25 mL 
 
Substrate buffer B 
      Na2HPO4⋅12H2O                           11.86 g 
      Urea peroxide (carbamide peroxide)          0.5 g  
      ddH2O             add up to               500 mL 
 
Stopping buffer 
              Sulfuric acid (98%)          11.2mL 
              ddH2O            add up to    2000mL 
 281
III. Main buffers used for human serodiagnostical DIGFA  
 
Tris-HCl storing buffer:  200Mm    PH8.5    400ml 
    Tris                        9.7 g 
    NaCl                       35 g 
    NaN3                                 3.0 g 
    Concentrated HCl   2.5ml 
 
Buffer A: Sample buffer 
    Tris-HCl storing buffer:      50  mL 
    Tween-20                 250  µL 
    Gelatin            5  mL (Sigma-Aldrich, G7765, from cold water fish skin) 
    Pure H2O                         445  mL 
 
Buffer B: Washing buffer 
    Tris-HCl storing buffer:      50  mL 
    Tween-20                 2.0  mL 
    NaCl                      4.5  g 
    Pure H2O                  448.5 mL 
 
Buffer C: Colloidal conjugate 
    Test for antibody volume to be conjugate:  
             Antibody (goat anti-human IgG (γ-chain) diluted to 1mg/ml with 20 mM 
Tris-HCl (200 mM Tris-HCl storing buffer 5mL and pure H2O 45 mL). 
              6 of 1.5 mL tubes were added as follows: 
Tube No. 1 2 3 4 5 6 
Colloidal gold 1mL 1mL 1mL 1mL 1mL 1mL 
1mg/ml antibody 4µL 8µL 16µL 32µL 64µL 128µL 
10% NaCl 100µL per tube 
The colour would be purple to wine red in order, choose the one just changed to 
wine red as the conjugate concentration and added 120% of selected conc. for 
fully conjugated (eg. 32 µL selected and 32*120%=38.4µL IgG for 1 mL colloidal 
gold) 
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Colloidal conjugate: 
            Colloidal gold                         100 mL 
            0.2 M Sodium borate                    10 ml 
            1mg/ml goat anti-human IgG (γ-chain)     3.84ml 
                      4 °C for 45 minutes or 1 hour 
    5% PEG 20,000                        440 µL 
            Blocking buffer                         29.4ml 
 
Blocking buffer 
    200mM Tris-HCl              20 mL  
    Over saturated sucrose       20 mL (made from 350g sucrose in 150mL 
pure H2O) 
   Gelatin                      2 mL  
    5% PEG 20,000              0.22 mL) 
    Filtered with 0.2 µm pore size syringe filter and stored in dark at 4°C. 
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IV. Main buffers used for rapid ICA test for coproantigen in dogs  
 
Conjugate: 
          Colloidal Gold                              10 ml 
          0.2 M Sodium borate                        1 ml 
          1mg/ml rabbit anti-EgB IgG               0.384ml 
                        4 °C for 45 minutes or 1 hour 
          5% PEG 20,000                           440 µL 
          Blocking buffer                            2.94ml 
 
Blocking buffer 
          200mM Tris-HCl              5 mL  
          Over saturated sucrose   5 mL (made from 350g sucrose in 150mL 
pure H2O) 
           Gelatine                          0.5 mL  
           BSA                           0.58 g ) 
           Filtered with 0.2 µm pore size syringe filter and stored in dark at 4°C. 
 
Conjugate purification: 
Centrifuged conjugate in 2000rpm for 30 minutes to get rid off some bigger 
particles.                
Concentrated above conjugate in a dialysing tube with covered sucrose powder 
until one third of original volume.                
Preparing a Sephadex G200 column (1g for a volume 15-20ml). Concentrated 
conjugate coupled with the column, elution with 2% BSA 20mM Tris-HCl. 
Collected the middle part of deep wine red part of conjugate according that 
different sizes of colloidal conjugate would have different pass speed to get similar 
size conjugate. The final volume of conjugate was around 4ml. Test OD value 
under the wavelength 570nm. Diluted the conjugate to lower the OD value to 0.7 
with conjugate buffer (the details would be talked in the following 2.7.3. 
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V. QIAamp DNA Stool Handbook 
----- 
2. Add 1.6 ml Buffer ASL to each stool sample. Vortex continuously for 1 min 
or until the stool sample is thoroughly homogenized. 
Note: It is important to vortex the samples thoroughly. This helps ensure 
maximum DNA concentration in the final eluate. 
3. Centrifuge sample at full speed for 1 min to pellet stool particles. 
4. Pipet 1.4 ml of the supernatant into a new 2 ml microcentrifuge tube (not 
provided) and discard the pellet. 
Note: The 2 ml tubes used should be wide enough to accommodate an InhibitEX 
Tablet. Transferring small quantities of pelleted material will not affect the 
procedure. 
5. Add 1 InhibitEX Tablet to each sample and vortex immediately and 
continuously for 1 min or until the tablet is completely suspended. Incubate 
suspension for 1 min at room temperature to allow inhibitors to adsorb to 
the InhibitEX matrix. 
6. Centrifuge sample at full speed for 3 min to pellet stool particles and 
inhibitors bound to InhibitEX matrix. 
Note: For most samples, 3 min centrifugation is sufficient. With some samples, 
however, centrifugation for 3 min may result in a pellet that is not sufficiently 
compact. Therefore it may be difficult to remove enough supernatant to transfer 
600 μl supernatant after the next centrifugation step (step 9). In these cases, we 
recommend to centrifuge for 6 min. 
Note: When processing more than 12 samples, for this step and step 7 we 
recommend processing batches of no more than 12 samples each. This is 
because the pellets formed after centrifugation will break up quickly if the 
supernatant is not removed immediately. 
7. Immediately after the centrifuge stops, pipet all of the supernatant into a 
new 1.5 ml microcentrifuge tube (not provided) and discard the pellet. 
Centrifuge the sample at full speed for 3 min. 
Transferring small quantities of pelleted material from step 6 will not affect the 
procedure. 
8. Pipet 25 μl proteinase K into a new 2 ml microcentrifuge tube (not 
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provided). 
9. Pipet 600 μl supernatant from step 7 to the 2 ml microcentrifuge tube 
containing proteinase K. 
10. Add 600 μl Buffer AL and vortex for 15 s. 
Note: Do not add proteinase K directly to Buffer AL. 
It is essential that the sample and Buffer AL are thoroughly mixed to form a 
homogeneous solution. 
11. Incubate at 70°C for 10 min. 
Centrifuge briefly to remove drops from the inside of the tube lid (optional). 
12. Add 600 μl of ethanol (96–100%) to the lysate, and mix by vortexing. 
Centrifuge briefly to remove drops from the inside of the tube lid (optional). 
13. Label the lid of a new QIAamp spin column provided in a 2 ml collection 
tube. Carefully apply 600 μl lysate from step 12 to the QIAamp spin column 
without moistening the rim. Close the cap and centrifuge at full speed for 1 
min. Place the QIAamp spin column in a new 2 ml collection tube, and 
discard the tube containing the filtrate. 
Close each spin column in order to avoid aerosol formation during centrifugation. 
If the lysate has not completely passed through the column after centrifugation, 
centrifuge again until the QIAamp spin column is empty. 
14. Carefully open the QIAamp spin column, apply a second aliquot of 600 μl 
lysate and centrifuge at full speed for 1 min. Place the QIAamp spin column 
in a new 2 ml collection tube, and discard the tube containing the filtrate. 
Close each spin column in order to avoid aerosol formation during centrifugation. 
If the lysate has not completely passed through the column after centrifugation, 
centrifuge again until the QIAamp spin column is empty. 
15. Repeat step 14 to load the third aliquot of the lysate onto the spin 
column. 
16. Carefully open the QIAamp spin column and add 500 μl Buffer AW1. 
Close the cap and centrifuge at full speed for 1 min. Place the QIAamp spin 
column in a new 2 ml collection tube, and discard the collection tube 
containing the filtrate. 
17. Carefully open the QIAamp spin column and add 500 μl Buffer AW2. 
Close the cap and centrifuge at full speed for 3 min. Discard the collection 
tube containing the filtrate. 
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Note: Residual Buffer AW2 in the eluate may cause problems in downstream 
applications. Some centrifuge rotors may vibrate upon deceleration, resulting in 
the flow-through, which contains Buffer AW2, contacting the QIAamp spin column. 
Removing the QIAamp spin column and collection tube from the rotor may also 
cause flow-through to come into contact with the QIAamp spin column. 
18. Recommended: Place the QIAamp spin column in a new 2 ml collection 
tube (not provided) and discard the old collection tube with the filtrate. 
Centrifuge at full speed for 1 min. 
This step helps to eliminate the chance of possible Buffer AW2 carryover. 
19. Transfer the QIAamp spin column into a new, labeled 1.5 ml 
microcentrifuge tube (not provided). Carefully open the QIAamp spin 
column and pipet 200 μl Buffer AE directly onto the QIAamp membrane. 
Close the cap and incubate for 1 min at room temperature, then centrifuge at 
full speed for 1 min to elute DNA. 
Note: When using eluates in PCR, for maximum PCR robustness we highly 
recommend adding BSA to a final concentration of 0.1 μg/μl to the PCR mixture. 
For maximum PCR specificity we recommend using QIAGEN HotStarTaq Plus 
DNA Polymerase (see ordering information on page 39). For best results in 
downstream PCR, use the minimum amount of eluate possible in PCR; the 
volume of eluate used as template should not exceed 10% of the final volume of 
the PCR mixture. Also, note that high amounts of template DNA may inhibit the 
PCR. 
DNA yield is typically 15–60 μg but, depending on the individual stool sample and 
the way it was stored, may range from 5 to 100 μg. DNA concentration is typically 
75–300 ng/μl. 
For more information about elution and how to determine DNA yield, purity, and 
length, see the Appendix, page 36. 
For long-term storage, we recommend keeping the eluate at –20°C. 
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VI. Questionnaire for human screening on hydatid disease in Xinjiang Uygur 
Autonomous Region, P.R,China 
中国新疆地区包虫病调查表 
 
1．登记号：            姓名：         性别：男□    女□   年龄：   
    Reg.no.                    Name                           Sex:  Male     Female
   Age 
民族：汉 □   回 □  蒙 □     维 □    哈 □    其他 □   
Ethnic: Han     Hui      Mongolian   Uygur   Kazak    Others 
职业：(1)农民□(2)牧民□(3)干部□(4)工人□(5)商人□(6)学生□(7)士兵□(8)家庭主妇□(9)其他
□Occupation:   Farmer     Herdsman   Cadre      Worker  Businessman Student   
Soldier    Housewife     Others 
2．住址：          县            乡                村              队 
    Domicile:        County        Commune                 Village            Group 
   曾居住地：                                                               
    Lived before: 
3．上一年年收入： (1)＜2000 元   (2)2000-5000 元  (3) ＞5000 元………………………□ 
    Income of last year (RMB): 
4．听说过包虫病吗？           是□ 否 □ 
    Have you heard of hydatid disease?  Yes   No 
5．过去得过包虫病吗？是□ 否□ ；如果是，囊型□ 泡型□ ；做过何种治疗：手术□药物□穿刺□    
Have you been a hydatid patient: Yes No; If yes, CE or AE;        Treatment:      Operation 
Drugs   PAIR  
6．家里有人得过包虫病吗：是□ 否□ ； 如果是，是：父□ 母□ 爱人□ 兄弟□ 姐妹□ 孩子□ 其他□    
Has someone in your family been a hydatid patient? Yes No; if yes, he is: father mother partner 
brother sister children others 
7．家里养过狗吗？ 是□  否□  ，  如果是， 
    Have you owned any dogs? Yes, No;       If yes, 
养过几年狗：    年；养过几只狗：（1）1 只，（2）2 只，（3）3 只，（4）＞3 只…□ 
No. of years dogs owned:   Yrs; No. of dogs owned: (1) 1，（2）2，（3）3，（4）＞3 
家庭中照顾狗的是：父□  母□  爱人□  兄弟□  姐妹□  孩子□  本人□  其他□    
Who cared dogs in your family: father, mother, partner, brother sister, children, yourself, others 
狗吃什么：（1）动物内脏  （2）剩饭   （3）野鼠、兔…     ……………………□ 
Dog’s food:        Viscera       House hold scraps  catch wild rodents 
狗接受过检查吗？是□ 否□ 
Have your dogs been tested/treated before: Yes No 
狗粪作肥料浇地吗？是□ 否□  狗用于放牧家畜吗？ 是□ 否□ 
Have you used dog faeces as fertile in the farm? Yes, No; Did dog go with livestock together? 
Yes, No 
8．你家里有家畜吗？是□ 否□ ；如果是，绵羊□  山羊□  牛□  马□  骆驼□   驴□   骡□  猪□ 
    Do you own livestock? Yes No; if yes, sheep, goat, cattle, horse, camel, donkey, mule, pig 
9．你在家屠宰牲畜吗？是□  否□ 
    Do you slaughter livestock at home? Yes No 
10．你见过狐狸：是□ 否□ ；狼：是□ 否□；野猫：是□ 否 ； 
     Have you seen fox: yes no; wolf: yes no; felines: yes no 
你打猎打过狐狸：是□ 否□ ；接触过狐狸皮：是□ 否□ 
Have you hunted fox before? Yes no; have you touched fox skin? Yes no 
11．你见过的老鼠：家鼠□   田鼠□    旱獭□    其他□ 
     Have you seen rodents: Rattus norvegicus,  Microtus,  Marmota 
12 ． 饮 用 水 ： (1) 自 来 水  (2) 深 井 水  (3) 浅 井 水  (4) 河 塘 水  (5) 溪 水   （ 6 ） 其
他……………………………□ 
     Drinking water: (1)tap in the street (2) deep well (3) pump in the yard (4)from river (5)from 
scream (6)others 
13．饭前洗手：是□  否□   ；饮用未经煮沸的生水：是□  否□  ；食用生的蔬菜：是□  否□ 
  Washing hands before eating: yes no; drinking un-boiled water: yes no; eating uncooked 
vegetables: yes no 
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14．血样品采集： （1）滤纸        （2）静脉         （3）两者均有…………………………………□ 
     Blood sample collection: filter-paper            vein                  both of them 
 
15．腹部 B 超检查结果：（1）正常□ （2）CE□ （3）AE□ （4）可疑□ （5）单纯钙化灶□   
     Abdomen ultrasound:         normal          CE          AE           query         
calcified lesion 
（6）其他腹部疾病:           胆结石□   胆囊炎□     脂肪肝□ 
Other abdomen abnormal:      gall-stone     cholecystitis    
fatty liver 
 
如果是 CE： 
If CE,  
T1=单纯囊型（直径＜4cm）……□ 
Type 1 =univesicular (Φ<4cm) 
T2=单纯囊型（直径>4cm）……□ 
Type 2 =univesicular (Φ>4cm) 
T3=多子囊型……        …………□ 
Type 3 =daughter cysts 
T4=内囊塌陷内囊破碎型………□ 
Type 4 =ruptured endocyst 
T5=实变型…           ……………□ 
Type 5 =solid cyst 
T6=钙化型…           ……………□ 
Type 6 =calcified cyst 
大小（mm）：          数量：   
Size (mm):                Number: 
位置：  左肝□  右肝□  左右均有□  脾
□ 
Location: left liver   right liver,    
both      spleen 
肾□    腹腔□     肝及其他部位□ 
kidney, abdominal cavity, liver and 
other organs 
症状：                                 
Symptom: 
如果是 AE： 
If AE,  
P1=病灶≤2 个肝段，无肝脏、胆道累及 …□ 
Single lesion≤ 2 segments, without 
intrahepatic vascular or biliary 
involvement 
P2=病灶≤2 个肝段，有肝脏胆道累及…… □ 
Single lesion≤2 segments with the above 
involvement 
P3=病灶占 3-5 个肝段，有肝胆道累及… □ 
  The lesion occupied 3-5 segments 
P4=病灶占 6-8 个肝段，有肝胆道累及… □ 
  The lesion occupied 6-8 segments 
其 他
型 …                 … ………………□ 
  Other types 
 
大小（mm）：            数量：          
Size (mm):               
Number: 
AE 病变有中央型坏死腔：是□  否□ 
Central necrosis in AE lesion:   Yes     
No 
位置：左肝□     右肝□    左右均有□ 
Location: left liver      right liver      
both; 
症状：                                  
Symptom 
 
 
 
16．其他部位包虫病检测结果： 
    Other tests for other organs hydatid disease: 
部位：                                                                                  
Location: 
检测结果：                                                                              
Test results: 
 
17．血清学检测结果： 
    Serology test results: 
(1)快速检测：   EgCF:  +++□ ++□ +□ +/-□ –□    EgP:  +++□ ++□ +□ +/-□ –□   
Rapid DIGFA:   EgB:    +++□ ++□ +□ +/-□ –□    Em2:  +++□ ++□ +□ +/-□ –□   
(2)酶联检测：   EgCF                                EgP 
  ELISA:             EgB                                 Em2 
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VII. Questionnaire for dog owners on hydatid disease in Xinjiang Uygur 
Autonomous Region, P.R,China  
 
China: Surveillance Data for Echinococcus spp. in dogs 
中国：关于有腔棘球绦虫的调查数据 
Date 日期                                            Grid point 坐标点          
全球定位系统坐标：GPS X          
GPS Y          
General Information 常规信息 
1. Village name 村庄名称               
2. Household name 户主名称            
3. Are you nomadic? (please circle one)        No 不是 
您 是牧民吗 ？（请选 择右边的 一项 ）    Yes-herdsman 是—放牧 
                                        Yes-dig herbs 是—采药 
                                        Yes-hunter 是—狩猎                        
4. Number of years at current location 请填写您在这个地区居住的时间为（年）          
5. What is your occupation？请填写您在这里所从事的职业       
6. Do you or have you ever hunted fox (explain)             
请叙述您以前猎捕狐狸的一些情况 
Dog Information 关于狗的信息 
7. Length of dog ownership(years) 请填写您养狗的时间（年）        
8. Number of dogs currently owned 请填写您家里目前所养狗的总数        
9. Name of dog 这只狗的名字是         
10. General description of dog 请您对这只狗进行概括的描述        
11. Age of dog(years) 这只狗的年龄是        
12. Sex of dog(please circle one)    Male 公 
请选择这只狗的性别    Female 母 
13. Does your dog eat raw meat?(please circle one)Yes-frequently 是—经常 
    请 选 择 这 只 狗 是 否 吃 未 经 过 烧 煮 的 肉     Yes-occasionally 是 —— 有时候               
No 不 
14. Has the dog been seen eating rodents? (please circle one) Yes-frequently 是—经常 
您的狗吃其他啮齿类的动物吗？                  Yes-occasionally 是—有时候 
                                                 No 不 
15. Is the dog tied? (please circle one)      Never 从来没有 
您拴着您的狗吗？         Yes-all of the time 是—总是 
Yes-during the day only 是—只有白天 
Yes-at night only 是—只有夜里 
16. Who cares for the dog 请填写您家里经常照顾狗的人是（男性或女性）?           
17. Do you use dog feces as fertilizer(please circle one)   Yes 是的 
您用狗的粪便做肥料吗？            No 不是 
Don’t have a garden 我家没有（菜、花）园 
18. Are there stray dogs in the area(please circle one)     Yes 有 
在附近有没有发现野狗             No 没有 
19. Do you play with or pet your dog(please circle one)    Yes 是的 
您和您的狗一起玩耍吗？            No 不是 
Livestock Information 关于牲畜的信息 
20. Do you own yaks? (please circle one)   Yes 有     
您有牦牛吗？           No 没有 
21. Do you own sheep or goats? (please circle one)  Yes 有     
您有绵羊或者山羊吗？          No 没有 
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Water Source 水源 
22.  What is your primary water source    central supply 集中提供  
您家里所使用的水源是      tap in the house 家用自来水 
  (please circle one)             tap in the street 自来水（公共场所） 
   （请选择）                 pump in the yard 院子里的水源 
                              tank filled from river 供水车中的水箱 
                              carried from river 河水 
                              carried from stream 泉水 
                              from a well 井水 
Human Hydatid Disease 人体包虫病 
23. Number of family members ultrasounded 请填写您家里有几位成员进行过超声波检查      
24. Presence of positive cases(please circle one)    Yes 有 
检查结果是否有人感染          No 没有 
If yes, please fill out the following (noting how disease was confirmed and location of lesion):
如果有请指出是下列哪项（说明：疾病是由什么方式检查出来以及病变所在的位置） 
Male AE confirmed 男—确诊ＡＥ Female AE confirmed 女—确诊ＡＥ 
Male CE confirmed 男—确诊ＣＥ Female CE confirmed 女—确诊ＣＥ 
Male hydatid disease suspected 男—怀疑感
染包虫病 
Female hydatid disease suspected 女—怀疑感
染包虫病 
 
How long ago was the most recent case diagnosed (in years) 请填写您上次检查的时间（几年
以前）? 
25. Was surgery performed on this case? 请填写您以前是否针对这种疾病进行了外科手术         
Knowledge of Hydatid Disease 对于包虫病的认识 
27.Correct description of hydatid disease (please circle one)     Yes 能 
您是否能对包虫病进行正确的描述           No 不能 
28.Correct transmission knowledge (please circle one)         Yes 能 
  您是否能把包虫病的知识传达给其他人           No 不能 
Samples and Findings 采样以及发现 
Sample collected(please circle one)    Feces (ground)粪便（地面）  
所采集的样品           Feces (loop)粪便（采样仪器） 
Purged sample 使用泄药采集的样品 
Necropsy 尸体检验时采集的样品 
Echinococcus multilocularis found (number) 发现泡状棘球绦虫的数目                 
Echinococcus granulosus found (number) 发现细粒棘球绦虫的数目                 
ELISA(please circle one)        Positive 阳性                         Negative 阴性 
PCR(please circle one)          Positive 阳性 Em/Eg                 Negative 阴性 
Other parasites found (please specify) 其它寄生虫病例                          
Where samples kept from this animal (please specify) 寄生虫感染的位置                    
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a b s t r a c t
A new 3-min rapid dot immunogold ﬁltration assay (DIGFA) for serodiagnosis of human cystic and alve-
olar echinococcosis was developed using four native antigen preparations: crude and partially puriﬁed
hydatid cyst ﬂuid extracts from Echinococcus granulosus (EgCF and AgB), E. granulosus protoscolex extract
(EgP) andEchinococcusmultilocularismetacestode antigen (Em2). Theoverall sensitivity ofDIGFA in ahos-
pital diagnostic setting was 80.7% for human cystic echinococcosis (CE) (n=857) and 92.9% for humaneywords:
chinococcosis
mmunodiagnosis
ot immunogold ﬁltration assay (DIGFA)
LISA
alveolar echinococcosis (AE) (n=42). Highest speciﬁcity was 93.4% with AgB extract for CE, and 90.3%
with Em2 antigen for AE when CE versus AE cross-reactivity was excluded. Anti-AgB antibodies were
present in 35.5% of AE cases and anti-Em2 in 7.4% of CE cases. In endemic communities in northwest
China screened for echinococcosis, the sensitivity of DIGFA ranged from 71.8% to 90.7% in comparison
to abdominal ultrasound; speciﬁcity for CE using AgB was 94.6% and for AE using Em2 was 97.1%. This
t can
ningsimple eye-read rapid tes
ultrasound for mass scree
. Introduction
Echinococcosis is a worldwide zoonosis caused by the larval
tages of tapeworms (cestodes) belonging to the genus Echinococ-
us (family Taeniidae). Echinococcus granulosus and Echinococcus
ultilocularis, which cause human cystic echinococcosis (CE) and
lveolar echinococcosis (AE), respectively, are highly endemic in
hina (Wen and Yang, 1997; Craig, 2004). Both cause serious and
otentially life-threatening diseases, the latter especiallywith high
atality rates and poor prognosis if not diagnosed and treated in
he early stages (Zhou et al., 2000; WHO/OIE, 2001; Craig et al.,
003). Mixed CE and AE cases are rare but have also been reported
n China (Wen et al., 1992; Yang et al., 2006a,b). Currently, mor-
ality for human CE may vary between 0.2% and 4.5%, and for
uman AE between 10% and 15% (Wen and Yang, 1997; WHO/OIE,
001; McManus et al., 2003; Zhang et al., 2003). Early diagnosis of
uman echinococcosis is difﬁcult because CE and AE cases usually
∗ Corresponding author. Tel.: +86 991 4366450; fax: +86 991 4324139.
E-mail addresses: feng xh cn@yahoo.com.cn (X. Feng), dr.wenhao@163.com
H. Wen), h.bradshaw@salford.ac.uk (H. Bradshaw), dvuitton@univ-fcomte.fr,
coms@chu-besancon.fr (D. Vuitton), p.s.craig@salford.ac.uk (P.S. Craig).
1 Tel.: +86 991 4366450; fax: +86 991 4324139.
2 Tel.: +44 161 2955488; fax: +44 161 2955015.
3 Tel.: +33 3 81 6689 28.
001-706X/$ – see front matter © 2009 Published by Elsevier B.V.
oi:10.1016/j.actatropica.2009.10.003be used for both clinical diagnostic support, as well as in conjunction with
in endemic CE and AE areas.
© 2009 Published by Elsevier B.V.
have no signs or symptoms during the ﬁrst few years of infection.
Human echinococcosis commonly comes to the attention of clin-
icians because of non-speciﬁc clinical signs (e.g. upper abdominal
pain, jaundice, allergic reactions), or due to incidental image ﬁnd-
ings of echinococcal cysts or lesions, or after speciﬁcmass screening
surveys by ultrasound and/or serology (WHO, 1996; WHO/OIE,
2001; Zhang and McManus, 2006).
The frequent difﬁculty in obtaining a deﬁnitive diagnosis is
one reason why immunological methods have played an impor-
tant role in diagnosis of human echinococcosis (Wen et al., 1995;
Rogan and Craig, 1997, 2002; WHO/OIE, 2001). Almost all tradi-
tional immunodiagnostic methods (e.g. Casoni intradermal test,
complement ﬁxation test, indirect haemagglutination test, indirect
immunoﬂuorescence antibody test, immunoelectrophoresis, and
latex agglutination test), have now been replaced by the enzyme-
linked immunosorbent assay (ELISA) and/or immunoblotting
which are commonly performed in routine laboratory diagnosis of
human echinococcosis (Rogan and Craig, 2002; Craig et al., 2003).
Hydatid cyst ﬂuid lipoprotein antigen B (AgB) from E. granulosus,
and Em2/Em2plus, and/or Em18 antigens from E. multilocularis, are
considered to be the most speciﬁc native or recombinant antigens
for immunodiagnosis of human CE and AE, respectively (Gottstein
et al., 1987; Ito, 2002; Zhang et al., 2003).
Although ELISA and immunoblotting are very useful laboratory
tests for human echinococcosis, a rapid and cheap immunological
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ethod that can be used for initial diagnosis of clinically suspected
E or AE, and that could also be applied in community screen-
ng, would be extremely convenient. Rapid serological test formats
uch as dot-ELISA have been previously assessed for both human
E and AE, and although useful in conjunction with mass ultra-
ound screening, they were temperamental, and difﬁcult to use
nd interpret (Zheng et al., 1986; Rogan et al., 1991; Eliades et al.,
998; Qiao et al., 1999; Craig et al., 2000). Dot immunogold ﬁl-
ration assay (DIGFA) is a rapid immunodiagnostic test similar to
‘pregnancy’ test that uses colloidal gold conjugated antibody or
ntigen instead of enzyme or ﬂuorescence conjugates (Faulk and
aylor, 1971; Horisberger et al., 1975; May, 1991; Chun and Chu,
989; Dar et al., 1994; Xiao et al., 1995). Antigens are attached on
nitrocellulose membrane, and serum or whole blood applied, fol-
owed by colloidal gold conjugated anti-human antibodies to give
desired color change to indicate a positive or negative reaction.
In the current study a rapid DIGFA has been developed for
uman echinococcosis and assessedwith four different native anti-
en preparations including E. granulosus crude hydatid cyst ﬂuid
ntigen (EgCF), hydatid cyst ﬂuid native antigen B (AgB), an E. gran-
losus protoscolex antigen extract (EgP), and an E. multilocularis
etacestode laminated layer extract (Em2). The test was assessed
n Xinjiang Medical University Hospital (Urumqi, northwestern
hina),which has treated over 6000 human echinococcosis cases in
he last 40 years (Wen and Yang, 1997). The current study showed
hat themajor advantagesofDIGFAwere rapidity, convenience, and
bility toprovide initial diagnosis andevendifferentiationofCEand
E in approximately 80% of cases either in clinical or community
creening settings.
. Materials and methods
.1. Preparation of diagnostic antigens
Native extracts of E. granulosus and E. multilocularis were used
ecause they can be prepared relatively easily by most laborato-
ies. Sheep hydatid cyst ﬂuid and protoscoleces from E. granulosus
ere collected in Xinjiang Uygur Autonomous Region (XUAR),
hina. Crude cystic ﬂuid (EgCF) was partially puriﬁed by afﬁn-
ty chromatography using a normal human serum coupled to
NBr–Sepharose 4B to remove non-speciﬁc host reactive pro-
eins from sheep hydatid cyst ﬂuid (Rogan et al., 1991; Zhang
t al., 2000). A crude somatic extract of E. granulosus protoscole-
es (EgP) with >85% viability were harvested from fertile sheep
epatic hydatid cysts, prepared by ice cold homogenization and
entrifugation (13,000× g for 30min at 4 ◦C) and partially puri-
ed by afﬁnity chromatography as for EgCF (Zhang et al., 2000).
. granulosus cyst ﬂuid antigen B (AgB) was puriﬁed from fresh
heep hydatid cyst ﬂuid by precipitation, boiling, centrifugation
nd concentration by dialysis as previously described (Rogan et al.,
991; Rogan and Craig, 1997; Zhang et al., 2000, 2001). Experi-
ental infections of gerbils (Meriones unguiculatus) after 3 months
ost-infection with E. multilocularis protoscoleces (in a metaces-
ode homogenate suspension) were used to produce metacestode
issue for extraction of a laminated layer enriched antigen (Em2) by
omogenization, centrifugation and afﬁnity chromatography using
abbit anti-E. granulosus cyst ﬂuid-IgG coupled CNBr–Sepharose 4B
olumn (Gottstein et al., 1983; Zhang et al., 2001).
.2. Serum samples and echinococcosis patients.2.1. Hospitalized hydatid patients
Archived serum panels used in the initial laboratory develop-
ent and standardization of the DIGFA, were available from 108
ost-operativehepaticCEcases, 34post-operativehepaticAEcases,113 (2010) 114–120 115
and 101 healthy controls collected from Xinjiang Medical Univer-
sity Hospital (XMUH) during 1998–2000. In addition 25 sera from
cysticercosis (Taenia solium) patients were a gift from Prof. Y.H. Liu,
Chongqing Medical University, PR China.
A serum panel was also available to assess hospital-based diag-
nosis of DIGFA and compared with standard ELISA. It consisted of
857 CE sera including 711 hepatic CE cases: among them, 516 ultra-
sound and/or surgery conﬁrmed patients with less than 2 years
post-surgery, 64 lung CE cases (diagnosed by X-ray or computer-
ized tomography (CT)), 11 abdominal CE (diagnosed by ultrasound
or CT), 18 multi-organ CE (diagnosed by ultrasound and CT) and
47 non-liver/lung CE cases (diagnosed by ultrasound, CT or mag-
netic resonance imaging (MRI)). In addition, sera from 42 liver AE
cases and 1 mixed AE/CE case were assessed. In total 702 serum
samples from non-hydatid disease patients were used as nega-
tive controls: non-parasite simple cystic disease 153, carcinoma
85, tuberculosis 28, solid or complicated space-occupying lesions
(non-echinococcosis by imaging) 266, cirrhosis 6, abscess 13, cys-
ticercosis 3, cholecystitis/gallstones 12, other patients treated in
internal medicine (for hypertension, diabetes, and other clinical
conditions) 88 and healthy individuals 5. All samples were col-
lected and tested in XMUH during the period 1999–2006. For
non-endemic controls, 35 sera from healthy people were collected
from a hospital in Greater Manchester, UK, which is a non-endemic
area.
2.2.2. Community screening
Echinococcosis endemic communities in northwest China that
were screened by ultrasound and serologywere: Qinghe, Hobuker-
saier, Wenquan, Xinyuan County and Bayanbulak Pasture in XUAR;
Xiji County in Ningxia Hui Autonomous Region (AR); Ganzi County
in Sichuan Province; and Dingqing County in Tibet AR. Based on
ultrasound scan as the gold standard, serum samples from 160 CE
and 108 AE cases, and from 2923 ultrasound normal persons were
processed from these endemic communities in northwest China
(Feng et al., 2002; Chen et al., 2005; Wang et al., 2001; Yang et
al., 2006a,b). Ultrasound normal cases with a previous history of
echinococcosis surgery were not included in the ‘negative’ group.
All persons included gave informed consent for their serum to be
collected and assessed in the study. Ethical permissionwas granted
by the Xinjiang Medical University Hospital Ethical Committee.
2.3. DIGFA procedure
The four native antigen preparations (mostly protein antigens
EgCF, EgP and AgB, and mostly carbohydrate antigen Em2) were
used at a protein concentration, measured by OD value under
280nm wavelength and then diluted to 2.2, 2.2, 0.5 and 2.2mg/mL,
respectively before optimized. Together with a quality control
(diluted normal human sera), they were coated 1L/dot onto
nitrocellulose (NCP) paper (pore size 0.45m, Millipore Co., Bed-
ford, USA) ﬁxed in a special plastic frame (5 cm×3.5 cm) with a
central well (diameter 0.7 cm) (XMUH Chinese patent: ZL 99 2
19078.9) (Fig. 1). Test serum was diluted with a 20mM Tris–HCl
(pH 8.2) based sample buffer (20L serum or 40L heparinised
blood in 5 drops (about 220–250L) buffer) onto the NCP in the
well until completely inﬁltrated. This was followed by 3 drops
(about 130–150L) of 20mM Tris–HCl (pH 8.2) washing buffer,
3 drops (about 130–150L) of colloidal gold conjugated anti-
human IgG antibody solution and ﬁnally by Tris–HCl washing
buffer. Colloidal gold was made by sodium citrate reduction of
hydrogen tetrachloroaurate (HAuCl4), and conjugated with goat
anti-human IgG (Sigma I1886, USA; Sino-American Biotechnology
Co., Luoyang, China) (Beesley, 1989; Millipore Corp., 1996; Oliver,
1999a,b; Reddy, 2006). Each reagent was added after the previous
was totally absorbed (generally 1min per step). The result could be
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aig. 1. DIGFA test kit. (i) Diagram of antigen dots: Dot A is for EgCF, Dot B for EgP, D
a) serum positive CE case, (b) serum positive AE case, and (c) negative control.
bserved and recorded immediately after the last washing buffer
ad ﬁltrated, and the whole assay usually took 3–4min (Fig. 1).
IGFA reagents were stable when stored at 4 ◦C for 1 year.
The intensity of the red color as a spot from the colloidal gold
onjugate indicated the degree of immune combination. A control
or correct working of the test was a diluted normal human serum
ool (from normal human serum pool) placed in a central well,
hich should always become positive if all reagents were in good
orking condition. The crude EgCF and EgP extracts were used pri-
arily for anti-Echinococcus antibody sensitivity, while AgB was
ainly speciﬁc for the conﬁrmation of CE, and Em2 primarily for
E (Gottstein et al., 1987; Rogan and Craig, 1997; Craig et al., 2000;
HO/OIE, 2001; Zhang et al., 2003). If either one of the respective
gCF, EgP, AgB or Em2 spots appeared (a red spot), the sera were
resumptively positive for echinococcosis. Color change in the AgB
pot indicated high probability of CE antibodies, and the Em2 spot
ndicated high probability of AE antibodies. If both AgB and Em2
pots appeared, the serum was considered to be either CE or AE,
espectively dependent on the strength of color change.WhenEgCF
nd/or EgP was/were positive, but both AgB and Em2 were nega-
ive, the serum was considered “doubtful”. If no antigen spots were
eactive, the serum was considered negative. The degree of color in
eneral reﬂected the antibody activity level in a serum sample. The
egree of positive color changewas subjective and judged between
+” to “++++”, according to the color-darkness level (Fig. 1(ii)).
.4. ELISA procedure
The panels of serum samples from hospital treated echinococ-
osis patients were tested by both DIGFA and ELISA. The ELISA
as the routine test used in the hospital (XMUH). Microtitration
lateswere coatedovernight at 4 ◦Cwith the above fournative anti-
en preparations at optimal concentrations (2–10g/mL) in 0.1M
arbonate/bicarbonate buffer (pH 9.6). The four antigens were sep-
rately coated on ELISA plates. The plates were then washed withor EgB and Dot D for Em2 antigens. (ii) Actual DIGFA result after serum test (3min)
0.1M PBS 0.1% Tween 20, and blocking buffer added (PBS, pH 7.2,
0.3% Tween 20, 1% bovine serum albumen (BSA), 2% gelatin) for
2h at 37 ◦C; washed with 0.1M PBS (0.1% Tween 20) and then
freeze-dried (using Labconco Freeze Dry System and Stoppering
Tray Dryer, Labconco Co., Kansas, USA) for storage at 4 ◦C until
used. Human serum samples were diluted 1:100 in PBS (pH 7.2,
0.1% Tween 20, 3.75% normal sheep serum) at 100L/well, added
in duplicate to the above four antigens coated microtitration plate
and incubated for 30min at 37 ◦C. Plates were washed as above
then incubated with 100L/well of horseradish peroxidase con-
jugated anti-human IgG (Sigma A6029, Saint Louis, USA), diluted
1:8000 with 0.1M PBS, 3% sheep serum and 0.05% enzyme stable
reagent (Beier Co., Lianyungang, Jiangsu, China) for 20min at 37 ◦C.
After the ﬁnal wash a substrate of 3,3′,5,5′-tetramethylbenzidine
(TMB) was used and allowed to develop for 15min, followed by
a stop solution of 50L 0.01M sulfuric acid. Wells were read at
450nm with a Bio-Rad 550 plate reader (Bio-Rad Laboratories, Inc.,
CA, US). Positive control sera from conﬁrmed CE or AE patients, and
negative control sera from healthy individuals, were used in each
microtitration plate for quality control. Sera were tested in dupli-
cate and the positive–negative cut-off value was determined as the
mean optical density of a panel of negative controls (n=35) plus
three standard deviations (OD cut-off for EgCF=0.286; EgP=0.609;
AgB=0.105; Em2=0.187) (Craig et al., 2000; Rogan and Craig, 1997,
2002). Sensitivity and speciﬁcity were calculated using 95% conﬁ-
dence intervals and signiﬁcance valueswere also determined at the
95% probability level.
3. Results3.1. Initial validation of multiple Echinococcus antigens (EgCF,
EgP, AgB and Em2) in DIGFA
In preliminary assessment of archived serum samples the sen-
sitivity of DIGFA for human CE (n=108) was 92.6%, 90.7% and 89.8%
X. Feng et al. / Acta Tropica 113 (2010) 114–120 117
Table 1
Comparison of rapid DIGFA and standard ELISA applications for serodiagnosis of human echinococcosis in hospitalized CE (n=857) or AE cases (n=42).
Clinical diagnosis N DIGFA ELISA p
Positivea Negative Sensitivity (%) (95% CIb) Positive Negative Sensitivity (%) (95% CI)
CE 857 692 165 80.7 (78.1–83.3) 643 214 75.0 (73.5–76.5) <0.01
AE 42 39 3 92.9 (88.9–96.8) 41 1 97.6 (95.2–99.9) >0.05
AE/CE 1 1 0 100 1 0 100
Controlsc 702 73 629d 10.4e 72 630d 10.3e >0.05
Total 1602 805 797 757 845
a Positive means any one of the four antigen dots changing color in DIGFA, and any one of the four antigens OD value over cut-off in ELISA.
b 95% conﬁdence interval, p ± 1.96
√
p(1 − p)/n, p means sensitivity or speciﬁcity, n means number.
c Controls were deﬁned as those free from either CE or AE infection.
d Negative concordance was 83.8% (588/702) between DIGFA and ELISA in control group.
e False positive rate in control group (non-CE/AE).
Table 2
Sensitivity and speciﬁcity of AgB antigen in DIGFA and ELISA for hospitalized CE cases.
Clinical diagnosis N DIGFA ELISA p value
Positive Negative Positive Negative
CE 857 586 271 492 365 <0.01
Non-CE
AE 42 28 14 21 21 >0.05
Controls 702 21 681 28 674 >0.05
Subtotal 744 49 695 49 695 >0.05
S 7) (95
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TTotal 1601 635
ensitivity was 68.4% (586/857) with 95% CI 66.8–69.9% in DIGFA and 57.4 (492/85
IGFA and ELISA. Negative concordance between DIGFA and ELISA was 94.2% (661/
ith EgCF, EgP and AgB native antigen preparations, respectively.
f the four different native antigen preparations the highest sen-
itivity occurred with antigen EgCF (92.6% for CE cases and 88.2%
or AE cases). For human AE (n=34) sensitivity of DIGFA was 91.1%
or Em2 antigen. The speciﬁcity for CE with AgB antigen in DIGFA
as 88.1% with 95% conﬁdence intervals (CI) (82.0–94.2%), and for
E with Em2 antigen was 93.6% with 95% CI (89.4–97.8%). Cross-
eactivity between human CE and AE for AgB antigen was 35.3%
or AE, while cross-reactivity for Em2 with human CE was 7.4%.
ross-reaction inDIGFAwith serumfromcysticercosis patientswas
able 3
ensitivity and speciﬁcity of Em2 antigen in DIGFA and ELISA for hospitalized AE cases.
Clinical diagnosis N DIGFA
Positive
AE patients 42 35
Non-AE CE 857 146
Controls 702 5
Subtotal 1559 151
Total 1601 186
ensitivity was 83.3% (35/42) with 95% CI 72.1–94.6% in DIGFA and 78.6% (33/42) (95%
IGFA and 78.0% (1249/1559) (95% CI 75.9–80.1%) in ELISA. Negative concordance betwe
able 4
omparison of DIGFA test with abdominal ultrasound imaging in mass screening commu
ibet AR).
US result N EgCF positive EgP positiv
CE 160 112 88
AE 108 95 83
Normal 2923 641 462
Sensitivity CE 70% 55%
For each antigen AE 87.9% 76.9%
Speciﬁcity 78.1% 84.2%
a 95% CI of general sensitivity for CE was 64.9–78.8%.
b 95% CI of general sensitivity for AE was 85.2–96.2%.
c 95% CI of general speciﬁcity for both CE and AE was 72.8–76.0%.966 541 1060
% CI 54.1–60.7%) in ELISA. Speciﬁcity was 93.4% (695/744) (95% CI 91.6–95.1%) in
n control group.
observed with all four antigens (60% and 56% with EgCF and EgP;
8% and 16%, respectively for AgB and Em2). There was no statis-
tical difference between results observed using DIGFA versus the
standard ELISA using above four native antigens (p>0.05).3.2. Diagnostic evaluation of the rapid DIGFA in a hospital setting
The DIGFA was applied for immunodiagnosis of clinical
echinococcosis using a panel of sera (n=899, CE=857 and AE=42)
taken from patients that were treated in XMUH over the period
ELISA p value
Negative Positive Negative
7 33 9 >0.05
711 290 567 <0.01
697 20 682 <0.01
1408 310 1249 <0.01
1415 343 1258
CI 66.2–91.0%) in ELISA. Speciﬁcity was 90.3% (1408/1559) (95%CI 89.6–91.0%) in
en DIGFA and ELISA was 95.7% (672/702) in control group.
nity studies in western China (data combined from Xinjiang, Ningxia, Sichuan and
e AgB positive Em2 positive All negative
82 18 45
74 84 10
91 70 2175
51.3% 11.3% 71.8%a
68.5% 77.8% 90.7%b
96.9% 97.6% 74.4%c
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Table 5
DIGFA test using AgB antigen for immunodiagnosis of CE in community mass
screening studies (data combined from Xinjiang, Ningxia, Sichuan and Tibet AR)
in comparison to abdominal ultrasound.
Ultrasound AgB-DIGFA Total
Positive Negative
CE patients 82 78 160
Non-CE patients
AE 74 34 108
Controls 91 2832 2923
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Table 6
DIGFA test using Em2 antigen for diagnosis of AE in community mass screening
studies (data combined fromXinjiang, Ningxia, Sichuan and Tibet AR) in comparison
to abdominal ultrasound.
Ultrasound Em2-DIGFA Total
Positive Negative
AE patients 84 24 108
Non-AE
CE 18 142 160
Controls 70 2853 2923
Subtotal 88 2995 3083Subtotal 165 2866 3031
Total 247 2944 3191
ensitivity 51.3% (82/160) and speciﬁcity 94.6% (2866/3031).
eptember 1999 to April 2006. The DIGFA test had a lower sen-
itivity for CE (80.7%) compared with the initial laboratory based
tudy (p<0.01) for all CE patients combined including liver, lung, or
ther organs (Table 1). Overall speciﬁcity of DIGFA for CEwas 93.4%
695/744 non-CE cases were negative); cross-reactions occurred
ith 28/42 AE cases (Table 2). The sensitivity of Em2-DIGFA for
uman AE showed no statistical difference between the laboratory
ased study (91.1%) and the main hospital study (90.3%) (p>0.05)
Table 3). However Em2 antigen showed cross-reaction with 17%
146/857) of CE cases. The sensitivity of DIGFA for CE in different
rgans was: 94.4% in multi-organ CE, 83.4% for hepatic CE, 80.7%
or pulmonary CE, 80% for CE in the pelvic cavity, 70% for CE in the
bdominal cavity, and 56.7% for CE in other organs (including heart,
idney, brain, spine, bone, subcutaneous). Signiﬁcant statistical dif-
erenceswereobservedbetweenDIGFAandELISA for serodiagnosis
f CE. The ELISA exhibited lower sensitivity for hospitalized human
E cases (75.0%), but higher speciﬁcity (97.6%) compared to DIGFA
p<0.01). For human AE both ELISA and DIGFA had similar sensi-
ivities (97.6% vs. 92.9%) (p>0.05) but different speciﬁcities (80.1%
s. 90.3%) (p<0.01) (Tables 1 and 3). Overall a false positive rate
f 10.4% occurred with the DIGFA for sera from persons without
chinococcosis. Negative concordance betweenDIGFA and ELISA in
he control group was 83.8% (588/702) in total, i.e. 94.2% (661/702)
or AgB and 95.7% (672/702) for Em2.
.3. Diagnostic evaluation of the DIGFA for endemic community
ass screening in northwest China
When DIGFA was used in conjunction with ultrasound in com-
unity mass screening studies, it showed good sensitivity for
uman AE (90.7%) but lower sensitivity for CE (71.8%). Overall
peciﬁcity for CE was 78.1% and for AE was 97.6% based on ultra-
ound abdominal screening as the gold standard. AgB antigen had
he lowest sensitivity (51.3%) in DIGFA in comparison to ultra-
ound conﬁrmed asymptomatic human CE (n=160), while Em2
ntigen in DIGFA had a sensitivity of 77.8% for ultrasound con-
rmed asymptomatic AE cases (n=108) (Table 4). Speciﬁcity of
gB for community detected human CE was 94.6% and Em2 for
E was 97.1% in this study (Tables 5 and 6). AgB antigen in DIGFA
ave high cross-reaction 68.6% (74/108) with community ultra-
ound detected AE cases, while Em2 antigen cross-reacted with
1.3% (18/160) of ultrasound conﬁrmed CE cases.
.4. False positives and negatives
There were in total 14.6% (131/899) false negative sera among
linically deﬁned echinococcosis patients using the DIGFA test
nd these were also negative using the standard ELISA. Clinical
eatures of false negative CE cases were collapsed, degenerated,
ecrotic (Type CE4), or consolidated cysts, or calciﬁed type cysts
CE5), or single, small univesicular cysts (Type CE 1), and also small
ingle cysts deep in organ locations (WHO/OIE, 2001). A false pos-Total 172 3019 3191
Sensitivity 77.8% (84/108) (95% CI 70.0–85.6%) and speciﬁcity 97.1% (2995/3083)
(95% CI 96.5–97.6%).
itive rate of 10.4% (73/702) occurred in hospitalized persons in
XMUH without echinococcosis. These cases included simple non-
parasitic cysts, carcinoma or tuberculosis and showed no evidence
of echinococcocal cysts or lesions by ultrasound or other imaging
methods (X-ray or CT). Three cysticercosis cases treated in XMUH
were all seronegative in DIGFA and ELISA.
4. Discussion
Gold standard laboratory tests for human echinococcosis serol-
ogy are currently based on standard ELISA or immunoblot formats
using E. granulosus hydatid cyst ﬂuid antigen B for CE, and E.
multilocularis metacestode antigen Em2 or antigen Em18 for AE
(Gottstein et al., 1983, 1987; Zhang et al., 2000, 2001; Rogan and
Craig, 2002; Ito, 2002;Craig et al., 2003;Carmenaet al., 2006). Rapid
diagnostic tests for human echinococcosis would provide several
advantages, not least more practical application in resource-poor
community settings, including them as a conﬁrmatory tool dur-
ing mass ultrasound screening surveys. Dot-ELISA rapid format has
been applied in a few community based studies for human CE but
has limitations since enzyme-conjugates are difﬁcult to store and
apply in ﬁeld conditions (Zheng et al., 1986; Rogan et al., 1991; Qiao
et al., 1999).
The current study reports the most comprehensive assessment
and application of a rapid immunodiagnostic format for human CE
and AE. We show that a dot immunogold ﬁltration assay (DIGFA)
exhibited the following features: (1) the test could give a reli-
able diagnostic result within 2–3min using only 20L of serum or
40L heparinized blood, with no signiﬁcant differences observed
between serum or heparinised blood (see also Chen et al., 2005);
(2) the test thoughqualitativewas able to detect human echinococ-
cosis in approximately 80–93% of cases and differentiate human
CE and AE in about 80% of conﬁrmed cases; (3) the DIGFA proce-
dure is simple and no special training was required and therefore it
had practical value for support of both community mass screening
in conjunction with ultrasound, and for hospital-based diagnostic
conﬁrmation of echinococcosis.
Based on a panel of 1601 serum samples from advanced CE
or AE patients conﬁrmed by imaging, pathology and/or surgery
in Xinjiang Medical University Hospital (XMUH), Urumqi, China,
and control sera, overall DIGFA sensitivity was 80.7% (692/857) for
human CE and 92.9% (39/42) for human AE. The lower sensitivity
for CE in the clinical hospital setting compared with the prelimi-
nary laboratory based assessment, could be considered to be due to
the inclusion of pre-operative CE cases in the hospital setting, ver-
sus mainly post-operative sera in the archived laboratory samples.
Post-surgery CE sera may show higher overall antibody positiv-
ity when compared to pre-operative sera. Speciﬁcity of DIGFA for
human echinococcosis overall (both CE and AE) in symptomatic
hospital treated cases was 89.6% (629/702); with antigen B speci-
ﬁcity for CE at 93.4%, and Em2 speciﬁcity for AE at 90.3%.
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When the rapid test was applied to community mass screening
tudies in western China (i.e. sites in Xinjiang, Ningxia, Sichuan,
ibet), the Echinococcus DIGFA showed slightly lower sensitiv-
ty (71.8% for CE and 90.7% for AE) and speciﬁcity (74.4% for
chinococcosis in general, 94.6% with antigen B for CE, 97.1% with
m2 for AE) compared with the hospital-based DIGFA assess-
ent. Recombinant antigens (e.g. rec AgB) might be used in the
IGFA test in further assessments since they are easier to stan-
ardize, but poor stability and reduced sensitivity was found to
ccur in initial studies (X. Feng, unpublished observations). The
IGFA test was nevertheless extremely useful in these resource-
oor settings as a combined diagnostic tool in conjunction with
ltrasound. Sera could be tested within 1h of ultrasound scan
nd up to 200 sera tested in 1 day. Diagnosis of CE or AE was
ble to be conﬁrmed in more than 80% of community detected
ases using the ultrasound/DIGFA serology approach and therefore
acilitated efﬁcient clinical treatment and/or follow-up recommen-
ations.
Reasons for lower sensitivity of DIGFA in community (vs. hos-
ital settings) may be due to exposure without a detectable
bdominal cyst lesion and especially involvement of sites not ultra-
ound detectable. However, “false positive” cases are actuallymore
ommon in mass screenings performed in endemic areas than in
on-endemic areas or in hospital settings; this has been attributed
o the high proportion of asymptomatic subjects that may have
pontaneously recovered after contact with the parasite (Craig et
l., 2000; Yang et al., 2006a,b). Lower sensitivity may be related
o false positive ultrasound images and thus misdiagnosed space-
ccupying lesions (e.g., neoplasia, abscesses, non-parasitic cysts
he nature of which cannot be conﬁrmed using CT scan or MRI)
nd/or to the presence of small cysts or lesions, or degenerate,
alciﬁed, or necrotic cysts/lesions, or more generally to unde-
ectable levels of circulating antibodies depending on the number,
ize, location and condition of the cyst (Gavidia et al., 2008). The
alse negative rate of DIGFA for hospitalized CE cases was 19.3%
165/857) compared to 7.1% (3/42) for AE, while false positives
ccurred in 6.6% of CE (49/744), and in 9.7% (151/1559) of AE
ases. The DIGFA test could reliably differentiate CE and AE cases
rom each other around 80% of the time and an Em2 positive
eaction appeared in 17.1% (146/857) of CE case sera. The DIGFA
esultswere comparable to those obtainedwith the standard ELISA
sing the above four antigens respectively (false negative for CE
5.0%, for AE 2.4%, false positive for both 10.3%). In general the
tandard ELISA was less sensitive (p<0.01) but exhibited compa-
able speciﬁcity with DIGFA for human CE. The AgB preparation
rom E. granulosus hydatid cyst ﬂuid and Em2 metacestode extract
rom E. multilocularis showed reasonable speciﬁcity (90.3–97.1%)
n DIGFA for CE or AE, and were comparable to other studies
sing traditional ELISA formats. Determination of the carbohydrate
oncentration, rather than protein, may be beneﬁcial in further
ptimization of Em2 use in the DIGFA because this antigen is
ssentially a carbohydrate (Gottstein et al., 1983, 1987; Liu and
hao, 1993; Poretti et al., 1999; Carmena et al., 2006; Dai et al.,
001).
In conclusion, a robust 3min eye-read dot immunogold ﬁltra-
ion assay (DIGFA) for the rapid serodiagnosis of human cystic
CE) and alveolar (AE) echinococcosis was developed in which 4
rude or semi-puriﬁed native antigens from E. granulosus (EgCF,
gP, AgB) and E. multilocularis (Em2) were utilized simultaneously.
he E. granulosus protoscolex (EgP) and crude cyst ﬂuid (EgCF)
xtracts, provided high sensitivity for the test; while E. granulosus
artiallypuriﬁedantigenB (AgB) andE.multilocularisantigen (Em2)
nsured speciﬁcity comparable to standard ELISA. The DIGFA for-
at was used successfully in conjunction with ultrasound for mass
creenings to identify or conﬁrm asymptomatic CE and AE cases in
o-endemic communities in western China.113 (2010) 114–120 119
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999例包虫病住院患者经济负担分析
王乐冯晓辉段新宇温浩
【关键词】囊型包虫病；疾病经济负担；人力资本法
Directandindirectonomicburdenof999cystic
echinococcosispatientsna tertiaryhospitalWANGk1。
FENGXiao-hui2。DUAN施n-yu2，WENHa02．1FirstAffiliated
HospitalofXinjiangMedicalUniversity，Wulumuqi830054，
China；2Xinjia增KeyLaboratoryofHydatidFundamental
Medicine，MedicalR searchCenter，FirstAffiliatedHospitalof
XinjiangMedicalUniversgty
Correspondingauthor：WENHao，Email：dr．wenhao@163．corn
Th／swork埘c玷sup即rtedhagrantfromtheNationalNatural
ScienceFoundationofChina(刀k执4thEducationof
且矾inococcosisinNorthwestArea)(No．30520001)．
【Keywords】Cystice．chinococcosis；Economicburdef
di∞a$o；Humancapitalmethod
包虫病为人畜共患寄生虫病，在农、牧区已成为当地居
民因病致贫、因病返贫的主要原因之一。为探讨造成包虫病
患者经济负担的影响因素和卫生决策者提供参考依据，本研
究利用2004--2008年乌鲁木齐市某三级医院包虫病住院患
者资料，分析其经济负担。
1．对象与方法：调查该医院2004—2008年包虫病患者
(1022人次，其中泡型包虫病23例，囊型包虫病999例)住院
治疗费用报表。由于泡型包虫病较难根治、费用较高且例数
少，本研究着重分析囊型包虫病患者费用。应用Excel软件
建立数据库资料，数据分析采用SPSS13．0软件。统计学方
法采用方差分析、多元逐步回归，并利用伤残调整生命年
(D舡Ⅳ)与人力资本法结合估计间接经济负担。
2．结果：
(1)基本情况：患者职业以农(林、牧)民最多515例
(51．55％)，其次是干部208例(20．82％)。汉族599例
(59．96％)，维吾尔族186例(18．62％)，哈萨克族loo例
(10．Ol％)，回族53例(5．3l％)，蒙古族47例(4．70％)，其他民
族14例(1．40％)。男性527例(52．75％)，女性472例
(47．25％)。患者年龄3—83岁，其中以30一34岁年龄组为主
173例(17．32％)，20～24岁组最少为7l例(7．11％)。2004—
2008年总调查病例数为999例，除2004年外，各年病例数有
逐年上升趋势，依次为186、161、178、189和285例。
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(2)直接经济负担分析：①住院费用：不同年龄组、性别
患者平均住院费用采用均数(i)和中位数(肘)描述。≥70岁
患者人均住院费用最高为17911．90元，其次是15—30岁组
为16126．22元(表1)。②住院费用影响因素分析：将所有调
查对象的住院总费用做因子进行方差分析。结果显示年龄
(F----4．004，P=0．003)、民族(F=3．201，P=0．007)、职业(F----
2．048，P=O．047)、治疗效果(F=44．757，P=0．000)、住院天
数(F----21 478，P=0．000)、有无医保(，=12．81l，P=0．000)、
西药费(，=127．262，P=0．000)、手术费(F=31．582，P=
0．002)和检查费(F--41．265，P----0．001)对住院总费用具有
影响。
表1不同年龄组、性别包虫病患者人均住院费用(元)
O一 599367219596．829251319 84．4l9325．96541．77
15—22315798．194013．7416481．85132 5．61 6126也1377135
30一伽14478．92142913214569．4513327．4014521．173863鹏
45。1941598】．69155l9．吆15677．421 枞65158配6914945尚
60—75143呓∞8683．8715305．9013518．561479r7．6212381．87
70一．2820962∞23180．1215624．2615539．9917911．9017448．00
合计99914817．9513803．8515082．8613327．4014943．II13681．90
(3)间接经济负担分析：用DALY估算“。】。由于目前国
内尚无包虫病疾病负担相关文献。Budke等¨1将包虫病失能
权重指标D按照治疗效果分为5个等级，即治愈、好转、未愈、
恶化、死亡，分别赋值为0、0．2、0．239、0．809、l。本研究按照
临床的划分：“治愈”指经过手术治疗将包囊完整摘除且无并
发症；“好转”指患者经过一段时间的药物治疗得到有效的控
制，且经B超检测包囊明显缩小；“未愈”指医生建议进行手
术治疗或药物治疗，而患者因为经济等因素未接受，而提前
出院；“恶化”指患者接受治疗后，包囊没有缩小且引发其他
并发症。由表2可知30～34岁年龄组人数最多为173例，该
组患者DALY损失最多，合计达到261．41年。20一24岁年龄
组人均DALY损失最多为1．88年。
用DALY与人力资本法结合估算间接经济负担。是将
间接经济负担中的时间转换为货币价值，包括用工资、人均
国民收入、人均国民生产总值。本文采用DALY与人力资本
法结合的计算公式：间接经济负担=人均国民生产总值
(GNP)×DALY×生产力权重。由于各年龄组生产力不同，
其权重亦不同。0—14岁年龄组未参加社会财富创造，其权数
为0．15；15—44岁和45—59岁组分别为O．75、0．80，≥60岁又
降为0．10[，j。2004--2008年5年平均GNP为15170．6元陆】，
999例患者总间接经济负担为12032538．63元，人均间接经
济负担为12044．58元(表3)。
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表2各年龄组不同性别包虫病患者DALY的分布
表3 2004--2008{Iz999例包虫病住院患者间接经济负担
鲨竺竺鲨笺垩鲨鲨
15— 643 842．320．75 14904．949583874．84∞
45— 194 182．130．80 ll393．902210417．1018
60一 103 90．880．10 1 338．55137870．4l1
合计 9991 159．44— 12044．5812032538．63100
3．讨论：本文显示住院天数、治疗效果、有无医保、年龄、
不同职业的住院费用有统计学意义。其中，住院天数对住院
费用影响最大，二者有正比关系。治疗效果也是住院费用的
一个重要影响因素，死亡患者总费用最高(人均43972．89
元)，这可能与有些患者在病情较重时才到三级医院治疗有
关。本文还显示西药费、手术费和检查费对住院费用有影
响，其中西药费用占最大份额，可能与患者术后多有感染或
并发症，需用抗生素有关。5年该院收治囊型包虫病患者
999例，共损失DALY高达1159．45(95％CI：991．02—1327．87)
年，人均损失1．16个DALY。15—44岁组患者间接经济负担
损失达9583874．84元，人均损失1490 ．94元，均在各年龄
组之首。应根据不同年龄组的特点制定相应的政策措施，以
达到卫生资源更加优化配置。
我国目前对包虫病的研究多集中于流行病学调查分析，
尚无对其经济负担研究的报道，即使是其他病种也多集中在
直接经济负担的报道，从某种意义上说，与直接经济负担相
比，疾病的间接经济负担虽然不是社会和家庭直接的经济支
出，但却是社会劳动力有效工作时间的减少和工作能力的降
低。因此，间接经济负担更能反映出疾病对社会危害程度的
大小，是一种劳动力价值降低状况的体现。本研究中包虫病
患者均间接经济负担损失高达12044．58元，且随着GNP的上
升呈逐年上升趋势。这与用同样方法估计的陕西省汉中市脑
卒中所致农村人口间接经济负担为人均12158．40元相近n】。
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新疆和布克赛尔蒙古自治县囊型包虫病
危险因素分析
初向东 王桂芝冯晓辉 尔西丁 贺金华温浩
【摘要】 目的分析新疆和布克赛尔蒙古自治县囊型包虫病流行相关的危险因素及探讨预
防措施。方法在和布克赛尔蒙古自治县采用随机抽样方法，进行人群囊型包虫病的流行病学调
查，调查内容包括民族、年龄、性别、职业及生活习惯等，并对囊型包虫病相关的危险因素进行多冈
素logistic回归分析。结果人群包虫病患病率为3．8％，血清阳性率为12．4％，其中囊型包虫病患
病率为3．7％，泡型包虫病患病率为0．16％。通过多因素logistic回归分析。发现年龄和家庭屠宰牲
畜与囊型包虫病患病有关，OR值分别是7．6(2．481—23．579)、3．2(1．297。7．809)。50．60岁年龄
组患病率最高，OR值是<20岁年龄组的7．6倍；牧民患病率最高。结论和布克赛尔蒙古自治县
囊型包虫病呈持续高流行势态；年龄和有家庭屠宰牲畜行为与患囊型包虫病相关。
【关键词】包虫病；囊型棘球蚴病；危险因素
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【Abstract】objectiveTostudytheriskfactorsfhumancystice hinococcosis(CE)in
HobukesarMongolianAutonomousCountyofXinjiang(HMACX)andtodiSCUSStherelatedstrategies
forpreventionandcontr01．MethodsArandomizedsamplingmethodwasusedtoscreenlocal
residentsforhumanCEinHMACX．CErelatedriskfactorsincludingethnicity．age．sex，occupation
andpersonalstatusonhygienetc．wereanalyzedundermulti．factorlogisticegression．Results11lc
prevalenceratesofCEandalveolarechinococcosis(AE)were3．7％(23／627)and0．16％(1／627)
respectively．withtheseropositiverateas12．4％(76／613)．Themainriskfactorsthatsignificantly
associatedwithCEwereage(OR=7．6。95％CI：2．481—23．579)andslaughteringlivestockinthe
households(OR=3．2．95％CI：1．297—7．809)．HerdsmenhadthehighestprevalencofCEinallofthe
occupationsinthistudy．ConclusionHMACXhadbeenahighlyendemicareaforhumanCE．
withageandfamilyslaughtering．1ivestock．behaviorappearedto themainpossibleriskfactors．
【Keywords】Hydatiddisease；Cysticechinococcosis；Riskfactors
包虫病是严重危害牧区人群健康的常见人畜共
患寄生虫病，在我国西北地区广泛流行’13，主要是细
粒棘球蚴病(又称囊型包虫病，cysticechinococcosis，
CE)和多房棘球蚴病(又称泡型包虫病或泡状棘球
蚴病，alveolarechinococcosis，AE)两种包虫病拉3。
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·现场调查·
新疆地区是包虫病高发区之一，主要以CE为主，AE
为散发。3]。2001--2002年在新疆额敏县包虫病的流
行病学基线调查显示，患病率为1．3l％，血清阳性率
为25．8％HJ。为了解和布克赛尔蒙古自治县CE流行
危险因素，评价和制定预防控制措施，于2007年10
月在该县进行了相关研究。
对象与方法
1．调查地点和对象：在和布克赛尔蒙古自治县
随机抽取1个牧业乡(布斯屯格牧场)和2个半农半
牧乡(查干库勒乡、巴音傲包乡)进行人群CE感染的
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现场调查；应答率为98％。问卷、B超调查627人，
血清学调查613人；其中男性256人，女性371人；年
龄6—76岁(平均年龄28．4岁)；其中以蒙古族(166
人)和哈萨克族(383人)人群为主。
2．调查方法与内容：在实施调查前，就各种调查
工具的使用方法、注意事项进行人员培训(精通蒙古
族和哈萨克族语的当地疾病预防控制中心专业人
员)。在各调查点逐人问卷调查，包括个人一般情
况、包虫病史及可能与包虫病传播相关的危险因素
等；调查对象均知情同意。并对其进行B超腹部探
查，同时采集被调查者静脉血标本3ml，采用新疆包
虫病I临床研究所研制的“组合抗原包虫病快速诊断
试剂盒”分别检测针对抗原EgCF＼EgP＼EgB＼Em2的
特异性抗体水平，以任一抗原阳性计算血清阳性率。
3．统计学分析：应用Excel程序录入调查问卷
后，用SPSS13．0软件分析民族、职业、年龄、家庭屠
宰牲畜等生活习惯与包虫病_口J．能的相关关系；选用
logistic回归模型进行单、多因素分析，二分变量以虚
拟变量形式赋值为l和2；多分变量则用指标编码设
置虚拟变量，并以第一类为参照类，多因素分析采用
前进法建立模型，联系强度为OR。
结 果
1．基本情况：在3个乡随机调查的627人中，包
虫病患病率为3．8％(24／627)；CE患病率为3．7％(23／
627)；AE患病率为0．16％(1／627)；血清阳性率为
12．4％(76／613)。不同职业人群间CE患病率以牧民
最高为6．9％()C2----8．503，P=0．048)。见图l。发病
最小年龄为6岁，最大为76岁。
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圈l和布克赛尔蒙古自治县不同职业人群CE患病率、
血清阳性率分布
不同年龄之间人群CE患病率、血清阳性率中，
在50一60岁年龄段的患病率为lO．3％(Fisher’s：f=
14．537，P----O．005)、血清阳性率21．1％最高()C2=
20．917，P=0．001)。见图2。
2．包虫病危险因素分析：对可能影响包虫感染
<2020～ 30～40～5U～ 6U～
年龄(岁)
图2和布克赛尔蒙古自治县不同年龄、性别CE的患病率
的12个变量的赋值见表1。经过单因素logistic回归
分析显示(表2)，民族、职业、年龄、家庭屠宰牲畜和
饮用水源5个因素与包虫感染相关。单因素分析有
统计学意义的因素进行多因素logistic回归分析，剔
除不显著变量，最终进入多因素模型的包括年龄和
家庭屠宰牲畜2个因素，各变量的参数值见表3。
表1分析变量及赋值
变量 赋值
性别 l=男，2--女
年龄(岁)41=<20，2=20～，3--30一，4=40一，5--50一，6=60一
民族 l=汉，2=蒙，3=哈，4--其他
职业4 l=牧民，2=农民，3=学牛，4--干部，5--其他
文化程度4 1=文盲，2=小学，3=中学。4----高中，5----大专以上
家庭养犬 l=是，2=否
家庭养牲畜1=是，2----否
家庭屠宰 l=是，2=否
野犬 1=是，2-----否
饮用水源‘l=自来水，2----"深水井。3=浅水井。4=河塘水
饮用生水 I=是，2----否
食用牛蔬菜1=是，2---否
注：。多分类变量进行哑变量处理．以第一个为对照组
由表3可见，有2个变量进入方程，年龄和家庭
屠宰为包虫病的可能危险因素。40一50岁和50。
60岁的年龄组患包虫病的DR值分别是<20岁年龄
组的4．4倍和7．6倍；在家屠宰牲畜患包虫病的DR值
是无家庭屠宰行为的3．2倍。
讨 论
本研究显示，在和布克赛尔蒙古自治县包虫病患
病率为3．8％，CE患病率为3．7％，AE患病率为0．16％，
平均血清阳性率12．4％。较乌鲁木齐南郊农牧区居
民CE平均患病率1．12％为高【5]。因此和布克赛尔蒙
古自治县CE仍处于高发与AE散发的流行势态。
多因素回归分析证实，CE流行可能的危险因素
是年龄和家庭屠宰牲畜。随着年龄的增加患CE的
风险越大，这与王谦等[61在四川藏区人群包虫病危
险因素调查一致。本次调查年龄在50一60岁的患
病率最高为10．3％(女性11．8％，男性7．4％)，可能是
包虫病的病程很长(可达数十年)，存在一定的累积
4
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表2 CE的患病率及可疑危险因素单因素logistic回归分析
闪素 患病率(％r OR值(95％Ct)
男
女
民族
汉
蒙古
哈萨克
其他
职业
牧民
农民
学生
干部
其他
年龄(岁)
6～
20～
30～
40—
50一
60～76
养过犬
是
否
养家畜
是
否
家庭屠宰牲畜
是
否
见过野犬
是
否
饮用水源
自来水
深井水
浅井水
河塘水
饭前洗手
2．3(6／2561 2．001(0．778—5．146)
4．6(17／371)
10．5(6／57)
3．6(6／166)
2．6f10／383)
4．8(1／21)
6．9(13／189)
3．4(2／58)
1．9(6／3181
5．0(2／40)
0．0(0／22)
1．9(6／321)
O．0(0／441
6．0(4／67)
6．3(4／63)
10．3(8／78)
1．9(1／54)
O．319(0．098～1．032)
O．228(0．079～0．654)6
0．425(0．048—3．757)
O．484(0．106—2．208、
0．260(0．097～0．697)6
O．713(0．154—3．289)
0
O
3．333(0．914～12．155)
3．559(o．975—13．000)
6．000(2．018—17．841)6
O．991(0．117—8．393)
3．0(12／395)1．589m．689—3．660)
4．7(11／232)
3．6(21／586)1．380(0．312—6．099)
4．9(2／41)
2．7(13／47312．457(1．055—5．723)‘
6．5(10／154)
3．9(10／259)0．912fo．394～2．113)
3．5(13／368)
6．3(15／237)
0．0(0／61
1．9(7／360)
4．2(1／24)
0
O．293(0．118—0．731)6
O．643(o．081—5．096)
是 3．6(22／619)3．877(0．457—32．885)
否 12．5(1／8)
饮用生水
是 3．2(14／439)1．526(0．649—3．590)
否4．8(9／188)
食用生蔬菜
是 3．8(20／533)0．846(0．246—2．9041
否 3．2(3／94)
注：。括号内数据分子为患病例数，分母为调查人数；6有统计学
意义
表3包虫病危险因素多阏素logistic回1月分析
因素 ／3 靶 Wald)[z值P值O月值(95％C／)
年龄 13．870．016
I -17．15960．210 0．9980．000
2 1．1 0．67 2．96 0．0853．142(0．853～11．572)
3 1．4 0．67 4．78 0．0294．360(1．165—16．313)
4 2．0 0．57l2．54 0．0007．648(2．481—23．5791
5 0．2 1．10 0．02 0．8801．180(0．138—10．126)
家庭屠宰牲畜 1．2 0．46 6．39 0．0113．183(1．297—7．809)
堂堑巫 =§：2 Q：丝垒§：塑 Q：QQQ ：螋
病例。女性略高于男性，女性20岁以后随着年龄的
增长患病率也逐步上升；由于长期的生产、家务劳动
(放牧、剪羊毛、喂犬等)，接触虫卵机会多。但男性在
40～50岁时的患病率最低，原因可能是被调查人群
中学生和老年人较多，年龄段分布不均，存在一定的
偏倚。本次调查CE发病最小年龄为6岁，提示有新
发病例，可见包虫病流行仍很活跃。圃比应对血清学
阳性者，特别是少年儿童定期检查，早发现、早治疗。
在和布克赛尔蒙古自治县引起CE流行的另一
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危险因素是家庭屠宰牲畜。由于目前当地生产方式
落后，多直接从事畜牧业生产，75．4％的人在家屠宰
牲畜，直接把患病动物内脏喂犬，犬是囊型棘球绦虫
的主要终宿主。成年绦虫在犬体中经6～8周发育
成熟，虫卵随犬粪排出且具有传染力。当地63．0％
的人养犬，流浪犬及不栓养犬随处可见，犬粪中的虫
卵传播到空气、土壤、水源中，造成周围植被、环境的
污染，人为地促成了棘球绦虫在当地的循环链。在
调查地区，人群因生产、生活之需密切接触棘球绦虫
虫卵污染物品和环境、频繁受其感染，可能也是导致
人体血清特异性抗体持续存留的原因。有报道显示
口J，宁夏地区包虫病危险因素主要是与民族、养犬和
饮用水有关。与本次调查并不一致，其主要原因可
能是当地蒙古族以牧业为主，与长期的生产生活环
境和行为习惯有关。
综上所述，本项调查结果提示，和布克赛尔蒙
古自治县CE患病率居高不下的原因是人群的年龄
和家庭屠宰牲畜。因此应广泛开展卫生宣传教育，
进行牧犬驱虫，加强犬的管理；并对家庭牲畜屠宰
进行宣传，不要把患病的动物内脏直接喂犬，要煮熟
或深埋处理。养成良好的饮食习惯，饮用开水；同
时，查治患者，坚持疫情监测。
(感谢和布克赛尔蒙古自治县人民政府、卫生局和疾病预防控
制中心，新疆包虫病临床研究所，新疆医科大学公共卫生学院对本
项目现场调查、实验室检测及数据库建立的大力支持与帮助)
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包虫八项检查在骨包虫病诊断中的应用
刘大鹏 冯晓辉 张静萍 温浩
·临床论著·
【摘要】 目的探讨包虫八项检查在骨包虫病诊断中的应用价值和骨包虫病的诊断策略。方法
对1999年10月至2008年9月因疑似骨包虫病而行包虫八项检查的36例患者进行回顾性研究。男19
例，女17例；年龄10-67岁，平均35．9岁。采用金标渗滤法和酶联免疫法同时检测患者体内抗包虫囊液
抗原(EsCF)、头节抗原(EgP)、囊液半纯化抗原B(EgB)、泡球蚴抗原(Em2)四个抗原的抗体水平，简称
包虫八项检查。全部病例的最终诊断均经手术、病理学检查或穿刺活组织检查证实。对包虫八项检查结
果进行ROC分析，确定最佳诊断界点(阈值)，并计算灵敏度、特异度、Youden指数、阳性似然比、阴性似
然比、阳性预报值、阴性预报值。结果经病理学检查证实，36例患者中1l例确诊为骨包虫病(胸椎包
虫2例、肋骨包虫1例、腰椎包虫3例、骶骨包虫4例、髂骨包虫1例)。包虫八项检查的灵敏度为
90．9l％，特异度为92．00％，Youden指数为0．8291，阳性似然比为11．3600，阴性似然比为0．0988，阳性预
报值为83．33％，阴性预报值为95．83％。结论血清学检查是骨包虫病鉴别诊断的重要手段。包虫八项
检查诊断骨包虫病有较高的准确性。
【关键词】棘球蚴病；诊断；血清学；脊柱
【证据等级】诊断性研究Ⅲ级
ClinicalappHcationofthe8-testforimmunodiagnosisofhumanbonecystice hinococcosisLIUDa-
pe疃，FENcXiao—hui,zHANGJing-ping,et01．"DepartmentofOrthopaedicSurgery,theklrstT aching
HospitalofXinjiangMedicolUniversity,Urumqi83D()D0．China
【Abstract】0bjectiveToinvestigatetheclinicalapplicationvalueofthe8-testforimmunodiagnosis
ofhumanbonecystice hinococeosisfBCE)．MethodsAretrospectivestudywasmadein36caseswho
weresuspectedtobeBCEinourhospitalfromOctober1999toSeptember2008．Themeanagewas35．9
yearswitharangeof10to67years，andi cluding19males，17females．A11casesacceptedthe8．testim．
munodiagnosisa dthefinaldiagnosiswereconfirmedbyoperationorbiopsy．Thedotimmunogoldfiltration
assay(DIGFA)andenzymelinkedimmunosorbentassay(ELISA)wereusedtodetecttheantibodiestoanti．
gensofEgCF，EgP，EgB，andEm2inpatientsatonetimeinouresearch，thenamabbreviatedtoth8-test
forimmunodiagnosisofhumanbonecystice hinococcosis．Thesensitivity，specificity，Youdenindex．positive
likelihoodratio，negativelikelihoodratio，positivepredictivevalueandnegativepredictivevalueofthe8-test
immunodiagnosiswerecalculatedndrecorded．ResultsBeconfirmedbypathology．11ofthese36cases
werediagnoseda bonehydatidosis(including2caseswiththoracicvertebrae，lcasewithrib，3caseswith
lumbarve tebrae，4caseswithsacrum，andl casewithillum)．Thesensitivitywas90．91％，thesp cificity
was92．00％．tIleYoudenindexwas0．8291．thepositivelikelihoodratioWas“．3600．thenegativelikelihood
ratiowas0．0988．thepositivepr dictivevaluewas83．33％，andthenegativepredictivevaluewag95．83％．
ConclusionSerologicalexaminationscanbeconsideredasdiagnosisandinitialdifferentiationforBCE，the
8-testimmunodiagnosishashJighaccurateratfordiagnosinghumanBEC．It’Shelpfulforidentificationof
BCE．
IKeywords]Echinococcosis；Diagnosis；Serology；Spine
包虫病是一种常见的严重危害人体健康的人畜
共患寄生虫病，全世界均有报道，在我国许多省份都
有分布。骨包虫病少见，文献报道骨包虫病约占包虫
DOI：10．3760／cma．j．issn．0253—2352．2010．02．013
作者单位：830000乌鲁木齐，叛疆医科大学第一附属医院显微
修复骨肿瘤科(刘大鹏)；新疆维吾尔自治区包虫病临床研究所(冯晓
辉、张静萍、温浩)
通信作者：温浩．E-maihdr．wenhao@163．corn
病的O．5％-4％⋯。国内新疆报告骨包虫病例最多，
新疆骨包虫病约占全身包虫病的0．65％[2】。
骨包虫病患者病史较长，早期症状不明显，多以
病变局部不适为主。脊柱包虫病多以脊髓、马尾受
压，神经功能受损导致的麻痹为首发症状。四肢骨包
虫病多以病理性骨折为表现，疼痛往往不明显。部分
骨包虫病患者既往无肝包虫病史。血常规、红细胞沉
降率及生化检查均可正常。
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骨包虫病的X线及CT表现缺乏特异性∞】。X
线主要表现为囊性或不规则骨质破坏。在四肢易被
误诊为骨囊肿和骨巨细胞瘤。在脊柱往往表现为不
规则的椎体骨质破坏，部分病例出现椎间隙狭窄、椎
管内占位。X线表现与结核、转移癌及骨肿瘤相似，
不易鉴别[2]。
MR是最有价值的影像学检查，脂肪抑制技术
和磁共振水成像技术(MR—Hydrography，MRH)[31是
MR诊断骨包虫病常用的技术手段。MRI可显示典
型的包虫特征(外囊囊壁、多房性)H’5]，但部分患者
的MRI影像缺乏特异性。
由于发病率低，临床表现无特异性，影像学表现
和结核、肿瘤鉴别困难，因此包虫病极易误诊[2]。血
清学检查是诊断肝包虫病的重要手段之一，但对骨
包虫病的诊断价值尚不明确。本文对因疑似骨包虫
病而行包虫八项检查的36例患者进行回顾性分析，
探讨包虫八项检查诊断骨包虫病的价值以及骨包虫
病的诊断策略。
资料与方法
一、一般资料
1999年10月至2008年9月因疑似骨包虫病
而行包虫八项检查的患者36例，男19例，女17例；
年龄l晰7岁，平均35．9岁。最终诊断均经手术、病
理学检查或穿刺活组织检查证实。
11例确诊为骨包虫病：胸椎包虫2例、肋骨包
虫l例、腰椎包虫3例、骶骨包虫4例、髂骨包虫1
例；其他诊断：骨巨细胞瘤2例、动脉瘤样骨囊肿2
例、软骨肉瘤2例、骨肉瘤1例、丛状神经纤维瘤l
例、骨内腱鞘囊肿1例、神经鞘瘤l例、巨大神经根
囊肿1例、骶骨脊索瘤l例、骨转移癌2例、纵隔囊
肿1例、畸胎瘤l例、椎管内血管瘤1例、左膝关节
内侧骨坏死l例、骨髓瘤l例、椎间盘脱出2例、脊
髓中心性出血坏死1例、脊柱结核l例、腰大肌脓肿
(结核)1例，左胫骨骨髓炎1例。
二、包虫八项检查的检测方法
包虫八项免疫试剂盒由新疆维吾尔自治区包虫
病临床研究所研制。其原理是同时用金标渗滤(dot
immunogoldfiltrationassay，DIGFA)和酶联免疫(en-
zymelinkedimmunosorbentassay，ELISA)两种方法
检测患者体内抗包虫囊液抗原(EgCF)、头节抗原
(EgP)、囊液半纯化抗原B(EgB)、泡球蚴抗原(Era2)
四个抗原的抗体水平，简称包虫八项检查。具体检测
方法见参考文献[7]。
三、统计学处理
分别对金标渗滤法和酶联免疫法的检查结果进
行ROC分析(接收者工作特征曲线分析)rs]，确定最
佳诊断界点(阈值)。
计算灵敏度、特异度、Youden指数、阳性似然
比、阴性似然比、阳性预报值及阴性预报值。
结 果
一、包虫八项检查结果
包虫八项检查结果如表1所示。检查结果均为
阴性的非骨包虫病例未列入表中。
二、ROC分析
进行ROC分析时将受试者对四个抗原的检测
结果分成六个等级：0级，对四个抗原均呈阴性反
应；1级，对任意一个抗原呈阳性反应；2级，对任意
两个抗原呈阳性反应；3级，对EgCF和EgB均呈阳
性反应；4级，对任意三个抗原呈阳性反应；5级，对
四个抗原均呈阳性反应。
将数据输入SPsS13．0(spssInc．，美国)统计软
件进行ROC分析，绘制ROC曲线，计算两种方法的
曲线下面积、标准误、P值、95％置信区间(表2)。
由表2可见两种检测方法对诊断骨包虫病均有
效(非参数检验，R0．001)。分别根据各曲线离坐标
左上角距离最短的一点确定最佳诊断界点(图1)。
1．O
O．8
越0．6
罄
嘣
O．4
O．2
ROC曲线
O．0 0．2 0．4 0．6 O．8 1．0
金标渗滤法
酶联免疫法
参考线
圈1金标渗滤法和酶联免疫法的ROC曲线
两者的诊断界点确定为：检测结果I>3级，则判
定为阳性。即受试者血清至少对EgCF和EgB均呈
阳性反应，诊断为骨包虫病。此诊断界点下两种检测
方法的灵敏度和特异度如表3所示。
由表3可以看出金标渗滤法的灵敏度偏低，而
特异度较高。为进一步提高诊断的灵敏度。在诊断过
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表l本组病例的包虫八项检查结果
注：。为骨包虫病患者
程中对两种检测方法采用并联策略，两种检测方法
中任意一种方法的检测结果I>3级，即判定为阳性。
以此诊断标准对患者进行诊断，结果如表4所示。
敏感度、特异度、阳性似然比、阴性似然比、阳性
预报值和阴性预报值如表5所示。结果显示将两种
检测方法并联后灵敏度提高，特异度无明显下降。
讨 论
一、血清学检查是鉴别诊断的蕈要手段
在影像学检查不能作出明确诊断时，血清学检
查是鉴别诊断的主要手段。如本组病例18髂骨腺癌
骨转移患者的MRI和骨包虫病(图2)非常相似。病
表2两种检测方法的ROC分析结果
表3两种检测方法的灵敏度和特异度
检测方法 灵敏度 1一特异度 特异度
金标渗滤法0．724 0．040 0．960
酶联免疫法0．909 0．080 O．920
表4包虫八项检查诊断试验结果
注：四=真阳性，FP=假阳性，TN=真阴性，FN=假阴性
表5将金标渗滤法和酶联免疫法并联后
诊断试验的各项指标
例1l骶骨脊索瘤的MRI表现与病例8和病例25
骶骨包虫的MRI表现(图3，4)非常相似，病例33
肋骨丛状神经纤维瘤的CT和MRI表现与病例19
肋骨包虫(图5，6)非常相似。依据影像学鉴别非常
困难。但病例18、病例11及病例33的包虫八项检
查结果提示可以排除骨包虫病。
二、包虫八项检查对骨包虫病的诊断价值
包虫病特异性抗体检测的方法包括皮内试验
(IDT，Casoni试验)、间接血凝试验(IHA)、对流免疫
电泳(CIEP)、酶联免疫吸附试验(ELISA)和金标抗
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圄2男，4l岁，脊柱危状嘶MRI显示椎旁
和腰大肌中多个高信号的圆形子囊
图3病例25，男，43岁，骶骨包虫矢状面MRI
显示骶骨病灶中等信号，病灶侵入周围
软组织，与肿瘤不易鉴别
图4病例8．男，44岁，骶骨包虫灭状回MRI显示骶管
和骶前病灶(箭头所示)，中等信号．缺乏特异性
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图5病例19，女，20岁，肋骨包虫CT显示肋骨
病变膨胀性生长，破坏骨质，内有分隔
圈6病例19，肋骨包虫的MRI显示肋骨病灶膨胀
性，￡长，内有多个囊性病灶
体等[7,9,10】。皮内试验、间接血凝试验和对流免疫电泳
俗称包虫三项。使用的抗原是从包虫囊液中提取的
粗抗原，非纯化的包虫特异性抗原，假阳性率高；且
多采用单一抗原，无放大效应，敏感性不高，假阴性
率也高。包虫八项检查可避免由于同一患者对不同
抗原的反应性不同而造成的假阳性或假阴性【7】，增
加了检出率。
本研究中，包虫八项检查对骨包虫病诊断的灵
敏度为90．91％，特异度为92．00％，与付艳等川在大
样本肝包虫病研究中的结果相近(敏感度92．61％，
特异度91．89％)。包虫八项检查中采用的两种检测
方法ROC曲线下面积均达到0．9以上，各项评价指
标均显示包虫八项检查对骨包虫病的诊断有较高的
价值。
机体对包虫的免疫反应与包囊的完整性、包虫
的活力和包囊位置有关。包囊完整较包囊破裂患者
的免疫反应轻，包囊破裂可引起过敏性休克导致患
者死亡。如果包虫衰老、包囊钙化或包虫死亡，血清
学检查常为阴性。一般认为肝包虫病的免疫反应比
肺包虫病、脑包虫病和脾脏包虫病强。但
Lightowlers和Gottstein[ill认为骨包虫病往往表现出
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更强烈的免疫反应，可能是由骨包虫没有纤维包膜，
包虫组织和机体接触较多所致。由于本组病例较少，
还无法证实这一观点。如果确实如此，将有利于血清
学检查诊断骨包虫病。
三、诊断界点和诊断策略
人体对包虫病灶的免疫反应越强烈，体内的抗
体水平就越高，血清学检查中呈阳性反应的抗原种
类就越多，对每种抗原的抗体滴度也越高。在实际工
作中，并非所有骨包虫病患者对四种抗原均呈阳性
反应，同时非骨包虫病患者也会对某一种或几种抗
原呈阳性反应(假阳性)。因此确定诊断界点是关键。
进行ROC分析按照呈阳性反应的抗原数的多
少对患者的检查结果进行分级。级别的高低一方面
反映了免疫反应的强弱，另一方面也反映了检查结
果特异度的高低。
本研究将患者的检查结果划分为六个等级。如
果进一步细分，第2级可以根据特异度的高低再分
为六个等级(对四个抗原中任意两个呈阳性反应)。
根据以往的试验结果，在细分的六种组合中，EgCF
和EgB两者的组合特异度最高，为了便于分析将其
从第2级中抽出细分为第3级。这样可以解决在第
2级中特异度相差太大、分级不够细的问题，也可以
避免无意义的过多分级。诊断性试验的结果也证实
这一诊断界点比较理想，灵敏度和特异度均达到
90％以上。
四、如何正确分析包虫八项检查结果
本组病例为一特定人群，即“在我院就诊的疑似
骨包虫病的患者”，其阳性预报值和阴性预报值(分
别为83．33％和95．83％)与针对总体人群时不同。当
针对总体人群时，计算包虫八项检查诊断骨包虫病
的阳性预报值和阴性预报值应知道总体人群患病
率口]。但骨包虫病的人群患病率未见文献报道，只能
根据特定地区的包虫病的患病率来推算。新疆各农
牧区的包虫病患病率为l％一5％[1k123，骨包虫病约占
其中的0．65％，推算骨包虫病患病率为0．0065％-
0．0325％，包虫八项检查诊断骨包虫病的阳性预报
值为0．073810％--0．362405％。由于骨包虫病的患病
率很低，所以包虫八项检查对于总体人群的阳性预
报值不高，对从总体中随机抽取的样本诊断价值不
高。因此在临床工作中，用包虫八项检查诊断骨包虫
病，必须结合患者的病史、临床和影像学表现，不能
单纯依靠包虫八项检查结果。
对包虫八项检查结果进行具体分析时，应注意
EgCF和EgP是粗抗原，其检测结果敏感度高，但易
引起假阳性；EgB是部分纯化抗原，其检测结果的敏
感度略低，但特异度较高。理论上说Era2用亲和吸
附的方法去除泡球蚴和棘球蚴中相同的抗原组分而
保留下来泡球蚴特异性抗原组分，也是一种纯化抗
原u31，可根据抗体反应梯度和显色程度对泡球蚴病
作出鉴别诊断。但付艳等(71观察到部分肝细粒棘球
蚴多子囊患者也对Era2有较强的反应，因此对此类
患者要结合影像学检查等手段来明确诊断。本研究
中骨包虫患者的Em2抗体阳性率也较高，可能与
Em2抗原的选择性不强有关。
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·现场调查·
2007年新疆和布克赛尔蒙古自治县棘球蚴病现况调查
王桂芝冯晓辉初向东 尔西丁 阿米娜周吉霞王巧 贺金华 温浩
【摘要】目的了解2007年新疆和布克赛尔蒙古自治县人群棘球蚴病主要流行现状及其分布特征。方法
采用整群抽样方法，在该县抽取铁布肯乌散乡、那f：和布克牧场2个地区的居民，用问卷调查、血清免疫学和B超
检查等方法进行人群棘球蚴病流行病学现况凋查。结果调查人群B超及手术史检出的棘球蚴病患病率为9．0％
(64／712)，虹清学阳性率为15．6％(11l／712)，其中细粒棘球蚴病患病率为8．7％(62／712)，多房棘球蚴病患病率为
0．3％(2／712)。不同职业、年龄、家庭屠宰牲畜和饮用水源的人群细粒棘球蚴病患病率．差异有统计学意义(P<
0．05)，其中职、世以牧民患病率(13．4％(27／201)】最高，年龄以20～(40岁年龄组人群患病率最高(12．8％)，但不
同性别、民族及文化程度人群细粒棘球蚴病患病率和m清学阳性率差异无统计学意义(P>0．05)。结论细粒棘
球蚴病在该地Ⅸ高度流行，职业、年龄及饮用水源可能是其主要的危险冈素。
【关键词】 棘球蚴病； 流行病学； 数据收集
EpidemiologiealstudyonhumanechinococcosisinHobukesarMongolianAutonomousCountyofXinjiang
WANGGui-zhi’，FENGXiao·hui，CHUXiang-dong，ERXIDING，AMINA，ZHOUJi—xia，WANGQioo， E^n—hua，
WENHao． "XinjiangHydatidClinicalResearchInstitute，TheFirstAffilimedHospital，Xi面iangMedicalOnivemi@，
Urumqi83001，，China
Correspondingauthor：FENGXiao—hui，Email：feng_xh_cn@yahoo．com．cn
【Abstract】0bjectiveToinvestigatethecharacteristicsanddistributionofhumanechinococcosisin
HobukesarMongolianAutonomousC nty(HMAC)inXinjiang．MethodsUsingclustersamplingmethods，the2
counties(TiebukenwusaandNarenhebuke)inHMACwerechosenasfocusingareasforinvestigation．Asurveyofhuman
echinoeoceosisincludingquestionnaire．serologicaltestandabdominaluhrasonicscanwascarriedout．ResultsThe
prevalenceofhumanechinococcosiswas9．0％(64／712)byultrasoundandSO嚼calhistory，including8．7％(62／712)for
cystice hinococcosis(CE)，0．3％(2／712)foralveolareehinococcosis(AE)and15．6％(111／712)fortotalofserological
positivesinHMAC．CEprevalencerateofdifferentoccupations，age，familyslaughteringlivestockandrinkingwater
sourcehadsignificantdifferences(P<0．05)．HerdsmenasthehighestiskgroupshowedaCEprevalenceofth13．4％
(27／201)incomparisonwiththeroccupations．Theagesbetween20to<40year-oldwereatthehighestriskstage
with12．8％incidence．ButCEprevalencerateofdifferentg nder．ethnicandeducationgr upshadnotsignificant
differences(P>0．05)．ConclusionsHMACcouldbeconsideredasahi【ghendemichumanCEregioninXinjiang．
Thecurrentstudyreportedhemainriskfactorsmayincludeoccupations，agediffer ncea drinkingwatersource．
【Keywords】Echinoeoceosis；Epidemiology；Datacollection
棘球蚴病(Echinococcosis)是由棘球属绦虫的
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作者单位：83001l岛鲁木齐．新疆医科大学第一附属医院包虫
病临床研究所f王桂芝(现在新疆医科大学公共l!生学院流行病学
与Ii生统计学教研室学习)、冯晓辉、温浩]；新疆和布克赛尔蒙古自
治县疾病预防控制巾心(初向东、贺金华)；新疆医科大学公共卫生
学院流行病学与卫乍统计学教研室(尔四丁、阿米娜、周吉霞、王巧)
作者简介：王桂芝(1974一)，女，安徽省毫州市人．硕七研究生．
主要从事医学统计学T作．Email：wang．gzddCmyahoo．com．cn
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幼虫寄生于人、畜体内引起的一种严重危害人群健
康和畜牧业发展的人畜共患寄生虫病。我国西北地
区，尤其新疆北部牧民感染细粒棘球蚴病(CE)的相
对危险性较高Ll引。1990年新疆疾病预防控制中心
在新疆12个地(州)，85个县(市)，共调查了15289
例患CE的医院病例．发现和布克赛尔蒙古自治县
发病率为30．17／10万，是CE的高发病区。为了解
和布克赛尔蒙古自治县防治CE现状．2007年3月
作者在该县开展了人群棘球蚴病流行病学调查，结
果报道如下。
l对象与方法
1．1调查对象：采用整群抽样方法，选择和布克赛
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尔蒙古自治县的铁布肯乌散乡(简称铁乡)和那仁
和布克牧场(简称那牧场)作为调查点，在每个调查
点抽取长期居住(>4年)并对此次调查知情同意
的居民，共712人作为调查对象，其中男337人，女
375人；平均年龄34．9岁(范围为7—77岁)；民族
构成为：汉族64人、蒙古族408人、哈萨克族237
人。维吾尔族3人；职业分布为：牧民303人、农民
201人、干部36人、学生160人、其他职业12人。
1．2调查内容
1．2．1问卷调查：由经过统一培训的疾病预防控制
人员(精通蒙古语、哈萨克语)对被调查者进行问卷
调查。问卷内容包括人员的基本信息．与棘球蚴病
相关的手术史、生产、生活行为等。
1．2．2人群棘球蚴病调查：采用便携式B超(GE
LOGOXP型)对被调杏者进行腹部检查。结果分为
正常、CE、多房棘球蚴病(AE)、可疑、钙化、其他6
种，存档并分析棘球蚴病的患病率。采集调查对象静
脉血3ml，静置1h后2000×g离心10min，分离
血清备用，用新疆棘球蚴病临床研究所研制的组合
抗原棘球蚴病快速诊断试剂盒．分别针对抗原
EgCF、EgP、EgB、Em2的特异性抗体进行检测．任意
一种抗原阳性即判定调查对象为血清学阳性。用以
计算血清学阳性率。
1．3统计方法：应用Excel程序进行资料输入，
SPSS13．0软件对数据进行x2检验或Fisher’S确切
概率法分析。
2结果
2．1人群棘球蚴病患病情况调查：712例调查对象
中，经B超及手术史检出棘球蚴病患者共计64人。
患病率为9．0％(64／712)；而血清学检验阳性111
人，阳性率为15．6％(111／712)，其中CE患者62人，
AE患者2人。
2．2不同性别、民族、职业之间人群CE患病率、血
清学阳性率比较：不同性别人群间CE患病率、血
清学阳性率未见明显改变(x2值分别为0．50、0．54，
P>0．05)；本次调查因维吾尔族的样本数太少．因
此只分析了汉、蒙、哈各民族间人群CE患病率和血
清学阳性率，经统计未见明显改变(x2值分别为0．77、
2．75，P>0．05)；职业方面．因f部和其他职业的样
本数较少，因此只分析了牧民、农民和学生间人群
CE患病率和血清学阳性率．其中牧民明显高于农
民和学生(x2值分别为13．24、10．02，P<0．05)。见
表l。
2．3不同年龄组人群CE患病率、血清学阳性率比
较：不同年龄组人群CE患病率和血清阳性率组间
比较，差异有统计学意义(x2值分别为11．02、15．45，
P<0．05)，其中20～<40岁和60一岁年龄组较
高，见表2。在20～<40岁年龄组两性的患病率相
近，而在其他年龄组男性略高于女性，见图1。
表1和布克赛尔蒙古自治县人群CE感染情况调查
Table1 PrevalenceofhumanCEseropositivesinHMAC
注：()内数字为百分数；a：5例中4例是有既往病史．其中3例
有过手术史。2例此次检查复发；b：商人、家庭主妇因样本数少。而
合并为其他．其中的3例患者均有既往手术史
表2和布克赛尔蒙古自治县不同年龄人群
CE感染情况调查
Table2 PrevalenceofhumanCEindifferent
agegroupsinHMAC
注：()内数字为百分数
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圈1和布克赛尔蒙古自治县不同年龄、性别人群CE患病情况
Figure1 PrevalenceofhumanCEindifferent
age-SeXgmupsinHMAC
2．4 2个调查点之间人群CE患病率、血清阳性率
比较：那牧场的患病率[12．0％(30／251)]较铁乡
[6．9％(32／461)]明显增高(x2=5．13，P<0．05)；血
清学阳性率分别为13．5％(34／251)、16．7％(77／461)，
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表3和布克塞尔蒙古自治县人群CE感染的相关因素调查结果
Table3 Correlationnalysison nfectionrateofhumanCEinHMAC
注：()内数早为百分数
二者间未见明显改变(x2=1．23，P>0．05)。
2．5饮水、职业、民族等相关因素人群CE患病率、
血清学阳性率比较：当地居民只有40．7％(290／712)
饮用自来水，而农民明显高于牧民，牧民饮用河塘
水和溪水较多，且有66．2％(133／201)的人习惯饮用
生水。不同饮用水源中饮用溪水人群的患病率最
高，相关冈素中家庭屠宰牲畜者牧民高于农民、蒙
古族高于汉族；而养犬、饲养家畜率的民族、职业组
间比较，差异无统计学意义(P>0．05)。见表3。
3讨论
3．1棘球蚴病的流行与分布：调查表明，该地区为
CE高发区，其中那牧场的新发病率为4．4％(11／251)。
高于Wang等。3一调查结果(2．7％)，也明显高于2005
年国内12省(区)的牧区和半农半牧Ⅸ的棘球蚴
病患病率(1．1％)及血清学阳性率(12．0％)⋯。当地
CE总患病率较高，此次有CE手术史患者亦高达
6．2％(44／712)，但在该乡的生产、生活习惯方面，如
在家宰杀牲畜率、游狗率和饮用生水率等CE危险
因素都较低．可能与该牧场居民在前次流行病学调
查中接受健康教育，改变了不良生活习惯有关。CE
新发病例的存在，说明该地区CE的传播链依然存
在，仍然处于高流行状态。
3．2棘球蚴病流行的相关因素：此次调查中发现，
男性总患病率略高于女性，与青海省棘球蚴病流行
病学分析中女性患病较高。5一的特点不同．其原因可
能是该地区以牧业为主，男性多从事放牧劳动。与
狗、牲畜接触较多。宰杀家畜，接触病原体机会也较
多．因此易受感染。
该地区人群棘球蚴病血清学阳性率和患病率
均较高．通过相关危险行为分析．可能与当地以牧
业为主，造成整个生活环境污染有关，职业、年龄、
家庭屠宰、饮用水源、饮用生水是当地主要危险因
素，尤其职业分布，与相关文献描述一致耐]。当地牧
民的患病率最高，家庭屠宰牲畜率明显高于农民，
饮用河塘水和溪水较多，只有22．4％(45／201)饮用
自来水，且有66．2％(133／201)的人习惯饮用生水。
本次调杏结果显示人群棘球蚴病在和布克赛
尔蒙古自治县的高发态势仍持续存在。建议应加强
新疆牧业地Ⅸ棘球蚴病防治力度，特别是在该地区
引导人们改变不良日常生活习惯和注意饮食卫生
知识的宣传及水源治理，以便降低棘球蚴病的感染。
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流行性出血热的护理
李霞刘慧敏任奉欣
【关键词】 肾综合征出血热； 观察； 护理
流行性出血热是野鼠中流行的一种
自然疫源性疾病．在我国东北地区12月
至次年2月为流行高峰。“。目前，对本病
尚无特殊治疗方法．根据多年的临床经
验和护理体会．流行性出血热治疗和护
理的关键在于发热期进行恰当的液体疗
法及免疫治疗：低血压少尿期需积极扩
容．恢复有效血容量：采取综合性利尿措
施．防止肺水肿．纠正酸中毒及电解质紊
乱，及时发现并预防并发症的出现。
1对象与方法
1．1对象：以2006—2008年黑龙江省医
院收治的流行性出血热患者48例作为
观察对象，其中男39例，女9例，年龄范
围为23～52岁。
1．2方法
1．2．1发热期的护理：早期卧床休息，创
造舒适、安静的环境．减少噪声．减少对
病人的刺激．予以高热量、高维牛素、易
消化饮食。随时观察体温的变化。特别是
高热的患者，体温过高时应及时采取物理
降温。由于此病有毛细血管中毒性损害．
故不宜用酒精擦浴．尽鼋少用解热镇痛药，
定期测量血压。患者发热后期多汗、J缸液浓
缩．应鼓励病人多口服补液．必要时给予
低分子右旋糖酐等防止休克和保护肾脏。
1．2．2低血压期的护理：严密观察血压
的变化，每30min测血压、脉搏1次，并
做好记录及时报告医生；注意补液速度，
DOI：10．3760／t’m叫．issn．1000_4955．2009．
02．028
作者单位：黑龙江省医院血液透析科(李
霞、刘慧敏)；哈尔滨市第五医院骨九科(任奉
欣)
作者简介：李霞(1971一)，女，黑龙江省哈
尔滨市人．主管护师，主要从事血液净化学及
肾脏病学的专科护理研究
低血压早期应快速补液。必要时加粗针
头或多静脉通道．但对老年体弱及心、肾
功能不全者，速度应适当放慢，减少用量
以防止肺水肿的发生：准确记录24h尿
量．尽早发现少尿倾向；低血压期患者注
意保暖，禁止搬动。
1．2．3少尿期的护理：少尿期应注意尿
量每日<1000ml即为少尿倾向，<500
ml为少尿期。<100ml为无尿期，注意
观察尿量变化和尿的颜色、性质。严格记
录液体出入量．以量出为人为原则。此时
严格控制进液量，给予足够热量，以口服
为主。输液时要注意保护血管。穿刺点由
远心端向近心端循序渐进．避免针头穿
破血管或液体漏出m管．以免因凝血机
制障碍而加重皮肤下出血淤血；导泻的
病人．必须记录大、小便的次数、量和性
质，并保持床单干燥清洁；加强口腔护
理．做口腔护理时动作要轻．仔细检查口
腔黏膜有无溃疡、义齿、龋齿等。
1．2．4多尿期护理：认真记录出入量，注
意水及电解质平衡。本病多尿期的尿量
一般每日>3000ml为依据．此时鼓励
患者食用营养丰富、易消化、含钾量较高
的饮食，对严重贫血者可酌情输入新鲜
血液。尿量每日>3000m1．补钾时应以
口服为主．必要时可缓慢静脉滴人，同时
注意钠、钙等电解质的补充。对尿量每日
>5000ml者．可试用双氢克尿塞、去氧
皮质酮、垂体后叶素、消炎痛等。由于免
疫功能低下，应注意预防感染。注意病室
内空气消毒．特别是加强口腔及皮肤的
护理。
1．2．5恢复期的护理：加强营养，高蛋
白、高糖、多维生素饮食。注意休息，一般
需l一3个月左右，应逐渐增加活动量，
重型病例可适当延长时间。
·简手艮·
1．2．6并发症的护理：①观察是否有鼻
出血、咯血、呕血、便血：是否有烦躁不
安、面色苍白、血压下降、脉搏增快等休
克的表现。根据出血部位的不同给予相
应的护理，并按医嘱给予止血药。②心
衰、肺水肿患者，应减慢输液或停止补
液。半卧位。注意保暖。氧气吸人保持呼
吸道通畅。③脑水肿发生抽搐等中枢神
经系统并发症时，应镇静、止痉脱水．注
意观察疗效。④高血钾病人静注葡萄糖
酸钙时宜慢。输注胰岛素时应缓慢静滴，
随时观察病人的生命体征，必要时町血
液透析治疗。⑧进行预防流行性出血热
的宣教，特别是宣传个人防护及预防接种
的重要性和方法．以降低本病的发病率。
向病人及家属说明。本病恢复后，肾功能
恢复还需较长时间，应定期复查肾功能、
血压、垂体功能，如有异常及时就医。
2结果
针对流行性出血热各期的特点．运
用护理程序．实施整体护理．明显地提高
了治疗效果，有效地预防了并发症的发生。
共治愈患者46例。2例危重型患者死亡。
3讨论
流行性出血热因各期治疗原则截然
不同．且各期也有交叉重叠．并发症严重
等而成为流行性出血热护理的难点．对
流行性出血热的病人实施整体护理，通
过护士严密观察病情．能及早发现病情变
化．积极配合医生进行危重病人抢救及护
理．预防并发症的发生，提高了治疗效果。
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